Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3051714	p-fidd	mg/l (mg/l)	62184	111599	0.63%
3051714	p-fidd	— (—)	31059	41685	100.00%	Distribution not available
3051714	p-fidd-o	mg/l (mg/l)	10921	13478	0.00%
3051714	p-fidd-o	— (—)	2616	2962	100.00%	Distribution not available
3051714	p-fidd	mg/L (mg/l)	2345	2603	0.00%
3051714	p-fidd	mg/l______ (mg/l)	1980	2714	0.00%
3051714	b-fidd	mg/l (mg/l)	1353	1741	0.00%
3051714	b-fiddp	mg/l (mg/l)	704	776	0.00%
3051714	p-fidd-lb	mg/l (mg/l)	613	808	0.00%
3051714	oma-b-fidd	mg/l (mg/l)	349	393	0.00%
3051714	b-fidd	— (—)	334	396	100.00%	Distribution not available
3051714	b-fidd-o	— (—)	331	378	100.00%	Distribution not available
3051714	p-fidd	mg/L_(FEU) (mg/l)	325	417	0.00%
3051714	b-fidd-o	ug/ml (mg/l)	303	440	0.00%
3051714	p-fiddpik	mg/l (mg/l)	275	310	0.00%
3051714	b-fidd-o	mg/l (mg/l)	273	317	0.00%
3051714	p-fidd-o	mg/l______ (mg/l)	172	214	0.00%
3051714	p-tkfiddo	— (—)	158	180	100.00%	Distribution not available
3051714	p-tkfiddo	mg/l (mg/l)	146	191	0.00%
3051714	p-fidd	ug/ml (mg/l)	125	149	0.00%
3051714	b-fidd-pt	mg/l (mg/l)	124	142	0.00%
3051714	p-fiddpik	— (—)	122	130	100.00%	Distribution not available
3051714	b-fiddp	— (—)	110	121	100.00%	Distribution not available
3051714	fibriinind-dimeerit,pikatesti(b-fidd-o)	mg/l (mg/l)	63	73	0.00%
3051714	fiddpika	— (—)	58	80	100.00%	Distribution not available
3051714	p-fidd-lb	— (—)	54	60	100.00%	Distribution not available
3051714	fibriinind-dimeerit,pikatesti,veri(23283b-fidd-pt)	mg/l (mg/l)	52	59	0.00%
3051714	b-fidd-pt	— (—)	52	56	100.00%	Distribution not available
3051714	b-fidd	ug/ml (mg/l)	52	64	0.00%
3051714	b-fidd-o	ug/mL (mg/l)	51	57	0.00%
3051714	fibriinind-dimeerit,pikatesti(fidd-o)	mg/l (mg/l)	40	42	0.00%
3051714	oma-b-fidd	— (—)	32	34	100.00%	Distribution not available
3051714	p-fidd-os	— (—)	25	28	100.00%	Distribution not available
3051714	b-fidd-pika	mg/l (mg/l)	25	27	0.00%
3051714	p-fidd	MG/L (mg/l)	25	30	0.00%
3051714	b-fidd-p	mg/L (mg/l)	24	27	0.00%
3051714	p-fiddp	mg/l (mg/l)	20	33	0.00%
3051714	fibriinind-dimeerit,plasmasta(p-fidd)	— (—)	19	19	100.00%	Distribution not available
3051714	fibriinind-dimeerit,plasmasta(p-fidd)	mg/l (mg/l)	19	19	0.00%
3051714	p-fiddhoi	— (—)	18	19	100.00%	Distribution not available
3051714	p-fiddhoi	mg/l (mg/l)	17	17	0.00%
3051714	fibriinind-dimeerit,pikatesti(3939b-fidd-o)	mg/l (mg/l)	16	16	0.00%
3051714	p-fidd-hoi	— (—)	15	17	100.00%	Distribution not available
3051714	fibriinind-dimeerit,plasmasta(4113p-fidd)	— (—)	13	15	100.00%	Distribution not available
3051714	p-fidd-ospkl	mg/l (mg/l)	11	12	0.00%	Distribution not available
3051714	b-fidd	mg/L (mg/l)	10	12	0.00%
3051714	fibriinind-dimeerit,plasmasta(4113p-fidd)	mg/l (mg/l)	10	11	0.00%
3051714	fibriinind-dimeerit,plasmasta(fidd)	— (—)	10	10	100.00%	Distribution not available
3051714	fibriinind-dimeerit,plasmasta(fidd)	mg/l (mg/l)	10	10	0.00%
3051714	fibriinind-dimeerit,pikatesti(b-fidd-o)	— (—)	9	10	100.00%	Distribution not available
3051714	p-fidd-poc	mg/l (mg/l)	8	9	0.00%	Distribution not available
3051714	p-fidd-hoi	mg/l (mg/l)	7	7	0.00%	Distribution not available
3051714	p-fidd-p	mg/l (mg/l)	7	7	0.00%	Distribution not available	Distribution not available
3051714	fibriinind-dimeerit,pikatesti,veri(3939b-fidd-pt)	mg/l (mg/l)	7	7	0.00%
3051714	p-fidd-po	MG/L (mg/l)	7	7	0.00%	Distribution not available	Distribution not available
3051714	fibriinind-dimeerit,pikatesti,veri(23283b-fidd-pt)	— (—)	6	6	100.00%	Distribution not available
3051714	p-fidd-po	— (—)	5	6	100.00%	Distribution not available	Distribution not available
3051714	p-fidd-poc	— (—)	5	5	100.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Injuries to the head

18113

80892

1.43

323.31

1.9

1.8

1.20

1.19

mg/l

0.09

13983

62256

Other neurological diseases

11257

61410

1.57

322.26

2.1

1.7

1.24

1.31

mg/l

1.00

8839

48025

Other anxiety disorders

7974

44728

1.72

322.23

2.0

1.8

0.95

1.06

mg/l

2.34

5871

33919

Disorders of eyelid, lacrimal system and orbit

14080

75309

1.50

321.86

1.9

1.8

1.11

1.24

mg/l

4.70

10929

58486

Genitourinary diseases

8451

27416

1.70

320.35

2.0

1.8

1.28

1.21

mg/l

0.78

6484

20723

Selective serotonin reuptake inhibitors

15667

59739

1.47

319.29

1.8

1.11

1.27

mg/l

5.34

11853

46315

Conduction disorders

4441

20108

2.06

319.20

2.2

1.6

1.42

1.45

mg/l

0.20

3473

15858

Diaphragmatic hernia

5739

35494

1.90

318.91

2.0

1.7

1.29

1.32

mg/l

0.20

4566

27905

Psychiatric diseases

15288

55916

1.48

318.54

1.9

1.8

1.13

1.26

mg/l

4.24

11680

43464

Presence of cardiac and vascular implants and grafts

6570

30391

1.81

316.35

3.0

1.6

1.44

1.49

mg/l

0.46

5259

24030

Hypertensive Heart Disease

3530

14097

2.24

312.39

1.9

1.6

1.53

1.50

mg/l

0.12

2854

10897

Other enthesopathies

4696

27509

1.99

311.79

1.8

1.7

0.94

1.23

mg/l

7.46

3594

21382

Chronic sinusitis

6976

45222

1.76

311.39

1.9

1.8

1.01

1.22

mg/l

5.78

5325

35041

Myocardial infarction, strict

6438

28541

1.81

310.95

2.3

1.6

1.43

1.48

mg/l

0.56

5217

22526

Nutritional anaemias

7940

50453

1.70

310.48

2.4

1.7

1.44

1.32

mg/l

1.88

6330

39450

Conjunctivitis (acute, non atopic), including avohilmo

16215

73043

1.45

310.30

1.9

1.8

1.03

1.24

mg/l

14.11

12400

56435

Other disorders of skin and subcutaneous tissue

11633

70225

1.54

308.13

2.0

1.7

1.24

1.26

mg/l

0.22

9273

54563

Allergic asthma (mode)

3777

19591

2.21

307.65

2.0

1.6

0.95

1.09

mg/l

1.74

2892

14609

Symptoms and signs involving the skin and subcutaneous tissue

12583

78825

1.72

307.65

2.0

1.8

1.07

1.23

mg/l

5.58

9692

61096

Asthma (mode)

15058

38941

2.47

307.65

2.0

1.6

1.01

1.18

mg/l

7.52

11706

29580

STROKE

8882

35688

1.94

307.65

2.4

1.6

1.27

1.18

mg/l

1.38

7025

27784

Angina pectoris

8885

34336

2.01

307.65

2.0

1.6

1.11

1.42

mg/l

16.66

7065

27068

Coagulation defects, purpura and other haemorrhagic conditions

3551

18466

2.48

307.65

3.2

1.8

1.70

1.21

mg/l

7.75

2877

14258

Major coronary heart disease event excluding revascularizations

9501

37105

1.97

307.65

2.3

1.6

1.31

1.42

mg/l

2.25

7591

29226

Gastrointestinal diseases

9762

30080

1.81

307.65

2.0

1.6

1.14

1.10

mg/l

0.37

7361

22558

Accidents

12761

44357

1.57

307.65

1.9

1.8

1.13

1.22

mg/l

2.04

9814

34070

Fall on same level

19200

73113

1.53

307.65

2.0

1.8

1.16

1.17

mg/l

0.18

14940

55842

Acute sinusitis

9074

52850

1.78

307.65

2.0

1.7

0.97

1.15

mg/l

6.85

6855

40586

Other disorders of fluid, electrolyte and acid-base balance

5234

27635

2.14

307.65

2.1

1.7

1.56

1.36

mg/l

2.69

4300

21519

Obesity, other/unspecified

6080

36734

1.98

307.65

2.1

1.8

1.01

1.08

mg/l

0.93

4850

28071

Mycoses, including avohilmo

15308

84059

1.52

307.65

1.9

1.8

1.03

1.22

mg/l

12.40

11654

64831

Persons encountering health services for specific procedures and health care

19026

74045

1.71

307.65

2.2

1.7

1.42

1.09

mg/l

22.20

15252

56061

Pulmonary heart disease

7038

27296

4.00

307.65

2.7

1.7

2.45

1.25

mg/l

68.88

5995

21311

ILD differential diagnosis

13655

38941

2.02

307.65

2.0

1.6

1.15

1.18

mg/l

0.42

10618

29580

Other acute lower respiratory infections

9553

55066

1.93

307.65

2.2

1.8

1.12

1.27

mg/l

4.01

7449

42340

Implicit viral Sepsis

4183

18705

3.02

307.65

3.0

1.6

1.46

1.24

mg/l

3.02

3468

14365

Obesity due to excess calories

8682

53157

1.94

307.65

2.0

1.8

1.07

1.11

mg/l

0.60

6903

40706

Asthma-related pneumonia

7100

35369

2.54

307.65

2.3

1.8

1.21

1.38

mg/l

4.05

5818

27386

Diseases of arteries, arterioles and capillaries (FINNGEN)

4258

10701

3.60

307.65

2.3

1.4

1.59

0.85

mg/l

27.50

3508

8159

Episodal and paroxysmal disorders

19894

61370

1.88

307.65

2.0

1.7

1.02

1.31

mg/l

22.54

15152

47220

Sleep apnoea

16769

67853

1.79

307.65

1.9

1.8

0.97

1.25

mg/l

28.06

12992

52727

Soft tissue disorders

19446

54911

2.13

307.65

2.0

1.7

1.03

1.31

mg/l

23.78

14875

41913

Provisional assignment of new diseases of uncertain etiology

12375

56716

2.96

307.65

2.5

1.7

1.29

1.22

mg/l

1.42

10329

43156

ILD medications

21893

68804

2.00

307.65

2.3

1.7

1.19

mg/l

0.08

17294

52231

Dermatitis and eczema

18368

80689

1.46

307.65

1.9

1.8

1.09

1.23

mg/l

4.94

14095

62207

Codes for special purposes

12385

56768

2.95

307.65

2.5

1.7

1.29

1.22

mg/l

1.43

10336

43192

Condition for Implicit Sepsis (Organ dysfunction codes)

15686

65441

1.94

307.65

2.4

1.7

1.60

1.10

mg/l

32.62

12530

50223

Bacterial Sepsis

9024

37973

2.45

307.65

2.6

1.6

1.90

1.29

mg/l

24.18

7529

29492

Transplanted organ and tissue status

1867

7859

3.44

307.65

6.2

1.7

2.18

1.22

mg/l

11.65

1681

6064

Urinary track infection

10122

33777

1.69

307.65

1.9

1.7

1.00

1.06

mg/l

1.03

7894

25635

Hernia of abdominal wall, postoperative

3224

15132

2.64

307.65

2.1

1.5

1.38

1.03

mg/l

6.14

2586

11669

Other septicaemia

6399

33376

2.16

307.65

2.7

1.7

2.00

1.30

mg/l

25.90

5391

25727

Other disorders of urethra and urinary system

12177

54074

1.78

307.65

1.9

1.7

1.16

1.26

mg/l

2.48

9606

41769

Certain infectious and parasitic diseases

16840

54029

1.75

307.65

2.1

1.6

1.24

1.10

mg/l

4.48

13131

40961

Other heart diseases

9163

25673

2.93

307.65

2.6

1.5

1.25

0.81

mg/l

21.18

7118

18942

Disorders of lipoprotein metabolism and other lipidaemias

13690

55060

1.70

307.65

1.9

1.7

1.24

1.18

mg/l

1.10

10929

42661

Renal failure

7962

39564

2.03

307.65

2.8

1.7

2.11

1.36

mg/l

30.91

6812

30881

Gout, FINNGEN

4489

25588

2.07

307.65

2.2

1.7

1.50

1.51

mg/l

0.07

3676

20231

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

18575

75988

1.89

307.65

2.3

1.7

1.40

1.11

mg/l

18.10

15164

57542

Abnormal findings on diagnostic imaging of lung

7639

46121

1.80

307.65

2.0

1.7

1.41

1.38

mg/l

0.19

6253

36291

Depression

16093

76120

1.56

307.65

2.0

1.8

1.05

1.18

mg/l

5.69

12126

58696

Low back pain

15256

56701

2.17

307.65

2.0

1.7

1.00

1.29

mg/l

25.80

11726

43580

Symptoms and signs involving the digestive system and abdomen

17624

53211

1.89

307.65

2.0

1.7

1.16

1.27

mg/l

3.30

13416

41106

Visual disturbances and blindness

8593

57528

1.69

307.65

2.1

1.8

1.11

1.28

mg/l

4.57

6568

44697

Caries of dentine

3838

19580

2.30

307.65

3.1

1.7

1.55

1.36

mg/l

1.50

3149

15434

Disorders of thyroid, IBD co-morbidities

3019

8054

3.15

307.65

2.6

1.5

0.91

1.37

mg/l

12.39

2292

6081

Early onset COPD, excluding more controls

3120

14992

2.55

307.65

2.1

1.6

1.23

1.30

mg/l

0.46

2523

11641

Erysipelas

10199

48860

2.16

307.65

2.0

1.6

1.37

1.19

mg/l

6.86

8318

37619

All influenza

4476

23924

2.28

307.65

2.3

1.7

1.17

1.24

mg/l

0.67

3516

18048

Cardiac arrhythmias

11522

37499

2.39

307.65

2.2

1.6

1.05

0.95

mg/l

2.25

8625

28312

Gonarthrosis [arthrosis of knee](FG)

12381

46530

1.72

307.65

1.8

1.7

1.17

1.21

mg/l

0.63

9965

36148

Other CVD (FINNGEN)

1936

4857

4.07

307.65

2.1

1.4

1.36

1.00

mg/l

4.54

1577

3643

Pain (limb, back, neck, head abdominally)

12415

32228

2.23

307.65

2.0

1.7

1.16

1.38

mg/l

8.67

9473

24987

Myalgia

4760

21751

2.87

307.65

2.1

1.7

0.88

1.22

mg/l

12.54

3592

16663

Asthma-related infections

12134

62799

2.33

307.65

2.2

1.8

1.05

1.27

mg/l

12.61

9589

48183

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

9709

23803

3.46

307.65

2.3

1.5

1.33

0.79

mg/l

32.80

7855

17792

Asthma (diagnoses ohter than nonallergic)

17061

81075

2.01

307.65

2.0

1.8

1.05

1.24

mg/l

12.90

13337

62255

Hard cardiovascular diseases

15056

50942

2.07

307.65

2.4

1.6

1.19

1.21

mg/l

0.21

11837

39615

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

10345

66293

1.75

307.65

2.1

1.7

1.42

1.22

mg/l

5.53

8397

51371

Intracranial trauma

9728

38538

1.94

307.65

2.0

1.7

1.14

1.27

mg/l

2.73

7403

29496

Obesity and other hyperalimentation

11851

68887

1.90

307.65

2.0

1.8

1.05

1.14

mg/l

2.32

9431

52811

Septicaemia

7207

36629

2.14

307.65

2.6

1.7

2.01

1.28

mg/l

29.90

6061

28210

Infections of the skin and subcutaneous tissue

9717

64697

1.66

307.65

2.2

1.8

1.18

1.19

mg/l

0.12

7609

49514

Other heart diseases, wide

17494

60987

2.05

307.65

2.3

1.7

1.17

1.11

mg/l

1.19

13393

46809

Intestinal infectious diseases, including avohilmo, including avohilmo

20396

75539

1.69

307.65

2.0

1.7

1.11

1.25

mg/l

7.30

15913

58160

Asthma, unspecified (mode), excluding more controls

10889

34048

2.92

307.65

2.0

1.5

1.04

1.15

mg/l

3.65

8538

25840

Pneumonias (Asthma/COPD co-morbidities)

19317

75578

1.95

307.65

2.3

1.7

1.39

1.11

mg/l

17.81

15809

57057

Nerve, nerve root and plexus disorders

18206

76411

1.59

307.65

1.8

1.06

1.24

mg/l

10.78

14200

59087

DVT of lower extremities

4314

16169

4.15

307.65

2.4

1.7

1.95

1.23

mg/l

19.98

3528

12620

Injuries to the knee and lower leg

19794

78207

1.49

307.65

1.9

1.8

1.10

1.22

mg/l

6.12

15507

59900

Other disorders of veins

7754

41164

2.32

307.65

1.9

1.7

1.11

1.10

mg/l

0.13

6118

31981

Hypertensive diseases

13275

47136

1.81

307.65

2.2

1.7

1.17

1.08

mg/l

1.77

10565

35712

Pulmonary embolism

7038

27204

4.02

307.65

2.7

1.7

2.45

1.25

mg/l

69.15

5995

21232

All kidney diseases

17276

76843

1.70

307.65

2.3

1.7

1.54

1.08

mg/l

38.83

13988

58558

Insomnia

14772

75046

1.50

307.65

1.8

0.88

1.21

mg/l

40.86

11127

57783

Complications of medical and surgical care

13104

75503

1.80

307.65

2.2

1.7

1.39

1.19

mg/l

6.73

10567

58317

Venous thromboembolism

13369

51112

3.75

307.65

2.5

1.6

2.05

1.16

mg/l

86.80

11163

39760

Complications of surgical and medical care, not elsewhere classified

18339

77706

1.81

307.65

2.1

1.7

1.34

1.18

mg/l

6.36

14731

59641

Neurological diseases

14716

44969

1.86

307.65

2.0

1.7

1.09

1.29

mg/l

7.62

11138

34499

COPD/asthma/ILD related infections

18160

55286

1.88

307.65

2.1

1.6

1.18

mg/l

0.03

14199

42052

Other bacterial diseases

17931

69239

2.03

307.65

2.4

1.7

1.64

1.10

mg/l

51.36

14759

52773

Asthma (only as main-diagnosis)

14267

38652

2.52

307.65

2.0

1.6

0.98

1.18

mg/l

10.75

11051

29353

Hypothyroidism, levothyroxine purchases

4186

9819

2.85

307.65

2.1

1.4

0.96

0.82

mg/l

1.64

3104

7198

Other specific joint derangements/joint disorders

13723

49481

2.02

307.65

1.9

1.8

0.95

1.22

mg/l

22.07

10464

37480

Hyperlipidaemia, other/unspecified

5995

32995

1.89

307.65

1.9

1.7

1.33

1.38

mg/l

0.52

4721

25813

General examination and investigation of persons without complaint and reported diagnosis

10337

32934

1.83

307.65

2.2

1.6

1.05

1.27

mg/l

10.83

7852

25548

Gonarthrosis

10530

36754

1.84

307.65

1.8

1.7

1.15

1.28

mg/l

3.44

8450

28653

20857

65620

1.84

307.65

2.0

1.7

1.09

1.27

mg/l

9.76

16069

50603

Any gastric operation

14074

40681

1.98

307.65

2.2

1.5

1.27

0.98

mg/l

12.93

10776

30424

Other headache syndromes

8307

42987

2.41

307.65

2.0

1.7

0.91

1.22

mg/l

16.23

6347

33168

Other diseases of intestines

18818

68167

1.73

307.65

2.1

1.7

1.15

1.18

mg/l

0.44

14542

52076

Emergency coronary revascularization (for ACS)

15456

53192

2.08

307.65

2.4

1.7

1.18

1.30

mg/l

3.30

12194

41714

Diverticular disease of intestine

11818

47067

1.77

307.65

1.9

1.7

1.23

1.27

mg/l

0.66

9352

37001

Other external causes of accidental injury

12853

44357

1.59

307.65

1.9

1.8

1.13

1.22

mg/l

1.93

9874

34070

Pure hypercholesterolaemia

12123

51522

1.67

307.65

1.9

1.7

1.31

1.21

mg/l

1.99

9755

40085

Complications of procedures, not elsewhere classified

14520

75232

1.78

307.65

2.1

1.7

1.32

1.18

mg/l

3.83

11587

57870

Explicit Sepsis, including avohilmo

7819

40234

2.09

307.65

2.6

1.6

1.94

1.25

mg/l

30.91

6555

31044

General symptoms and signs

21507

55234

2.35

307.65

2.1

1.6

1.14

1.17

mg/l

0.44

16657

42126

Functional dyspepsia

4683

27003

2.10

307.65

2.0

1.7

0.90

1.18

mg/l

12.85

3596

20994

Explicit Sepsis

7636

39465

2.09

307.65

2.6

1.6

1.95

1.24

mg/l

31.19

6395

30451

Falls/tendency to fall

17525

63105

1.51

307.65

1.9

1.8

1.10

1.18

mg/l

1.98

13531

48155

Dental caries

4383

21909

2.29

307.65

3.2

1.7

1.57

1.35

mg/l

2.05

3598

17289

Migraine with aura

4573

24726

2.26

307.65

2.1

1.7

0.83

1.09

mg/l

10.38

3407

18715

Certain infectious and parasitic diseases, including avohilmo

11892

36268

1.84

307.65

2.0

1.6

1.20

1.18

mg/l

0.14

9224

27652

Gonarthrosis,primary

14027

60000

1.56

307.65

1.7

1.8

1.23

1.27

mg/l

0.73

11241

47163

Influenza and pneumonia

20332

74637

1.97

307.65

2.3

1.7

1.34

1.11

mg/l

12.90

16466

56314

Viral Sepsis

4185

18739

3.01

307.65

3.0

1.6

1.46

1.24

mg/l

2.99

3470

14385

Implicit viral Sepsis, including avohilmo

6125

28934

2.78

307.65

2.7

1.6

1.39

1.24

mg/l

2.44

4979

22301

Other arrhythmias

11498

50294

2.00

307.65

2.1

1.6

1.00

1.15

mg/l

6.07

8599

39098

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

18258

76167

1.87

307.65

2.4

1.7

1.51

1.13

mg/l

25.62

14636

58497

Asthma, hospital admissions 3, pneumonia

7110

35431

2.54

307.65

2.3

1.8

1.21

1.38

mg/l

4.02

5823

27436

Phlebitis and thrombophlebitis (not including DVT)

5329

20456

4.07

307.65

2.4

1.7

1.63

1.13

mg/l

15.37

4394

15871

All pneumoniae

19433

75596

1.95

307.65

2.3

1.7

1.38

1.11

mg/l

16.96

15890

57088

Coronary revascularization (ANGIO or CABG)

14374

48706

2.16

307.65

2.4

1.6

1.17

1.26

mg/l

2.06

11324

38151

Artrosis, including avohilmo

13069

49783

1.58

307.65

1.8

1.09

1.24

mg/l

4.93

10299

38299

Endocrine, nutritional and metabolic diseases

13087

43301

1.69

307.65

2.0

1.7

1.14

1.11

mg/l

0.28

10075

32352

Shoulder lesions

12604

45775

1.89

307.65

1.8

1.7

1.03

1.33

mg/l

19.75

9807

35573

Recurrent or chronic depression

6634

27422

1.93

307.65

1.9

1.8

0.92

1.19

mg/l

9.29

4923

21310

Excluding asthma or asthma-COPD overlap

13756

39016

2.03

307.65

2.0

1.6

1.15

1.18

mg/l

0.40

10699

29623

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

16573

67960

1.91

307.65

2.4

1.7

1.51

1.08

mg/l

27.86

13183

51879

Paroxysmal tachycardia

3657

13255

2.83

307.65

3.1

1.5

1.09

0.85

mg/l

5.74

2801

9893

Sleep disorders

15028

75159

1.51

307.65

1.8

0.88

1.22

mg/l

46.15

11348

57979

Persons encountering health services for examination and investigation

10118

32979

1.69

307.65

1.9

1.6

1.17

1.28

mg/l

1.89

7710

25576

Myocardial infarction

7191

30471

1.90

307.65

2.3

1.6

1.44

1.46

mg/l

0.11

5821

24018

Other embolism and thrombosis

2707

10507

3.89

307.65

2.7

1.7

1.88

1.21

mg/l

11.52

2206

8183

Unstable angina pectoris

5573

24479

2.12

307.65

1.9

1.6

1.13

1.57

mg/l

22.11

4362

19317

Antihypertensive medication - note that there are other indications

10733

31230

2.08

307.65

2.3

1.6

0.97

1.04

mg/l

1.38

8070

22962

Chronic lower respiratory diseases

22132

74097

1.79

307.65

2.0

1.8

1.05

1.24

mg/l

12.88

17246

56670

Heart failure and coronary heart disease

7037

25399

2.38

307.65

3.0

1.6

1.45

1.58

mg/l

1.95

5817

20029

Asthma, hospital admissions , main diagnosis only

15210

81703

1.88

307.65

2.0

1.8

0.99

1.23

mg/l

20.37

11782

62753

Syncope and collapse

8086

34287

2.37

307.65

2.1

1.6

1.25

1.32

mg/l

0.98

6209

26435

Other anaemias

6907

40234

1.86

307.65

2.3

1.7

1.72

1.40

mg/l

6.19

5689

31591

Other arthrosis

8488

35285

1.84

307.65

1.8

1.7

1.07

1.28

mg/l

9.43

6676

27499

Diseases of the skin and subcutaneous tissue

15941

57464

1.51

307.65

1.9

1.7

1.13

1.23

mg/l

2.89

12261

44079

Arthropathies

14958

50533

1.65

307.65

1.9

1.8

1.05

1.24

mg/l

8.40

11413

38261

Other nutritional deficiencies

12595

70579

1.92

307.65

2.0

1.8

1.05

1.16

mg/l

3.45

9993

54087

Obesity related asthma

7007

35077

2.62

307.65

2.2

1.7

0.93

1.19

mg/l

15.06

5595

27177

Abnormalities of breathing

21573

47117

3.52

307.65

2.2

1.6

1.07

1.30

mg/l

16.40

16880

36164

Symptoms and signs involving the nervous and musculoskeletal systems

9453

64170

1.66

307.65

2.0

1.8

1.09

1.27

mg/l

5.79

7255

49959

Bacterial infection, other or unspecified

9816

45127

2.23

307.65

2.5

1.6

1.84

1.23

mg/l

33.75

8211

34755

Malaise and fatigue

10618

38558

2.74

307.65

2.2

1.6

1.33

1.27

mg/l

0.70

8395

29754

Acute bronchitis

7399

41606

2.08

307.65

2.3

1.8

1.13

1.30

mg/l

3.62

5742

32120

Other/unspecified dorsalgia

6763

36530

2.20

307.65

2.0

1.7

1.06

1.32

mg/l

9.03

5203

28309

Diseases of oesophagus, stomach and duodenum

19261

73223

1.77

307.65

2.0

1.7

1.13

1.21

mg/l

2.68

14855

56546

Anaemias

4514

9461

4.04

307.65

2.9

1.4

1.42

0.84

mg/l

11.71

3600

6980

Asthma

15415

38652

2.51

307.65

2.0

1.6

1.02

1.18

mg/l

7.24

12005

29353

Pain in throat and chest

19855

46076

3.38

307.65

2.0

1.6

0.88

1.30

mg/l

60.54

14975

35405

Codeine or tramadol medication

21944

69831

2.00

307.65

1.9

1.7

1.08

1.24

mg/l

9.23

17058

53501

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

16508

73227

1.57

307.65

2.5

1.7

1.29

1.15

mg/l

4.70

13092

56145

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

6187

12147

3.02

307.65

2.0

1.5

0.99

1.12

mg/l

2.65

4592

9323

Asthma/COPD (KELA code 203)

17130

74031

1.75

307.65

1.9

1.8

1.02

1.24

mg/l

17.76

13395

56625

Non-allergic asthma (mode), excluding more controls

3017

14212

2.56

307.65

2.0

1.5

1.09

1.23

mg/l

1.78

2368

10759

Headache

14283

51830

2.69

307.65

2.1

1.6

0.88

1.15

mg/l

21.40

10736

39459

Hypertension

13261

47111

1.80

307.65

2.2

1.7

1.17

1.08

mg/l

1.73

10558

35693

Non-invasive ventilation

3828

16637

2.34

307.65

2.0

1.5

1.37

1.02

mg/l

6.02

3252

12772

Finngen Rheumatological endpoints

16411

62344

1.66

307.65

1.9

1.8

1.13

1.16

mg/l

0.55

12887

47254

Symptoms and signs involving the circulatory and respiratory systems

21650

47202

2.89

307.65

2.0

1.6

1.01

1.30

mg/l

22.42

16435

36220

Coronary atherosclerosis

10174

38448

1.94

307.65

2.2

1.6

1.28

1.36

mg/l

1.35

8036

30289

ILD medications: immunosuppressive drugs

10969

62236

1.83

307.65

2.6

1.7

1.41

1.17

mg/l

7.50

8870

47343

Autoimmune diseases related-to ILD

13718

83372

1.50

307.65

2.0

1.8

1.16

1.19

mg/l

0.55

10779

63940

Diseases of arteries, arterioles and capillaries

10206

50744

1.65

307.65

2.1

1.7

1.69

1.29

mg/l

16.17

8357

39709

Gout

4489

19303

2.43

307.65

2.2

1.7

1.50

1.57

mg/l

0.59

3676

15277

Diseases of the musculoskeletal system and connective tissue

9091

24412

2.13

307.65

2.0

1.8

1.08

1.39

mg/l

8.95

6808

18400

Asthma, hospital admission 2, infections

12134

62799

2.33

307.65

2.2

1.8

1.05

1.27

mg/l

12.61

9589

48183

Cardiovascular diseases (excluding rheumatic etc)

12991

33529

2.77

307.65

2.4

1.5

1.11

0.83

mg/l

13.58

10073

24383

Gastro-oesophageal reflux disease

11957

64056

1.81

307.65

1.9

1.7

1.06

1.23

mg/l

7.07

9057

49937

Undetermined asthma

2389

10186

3.07

307.65

2.1

1.6

0.98

1.17

mg/l

3.06

1883

7750

Haemorrhage from respiratory passages

5917

23209

2.79

307.65

2.4

1.6

1.32

1.57

mg/l

4.82

4700

18300

Asthma, unspecified (mode)

11213

36685

2.79

307.65

2.0

1.6

1.05

1.19

mg/l

4.81

8803

27965

Bronchitis

20606

76844

1.85

307.65

2.1

1.7

1.06

1.24

mg/l

10.09

15795

59249

Symptoms and signs involving cognition, perception, emotional state and behaviour

17363

75205

1.75

307.65

2.0

1.7

1.12

1.21

mg/l

3.00

13368

58220

Pain, not elsewhere classified

5846

25666

3.01

307.65

2.3

1.6

1.04

1.20

mg/l

3.89

4577

19617

Soft tissue disorders related to use, overuse and pressure

4508

24609

2.20

307.65

2.0

1.7

1.07

1.35

mg/l

7.71

3575

19203

Abnormalities of heart beat

7361

28721

3.28

307.65

2.1

1.6

0.94

1.40

mg/l

25.74

5451

22229

Lumbar disc prolapse

10778

50394

1.81

307.65

1.8

1.7

0.97

1.29

mg/l

22.58

8379

39116

Nausea and vomiting

4804

23868

2.40

307.65

2.5

1.7

1.36

mg/l

0.02

3815

18472

Osteopathies and chondropathies

9277

56872

1.69

307.65

2.1

1.8

1.24

mg/l

0.09

7413

44043

Asthma (only as main-diagnosis), excluding more controls

13863

35895

2.63

307.65

2.0

1.5

0.96

1.15

mg/l

10.01

10729

27128

Abdominal and pelvic pain

17863

53207

1.93

307.65

2.0

1.7

1.12

1.27

mg/l

6.87

13580

41102

Aplastic and other anaemias

7471

42540

1.86

307.65

2.3

1.7

1.73

1.38

mg/l

7.50

6144

33329

Disturbances of skin sensation

5230

29083

2.24

307.65

2.1

1.7

0.84

1.10

mg/l

6.37

3945

22372

Sleep apnoea, including avohilmo

17559

69423

1.74

307.65

1.9

1.8

0.95

1.26

mg/l

34.17

13536

53845

Bleeding

13337

64003

1.63

307.65

2.4

1.7

1.40

1.25

mg/l

4.09

10662

49671

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

9448

63129

1.70

307.65

2.1

1.7

1.41

1.23

mg/l

4.14

7655

49052

Pain in limb

20435

53701

3.30

307.65

2.1

1.7

1.05

1.32

mg/l

22.22

16123

41156

COPD

6702

33518

1.87

307.65

2.0

1.7

1.40

1.51

mg/l

1.34

5513

26379

Lower back pain or/and sciatica

20619

78663

1.89

307.65

1.9

1.7

1.00

1.25

mg/l

25.66

15912

60600

Any reimbursement code in KELA

9709

29859

1.83

307.65

2.1

1.5

1.10

0.90

mg/l

5.60

7331

21974

17275

55286

2.18

307.65

2.3

1.6

1.38

1.18

mg/l

7.84

14091

42052

Other chronic obstructive pulmonary disease

6361

32235

1.85

307.65

2.0

1.7

1.40

1.51

mg/l

1.53

5234

25370

Other bacterial diseases, including avohilmo

19606

71044

2.03

307.65

2.3

1.7

1.49

1.08

mg/l

38.72

15959

53807

Implicit bacterial Sepsis, including avohilmo

8964

36809

2.57

307.65

2.6

1.6

1.86

1.30

mg/l

20.78

7464

28640

Other soft tissue disorders, not elsewhere classified

21874

54577

2.99

307.65

2.1

1.7

1.04

1.31

mg/l

25.24

16993

41699

Constipation

14806

69745

1.60

307.65

1.9

1.8

1.22

1.24

mg/l

0.27

11492

54379

Mood disorders

17114

78394

1.53

307.65

2.0

1.8

1.07

1.20

mg/l

4.81

12934

60528

Heart failure and bmi 25plus

5681

21606

2.12

307.65

2.6

1.6

1.47

1.40

mg/l

0.72

4701

16960

Arthrosis

11456

40728

1.72

307.65

1.8

1.7

1.12

1.25

mg/l

3.44

9068

31423

External causes of morbidity and mortality

10285

34661

1.63

307.65

1.9

1.7

1.13

1.18

mg/l

0.66

7909

26450

9149

47091

2.42

307.65

2.2

1.8

0.94

1.21

mg/l

14.58

7113

35934

GASTRO-related operations

14074

40681

1.98

307.65

2.2

1.5

1.27

0.98

mg/l

12.93

10776

30424

Diseases of the respiratory system

10561

31415

1.90

307.65

1.9

1.6

1.16

1.24

mg/l

1.30

8181

23813

Disorders of synovium and tendon

8800

45566

1.87

307.65

1.9

1.7

0.95

1.29

mg/l

29.52

6936

35217

Acute upper respiratory infections of multiple and unspecified sites

14283

64001

1.88

307.65

2.2

1.7

0.99

1.23

mg/l

14.27

10849

49348

Renal tubulo-interstitial diseases

15169

72979

1.73

307.65

2.4

1.7

1.68

1.12

mg/l

42.85

12440

55949

Exposure to unspecified factor

17763

82752

1.63

307.65

2.0

1.8

1.13

1.21

mg/l

2.53

13742

63630

Valvular heart disease excluding rheumatic fever

7307

30247

2.01

307.65

2.2

1.6

1.37

1.35

mg/l

0.14

5732

23869

Non-ischemic cardiomyopathy

5011

20650

2.35

307.65

2.4

1.6

1.63

1.51

mg/l

1.18

4185

16070

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

10988

62946

1.73

307.65

2.0

1.7

1.35

1.28

mg/l

1.16

8873

49179

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

17275

55286

2.18

307.65

2.3

1.6

1.38

1.18

mg/l

7.84

14091

42052

COPD (mode)

4775

18911

2.36

307.65

2.0

1.5

1.43

1.42

mg/l

0.08

3931

14664

Hypertension, essential

13308

45973

1.88

307.65

1.9

1.6

1.15

1.08

mg/l

1.45

10547

34913

Heart failure, strict

10065

38447

2.21

307.65

2.7

1.6

1.51

1.45

mg/l

0.86

8379

30126

Dorsopathies

17954

57847

1.77

307.65

1.9

1.8

1.02

1.30

mg/l

25.32

13696

44331

COPD differential diagnosis

13663

38954

2.02

307.65

2.0

1.6

1.15

1.18

mg/l

0.40

10624

29593

Other and unspecified anaemias

6852

39952

1.86

307.65

2.3

1.7

1.72

1.40

mg/l

6.15

5641

31375

Acute renal failure

3755

19833

2.36

307.65

3.3

1.7

2.37

1.35

mg/l

23.15

3254

15487

Oxycodone

6827

30270

2.33

307.65

2.1

1.6

1.70

1.34

mg/l

11.62

5689

23523

Iron deficiency anaemia

7044

44449

1.79

307.65

2.5

1.7

1.40

1.31

mg/l

1.26

5612

34645

Polyarthropathies

11487

44494

1.90

307.65

2.0

1.8

1.31

1.26

mg/l

0.90

9205

34102

Concussion

8668

38093

2.03

307.65

2.0

1.7

1.05

1.27

mg/l

6.68

6553

29160

Neurotic, stress-related and somatoform disorders

15351

72626

1.63

307.65

2.1

1.8

1.05

1.15

mg/l

2.88

11513

55977

Infections, IBD-co-morbidities

2746

6437

3.85

307.65

2.6

1.6

1.44

1.43

mg/l

0.04

2235

4880

Chronic kidney disease

5075

27981

2.07

307.65

2.8

1.7

1.99

1.41

mg/l

13.14

4343

21883

Ischemic heart diseases

14920

50827

2.08

307.65

2.4

1.6

1.21

1.24

mg/l

0.32

11714

39706

Medical observation and evaluation for suspected diseases and conditions

11614

32974

2.08

307.65

2.1

1.6

1.12

1.28

mg/l

3.91

8783

25573

Other special examinations and investigations of persons without complaint or reported diagnosis

10678

32979

1.84

307.65

2.0

1.6

1.17

1.28

mg/l

1.85

8160

25576

Other diseases of pleura

7017

37713

1.87

307.65

2.2

1.7

1.69

1.43

mg/l

5.63

5838

29629

Spinal stenosis

8129

35656

1.95

307.65

1.8

1.7

1.19

1.46

mg/l

12.04

6582

28238

Obesity

11796

68657

1.90

307.65

2.0

1.8

1.05

1.14

mg/l

2.31

9393

52629

Mood [affective] disorders

17078

78355

1.53

307.65

2.0

1.8

1.07

1.20

mg/l

4.83

12906

60502

Coxibs

4394

10747

2.51

307.65

1.7

2.1

1.11

1.75

mg/l

20.93

3320

8343

Pneumonia, organism unspecified

17250

70392

1.97

307.65

2.3

1.7

1.41

1.12

mg/l

16.19

14089

53298

Depression medications

4766

10240

2.76

307.65

1.9

1.4

0.88

0.80

mg/l

1.06

3436

7432

Migraine

9765

42213

2.16

307.65

2.1

1.7

0.84

1.14

mg/l

18.65

7302

32129

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

18244

76538

1.73

307.65

2.0

1.7

1.06

1.24

mg/l

11.30

14137

58889

Hypertensive diseases (excluding secondary)

9312

25719

2.56

307.65

2.3

1.5

1.10

0.78

mg/l

12.09

7354

19016

Hypothyroidism (congenital or acquired)

4219

9843

2.87

307.65

2.1

1.4

0.96

0.82

mg/l

1.63

3138

7213

Myocardial infarction, without ST-elevation

6102

33568

1.90

307.65

2.0

1.7

1.42

1.53

mg/l

1.51

4964

26599

Anxiety disorders

15494

73015

1.63

307.65

2.1

1.8

1.05

1.15

mg/l

3.05

11623

56283

Asthma, excluding more controls

14921

35895

2.63

307.65

2.0

1.5

1.00

1.15

mg/l

6.18

11609

27128

Cardiovascular diseases

12267

28346

2.85

307.65

2.3

1.5

1.04

0.85

mg/l

6.36

9270

20595

Heart failure, not strict

14098

49022

2.41

307.65

2.7

1.6

1.54

1.21

mg/l

17.26

11659

38053

Parasetamol

13082

33860

2.27

307.65

1.9

1.7

1.08

1.24

mg/l

6.20

9975

25373

Acute upper respiratory infections

18470

73026

1.71

307.65

2.0

1.7

1.04

1.27

mg/l

15.52

14128

56585

All-cause Heart Failure

9878

37826

2.20

307.65

2.6

1.6

1.50

1.45

mg/l

0.64

8230

29656

Sleep disorders (combined)

19393

66213

1.72

307.65

1.8

0.98

1.32

mg/l

41.34

14829

51203

Tramadol

15869

48090

2.43

307.65

2.1

1.6

1.18

1.17

mg/l

0.10

12564

36656

Pulmonary heart disease, diseases of pulmonary circulation

7506

29689

3.83

307.65

2.8

1.7

2.40

1.26

mg/l

66.40

6377

23181

Other functional intestinal disorders

7895

42494

1.96

307.65

2.1

1.7

1.20

1.30

mg/l

1.46

6234

32915

Viral pneumonia

2800

10871

3.81

307.65

3.1

1.7

1.37

1.23

mg/l

1.13

2399

8200

Other dorsopathies, not elsewhere classified

18431

57709

1.90

307.65

1.9

1.7

1.02

1.29

mg/l

23.63

14078

44219

Dorsalgia

18731

57623

2.00

307.65

1.9

1.7

1.02

1.29

mg/l

22.21

14311

44167

Oxicams

3436

9499

2.39

307.65

1.7

2.0

1.16

1.79

mg/l

14.47

2632

7510

Acetic acid derivatives and related substances

4110

10626

2.29

307.65

1.8

2.1

1.15

1.75

mg/l

11.97

3150

8263

Anxiety disorders, excluding more controls

14366

60487

1.71

307.65

2.1

1.7

1.06

1.17

mg/l

3.31

10831

46753

Viral pneumonia (unknown virus, not influenza)

1642

5531

5.33

307.65

3.6

1.8

1.38

1.18

mg/l

1.30

1463

4167

Codeine

18454

52698

2.27

307.65

1.9

1.7

1.02

1.17

mg/l

7.20

14319

39784

Depression or dysthymia

10675

37078

1.76

307.65

1.9

1.8

1.06

1.35

mg/l

14.41

8093

29069

All anxiety disorders

10643

56086

1.65

307.65

2.0

1.8

0.95

1.07

mg/l

3.51

7849

42895

Hypothyroidism and >3 levothyroxin purchases

4186

9819

2.85

307.65

2.1

1.4

0.96

0.82

mg/l

1.64

3104

7198

Oral corticosteroids

21207

70829

2.09

307.65

2.1

1.7

1.14

1.21

mg/l

1.82

16825

54144

All chronic kidney diseases

8965

44583

1.84

307.65

2.4

1.7

1.87

1.23

mg/l

27.23

7484

34325

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

1920

3816

4.82

307.65

2.6

1.5

1.50

1.73

mg/l

1.13

1611

2970

Cerebrovascular diseases (FINNGEN)

5151

16091

2.76

307.65

2.6

1.4

1.25

0.80

mg/l

20.02

4098

12203

Hypertensive heart and/or renal disease

3893

15124

2.22

307.65

1.9

1.6

1.58

1.48

mg/l

0.68

3184

11683

Oedema, not elsewhere classified

8042

28241

4.18

307.65

2.1

1.6

1.24

1.31

mg/l

1.41

6639

21940

Dyspnoea

22624

68917

3.29

307.65

2.2

1.7

1.14

1.24

mg/l

4.59

18003

53088

Cystitis

14483

56556

1.72

307.65

1.9

1.7

1.06

1.26

mg/l

10.44

11311

43640

Other diseases of upper respiratory tract

17410

67567

1.45

307.65

1.8

1.08

1.30

mg/l

13.93

13337

52300

Bacterial infection, other or unspecified, including avohilmo

10826

48832

2.19

307.65

2.5

1.7

1.80

1.21

mg/l

34.57

9015

37496

Acute tubulo-interstitial nephritis

10064

58320

1.62

307.65

2.0

1.7

1.51

1.17

mg/l

12.14

8104

44809

Care involving use of rehabilitation procedures

10642

63392

1.70

307.65

2.1

1.7

1.24

1.12

mg/l

2.65

8578

48587

Implicit Sepsis, including avohilmo

15668

64300

2.07

307.65

2.4

1.7

1.59

1.12

mg/l

29.09

12529

49447

Intestinal infectious diseases

16028

83400

1.58

307.65

2.2

1.7

1.19

1.21

mg/l

0.26

12465

64063

Dysphagia

4059

22160

2.20

307.65

2.0

1.6

1.18

1.40

mg/l

2.36

3136

17469

Asthma-related pneumonia or sepsis

7110

35431

2.54

307.65

2.3

1.8

1.21

1.38

mg/l

4.02

5823

27436

Benzodiazepine use

16692

82009

1.50

307.65

1.9

1.8

1.17

1.21

mg/l

0.46

12736

63403

Asthma, including avohilmo

22410

75806

1.88

307.65

1.9

1.8

1.00

1.27

mg/l

28.95

17321

58264

Dizziness and giddiness

13667

65799

1.87

307.65

2.0

1.7

1.07

1.25

mg/l

8.31

10477

51272

Rotator cuff syndrome

9847

41800

1.85

307.65

1.8

1.7

1.06

1.34

mg/l

13.33

7706

32738

Cough

7257

31988

2.60

307.65

2.1

1.6

1.08

1.39

mg/l

9.80

5601

24864

Ischaemic heart disease, wide definition

12777

48298

1.89

307.65

2.2

1.7

1.23

1.30

mg/l

1.21

10063

37980

Atrial fibrillation and flutter

5129

14157

2.88

307.65

2.4

1.4

1.35

0.81

mg/l

14.87

3981

10737

Diarrhoea and gastroenteritis of presumed infectious origin

12187

72569

1.69

307.65

2.2

1.8

1.19

1.20

mg/l

0.13

9536

55655

Symptoms and signs involving the urinary system

12103

64082

1.58

307.65

1.9

1.8

1.34

1.26

mg/l

1.20

9425

49920

Pain in joint

11171

31376

2.67

307.65

1.9

1.7

0.99

1.35

mg/l

26.33

8528

24332

Other intervertebral disc disorders

14294

53259

1.82

307.65

1.8

1.7

1.01

1.30

mg/l

23.26

11094

41241

Examination and observation for other reasons

11248

32770

2.32

307.65

2.2

1.6

1.18

1.27

mg/l

1.49

8764

25426

Persons encountering health services in other circumstances

6781

42533

1.80

307.65

2.0

1.7

1.10

1.22

mg/l

2.00

5090

32585

Opioids

18812

53230

2.15

307.65

2.0

1.7

1.12

1.17

mg/l

0.82

14613

40110

Spondylosis

9072

42629

1.93

307.65

1.9

1.7

1.05

1.35

mg/l

17.66

7123

33558

First line medication for Crohn's disease

21299

66594

2.01

307.65

2.2

1.7

1.23

1.15

mg/l

2.36

16862

50378

Neurological diseases, wide definition

5174

10444

2.98

307.65

2.2

1.7

0.98

1.36

mg/l

8.49

3825

7703

Anxiety (asthma-related co-morbidities)

10409

53078

1.68

307.65

2.0

1.8

0.96

1.07

mg/l

3.06

7694

40620

Erysipelas, including avohilmo

13825

57533

2.13

307.65

2.0

1.7

1.30

1.13

mg/l

8.41

11189

44000

Other joint disorders

15196

50465

1.76

307.65

1.8

0.99

1.24

mg/l

15.94

11506

38207

Covid-19 confirmed case

9077

36771

3.70

307.65

2.7

1.7

1.39

1.31

mg/l

1.14

7752

28167

Disorders of gallbladder, biliary tract and pancreas

16117

72485

1.52

307.65

2.0

1.7

1.29

1.19

mg/l

2.62

12819

56241

Visual disturbances

8033

53185

1.73

307.65

2.2

1.8

1.09

1.26

mg/l

4.51

6148

41317

DVT of lower extremities and pulmonary embolism

10360

39762

4.00

307.65

2.6

1.6

2.26

1.20

mg/l

82.19

8693

31030

Metabolic disorders

16597

64173

1.76

307.65

2.1

1.7

1.29

1.15

mg/l

4.78

13186

49263

Inflammatory bowel disease treatment related agents

22111

72621

1.97

307.65

2.2

1.7

1.15

1.21

mg/l

1.27

17464

55336

Percutaneous Coronary Intervention

14479

48682

2.18

307.65

2.4

1.6

1.17

1.26

mg/l

1.90

11412

38136

Other diseases of urinary system

16519

63317

1.63

307.65

1.9

1.8

1.14

1.24

mg/l

2.86

12913

48847

Any mental disorder

17353

64443

1.46

307.65

2.0

1.7

1.15

1.22

mg/l

1.67

13308

49975

Major coronary heart disease event

15000

51892

2.05

307.65

2.4

1.6

1.19

1.27

mg/l

1.61

11828

40593

Continuous positive airway pressure

3005

10552

2.96

307.65

2.5

1.6

1.31

1.13

mg/l

1.76

2311

8276

Atrial fibrillation and flutter with reimbursement

4066

10317

3.10

307.65

2.3

1.4

1.35

0.87

mg/l

9.81

3135

7942

Allergic asthma (mode), excluding more controls

3777

19175

2.27

307.65

2.0

1.5

0.95

1.08

mg/l

1.51

2892

14264

COPD/asthma related infections

18160

55286

1.88

307.65

2.1

1.6

1.18

mg/l

0.03

14199

42052

Other antidepressants

17276

59594

1.64

307.65

1.9

1.8

1.11

1.26

mg/l

7.07

13134

46208

Follow-up examination after treatment for conditions other than malignant neoplasms

7099

28572

1.88

307.65

1.9

1.6

1.18

1.28

mg/l

1.57

5521

22203

Sciatica+with lumbago

9606

47908

2.13

307.65

1.9

1.7

0.96

1.28

mg/l

22.59

7491

37265

Other pulmonary diagnosis

13871

39016

2.06

307.65

2.0

1.6

1.14

1.18

mg/l

0.48

10782

29623

Heart failure and antihypertensive medication

4648

11201

3.63

307.65

3.7

1.6

1.54

1.21

mg/l

5.96

3900

8722

Other septicaemia, including avohilmo

6555

34039

2.16

307.65

2.6

1.7

1.98

1.29

mg/l

26.52

5529

26238

Implicit Sepsis

14553

59588

2.17

307.65

2.5

1.6

1.62

1.15

mg/l

27.24

11732

45914

Undetermined asthma, excluding more controls

2389

9826

3.20

307.65

2.1

1.5

0.98

1.18

mg/l

3.19

1883

7447

ILD medications: prednisolone, methylprednisolone, prednisone

21606

67953

2.09

307.65

2.2

1.6

1.19

mg/l

0.08

17130

51680

Behavioural syndromes associated with physiological disturbances and physical factors

15528

76417

1.51

307.65

1.8

0.91

1.22

mg/l

32.66

11737

58975

Irritable bowel syndrome

4874

27856

2.11

307.65

2.0

1.7

0.93

1.13

mg/l

3.37

3605

21430

Persons encountering health services in other circumstances, wide

19950

68898

1.66

307.65

2.1

1.7

1.21

mg/l

0.06

15394

53079

Implicit bacterial Sepsis

8040

33962

2.57

307.65

2.7

1.6

1.92

1.31

mg/l

21.26

6731

26407

Heart failure,strict

9269

32554

2.48

307.65

2.8

1.6

1.51

1.38

mg/l

2.57

7729

25344

Mood disorders, excluding more controls

15746

63595

1.61

307.65

2.0

1.7

1.10

1.21

mg/l

3.22

11951

49271

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

18961

67616

2.13

307.65

2.1

1.7

1.43

1.13

mg/l

19.29

15240

52231

Spondylopathies

13283

48610

1.84

307.65

1.8

1.7

1.10

1.32

mg/l

12.19

10475

37919

Non-rheumatic valve diseases

7230

30083

1.99

307.65

2.2

1.6

1.36

1.35

mg/l

0.06

5666

23738

Non-allergic asthma (mode)

3017

14810

2.44

307.65

2.0

1.6

1.09

1.25

mg/l

2.22

2368

11225

Fever of other and unknown origin

10935

46647

2.49

307.65

2.4

1.6

1.44

1.22

mg/l

6.37

8799

35651

Persons encountering health services for other counselling and medical advice, not elsewhere classified

19271

68652

1.67

307.65

2.1

1.7

1.21

mg/l

0.00

14959

52901

Later onset COPD, excluding more controls

3020

11571

2.39

306.65

1.9

1.5

1.53

1.60

mg/l

0.38

2524

9014

Paracetamol or NSAID medication

2332

4943

2.69

305.47

1.9

2.3

1.22

1.81

mg/l

6.86

1748

3737

Factors influencing health status and contact with health services

4315

11751

2.05

302.94

1.9

1.4

1.23

1.18

mg/l

0.38

3271

9033

Migraine without aura

3580

19626

2.21

302.79

2.2

1.8

0.83

1.02

mg/l

3.32

2653

14734

Exposure to other specified factors

13084

82258

1.49

299.95

1.9

1.8

1.07

1.19

mg/l

4.18

9934

63313

Gout, idiopatic and unspecified

3874

21915

2.14

298.33

2.1

1.7

1.47

1.52

mg/l

0.36

3158

17351

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

14639

84806

1.46

297.72

2.0

1.8

1.12

1.21

mg/l

1.92

11280

65289

Bacterial pneumoniae

6228

34672

1.79

296.34

2.3

1.6

1.52

1.28

mg/l

5.28

5228

26442

Cholelithiasis, broad definition with cholecystitis

13792

67551

1.48

294.64

1.9

1.7

1.20

mg/l

0.05

10898

52501

Meniscus derangement

8266

36669

1.66

294.42

1.8

1.7

1.13

1.28

mg/l

3.17

6537

28464

Cholelithiasis

13299

66523

1.49

292.93

1.9

1.7

1.17

1.20

mg/l

0.55

10499

51702

Other coagulation defects

1584

6627

3.67

291.17

4.0

1.7

1.30

1.09

mg/l

1.56

1249

5083

Hernia

14687

72647

1.46

289.38

2.0

1.8

1.29

1.18

mg/l

2.56

11530

55968

Autoimmune diseases excluding thyroid diseases

16511

67339

1.43

288.51

1.9

1.8

1.27

1.20

mg/l

1.75

12997

51533

Type 2 diabetes, wide definition

12094

55024

1.52

287.67

2.0

1.7

1.35

1.21

mg/l

3.61

9780

42750

Bacterial pneumonia, not elsewhere classified

5891

32625

1.80

286.69

2.3

1.6

1.49

1.28

mg/l

4.03

4954

24919

Pain in thoracic spine

2700

13767

2.46

286.50

2.1

1.7

0.85

1.21

mg/l

13.63

2040

10610

Other and unspecified iron deficiency

5592

35165

1.84

286.46

2.2

1.7

1.30

mg/l

0.04

4455

27343

Internal derangement of knee

5761

35945

1.80

285.48

1.9

1.8

1.00

1.27

mg/l

9.58

4387

27737

Used for control exclusion in common control thyroid runs

16595

62954

1.43

285.27

2.0

1.8

1.18

1.21

mg/l

0.38

12794

48139

Hypothyroidism, drug reimbursement

2075

6318

2.73

284.63

1.9

1.4

0.87

0.74

mg/l

1.76

1594

4755

Other reaction to severe stress, and adjustment disorders

6133

39460

1.78

284.58

2.3

1.7

1.16

1.04

mg/l

1.14

4610

30026

Varicose veins

9029

47058

1.61

282.80

1.8

1.7

1.26

1.18

mg/l

1.16

7143

36863

Vocal cord dysfunction

2236

9184

2.61

281.48

2.0

1.5

1.04

1.07

mg/l

0.19

1724

7058

Oter anti-inflammatory and antirheumatic agents, non-steroids

3055

8450

2.29

277.38

1.7

2.0

1.36

1.82

mg/l

6.81

2415

6755

Autoimmune diseases excluding thyroid diseases, strict definition

15986

65514

1.43

276.65

1.9

1.8

1.27

1.20

mg/l

1.90

12578

50107

Chronic rhinitis, nasopharyngitis and pharyngitis

5315

33338

1.85

276.28

1.9

1.8

0.92

1.22

mg/l

8.13

4031

25766

Intracranial injury

9262

60495

1.57

275.12

2.0

1.8

1.20

1.27

mg/l

1.11

7087

46619

Benign neoplasm of colon, rectum, anus and anal canal

9651

57643

1.57

274.97

2.0

1.7

1.27

1.34

mg/l

1.35

7672

45512

Dialysis, with operation codes

2145

10304

2.76

273.50

5.3

1.8

2.80

1.28

mg/l

23.48

1940

7950

Benign neoplasms

15512

63462

1.43

272.60

2.0

1.8

1.13

1.21

mg/l

1.64

11996

48521

Other and unspecified coagulation defects

1178

4475

4.62

270.73

4.2

1.7

1.25

1.00

mg/l

1.80

938

3398

Heartburn

2017

9432

2.78

269.87

2.3

1.6

0.95

1.25

mg/l

3.57

1503

7310

Gout, unspecified

3175

17442

2.23

269.73

2.2

1.7

1.49

1.54

mg/l

0.25

2587

13796

L04AD Calcineurin inhibitors

1978

9341

2.92

268.71

5.4

1.8

2.07

1.15

mg/l

12.30

1765

7143

Neoplasms

12025

45592

1.50

267.65

2.1

1.8

1.19

1.03

mg/l

4.70

9247

34162

Other bursopathies

2142

10254

2.65

267.62

2.0

1.7

1.08

1.41

mg/l

6.14

1724

7947

Autoimmune diseases

17432

67699

1.40

267.18

1.9

1.8

1.20

1.19

mg/l

0.12

13500

51809

Injury, poisoning and certain other consequences of external causes

8215

27608

1.63

265.86

1.9

1.7

1.15

1.21

mg/l

0.69

6305

21036

Dermatitis

9976

69956

1.54

265.52

2.0

1.8

1.14

1.24

mg/l

2.19

7733

54262

Other chronic obstructive pulmonary disease, including avohilmo

7841

44012

1.64

264.33

2.0

1.7

1.35

1.41

mg/l

0.71

6390

34722

Liquid cancers, including Hilmo

5458

30524

1.81

264.04

2.4

1.8

1.78

1.21

mg/l

14.12

4566

23738

Artificial joint operation, meniscal resection

13858

66331

1.45

263.59

1.7

1.8

1.25

mg/l

0.02

11136

51598

Cervicobrachial syndrome

3605

20656

2.08

263.30

1.9

1.7

0.80

1.21

mg/l

23.37

2775

16026

Liquid cancers

4512

25950

1.92

263.01

2.5

1.8

1.74

1.24

mg/l

8.68

3764

20164

Diseases of the eye and adnexa

12441

45359

1.48

262.87

2.0

1.8

1.11

1.15

mg/l

0.45

9451

34639

Type 2 diabetes

15542

68266

1.42

262.51

1.9

1.7

1.21

1.16

mg/l

0.93

12360

52363

Triptan medication for migraine, single purchase ok

12076

60146

1.49

260.90

1.9

1.8

0.85

1.12

mg/l

22.24

9182

45805

Migraine, single triptan purchase ok & required. ICD-code if available is included

12076

60146

1.49

260.90

1.9

1.8

0.85

1.12

mg/l

22.24

9182

45805

Superficial injury of lower leg

4387

26632

1.93

260.77

2.0

1.8

1.07

1.19

mg/l

1.57

3419

20280

Gonarthrosis, primary, with knee surgery

8522

46166

1.60

259.91

1.7

1.35

1.37

mg/l

0.34

6929

36518

Other medical care

7339

41655

1.65

259.76

2.1

1.7

2.14

1.25

mg/l

36.78

6175

32060

Trochanteric bursitis

2424

12327

2.46

258.47

2.0

1.6

0.98

1.30

mg/l

6.82

1925

9612

Other systemic involvement of connective tissue (FG)

4079

23882

1.97

256.27

1.9

1.7

1.18

1.24

mg/l

0.67

3266

18372

Diabetes mellitus

16094

71070

1.40

256.21

2.0

1.8

1.21

1.16

mg/l

0.96

12752

54258

Candidiasis, including avohilmo

5110

32526

1.84

254.54

2.1

1.8

1.01

1.18

mg/l

5.74

3876

25023

Injuries to the ankle and foot

11634

73326

1.48

254.05

2.0

1.8

0.95

1.14

mg/l

11.45

8842

56127

Diseases of the ear and mastoid process

18096

70235

1.38

253.83

1.9

1.8

1.06

1.20

mg/l

5.54

13770

54201

Cholecystectomy

11045

68761

1.50

252.89

1.9

1.7

1.19

1.23

mg/l

0.61

8761

53576

Use of hypnotics and sedatives

16639

73210

1.40

252.66

1.9

1.8

1.18

1.20

mg/l

0.25

12876

56688

Ulcer of lower limb, not elsewhere classified

2426

12513

2.47

252.62

2.3

1.7

1.54

1.46

mg/l

0.52

2046

9767

Diabetes, varying definitions

15999

71037

1.40

252.13

2.0

1.8

1.21

1.16

mg/l

1.13

12685

54237

Other disorders of lacrimal gland

5964

39398

1.74

250.33

2.1

1.7

0.99

1.23

mg/l

8.84

4611

30677

Statin medication

10338

41602

1.52

250.13

2.2

1.6

1.05

1.14

mg/l

1.65

7961

31633

ILD, hospital admission 2, with pulmonary infections

1623

7141

2.99

249.99

2.7

1.6

1.62

1.44

mg/l

0.85

1381

5519

COPD related to multimorbidity

5610

30640

1.76

247.58

2.0

1.7

1.40

1.51

mg/l

1.27

4614

24234

Coxarthrosis

7201

31199

1.64

247.58

1.8

1.7

1.35

1.36

mg/l

0.05

5884

24547

Secondary hypertension

1175

4294

3.46

247.56

2.1

1.5

1.65

0.94

mg/l

3.97

967

3178

Respiratory insufficiency

1315

5211

3.28

246.81

2.7

1.6

1.41

1.46

mg/l

0.18

1110

4023

Injuries to the thorax

7086

48405

1.64

245.65

2.0

1.8

1.33

1.31

mg/l

0.22

5602

37575

Covid-19 suspected case

3622

21277

2.04

245.55

2.1

1.7

1.03

1.07

mg/l

0.29

2886

15968

Other diseases of the respiratory system

3153

17752

2.13

244.84

2.5

1.8

1.51

1.46

mg/l

0.25

2637

13909

Other respiratory disorders and diseases

3153

17752

2.13

244.84

2.5

1.8

1.51

1.46

mg/l

0.25

2637

13909

Other specified/unspecified arthritis

4135

25014

1.91

244.33

1.9

1.8

1.22

1.26

mg/l

0.42

3319

19310

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

7974

53754

1.58

242.63

1.9

1.8

1.00

1.26

mg/l

12.14

6051

41733

Other and unspecified dermatitis

8347

59100

1.57

240.82

2.0

1.8

1.13

1.24

mg/l

1.75

6469

45903

Disorders of the thyroid gland

14746

73147

1.41

240.46

2.0

1.7

1.09

1.23

mg/l

5.14

11322

56683

Primary gonarthrosis, bilateral

7599

44086

1.61

239.77

1.7

1.30

1.36

mg/l

1.05

6125

34785

Ovarian cyst

5471

19957

1.79

239.15

1.9

1.7

0.97

1.21

mg/l

6.37

4196

15321

COPD, early/later onset

6415

36081

1.68

238.94

2.0

1.7

1.40

1.47

mg/l

0.80

5271

28488

COPD, hospital admissions

6354

35830

1.68

238.06

2.0

1.7

1.37

1.47

mg/l

1.51

5220

28288

Disorders of conjunctiva

13296

78184

1.43

236.58

1.9

1.8

1.06

1.18

mg/l

3.03

10160

59989

Nephropathy related operations

2033

10134

2.64

236.49

5.4

1.8

2.73

1.33

mg/l

20.37

1851

7867

Benign neoplasm: Colon

8034

53133

1.58

236.17

2.0

1.7

1.27

1.38

mg/l

2.05

6382

42014

Other symptoms and signs involving the circulatory and respiratory systems

1138

4330

3.56

235.80

2.3

1.6

1.02

1.48

mg/l

3.99

889

3349

Type 2 diabetes, definitions combined

14768

65732

1.41

235.53

2.0

1.7

1.23

1.17

mg/l

1.17

11773

50581

Disorders of lacrimal system

7028

47698

1.63

235.31

2.0

1.7

1.01

1.23

mg/l

8.87

5430

37137

Subjective visual disturbances

4195

25955

1.91

235.24

2.2

1.7

0.95

1.20

mg/l

8.95

3165

20067

Type 2 diabetes, strict (exclude DM1)

14820

66012

1.40

235.21

2.0

1.7

1.23

1.17

mg/l

1.14

11813

50815

Synovial cyst of popliteal space [Baker]

1315

5451

3.35

235.21

2.1

1.7

1.11

1.46

mg/l

4.09

1074

4206

Bacterial pneumonia (organism specified)

6629

40678

1.64

234.06

2.3

1.7

1.54

1.34

mg/l

3.69

5567

31391

Cardiomyopathy

2511

13254

2.27

233.93

4.3

1.6

1.48

1.43

mg/l

0.29

2010

10474

Excessive, frequent and irregular menstruation

5953

20678

1.73

233.42

1.9

1.7

0.89

1.21

mg/l

15.42

4506

15815

Cervicalgia

3278

18896

2.05

233.16

2.0

1.7

0.98

1.29

mg/l

5.42

2490

14647

AV-block

2592

11682

2.23

232.26

2.2

1.6

1.55

1.61

mg/l

0.36

2074

9289

Cervical disc disorders

5238

33977

1.74

231.18

1.8

1.7

1.01

1.34

mg/l

13.20

4047

26719

Type 2 diabetes, definitions combined, including avohilmo

14798

65631

1.40

230.94

1.9

1.7

1.21

1.17

mg/l

0.73

11790

50456

COPD, hospital admission 2, with asthma infections

4617

24964

1.82

230.46

2.1

1.7

1.39

1.53

mg/l

1.77

3824

19732

Migraine with aura and triptan purchases

2865

16070

2.20

230.34

2.2

1.8

0.76

0.99

mg/l

5.77

2137

12075

Diseases of pulp and periapical tissues, including avohilmo

16126

64510

1.38

229.95

1.9

1.8

1.15

1.27

mg/l

4.11

12262

49854

Diseases of the digestive system

6850

46757

1.62

228.93

2.4

1.7

1.40

1.35

mg/l

0.60

5473

36373

Other diseases of anus and rectum

4587

28829

1.81

228.47

2.1

1.7

1.31

1.35

mg/l

0.22

3529

22493

Inflammatory diseases of female pelvic organs

10210

51319

1.50

227.40

1.9

1.7

0.89

1.09

mg/l

9.57

7734

39477

Chronic apical periodontitis

17477

76973

1.36

226.55

1.9

1.7

1.16

1.20

mg/l

0.90

13337

59355

Pain and other conditions associated with female genital organs and menstrual cycle

3437

16823

2.01

224.74

1.9

1.7

0.73

1.10

mg/l

20.20

2501

12754

Adjustment and management of implanted device

2738

15140

2.17

224.28

2.9

1.6

1.51

1.48

mg/l

0.18

2215

11748

Transient ischemic attack

7489

41646

1.59

224.18

2.1

1.7

1.23

1.43

mg/l

4.57

5966

32862

Systemic connective tissue disorders

5473

36356

1.72

223.34

2.1

1.7

1.27

1.26

mg/l

0.11

4408

28228

Cerebrovascular diseases

10692

54862

1.47

222.17

2.2

1.7

1.42

1.31

mg/l

2.35

8520

43173

Other arthritis (FG)

4711

30174

1.78

221.41

2.0

1.7

1.21

mg/l

0.03

3775

23167

Carpal tunnel syndrome

9505

60333

1.50

219.69

1.8

1.7

1.02

1.22

mg/l

9.82

7514

47070

Polyarthrosis

3092

15958

2.05

219.35

1.9

1.7

1.19

1.37

mg/l

2.80

2471

12479

Other and unspecified effects of external causes

4451

28342

1.82

218.91

2.1

1.9

1.00

1.13

mg/l

1.58

3347

21505

Unspecified fall

7870

54975

1.55

218.07

2.0

1.8

1.28

1.29

mg/l

0.04

6178

42415

Coxarthrosis [arthrosis of hip](FG)

7855

38002

1.56

216.76

1.8

1.7

1.36

1.30

mg/l

0.72

6424

29766

Implicit fungal Sepsis, including avohilmo

1343

5906

3.22

215.69

3.0

1.6

1.37

1.18

mg/l

0.95

1063

4536

Fibromyalgia

1647

7817

2.76

214.26

2.1

1.6

0.76

1.02

mg/l

5.18

1241

5955

Speech therapy

4037

25400

1.87

211.46

2.0

1.8

1.23

1.26

mg/l

0.17

3396

19765

Injuries to the abdomen, lower back, lumbar spine and pelvis

6304

42751

1.62

211.31

2.0

1.8

1.34

1.28

mg/l

0.65

4932

32953

Hernia of abdominal wall

6798

47646

1.59

208.50

1.9

1.8

1.30

1.27

mg/l

0.24

5428

37160

Transport accidents

7048

40908

1.57

208.22

1.9

1.8

1.08

1.21

mg/l

3.05

5391

31359

Rheumatism, unspecified

2075

10783

2.38

207.58

1.9

1.6

1.01

1.25

mg/l

3.65

1617

8381

Other bacterial intestinal infections, including avohilmo

3692

22740

1.89

206.81

2.3

1.7

1.29

1.27

mg/l

0.15

2937

17598

Gout, strict definition

2692

15245

2.13

206.68

2.2

1.7

1.49

1.54

mg/l

0.32

2185

12070

Hypothyroidism, strict autoimmune

11333

55966

1.43

206.50

1.9

1.7

1.14

1.20

mg/l

0.95

8698

43111

Other symptoms and signs involving cognitive functions and awareness

6827

42240

1.58

206.37

2.0

1.7

1.35

1.40

mg/l

0.56

5367

33297

Sequelae of external causes of morbidity and mortality

4021

25397

1.85

206.07

2.2

1.8

1.39

1.26

mg/l

1.79

3330

19704

Substance abuse, excluding more controls

8164

48987

1.52

205.96

1.9

1.7

1.27

1.22

mg/l

0.73

6390

37937

Enthesopathies of lower limb, excluding foot

3538

21544

1.91

205.45

1.9

1.7

0.99

1.20

mg/l

3.26

2747

16665

Dental pulpitis, including avohilmo

14249

70997

1.38

204.65

1.9

1.8

0.91

1.16

mg/l

20.50

10603

54602

Other diseases of the digestive system

4691

30557

1.74

204.56

2.6

1.7

1.46

1.42

mg/l

0.30

3787

23936

Asthma and allergy, excluding more controls

2029

10262

2.32

203.20

2.0

1.6

0.73

1.00

mg/l

6.87

1520

7553

Conjunctivitis

11943

73520

1.41

202.76

1.9

1.8

1.04

1.15

mg/l

2.58

9110

56238

Hypothyroidism, other/unspecified

13579

69192

1.38

201.12

1.9

1.7

1.12

1.22

mg/l

2.43

10424

53638

Enlarged lymph nodes

2359

12825

2.18

200.84

2.3

1.6

1.35

1.25

mg/l

0.50

1914

9786

Convulsions, not elsewhere classified

3266

19164

1.90

199.97

2.2

1.6

1.39

1.25

mg/l

1.20

2542

14453

Fenamates

2085

7187

2.31

198.86

1.8

2.0

0.99

1.68

mg/l

18.61

1628

5630

Migraine without aura and triptan purchases

2865

16758

2.06

198.45

2.2

1.8

0.76

0.96

mg/l

3.41

2119

12569

Asthma and allergy

2028

10345

2.29

198.09

2.0

1.6

0.73

1.01

mg/l

6.85

1519

7642

Adverse effects, not elsewhere classified

3233

19582

1.97

197.58

2.1

1.9

0.93

1.13

mg/l

3.78

2451

14903

Persons encountering health services for specific procedures, not carried out

1578

7651

2.72

196.31

2.3

1.7

1.23

1.06

mg/l

1.30

1230

5721

GI-bleeding

4646

30460

1.72

196.07

2.6

1.7

1.46

1.43

mg/l

0.24

3778

23853

Paralytic ileus and intestinal obstruction

3732

23199

1.83

196.06

2.1

1.7

1.61

1.40

mg/l

2.79

3112

18200

Pacemaker

5081

31543

1.69

195.53

2.9

1.7

1.49

1.53

mg/l

0.29

4021

25015

L04AA Selective immunosuppressants

3517

21837

1.91

195.18

3.5

1.8

1.66

1.12

mg/l

9.50

2982

16760

Injuries to the shoulder and upper arm

13024

77988

1.38

194.92

1.8

1.14

1.24

mg/l

3.94

10232

60134

Any operation in hilmo

553

602

5.41

194.14

1.9

1.2

1.16

0.49

mg/l

4.24

409

423

Symptoms and signs involving speech and voice

5112

34476

1.69

193.97

2.1

1.7

1.06

1.25

mg/l

4.17

4006

26854

Other CVD

3039

18106

1.98

193.75

2.0

1.7

1.46

1.50

mg/l

0.21

2470

14236

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

4294

27380

1.75

193.47

2.0

1.7

1.04

1.05

mg/l

0.09

3254

20878

Disorders of vestibular function (Vertigo)

7051

49140

1.55

192.71

1.9

1.7

1.07

1.30

mg/l

7.69

5450

38563

Hypothyreosis and Thyroxine purchase for inclusion criteria

14081

72229

1.37

192.59

1.9

1.7

1.12

1.21

mg/l

2.17

10821

55962

Propionic acid derivatives

3704

11069

1.84

192.34

1.8

2.2

1.26

1.73

mg/l

8.92

2783

8573

ILD, hospital admissions 3, with pneumonia sepsis

1373

6315

2.84

191.61

2.7

1.7

1.70

1.45

mg/l

1.21

1192

4870

Cellulitis

3476

21532

1.89

191.46

2.2

1.8

1.19

1.24

mg/l

0.44

2766

16573

2334

12972

2.19

190.65

3.5

1.7

1.28

1.08

mg/l

1.98

1829

9890

Other viral diseases, including avohilmo

5933

40778

1.61

190.43

2.3

1.9

1.09

1.07

mg/l

0.12

4532

30796

Hypo-osmolality and hyponatraemia

2670

15283

2.06

189.84

2.0

1.7

1.62

1.38

mg/l

1.70

2201

11850

Other symptoms and signs involving the nervous and musculoskeletal systems

6357

44828

1.58

188.41

2.1

1.8

0.93

1.22

mg/l

14.59

4792

34742

Polycystic ovarian syndrome, consortium definition

11409

49986

1.42

188.37

1.9

1.7

0.94

1.10

mg/l

6.14

8619

38460

Unspecified haematuria

5931

33311

1.60

188.26

1.9

1.8

1.51

1.39

mg/l

1.36

4685

26177

Personality disorders, excluding more controls

3940

25071

1.79

188.10

2.0

1.7

0.99

1.04

mg/l

0.49

2906

19083

Peripheral artery disease

5886

32011

1.61

187.96

2.0

1.7

1.63

1.43

mg/l

3.44

4877

25199

Urticaria and erythema

5681

39328

1.62

187.20

2.2

1.8

1.01

1.13

mg/l

2.07

4299

30194

Deforming dorsopathies

4084

26291

1.76

186.35

1.9

1.7

1.15

1.31

mg/l

2.60

3212

20278

Valvular operations

1945

10174

2.28

185.42

2.6

1.6

1.41

1.58

mg/l

1.53

1535

8059

Irregular menses

7769

42491

1.52

184.95

1.9

1.7

0.80

1.02

mg/l

13.56

5834

32559

Polyneuropathies and other disorders of the peripheral nervous system

3218

19746

1.92

184.90

2.3

1.8

1.31

1.39

mg/l

0.56

2585

15533

Somatoform disorder

2672

15658

2.06

184.25

2.2

1.7

0.90

1.13

mg/l

5.15

1995

12079

Other respiratory diseases principally affecting the interstitium

2666

15580

2.04

183.51

2.5

1.7

1.58

1.46

mg/l

0.74

2237

12271

Dislocation, sprain and strain of joints and ligaments of knee

9310

63166

1.44

182.63

1.8

0.95

1.13

mg/l

7.89

7175

48081

Panic disorder

2484

14239

2.09

182.48

2.1

1.7

0.97

1.01

mg/l

0.16

1796

10686

Temporomandibular joint disorders, including avohilmo

7165

50242

1.53

182.18

1.9

1.8

0.78

1.06

mg/l

18.00

5324

38272

Dipeptidyl peptidase 4 (DPP-4) inhibitors

7834

44840

1.50

181.90

2.0

1.7

1.48

1.35

mg/l

2.02

6362

35300

Second line medication for Crohn's disease

8707

64960

1.46

181.38

2.2

1.8

1.33

1.16

mg/l

3.79

6949

49965

Other diseases of hard tissues of teeth

8180

30644

1.50

181.12

1.9

1.7

1.16

1.42

mg/l

8.38

6224

24339

Other gastritis (incl. Duodenitis)

3257

20068

1.88

181.06

2.1

1.7

1.28

1.35

mg/l

0.47

2607

15776

Non-selective monoamine reuptake inhibitors

5387

35477

1.62

180.94

1.9

1.7

1.12

1.28

mg/l

3.62

4207

27977

Nonorganic sleeping disorders, excluding more controls

3249

20020

1.88

180.13

2.1

1.7

0.87

1.10

mg/l

6.74

2435

15272

L04AX Other immunosuppressants

8436

62816

1.47

178.79

2.3

1.8

1.33

1.16

mg/l

3.63

6734

48422

COPD, hospital admissions 1, only main diagnosis

4646

26593

1.68

177.98

2.0

1.7

1.40

1.52

mg/l

1.46

3819

21037

Diseases of oral cavity, salivary glands and jaws

8264

30892

1.48

177.71

1.9

1.7

1.23

1.42

mg/l

4.88

6361

24515

COPD, hospital admissions 3, with asthma pneumonia sepsis

3737

20325

1.79

177.49

2.2

1.7

1.44

1.57

mg/l

1.19

3136

16074

Hypotension

2626

15407

2.02

177.10

2.0

1.7

1.48

1.54

mg/l

0.33

2148

12114

Triptan medication for migraine, min. 3 purchases

8899

49747

1.46

176.68

1.9

1.8

0.79

1.01

mg/l

12.81

6776

37783

Primary_lymphoid and hematopoietic malignant neoplasms

3454

21809

1.84

175.58

2.6

1.8

1.89

1.39

mg/l

5.60

2907

17041

Special screening examination for infectious and parasitic diseases

3777

17345

1.77

175.57

2.0

1.6

0.97

1.03

mg/l

0.43

2685

13054

Other bacterial intestinal infections

2774

16572

1.97

174.98

2.4

1.7

1.36

1.33

mg/l

0.21

2242

12889

ILD, hospital admissions

2254

12789

2.14

173.35

2.4

1.7

1.54

1.47

mg/l

0.28

1887

10070

Anti-inflammatory and antirheumatic products, non-steroids

3619

11070

1.79

172.10

1.8

2.2

1.25

1.73

mg/l

9.52

2730

8574

Other shoulder lesions

1536

7668

2.51

171.95

2.0

1.7

0.95

1.24

mg/l

3.75

1165

5851

Other interstitial pulmonary diseases

2277

12993

2.12

171.41

2.4

1.7

1.55

1.48

mg/l

0.32

1904

10237

Interstitial lung disease endpoints

2277

13000

2.12

171.10

2.4

1.7

1.55

1.48

mg/l

0.30

1904

10239

Interstitial lung disease

2277

13000

2.12

171.10

2.4

1.7

1.55

1.48

mg/l

0.30

1904

10239

Other and unspecified polyneuropathies, also in other diseases

2812

17017

1.96

170.88

2.3

1.8

1.30

1.42

mg/l

0.92

2256

13394

Other viral diseases, not elsewhere classified, including avohilmo

4178

27500

1.72

170.73

2.3

1.9

1.02

1.09

mg/l

0.51

3211

20803

Noninfective enteritis and colitis

6911

50136

1.51

170.49

2.1

1.8

1.19

1.18

mg/l

0.10

5373

38404

Missing teeth due to accident, extraction or parodontitis

9041

61086

1.44

170.10

1.9

1.7

1.20

1.29

mg/l

1.72

6949

48150

Atherosclerosis, excluding cerebral and coronary sclerosis

5447

29588

1.60

169.61

2.0

1.7

1.68

1.45

mg/l

3.71

4545

23331

Diseases of inner ear

7960

56657

1.47

169.23

1.9

1.7

1.11

1.29

mg/l

3.98

6161

44425

Fracture of rib(s), sternum and thoracic spine

4500

30311

1.67

169.14

2.0

1.8

1.46

1.34

mg/l

1.29

3613

23669

Cutaneous abscess, furuncle and carbuncle

4001

26338

1.73

168.56

2.3

1.8

1.25

1.17

mg/l

0.76

3132

20063

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

5097

21936

1.65

168.38

2.0

1.7

0.94

0.79

mg/l

3.31

3898

16173

Sequelae with surgical and medical care as external cause

3122

19524

1.89

168.22

2.2

1.8

1.44

1.28

mg/l

1.93

2614

15205

Chronic gastritis

3787

24583

1.75

167.96

1.9

1.7

1.27

1.43

mg/l

2.96

2949

19419

Diseases of liver

5072

35079

1.62

167.70

2.2

1.8

1.62

1.19

mg/l

12.44

4136

27331

Injuries to the wrist and hand

15474

82627

1.32

166.46

1.9

1.8

1.04

1.22

mg/l

8.68

11697

63837

Spontaneous rupture of synovium and tendon

1303

6205

2.69

166.19

2.0

1.7

1.20

1.44

mg/l

2.41

1049

4805

Other obstetric conditions, not elsewhere classified

5196

22564

1.64

165.59

2.0

1.7

0.94

0.79

mg/l

3.42

3977

16646

Stroke, excluding SAH

8179

43873

1.46

165.51

2.2

1.7

1.47

1.41

mg/l

0.63

6561

34535

Diabetes medication

15802

74394

1.31

164.57

1.9

1.8

1.22

1.17

mg/l

0.95

12519

56951

Disorders of other endocrine glands

6643

47498

1.51

164.46

2.1

1.8

1.20

1.21

mg/l

0.02

5117

36505

Early onset COPD

3120

19532

1.86

164.40

2.1

1.8

1.23

1.31

mg/l

0.65

2523

15333

Other systemic involvement of connective tissue

4162

27872

1.71

163.70

2.0

1.7

1.17

1.25

mg/l

0.90

3336

21647

Other diseases of blood and blood-forming organs, wide

3293

20973

1.83

163.55

2.5

1.8

1.60

1.24

mg/l

5.33

2654

16309

Rheumatoid arthritis

4409

26132

1.66

163.51

1.8

1.7

1.45

1.31

mg/l

1.75

3566

20297

Viral hepatitis, IBD co-morbidity

788

2938

3.35

163.19

2.2

1.5

1.43

1.20

mg/l

0.48

620

2125

Glucagon-like peptide-1 (GLP-1) analogues

4653

31887

1.65

162.96

2.0

1.8

0.95

1.12

mg/l

4.32

3673

24842

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

4653

31887

1.65

162.96

2.0

1.8

0.95

1.12

mg/l

4.32

3673

24842

Zoster [herpes zoster], including avohilmo

7635

54806

1.47

162.37

2.0

1.7

1.20

1.30

mg/l

1.46

5982

42835

Voice disturbances

4066

27202

1.72

161.71

1.9

1.7

0.96

1.20

mg/l

7.29

3166

21170

Radiculopathy

2306

13350

2.02

160.58

2.1

1.7

1.10

1.44

mg/l

5.56

1782

10437

Injuries to the hip and thigh

7042

46333

1.48

159.30

1.9

1.7

1.40

1.33

mg/l

0.85

5707

35944

ILD, hospital admissions 1, main diag only

2016

11375

2.17

158.64

2.5

1.7

1.52

1.48

mg/l

0.15

1699

8952

Presence of other functional implants

8210

41971

1.45

158.42

1.8

1.6

1.29

1.36

mg/l

1.05

6456

33068

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

13858

65571

1.33

158.35

1.9

1.8

1.23

1.17

mg/l

1.17

10922

50347

Myocarditis

719

2622

3.57

158.04

3.2

1.5

1.44

0.76

mg/l

2.29

564

1910

Malignant neoplasm, wide definition

12992

59919

1.34

157.99

2.0

1.8

1.49

1.01

mg/l

31.56

10369

45967

Malignant neoplasm, including Hilmo

12977

59876

1.34

157.98

2.0

1.8

1.49

1.01

mg/l

31.36

10362

45921

COPD-related respiratory insufficiency

1702

9068

2.30

157.90

2.4

1.7

1.51

1.58

mg/l

0.24

1421

7162

Menorrhagia

4911

18644

1.64

157.64

1.9

1.7

0.95

1.23

mg/l

9.20

3724

14441

Polyuria

3209

20410

1.81

157.23

1.9

1.8

1.21

1.38

mg/l

1.97

2455

15991

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

5905

41834

1.53

156.45

2.1

1.8

0.89

1.08

mg/l

5.72

4445

31444

Endometriosis

4921

19549

1.63

156.41

1.8

1.7

0.96

1.22

mg/l

5.14

3750

15056

Dermatophytosis, including avohilmo

9802

74354

1.39

155.64

1.8

1.03

1.22

mg/l

8.50

7500

57365

Diseases of pulp and periapical tissues and dental caries

9498

36951

1.41

154.00

1.8

1.7

1.23

1.38

mg/l

3.82

7247

29146

Stroke, including SAH

8580

46597

1.43

153.44

2.2

1.7

1.47

1.38

mg/l

1.47

6885

36665

Other enthesopathy of foot (+metatarsalgia)

1609

8508

2.31

152.28

1.9

1.7

0.94

1.24

mg/l

4.03

1235

6527

Urticaria

4581

31711

1.62

151.36

2.2

1.8

0.96

1.12

mg/l

2.58

3436

24272

Hypokalaemia

1881

10518

2.17

150.78

2.0

1.7

1.44

1.30

mg/l

0.90

1518

8136

Cardiomyopathies, Primary/intrinsic

1639

8693

2.25

150.76

5.4

1.6

1.56

1.46

mg/l

0.46

1337

6885

Dentofacial anomalies [including malocclusion]

10731

65817

1.37

150.59

1.9

1.8

0.87

1.11

mg/l

15.00

7940

50479

Other (not insulin) diabetes medications

14683

69613

1.31

150.55

1.9

1.7

1.23

1.18

mg/l

0.90

11684

53664

Mycoses

4185

28516

1.66

150.39

2.2

1.8

1.15

1.22

mg/l

0.71

3242

22058

Caries of dentine, including avohilmo

11425

45610

1.36

150.10

1.8

1.20

1.33

mg/l

3.82

8734

35826

Dental caries, including avohilmo

10576

41869

1.38

149.86

1.8

1.7

1.23

1.35

mg/l

2.60

8098

33003

Disease of hard tissues of teeth, NOS

7698

29807

1.46

149.65

1.8

1.7

0.96

1.40

mg/l

30.81

5839

23691

Other inflammation of eyelid, including avohilmo

6910

51326

1.47

148.85

1.9

1.8

0.89

1.15

mg/l

11.25

5275

39171

Ischaemic Stroke, excluding all haemorrhages

7566

41586

1.45

148.69

2.2

1.7

1.44

mg/l

0.01

6070

32779

Other or unspecified ileus, impaction or obstruction

2584

15739

1.88

147.73

2.1

1.7

1.71

1.42

mg/l

3.05

2194

12324

Injuries to the neck

3535

23345

1.73

147.51

2.0

1.8

0.95

1.16

mg/l

3.34

2657

17767

Benign paroxysmal vertigo

4335

29907

1.64

147.15

1.9

1.7

1.07

1.29

mg/l

4.37

3385

23433

Retention of urine

4591

25527

1.60

147.04

1.9

1.7

1.56

1.46

mg/l

0.88

3700

20159

Impingement syndrome of shoulder

3093

19720

1.77

146.72

1.9

1.7

1.07

1.37

mg/l

6.04

2396

15493

All influenza (not pneumonia)

2161

12618

2.00

146.17

2.3

1.7

1.09

1.17

mg/l

0.41

1655

9437

Peripheral arterial reconstruction

2318

13854

1.96

145.05

2.1

1.7

1.72

1.59

mg/l

0.95

1960

10957

Superficial injury of head

3622

24035

1.70

144.97

1.9

1.8

1.22

1.28

mg/l

0.50

2861

18500

Malignant neoplasm

12549

58634

1.33

144.19

2.0

1.8

1.48

1.01

mg/l

31.38

10057

45074

Metatarsalgia

1488

7812

2.34

144.11

1.9

1.7

0.95

1.25

mg/l

3.68

1145

5988

Chronic diseases of tonsils and adenoids

11443

57066

1.34

142.47

1.9

1.8

0.90

1.21

mg/l

21.73

8770

43851

Gingivitis and periodontal diseases

14663

61337

1.30

142.42

1.9

1.7

1.18

1.25

mg/l

1.58

11182

47820

Bacterial intestinal infections, IBD co-morbidities

2735

17182

1.85

142.29

2.4

1.8

1.35

1.31

mg/l

0.22

2216

13373

Dental operations

8706

33937

1.41

142.17

1.8

1.7

1.26

1.38

mg/l

2.03

6705

26845

Care involving dialysis

1233

6133

2.58

142.17

3.6

1.7

2.36

1.28

mg/l

8.06

1103

4700

Malignant neoplasm

12527

58616

1.33

142.07

2.0

1.8

1.48

1.01

mg/l

31.33

10041

45066

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1477

7851

2.38

141.84

2.6

1.8

1.20

1.19

mg/l

0.04

1160

5989

Dislocation, sprain and strain of joints and ligaments at neck level

2453

15080

1.92

141.06

2.0

1.8

0.74

1.06

mg/l

11.57

1817

11356

Other noninfective gastroenteritis and colitis

3605

24082

1.69

140.55

2.2

1.9

1.27

1.24

mg/l

0.21

2813

18500

Symptoms and signs concerning food and fluid intake

1525

8067

2.25

140.36

2.2

1.6

1.32

1.38

mg/l

0.18

1130

6192

Gastroduodenal ulcer

3435

22569

1.69

139.52

2.2

1.7

1.59

1.50

mg/l

0.63

2817

17855

Ventral hernia

3432

22777

1.71

139.25

2.0

1.7

1.36

1.26

mg/l

0.97

2767

17818

Streptococcal septicaemia, including avohilmo

1387

7208

2.38

138.95

2.5

1.7

2.15

1.35

mg/l

5.90

1167

5502

Explicit bacterial Sepsis, including avohilmo

1608

8748

2.21

138.67

2.5

1.7

2.05

1.26

mg/l

7.30

1348

6698

Mental and behavioural disorders due to psychoactive substance use

8442

59478

1.39

138.12

1.9

1.8

1.27

1.22

mg/l

0.88

6595

45722

Complications of internal orthopaedic prosthetic devices, implants and grafts

3160

20641

1.75

137.94

1.9

1.7

1.48

1.38

mg/l

1.00

2647

16198

Vasomotor and allergic rhinitis

5541

39203

1.51

137.83

1.9

0.90

1.16

mg/l

7.59

4159

29884

Volume depletion

1422

7439

2.31

137.46

2.4

1.7

1.73

1.47

mg/l

1.16

1179

5740

Cardiomyopathy (excluding other)

1679

9253

2.14

137.27

5.3

1.6

1.58

1.43

mg/l

0.83

1370

7273

Viral infections characterized by skin and mucous membrane lesions

6169

45605

1.48

136.54

2.2

1.8

1.19

1.20

mg/l

0.06

4797

35248

Insulin, intermediate and long-acting

7639

56150

1.42

136.36

2.0

1.8

1.32

1.31

mg/l

0.17

6162

43481

Osteoporosis

3809

23798

1.66

136.28

2.2

1.7

1.52

1.41

mg/l

1.03

3120

18644

Haemorrhoids and perianal venous thrombosis

4711

32984

1.55

135.84

1.9

1.7

1.14

1.34

mg/l

3.25

3666

25714

Substance abuse

8164

58268

1.40

135.11

1.9

1.8

1.27

1.22

mg/l

0.77

6390

44786

Other complications of surgical and medical care, not elsewhere classified

1563

8580

2.26

135.00

2.4

1.7

1.17

1.19

mg/l

0.09

1259

6571

Hypothyroidism, strict autoimmune, 3 medication purchases required

12492

67694

1.32

133.76

1.8

1.7

1.14

1.21

mg/l

1.04

9590

52455

Hallux valgus (acquired)

4569

22809

1.58

133.31

1.7

1.10

1.22

mg/l

1.89

3611

17698

Fibroblastic disorders

2964

19072

1.73

133.18

1.8

1.7

1.24

1.47

mg/l

2.66

2327

14979

Other diseases of intestine

2230

13508

1.92

132.80

2.1

1.7

1.42

1.32

mg/l

0.66

1802

10587

Intestinal stricture

4292

30058

1.59

131.88

2.1

1.8

1.74

1.33

mg/l

8.07

3575

23538

Pleural effusion

2137

12828

1.94

131.71

2.1

1.7

2.00

1.52

mg/l

6.24

1813

10058

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

9530

68315

1.36

131.59

2.0

1.8

1.12

1.10

mg/l

0.17

7340

51968

Streptococcal septicaemia

1341

7017

2.35

131.55

2.5

1.7

2.16

1.34

mg/l

5.77

1124

5349

Inflammatory disease of uterus

2267

13954

1.94

131.55

2.1

1.7

0.79

0.99

mg/l

4.11

1735

10637

Purpura and other haemorrhagic conditions

2022

12036

2.01

131.54

2.7

1.8

1.91

1.25

mg/l

6.65

1669

9320

Explicit bacterial Sepsis

1557

8535

2.19

131.01

2.5

1.6

2.06

1.27

mg/l

6.93

1302

6528

Abnormal involuntary movements

2058

12331

1.99

130.97

2.2

1.8

1.16

1.29

mg/l

0.84

1618

9534

Misadventures to patients during surgical and medical care

2174

13210

1.95

130.77

2.2

1.7

1.44

1.25

mg/l

1.42

1766

10213

Haemorrhage, not elsewhere classified

648

2527

3.53

129.93

4.0

1.6

2.31

1.56

mg/l

2.02

525

1963

Cervicocranial syndrome

1646

9233

2.14

129.86

1.9

1.6

0.89

1.30

mg/l

7.89

1282

7102

Umbilical hernia

3838

26417

1.63

129.72

1.9

1.8

1.27

1.22

mg/l

0.34

3047

20538

Other general symptoms and signs

858

3760

2.93

129.67

2.4

1.6

1.05

1.16

mg/l

0.26

638

2830

Diabetes, insulin treatment (Kela reimbursement)

14710

71849

1.28

129.48

1.9

1.8

1.24

1.19

mg/l

1.02

11626

55435

Insulin medication

8387

53844

1.38

129.38

2.0

1.8

1.33

1.27

mg/l

0.85

6778

41548

Viral and other specified intestinal infections, including avohilmo

4119

27491

1.59

129.36

2.3

1.8

1.01

1.13

mg/l

1.49

3109

20252

Other disorders of patella

2491

15633

1.83

128.30

1.8

1.7

0.89

1.08

mg/l

2.97

1909

11950

Reimbursement for rheumatic diseases

8191

63256

1.39

127.77

1.9

1.8

1.32

1.19

mg/l

2.94

6539

48945

Other viral diseases

4231

29610

1.58

127.58

2.4

1.9

1.22

1.10

mg/l

0.96

3241

22350

Fungal Sepsis

747

3206

3.30

126.40

3.5

1.6

1.67

1.24

mg/l

1.55

612

2468

Other cataract

5932

32524

1.47

125.78

1.9

1.7

1.30

1.34

mg/l

0.34

4722

25652

Biguanides

14064

69653

1.28

125.18

1.8

1.7

1.23

1.19

mg/l

0.64

11168

53850

Any event in cancer register

13509

64426

1.29

125.12

2.0

1.8

1.45

1.03

mg/l

27.74

10732

49387

Implicit fungal Sepsis

700

2947

3.41

124.00

3.4

1.6

1.63

1.22

mg/l

1.33

570

2274

Other disorders of bone

2910

19151

1.74

123.95

2.1

1.8

0.95

1.11

mg/l

2.08

2217

14685

Poisoning by drugs, medicaments and biological substances

3491

23835

1.65

123.41

2.0

1.8

1.13

1.06

mg/l

0.45

2628

18010

ILD medications: azathioprine

2083

12639

1.91

122.55

2.9

1.7

1.57

1.11

mg/l

3.64

1676

9526

Unspecified acute lower respiratory infection

2274

14154

1.86

122.40

2.4

1.8

1.13

1.25

mg/l

1.01

1878

10923

Noninflammatory disorders of female genital tract

5667

20707

1.49

121.45

1.9

1.7

1.03

1.21

mg/l

2.85

4286

15835

Calcific aortic valvular stenosis

3836

25644

1.59

121.07

1.8

1.7

1.40

1.60

mg/l

3.44

3107

20365

Calcific aortic valvular stenosis, operated

3836

25644

1.59

121.07

1.8

1.7

1.40

1.60

mg/l

3.44

3107

20365

Other diseases of liver

2688

17515

1.77

120.67

2.2

1.8

1.35

1.16

mg/l

1.79

2119

13549

Calcific aortic valvular stenosis, diagnosis (helper)

3825

25607

1.59

119.76

1.8

1.7

1.40

1.60

mg/l

3.45

3099

20336

Operations 2 for CAVS

3825

25607

1.59

119.76

1.8

1.7

1.40

1.60

mg/l

3.45

3099

20336

Spondylolisthesis/Spondylolysis

2510

16033

1.78

119.76

1.8

1.7

1.17

1.30

mg/l

1.21

1995

12485

Congenital malformations, deformations and chromosomal abnormalities

8537

63598

1.36

119.75

2.1

1.8

1.12

1.08

mg/l

0.33

6556

48206

Epilepsy

4032

28157

1.56

119.45

2.0

1.8

1.25

1.38

mg/l

1.59

3193

21817

Substance use, excluding alcohol

2873

18967

1.72

119.24

2.0

1.8

1.12

1.10

mg/l

0.10

2203

14238

Abnormal findings on examination of blood, without diagnosis

6339

43339

1.43

119.18

2.1

1.8

1.51

1.33

mg/l

2.52

5120

33941

Other disorders of ear

13297

70532

1.28

118.69

1.8

1.20

1.23

mg/l

0.26

10221

55039

Other and unspecified drugs and medicaments

1367

7536

2.28

118.40

2.6

1.9

1.22

1.19

mg/l

0.14

1079

5784

Aortic aneurysm

2910

18792

1.69

118.39

2.1

1.7

2.26

1.47

mg/l

13.57

2355

14773

Calcific aortic valvular stenosis, including rheumatic fever

3831

25689

1.58

118.15

1.8

1.7

1.39

1.60

mg/l

3.51

3103

20402

Gastric ulcer

2354

14820

1.80

118.13

2.2

1.7

1.60

1.49

mg/l

0.69

1935

11701

Thoracic aortic aneurysm

1945

11754

1.94

118.04

2.0

1.7

1.76

1.38

mg/l

2.80

1538

9193

Disorders of muscles

1463

8121

2.14

117.69

2.1

1.7

1.07

1.30

mg/l

2.27

1161

6203

Extrapyramidal and movement disorders

5351

39652

1.48

117.65

1.8

1.7

1.20

1.35

mg/l

2.59

4154

31100

Unspecified kidney failure

1492

8359

2.13

117.62

2.5

1.7

1.91

1.50

mg/l

3.65

1283

6525

Other pulmonary heart/vessel disease

739

3240

3.11

117.54

4.9

1.7

1.59

1.41

mg/l

0.48

614

2535

Open wound of lower leg

2212

13810

1.85

117.28

2.1

1.9

1.26

1.31

mg/l

0.33

1764

10555

Emphysema

1045

5202

2.48

116.93

2.2

1.7

1.33

1.60

mg/l

1.79

874

4112

Striking against or struck by other objects

4767

34637

1.50

116.19

2.0

1.9

1.06

1.17

mg/l

1.53

3547

26214

Poisoning by medicine

3164

21450

1.67

116.18

2.0

1.8

1.08

1.06

mg/l

0.14

2386

16187

Nonorganic sleeping disorders

3249

22161

1.66

116.11

2.1

1.8

0.87

1.09

mg/l

6.58

2435

16773

Other disorders of eye and adnexa

2182

13728

1.87

114.67

2.3

1.8

1.19

1.15

mg/l

0.13

1619

10543

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

8157

61450

1.36

114.53

1.8

1.04

1.11

mg/l

0.93

6212

46875

Glomerular diseases

2485

16091

1.78

113.78

2.2

1.8

1.82

1.29

mg/l

6.84

2108

12480

Need for other prophylactic measures

946

4675

2.69

113.46

3.3

1.9

1.37

1.22

mg/l

0.49

786

3589

Hyperkalaemia

896

4279

2.66

113.10

2.7

1.6

1.62

1.57

mg/l

0.11

767

3312

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

4294

30929

1.53

113.03

2.0

1.8

1.04

mg/l

0.01

3254

23388

Generalized anxiety disorder

2484

16020

1.76

112.99

2.0

1.8

0.95

1.02

mg/l

0.43

1758

11951

Conjunctivitis (acute, non atopic)

4103

29189

1.55

112.78

2.1

1.9

1.04

1.15

mg/l

1.55

3138

22348

Azathioprine

2083

12928

1.86

112.45

2.9

1.8

1.57

1.12

mg/l

3.44

1676

9787

Secondary right heart disease

676

2913

3.21

112.19

5.1

1.6

1.63

1.41

mg/l

0.54

562

2285

Solid cancers, including Hilmo

12356

58926

1.29

112.00

1.8

1.50

1.01

mg/l

30.39

9824

45275

Personality disorders

3940

28032

1.56

111.66

2.0

1.8

0.99

1.03

mg/l

0.32

2906

21181

Appendectomy

9409

71824

1.33

111.52

1.9

1.8

1.12

mg/l

0.02

7273

55112

Use of pramipexole

3063

20857

1.67

111.30

1.9

1.7

1.13

1.32

mg/l

3.54

2403

16359

Disorders of lens

8993

44146

1.34

111.09

1.9

1.8

1.28

1.25

mg/l

0.35

7195

34886

Mouth breathing

5327

39744

1.46

110.92

1.9

1.00

1.22

mg/l

5.77

4116

30941

Other symptoms and signs involving the digestive system and abdomen

2336

14922

1.77

110.40

2.0

1.6

1.18

1.24

mg/l

0.44

1782

11651

Fall on same level involving ice and snow

8378

66491

1.35

109.44

1.8

1.14

1.22

mg/l

1.45

6540

51423

Insulin, combination of fast acting with intermediate-acting or long-acting

8401

60347

1.34

109.06

2.0

1.8

1.33

1.30

mg/l

0.32

6789

46711

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

6632

44396

1.41

109.03

2.0

1.7

1.15

0.97

mg/l

4.46

5263

33880

Enterocolitis due to Clostridium difficile

1562

9096

2.04

108.85

2.7

1.8

1.58

1.42

mg/l

0.93

1287

7098

Other diseases of pericardium

709

3144

2.99

108.51

2.4

1.6

1.90

1.36

mg/l

3.13

592

2472

Problems related to lifestyle

1564

9096

2.03

108.36

2.1

1.7

1.08

1.12

mg/l

0.24

1207

6927

Other extrapyramidal and movement disorders in other diseases

3494

24512

1.60

108.12

1.8

1.11

1.27

mg/l

1.91

2666

19173

Abnormalities of gait and mobility

1707

10229

1.98

107.92

2.0

1.8

1.59

1.48

mg/l

0.37

1339

8003

Other disorders of eyelid

6007

43163

1.42

107.67

1.8

1.7

1.26

1.39

mg/l

1.61

4723

34107

Allergic conjunctivitis

8479

64975

1.34

107.44

1.8

1.03

1.11

mg/l

0.97

6463

49544

Other/unspecified synovitis and tenosynovitis

1580

9218

2.00

107.03

1.9

1.7

1.00

1.31

mg/l

4.72

1229

7076

Other hammer toe(s) (acquired)

2228

12863

1.79

106.93

1.8

1.7

1.26

1.42

mg/l

1.61

1770

10062

Fracture of lower leg, including ankle

7722

59691

1.35

106.76

1.8

1.26

1.24

mg/l

0.24

6129

45924

Disorders of adult personality and behaviour

4123

29781

1.53

106.63

2.0

1.8

0.99

1.02

mg/l

0.31

3025

22448

Candidiasis

2159

13807

1.83

106.15

2.4

1.8

1.05

1.18

mg/l

1.88

1649

10622

Disorders of skin appendages

7222

56236

1.37

105.97

2.0

1.8

0.97

1.14

mg/l

6.80

5442

42932

Unspecified privation

1605

9534

2.02

105.93

2.5

1.8

1.38

1.24

mg/l

0.78

1292

7279

Other diseases of lip and oral mucosa

5996

45901

1.42

105.90

2.0

1.8

1.05

1.19

mg/l

3.27

4533

35627

Coxarthrosis, primary

7991

52420

1.35

105.86

1.8

1.7

1.38

1.37

mg/l

0.07

6525

41384

Kidney transplant status

849

4144

2.75

105.79

3.0

2.0

2.11

1.22

mg/l

4.08

781

3158

Certain disorders involving the immune mechanism

2659

17801

1.71

105.22

2.6

1.8

1.32

1.21

mg/l

0.58

2133

13830

Exclusions for E4_PCOS_CONSORTIUM

10711

54412

1.30

105.11

1.8

1.03

1.10

mg/l

1.66

8181

41674

Ganglion

2829

19019

1.65

105.03

1.7

0.85

1.18

mg/l

10.73

2179

14588

Atopic dermatitis

8785

55886

1.33

104.72

1.8

0.95

1.08

mg/l

3.23

6578

42509

Lateral epicondylitis

1814

11056

1.89

104.61

1.7

0.91

1.14

mg/l

1.50

1384

8566

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

4038

28823

1.53

104.26

2.5

1.8

1.03

mg/l

0.03

3098

21657

Open wound of head

7493

55262

1.35

104.17

1.9

1.8

1.38

1.30

mg/l

1.25

5815

42725

Glomerular disorders in diseases classified elsewhere

1644

9856

1.98

104.15

2.3

1.8

1.89

1.31

mg/l

5.10

1420

7626

Unspecified/other endometriosis

1443

8133

2.07

104.04

1.9

1.7

0.80

1.06

mg/l

4.02

1058

6163

Sulfasalazine

3855

27565

1.53

103.92

1.8

1.7

1.25

1.16

mg/l

0.94

3052

21116

Superficial injury of abdomen, lower back and pelvis

2323

15112

1.76

103.71

2.0

1.8

0.98

1.19

mg/l

2.74

1755

11487

Iron deficiency anaemia secondary to blood loss (chronic)

2270

14693

1.77

103.65

3.3

1.7

1.65

1.35

mg/l

2.22

1820

11498

Disorders of vitreous body

6891

51205

1.38

103.40

1.9

1.7

1.09

1.31

mg/l

6.87

5391

40483

Diseases of salivary glands

4664

34573

1.48

103.28

1.9

1.8

1.06

1.17

mg/l

1.89

3606

26672

Post-traumatic stress disorder

1392

7970

2.09

103.06

2.2

1.7

0.76

0.97

mg/l

3.00

1025

5926

Disorder of lipoprotein metabolism, unspecified

1747

10603

1.91

102.99

1.9

1.7

1.47

1.41

mg/l

0.24

1394

8273

Disorders of vitreous body and globe

7059

52318

1.37

102.89

1.8

1.7

1.09

1.31

mg/l

6.95

5517

41357

Other and unspecified tonsillitis

4671

28514

1.47

102.82

2.1

1.8

0.96

1.06

mg/l

1.26

3442

21446

Fissure and fistula of anal and rectal regions

3260

22693

1.59

102.09

1.9

1.7

1.08

1.20

mg/l

1.13

2439

17533

Deviated nasal septum

4274

31143

1.49

101.99

1.8

1.15

1.31

mg/l

1.95

3240

24329

Specific personality disorders

3406

24050

1.58

100.95

2.0

1.8

1.00

1.03

mg/l

0.24

2508

18214

Other viral diseases, not elsewhere classified

2610

17448

1.69

100.70

2.5

1.9

1.20

1.12

mg/l

0.37

2026

13278

Other retinal disorders

8666

52687

1.32

100.65

1.8

1.7

1.37

1.35

mg/l

0.22

6848

41176

Bipolar affective disorders

2703

18255

1.67

100.49

2.0

1.7

1.04

1.05

mg/l

0.01

2015

13865

Other abnormal uterine and vaginal bleeding

3145

15545

1.61

100.46

1.9

1.7

1.10

1.28

mg/l

2.16

2416

12129

Disorders of sclera, cornea, iris and ciliary body

7812

62195

1.34

100.00

1.9

1.8

1.11

1.20

mg/l

1.61

6063

48056

Idiopathic gout

1300

7382

2.13

99.51

1.9

1.7

1.43

1.51

mg/l

0.46

1065

5829

Cardiomyopathy, other and unspecified

1049

5536

2.29

99.43

4.7

1.6

1.48

1.36

mg/l

0.41

834

4353

Childhood asthma (age<16), excluding more controls

1719

7989

1.87

99.34

2.1

1.6

0.98

1.01

mg/l

0.12

1214

5626

Superficial injury of wrist and hand

3035

21015

1.61

99.22

2.1

1.9

0.86

1.16

mg/l

11.70

2258

15948

Adhesive capsulitis of shoulder

2118

13553

1.76

99.03

1.9

1.7

1.04

1.33

mg/l

3.97

1666

10586

Neuralgia and neuritis, unspecified

797

3841

2.65

99.01

2.0

1.7

1.01

1.30

mg/l

1.56

613

2936

Nonischemic cardiomyopathy

1328

7558

2.07

98.53

4.0

1.7

1.72

1.47

mg/l

1.26

1099

5874

Fracture of lumbar spine and pelvis

3095

21499

1.60

98.20

2.0

1.7

1.58

1.40

mg/l

1.90

2515

16763

Solid cancers

11878

57531

1.27

98.15

1.8

1.49

1.01

mg/l

29.72

9483

44288

Ocular pain

1364

7959

2.10

97.41

2.3

1.8

0.88

1.09

mg/l

1.95

1002

6091

Pregnancy hypertension

5974

41299

1.40

97.37

2.0

1.7

1.17

0.94

mg/l

5.82

4732

31494

Senile cataract

8042

38797

1.34

96.84

1.9

1.7

1.33

1.31

mg/l

0.26

6416

30753

Other and unspecified visual disturbances

1599

9736

1.96

96.49

2.3

1.8

1.08

1.23

mg/l

0.65

1255

7515

Childhood asthma (age<16)

1720

8073

1.85

95.96

2.1

1.7

0.98

1.02

mg/l

0.15

1214

5690

Disorders of choroid and retina

11122

64232

1.27

95.71

1.9

1.8

1.32

1.28

mg/l

0.60

8750

50220

Female infertility

3937

16952

1.52

95.58

1.8

1.7

1.01

1.12

mg/l

1.67

3016

12962

Diseases of external ear

4893

36913

1.44

95.33

1.9

1.8

1.06

1.26

mg/l

5.10

3706

28633

Trigger finger

1927

12189

1.79

95.14

1.9

1.7

0.91

1.26

mg/l

7.82

1523

9450

Cardiac arrest

722

2763

2.56

94.66

3.1

1.4

3.20

1.04

mg/l

7.43

604

2069

Diseases of male genital organs

6097

23380

1.39

94.58

1.8

2.0

1.26

1.38

mg/l

1.46

4674

18011

Plantar fascial fibromatosis

1380

8050

2.01

94.46

1.8

1.7

1.08

1.21

mg/l

0.77

1072

6214

Periodontitis

14382

77502

1.24

93.88

1.9

1.7

1.25

1.19

mg/l

1.24

11125

60092

Noninfectious colitis NAS

1968

12633

1.80

93.77

2.1

1.8

1.20

1.24

mg/l

0.19

1524

9662

Chronic laryngitis and laryngotracheitis

1954

12511

1.80

93.71

1.9

1.7

0.91

1.31

mg/l

11.35

1451

9811

Herpesviral [herpes simplex] infections, including avohilmo

3778

27529

1.52

93.52

1.9

1.8

0.94

1.08

mg/l

2.18

2852

21064

Stomatitis and related lesions

2836

19663

1.62

93.39

2.2

1.8

1.09

1.17

mg/l

1.01

2187

15023

Other maternal disorders predominantly related to pregnancy

8030

40194

1.34

93.32

1.8

1.7

0.90

1.00

mg/l

3.08

6181

30671

Localized swelling, mass and lump of skin and subcutaneous tissue

4406

32848

1.46

92.99

2.0

1.8

1.22

1.23

mg/l

0.08

3437

25508

Fracture of foot, except ankle

3506

25210

1.53

92.90

2.0

1.8

0.99

1.14

mg/l

2.66

2750

19126

Zoster [herpes zoster]

2578

17559

1.66

92.87

2.2

1.7

1.34

1.35

mg/l

0.05

2048

13724

Status post-ami

2932

15270

1.59

92.48

2.5

1.6

1.42

1.67

mg/l

3.47

2361

12055

Chronic periodontitis, including avohilmo

14342

77465

1.24

92.37

1.9

1.7

1.25

1.19

mg/l

1.26

11103

60064

Diagnoses used for exclusion with ILD

3345

23858

1.54

92.35

2.1

1.8

1.47

1.34

mg/l

0.87

2681

18675

Chondrocostal junction syndrome [Tietze]

676

3211

2.96

92.24

2.5

1.7

0.67

1.11

mg/l

11.06

519

2449

Maternal care for other conditions predominantly related to pregnancy

3095

21306

1.58

92.22

1.9

1.7

0.77

0.86

mg/l

1.73

2374

16011

Alcohol use disorder, Swedish definition

7262

52440

1.34

91.75

1.9

1.8

1.43

1.23

mg/l

4.35

5713

40524

Vascular disorders of the intestines

947

4956

2.31

91.67

2.7

1.6

1.91

1.59

mg/l

1.42

805

3903

Other local infections of skin and subcutaneous tissue

1514

9186

1.95

91.56

2.3

1.8

1.23

1.24

mg/l

0.05

1210

7054

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

4171

30904

1.47

91.48

1.9

1.8

0.83

1.12

mg/l

15.32

3099

23578

Other sleep disorders

1553

9436

1.90

90.92

1.9

1.7

0.92

1.31

mg/l

6.86

1178

7305

Extreme obesity with alveolar hypoventilation

690

3313

2.87

90.88

2.1

1.8

1.14

1.22

mg/l

0.33

563

2559

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

4748

35989

1.44

90.60

2.3

1.8

1.07

1.18

mg/l

1.71

3668

27825

Injury of muscle and tendon at shoulder and upper arm level

4673

35295

1.44

90.38

1.8

1.05

1.33

mg/l

10.00

3697

27725

Lung cancer and mesothelioma

2177

11994

1.69

90.25

1.7

1.5

2.00

1.51

mg/l

3.28

1835

9317

False labour

4375

20139

1.48

90.21

1.9

1.8

0.72

0.81

mg/l

2.46

3226

15137

Other and unspecified urticaria

2793

19439

1.61

90.15

2.2

1.8

1.05

1.13

mg/l

0.50

2103

14808

Other and unspecified local infections of skin and subcutaneous tissue

1434

8622

1.97

89.92

2.4

1.9

1.25

mg/l

0.02

1152

6615

Acute pancreatitis

2570

17547

1.63

89.89

2.0

1.7

1.60

1.30

mg/l

2.62

2065

13651

Coronary artery bypass grafting

2845

14469

1.59

89.74

2.0

1.6

1.55

1.70

mg/l

1.33

2320

11417

Other and unspecified nerve root and plexus disorders, also in other diseases

2903

20363

1.59

89.25

1.8

0.94

1.18

mg/l

4.30

2258

15802

Endometriosis of pelvic peritoneum

2227

13426

1.70

88.86

1.9

1.7

0.79

1.12

mg/l

9.98

1665

10359

Insulin, fast-acting

4796

36389

1.42

88.75

2.1

1.8

1.20

1.27

mg/l

0.97

3857

27908

Faecal incontinence

1280

7453

2.03

88.70

1.9

1.6

1.37

1.38

mg/l

0.03

981

5868

Superficial injury of hip and thigh

2134

14078

1.71

88.53

2.0

1.7

1.30

1.34

mg/l

0.17

1672

10854

8117

56997

1.31

88.38

1.9

1.8

1.40

1.22

mg/l

4.41

6374

43916

Arterial embolism and thrombosis

820

4148

2.44

88.18

2.9

1.6

2.03

1.48

mg/l

4.03

696

3232

Cardiac murmurs and other cardiac sounds

1147

6309

2.05

88.08

2.3

1.9

1.26

1.38

mg/l

0.45

895

4773

Benign neoplasm of other and ill-defined parts of digestive system

2438

16659

1.66

87.59

2.3

1.7

1.12

1.31

mg/l

3.18

1950

13072

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2778

19441

1.61

87.54

2.0

1.7

0.80

1.01

mg/l

2.63

2072

14754

Hyperkinetic disorders, excluding more controls

1757

10270

1.78

87.47

2.2

1.8

0.76

0.97

mg/l

3.06

1184

7369

Mental and behavioural disorders due to alcohol

6756

51022

1.34

87.21

1.8

1.32

1.24

mg/l

1.25

5302

39265

Other skin changes

2732

19043

1.61

87.18

2.1

1.7

1.15

1.33

mg/l

2.30

2134

14892

Flat foot [pes planus] (acquired)

1343

7960

1.98

87.11

1.8

1.7

0.99

1.21

mg/l

2.67

1056

6090

Thrombocytopenia, unspecified

1054

5873

2.21

87.04

2.7

1.7

1.93

1.30

mg/l

5.75

892

4552

Cardiodefibrillation

4356

32672

1.44

86.48

2.6

1.7

1.34

1.49

mg/l

1.74

3284

26040

7693

55296

1.31

86.37

1.9

1.8

1.42

1.23

mg/l

4.35

6059

42601

Intestinal adhesions without obstruction

1180

6796

2.06

84.96

2.1

1.7

1.53

1.40

mg/l

0.63

990

5284

Endocarditis

539

2365

2.99

83.97

2.9

1.7

1.97

1.45

mg/l

2.40

468

1857

Seropositive rheumatoid arthritis

3166

22579

1.52

83.74

1.8

1.7

1.51

1.25

mg/l

3.48

2588

17462

Extracorporeal dialysis

885

4742

2.36

83.67

4.1

1.8

2.54

1.36

mg/l

6.21

796

3684

Postmenopausal bleeding

3458

12998

1.53

83.00

1.9

1.7

1.15

1.32

mg/l

1.99

2649

10335

Uterine polyps

3763

16066

1.49

82.95

1.8

1.7

1.11

1.24

mg/l

1.51

2892

12596

Procreative management

4515

28127

1.43

82.92

2.2

1.9

1.22

1.02

mg/l

2.71

3463

20993

Other/unspecified enthesopathies of lower limb, excluding foot

1058

5960

2.13

82.53

2.1

1.7

0.95

1.19

mg/l

2.02

787

4572

Acute pharyngitis

2088

13724

1.68

82.50

2.3

1.8

0.91

1.13

mg/l

2.21

1535

10276

Inflammatory bowel disease

4299

32501

1.43

82.40

2.0

1.8

1.14

1.13

mg/l

0.06

3339

24731

Other and unspecified disorders of vitreous body

5609

43025

1.37

82.18

1.9

1.7

1.09

1.31

mg/l

5.39

4350

34087

Polyp of the female genital tract

4001

16719

1.47

82.15

1.7

1.11

1.24

mg/l

1.07

3077

13082

Mental and behavioural disorders due to alcohol, excluding acute intoxication

5758

44803

1.36

81.67

1.8

1.35

1.25

mg/l

1.56

4527

34627

Female infertility, cervical, vaginal, other or unspecified origin

3573

16623

1.50

81.49

1.8

1.7

1.01

1.12

mg/l

1.66

2748

12740

Recurrent aphthous stomatitis , including avohilmo

2039

13625

1.71

81.42

2.3

1.8

1.07

1.22

mg/l

1.75

1556

10421

Chronic ulcer of skin, not elsewhere classified

990

5516

2.19

81.18

2.1

1.7

1.43

1.45

mg/l

0.07

799

4291

Benign neoplasm: Colon, unspecified

3244

23580

1.52

81.13

1.9

1.7

1.30

1.41

mg/l

0.97

2562

18673

Allergic rhinitis

4327

32375

1.43

81.12

2.0

1.9

0.86

1.06

mg/l

3.97

3216

24391

Idiopathic pulmonary fibrosis

1042

5888

2.13

81.06

2.5

1.7

1.74

1.60

mg/l

0.39

869

4666

Congenital malformations of the circulatory system

1924

12315

1.73

80.76

3.1

2.0

1.23

1.18

mg/l

0.29

1481

9365

Supplementary factors related to causes of morbidity and mortality classified elsewhere

4306

32666

1.43

80.68

2.0

1.8

1.23

1.21

mg/l

0.11

3386

24977

Injuries to unspecified part of trunk, limb or body region

1470

9150

1.88

80.50

2.4

1.8

1.29

1.26

mg/l

0.13

1194

6994

Other and unspecified injuries of lower leg

1161

6787

2.04

80.45

2.0

1.9

0.98

1.11

mg/l

0.89

911

5092

Other pleural conditions

1324

7978

1.93

80.38

2.1

1.7

1.83

1.59

mg/l

1.54

1107

6270

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1405

8677

1.92

80.26

2.4

1.8

1.55

1.31

mg/l

1.36

1183

6705

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

4024

30309

1.44

78.82

1.9

1.8

0.99

1.20

mg/l

6.86

3128

23246

Emotionally unstable personality disorder

1828

12024

1.74

78.68

2.0

1.8

0.94

0.96

mg/l

0.09

1317

8932

Otitis externa

3147

22880

1.52

78.67

1.9

1.8

0.98

1.19

mg/l

3.78

2377

17605

Diseases of appendix

10423

78123

1.25

78.41

1.8

1.08

1.17

mg/l

2.13

8000

60180

Later onset COPD

3331

19459

1.49

78.26

1.9

1.6

1.54

1.67

mg/l

0.99

2779

15473

Appendicitis, broad definition

10344

77774

1.25

78.24

1.8

1.07

1.17

mg/l

2.57

7941

59894

Adenomyosis (Endometriosis of uterus)

1797

11736

1.74

78.20

1.9

1.7

0.83

1.25

mg/l

12.29

1399

9214

Superficial injury of thorax

2092

14132

1.67

78.10

2.1

1.8

1.04

1.25

mg/l

2.37

1641

10891

Chronic Coagulation defects

459

2007

3.48

77.87

3.9

1.9

0.72

1.01

mg/l

2.52

345

1517

Alcohol use disorder, ICD-based

5334

41805

1.36

77.06

1.9

1.8

1.34

1.24

mg/l

1.40

4185

32288

Female genital prolapse

3779

15514

1.47

76.95

1.8

1.7

0.99

1.25

mg/l

6.98

2945

12192

Abnormal blood-pressure reading, without diagnosis

626

2995

2.55

76.95

1.8

1.6

0.89

1.44

mg/l

4.04

475

2316

Excessive attrition of teeth

8666

70965

1.27

76.91

1.9

1.8

0.92

1.14

mg/l

10.76

6446

54629

Fitting and adjustment of other devices

4603

31057

1.39

76.89

1.8

1.6

1.29

1.34

mg/l

0.57

3669

24072

Other disorders of skin and subcutaneous tissue, not elsewhere classified

1938

12947

1.70

76.76

2.0

1.7

1.24

1.32

mg/l

0.58

1498

10041

Lung transplantation

204

598

9.72

76.72

6.3

1.9

1.59

1.31

mg/l

0.58

180

469

Cerebral palsy and other paralytic syndromes

1533

9730

1.82

76.63

2.5

1.9

1.27

1.24

mg/l

0.08

1223

7524

Cluster headache, strict

591

2821

2.74

76.57

2.0

1.7

0.83

1.06

mg/l

1.43

442

2126

Restless leg syndrome

2031

13774

1.69

76.28

1.8

1.07

1.20

mg/l

0.80

1526

10711

Exclusions for E4_PCOS_BROAD

2355

16363

1.61

76.15

2.2

2.0

1.07

1.18

mg/l

0.76

1835

12543

Lung transplant status

202

592

9.66

75.93

6.0

1.9

1.51

1.32

mg/l

0.38

178

466

Cluster headache, wide

620

3021

2.65

75.82

2.0

1.7

0.87

1.08

mg/l

1.14

466

2284

Budesonide

1921

12805

1.69

75.81

1.9

1.7

1.18

1.11

mg/l

0.40

1491

9706

Disorders of breast

7132

51038

1.31

75.77

1.8

1.7

0.95

1.09

mg/l

2.97

5508

39348

Viral and other specified intestinal infections

2794

19426

1.52

75.37

2.5

1.8

1.08

1.15

mg/l

0.43

2115

14194

Lesion of ulnar nerve

1879

12524

1.70

75.10

2.1

1.8

1.16

1.24

mg/l

0.45

1456

9759

Type of accident

3981

30187

1.43

74.93

2.0

1.8

1.24

1.20

mg/l

0.26

3113

23126

Insulin, fast-acting or short human

4815

37402

1.38

74.81

2.1

1.8

1.20

1.28

mg/l

1.27

3874

28722

Achilles tendinitis

1387

8618

1.85

74.71

1.9

1.7

1.10

1.28

mg/l

1.12

1098

6694

Acute myeloid leukaemia and myelodysplastic syndromes

384

1534

3.49

74.44

3.0

1.6

3.26

1.36

mg/l

4.25

344

1205

Pericarditis

525

2397

2.82

74.37

2.2

1.7

1.35

1.30

mg/l

0.15

442

1866

Other metabolic disorders

1885

12613

1.70

74.30

2.5

1.7

1.21

1.07

mg/l

0.52

1502

9665

Nonalcoholic fatty liver disease

1454

9236

1.85

74.03

2.0

1.8

1.13

1.12

mg/l

0.02

1124

7101

Diplopia

1789

11861

1.72

74.01

2.2

1.7

1.17

1.29

mg/l

0.77

1392

9242

Pain associated with micturition

1669

10894

1.76

74.00

2.2

1.8

1.05

1.22

mg/l

1.36

1267

8400

Suicide or other Intentional self-harm

3297

24369

1.48

73.94

2.0

1.8

1.08

mg/l

0.03

2486

18511

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2293

15968

1.61

73.79

2.0

1.8

1.05

1.01

mg/l

0.27

1714

11999

Sequelae of injuries, of poisoning and of other consequences of external causes

3168

23292

1.49

73.72

1.9

1.8

1.10

1.15

mg/l

0.44

2477

17950

Caries of enamel

13748

77320

1.21

73.46

2.0

1.8

1.01

1.18

mg/l

8.64

10290

59809

Familial hypercholesterolemia, with ischemic heart disease

1117

6583

1.97

73.42

1.9

1.6

1.44

1.75

mg/l

1.70

913

5211

Peripheral artery operations in Hilmo

1544

9831

1.76

73.37

2.1

1.7

1.66

1.46

mg/l

1.41

1297

7679

Fentanyl

1257

7586

1.86

72.70

2.0

1.6

1.82

1.49

mg/l

1.64

1060

5874

Sequelae of cerebrovascular disease

4500

29628

1.39

72.20

2.3

1.7

1.50

1.48

mg/l

0.12

3608

23405

Other or ill-defined heart diseases

730

3781

2.31

72.18

3.0

1.6

1.21

1.23

mg/l

0.09

558

2871

Suggestive for eosinophilic asthma

1232

7530

1.92

72.10

1.9

1.7

1.03

1.32

mg/l

2.20

978

5885

Other inflammation of eyelid

1985

13535

1.66

71.62

1.9

1.8

0.96

1.27

mg/l

7.41

1513

10491

Degeneration of macula and posterior pole

6038

37228

1.33

71.59

1.8

1.7

1.44

1.50

mg/l

0.48

4784

29498

Chondropathies

2076

14290

1.64

71.26

2.1

1.9

0.87

1.15

mg/l

4.93

1563

10974

Necrosis of pulp, including avohilmo

8235

67497

1.27

71.21

1.9

1.8

1.04

1.11

mg/l

1.52

6189

51962

Ascites

986

5670

2.05

71.13

2.5

1.6

2.73

1.43

mg/l

13.03

878

4436

Other necrotizing vasculopathies (FG)

808

4400

2.23

70.57

2.2

1.7

1.64

1.42

mg/l

0.81

674

3374

Failure and rejection of transplanted organs and tissues

274

972

4.80

70.38

5.8

2.1

1.77

1.08

mg/l

2.42

246

753

Acute appendicitis

9656

75419

1.24

69.96

1.8

1.07

1.16

mg/l

2.11

7414

58061

Glucosamine medication

5786

36898

1.33

69.96

1.7

1.39

1.44

mg/l

0.49

4591

29217

Other noninfective disorders of lymphatic vessels and lymph nodes

572

2800

2.67

69.86

2.3

1.7

1.28

1.08

mg/l

0.74

459

2151

Cramp and spasm

741

3988

2.37

69.85

2.2

1.8

0.86

1.16

mg/l

3.06

595

3064

Artificial opening status

772

4180

2.28

69.67

2.7

1.7

2.30

1.43

mg/l

3.08

667

3259

Alcohol abuse, main dg, excluding more controls

1905

12882

1.64

69.35

1.9

1.8

1.25

1.18

mg/l

0.33

1514

9917

Acute pancreatitis (for exclusion)

2570

18449

1.54

69.02

2.0

1.8

1.60

1.31

mg/l

2.44

2065

14424

Conductive and sensorineural hearing loss

10575

59362

1.23

68.99

1.8

1.28

mg/l

0.01

8258

46739

Acute appendicitis, no complications

7666

62981

1.28

68.67

1.8

0.96

1.11

mg/l

4.89

5856

48411

Complications associated with artificial fertilization

345

1379

3.69

68.55

2.3

1.6

1.10

0.77

mg/l

3.78

292

1013

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

2251

15343

1.58

68.43

2.8

2.0

1.51

1.17

mg/l

2.09

1739

11663

Sensorineural hearing loss

9995

56110

1.24

68.42

1.8

1.29

1.30

mg/l

0.03

7802

44307

Hallux rigidus

1678

11088

1.69

68.39

1.8

1.7

1.12

1.39

mg/l

3.26

1289

8667

Disorders of mineral metabolism

1168

7147

1.91

67.92

2.0

1.7

1.53

1.28

mg/l

1.77

925

5473

Osteoporosis with pathological fracture (FG)

972

5662

2.03

67.76

2.1

1.7

1.53

1.39

mg/l

0.52

795

4397

Gestational [pregnancy-induced] hypertension

3592

27265

1.44

67.73

2.0

1.7

1.11

0.88

mg/l

5.95

2841

20536

Rheumatoid arthritis, including avohilmo

4979

39413

1.35

67.72

1.8

1.7

1.40

1.24

mg/l

2.40

4012

30761

Other disorders of kidney and ureter

1702

11391

1.70

67.45

2.2

1.8

1.69

1.35

mg/l

2.16

1397

8928

Other specified/unspecified soft tissue disorders

666

3441

2.36

67.41

2.1

1.6

1.05

1.40

mg/l

3.03

503

2621

Overexertion and strenuous or repetitive movements

1377

8835

1.81

66.73

2.0

1.8

1.07

1.16

mg/l

0.60

1089

6720

Neuromuscular dysfunction of bladder

1202

7442

1.87

66.40

2.0

1.8

1.23

1.35

mg/l

0.65

937

5790

Bronchiectasis

1012

5997

1.99

66.32

2.2

1.7

1.30

1.53

mg/l

1.19

815

4703

Left ventricular outflow tract obstruction (LVOTO), broad definition

1344

8592

1.82

66.07

3.0

2.0

1.38

1.17

mg/l

1.19

1023

6626

Non-Hodgkin lymphoma, all, including Hilmo

1642

10917

1.70

66.04

2.1

1.7

1.85

1.25

mg/l

4.87

1361

8476

Other noninflammatory disorders of vulva and perineum

1331

8445

1.80

66.00

1.9

1.7

0.88

1.19

mg/l

5.59

1007

6502

Otalgia

1192

7408

1.89

65.98

2.2

2.0

1.03

1.18

mg/l

0.39

878

5674

Left bundle-branch block

937

5410

2.02

65.96

2.1

1.6

1.32

1.42

mg/l

0.34

707

4277

ILD-related respiratory insufficiency

505

2418

2.79

65.85

3.0

1.7

1.65

1.56

mg/l

0.14

442

1904

Injury of unspecified body region

1087

6610

1.95

65.70

2.5

1.8

1.31

1.26

mg/l

0.17

887

5053

Haemorrhage in early pregnancy

3794

28320

1.41

65.64

1.8

1.7

0.86

0.96

mg/l

1.91

2849

21577

Disorders of parathyroid gland

2678

19307

1.51

65.44

2.1

1.7

1.43

1.37

mg/l

0.33

2110

15136

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

2092

14164

1.59

65.31

2.8

2.0

1.54

1.16

mg/l

2.24

1615

10765

Superficial injury of shoulder and upper arm

1658

11091

1.69

65.22

2.0

1.8

0.99

1.20

mg/l

2.84

1276

8474

Urolithiasis

3974

30676

1.39

65.13

1.9

1.8

1.30

1.36

mg/l

0.51

3119

24057

Pruritus

1633

10917

1.70

64.97

2.1

1.8

1.06

1.22

mg/l

1.33

1247

8457

Fall on and from stairs and steps

3527

26854

1.42

64.94

1.9

1.8

1.16

1.22

mg/l

0.35

2787

20827

5-aminosalicylic acid

2700

19678

1.49

64.79

2.0

1.7

1.13

mg/l

0.02

2117

14840

Other diseases of oesophagus

1220

7609

1.84

64.68

2.0

1.7

1.13

1.41

mg/l

3.38

967

5956

Dilated cardiomyopathy

1462

9551

1.75

64.58

5.8

1.8

1.56

1.43

mg/l

0.59

1191

7538

Tonsillectomy and adenotomy

7879

45490

1.27

64.43

1.9

0.86

1.02

mg/l

3.63

5929

34090

Injuries to the elbow and forearm

10019

72966

1.23

64.23

1.9

1.8

1.23

1.18

mg/l

0.59

7770

56000

Elevated blood glucose level

1164

7233

1.88

64.23

2.5

1.8

1.28

1.29

mg/l

0.04

949

5524

Acute gastritis

996

5925

1.97

64.19

1.9

1.7

1.19

1.33

mg/l

0.67

781

4638

Superficial injury of ankle and foot

1739

11776

1.66

64.17

2.1

1.9

0.98

1.07

mg/l

0.54

1273

8770

Familial hypercholesterolemia

1790

12149

1.63

64.05

1.8

1.7

1.38

1.44

mg/l

0.32

1443

9499

Coxarthrosis, primary, with hip surgery

5825

43698

1.31

64.05

1.7

1.45

1.42

mg/l

0.22

4785

34548

Polymyalgia rheumatica

1706

11526

1.67

64.02

1.8

1.7

1.45

1.49

mg/l

0.22

1396

9114

Pregnancy examination and test

2205

9560

1.59

64.02

1.9

1.7

0.81

0.75

mg/l

0.50

1654

6999

Ulcerative colitis

3221

24240

1.44

63.80

2.1

1.8

1.17

1.14

mg/l

0.19

2536

18445

Arterial embolism and thrombosis of lower extremity artery

493

2335

2.67

63.59

3.0

1.6

1.97

1.52

mg/l

1.97

425

1831

Psoriatic and enteropathic arthropathies

1521

10037

1.71

63.24

1.8

1.7

1.01

1.12

mg/l

1.19

1214

7644

Unspecified misadventure during surgical and medical care

835

4815

2.14

62.56

2.3

1.8

1.40

1.26

mg/l

0.40

698

3735

Brachial plexus disorders

1337

8658

1.79

62.27

2.0

1.8

0.72

0.96

mg/l

4.56

997

6605

Keratitis

4816

38331

1.34

62.16

1.9

1.8

1.10

1.18

mg/l

1.00

3704

29488

Decubitus ulcer and pressure area

829

4722

2.08

62.12

2.8

1.7

1.82

1.59

mg/l

0.92

693

3695

Cholecystitis

1753

11949

1.63

61.52

1.9

1.7

1.46

1.41

mg/l

0.23

1402

9305

Calculus of kidney and ureter

3690

28433

1.40

61.52

1.9

1.8

1.29

1.35

mg/l

0.46

2896

22266

Assault

1794

12325

1.62

61.34

2.0

1.9

1.13

1.00

mg/l

0.50

1321

9101

Acute myeloid leukaemia, including Hilmo

242

855

4.49

61.19

3.4

1.7

3.86

1.29

mg/l

3.53

219

664

Acute myeloid leukaemia, helper endpoint

242

855

4.49

61.19

3.4

1.7

3.86

1.29

mg/l

3.53

219

664

Acute myeloid leukaemia

242

855

4.49

61.19

3.4

1.7

3.86

1.29

mg/l

3.53

219

664

Other disorders of the musculoskeletal system and connective tissue

1944

13626

1.60

60.93

1.9

1.7

1.27

1.29

mg/l

0.12

1611

10653

Multiple myeloma, including Hilmo

619

3254

2.36

60.93

2.4

1.6

1.58

1.37

mg/l

0.68

529

2573

Pre-eclampsia or eclampsia

2928

21982

1.46

60.81

2.2

1.7

1.40

0.93

mg/l

8.05

2335

16824

Postprocedural disorders of nervous system

1063

6579

1.92

60.58

2.1

1.8

0.80

0.91

mg/l

0.84

788

4964

Other necrotizing vasculopathies

963

5808

1.97

60.25

2.4

1.8

1.64

1.41

mg/l

1.11

806

4556

Collagenous colitis

1277

8256

1.80

60.15

2.4

1.8

1.23

1.26

mg/l

0.14

1008

6362

Parkinson's disease, excluding more controls

1490

8994

1.67

59.98

1.7

1.6

1.45

1.79

mg/l

3.00

1216

7200

Amputation

1235

7863

1.78

59.71

2.2

1.7

1.67

1.52

mg/l

0.85

1048

6177

Asthma and opportunity respiratory infection

643

3461

2.32

59.67

2.1

1.8

1.29

1.39

mg/l

0.29

521

2732

KRA_PSY_EATING, excluding more controls

1145

7087

1.82

59.63

2.3

1.7

0.83

0.98

mg/l

0.72

798

5270

Amiodarone users

1244

7992

1.80

59.59

4.9

1.7

1.58

1.53

mg/l

0.16

966

6352

Reactive arthropathies

1112

6915

1.84

59.55

1.8

1.16

1.27

mg/l

0.62

884

5291

Medical abortion

8868

40491

1.25

59.49

1.8

1.7

0.98

1.12

mg/l

4.25

6794

31089

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1920

13446

1.59

59.36

1.8

1.7

1.96

1.19

mg/l

8.66

1606

10425

Excessive vomiting in pregnancy

1179

7517

1.84

59.20

1.9

1.8

0.78

0.92

mg/l

1.20

897

5665

Other problems related to primary support group, including family circumstances

1546

10113

1.68

59.13

3.6

1.9

1.17

0.98

mg/l

0.90

1185

7511

Parkinson's disease, strict definition, excluding more controls

1391

8423

1.69

58.94

1.7

1.6

1.45

1.81

mg/l

2.90

1137

6740

Other/unspecified enthesopathies, not elsewhere classified

1039

6355

1.87

58.93

1.8

1.7

1.08

1.38

mg/l

1.88

802

4892

Traumatic subdural haemorrhage

1506

9308

1.66

58.84

2.0

1.6

1.71

1.76

mg/l

0.19

1225

7370

Preparatory care for dialysis

625

3369

2.36

58.63

3.0

1.8

2.05

1.32

mg/l

3.17

568

2624

Papulosquamous disorders

5162

41703

1.32

58.63

1.8

1.15

1.22

mg/l

0.98

4122

32403

5057

36578

1.32

58.41

1.7

1.43

1.49

mg/l

0.38

3956

29081

Adrenocortical insufficiency

570

2992

2.47

58.34

2.8

1.8

1.15

1.21

mg/l

0.18

451

2318

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1696

11668

1.63

58.28

2.5

1.7

1.11

1.06

mg/l

0.22

1345

8937

Benign neoplasm: Sigmoid colon

2370

17299

1.51

58.25

2.0

1.8

1.23

1.39

mg/l

1.48

1885

13645

Speech and linguistic disorders, excluding more controls

1004

5680

1.86

58.25

3.1

2.0

1.41

1.17

mg/l

0.72

744

4091

Allergic urticaria

1159

7372

1.83

58.23

2.6

1.9

0.97

1.12

mg/l

0.76

870

5616

Tinnitus

3070

23303

1.43

58.04

1.8

1.15

1.23

mg/l

0.45

2289

18255

Infections with a predominantly sexual mode of transmission, including avohilmo

5497

40862

1.30

57.79

1.9

1.8

0.87

1.00

mg/l

3.47

4036

30467

Other disorders of adrenal gland

675

3738

2.25

57.73

2.7

1.9

1.13

1.21

mg/l

0.29

524

2872

Myeloid leukaemia

424

2003

2.87

57.70

3.2

1.7

3.11

1.38

mg/l

4.12

373

1581

Other infectious diseases, including avohilmo

1199

7687

1.79

57.66

2.2

1.8

1.37

1.31

mg/l

0.20

991

5934

Persistent mood disorders

2517

18543

1.48

57.50

2.0

1.7

1.11

1.19

mg/l

0.69

1884

14324

Inflammatory diseases of prostate (prostatitis)

1464

9739

1.67

57.46

1.9

1.04

1.53

mg/l

9.76

1113

7703

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2861

18632

1.44

57.40

2.4

2.0

0.91

0.97

mg/l

0.36

1960

13354

Pre-eclampsia

2725

20422

1.47

57.31

2.3

1.7

1.42

0.90

mg/l

8.86

2181

15594

Postmenopausal atrophic vaginitis

3242

13351

1.43

57.04

1.6

1.7

0.92

1.29

mg/l

7.22

2517

10594

Agranulocytosis

1463

9845

1.70

56.99

2.6

1.8

1.88

1.24

mg/l

4.78

1174

7636

3610

23974

1.38

56.90

1.8

1.7

1.49

1.60

mg/l

1.02

2879

19131

Other and unspecified injuries of head

1021

6324

1.88

56.73

2.2

1.8

1.20

1.27

mg/l

0.34

802

4845

Pneumonia due to other infectious organisms, not elsewhere classified

487

2419

2.57

56.65

2.4

1.7

1.68

1.28

mg/l

0.85

419

1825

Car occupant injured in other and unspecified transport accidents

2517

18607

1.48

56.62

2.0

1.8

1.04

1.12

mg/l

0.65

1931

14038

Diseases of the myoneural junction and muscle

1570

10702

1.65

56.51

2.0

1.8

1.60

1.35

mg/l

1.56

1234

8359

Other disorders of bladder

1451

9702

1.68

56.49

1.9

1.7

1.47

mg/l

0.01

1095

7601

Skin changes due to chronic exposure to nonionizing radiation

4750

34476

1.33

56.44

1.7

1.44

1.52

mg/l

0.50

3715

27452

Seronegative rheumatoid arthritis

1445

9660

1.68

56.40

1.9

1.7

1.33

1.24

mg/l

0.57

1166

7449

Aortic valve malfunction, age under 60 years

1234

8034

1.78

56.25

2.7

1.9

1.32

1.17

mg/l

0.73

942

6201

Benign thyroid growths and nodules

4300

31748

1.35

56.22

1.8

1.7

1.09

1.25

mg/l

3.61

3394

24937

Thyrotoxicosis, other and/or unspecified

2713

20334

1.46

56.12

2.7

1.7

1.03

1.16

mg/l

1.71

2080

15766

Actinic keratosis

4606

33502

1.33

56.07

1.7

1.46

1.53

mg/l

0.43

3596

26681

Pyogenic arthritis

828

4833

1.98

56.03

1.9

1.8

1.42

1.43

mg/l

0.05

691

3730

Fibrosis and cirrhosis of liver

1031

6455

1.87

55.61

2.4

1.8

2.20

1.31

mg/l

7.44

893

5088

Schizophrenia or delusion, excluding more controls

3758

28965

1.36

55.43

1.9

1.7

1.24

1.11

mg/l

1.32

2854

22121

Other diseases of arteries and capillaries

1169

7509

1.78

55.41

2.3

1.7

1.47

1.28

mg/l

0.76

937

5806

Mental and behavioural disorders due to sedatives or hypnotics

949

5822

1.92

55.39

2.2

1.8

1.21

1.01

mg/l

1.40

736

4361

Hyperplasia of prostate

4032

17667

1.36

55.30

1.8

1.38

1.49

mg/l

1.04

3195

14225

Viral pneumonia (known virus, not influenza)

437

2118

2.73

55.18

2.6

2.0

1.63

1.44

mg/l

0.32

371

1638

Supervision of high-risk pregnancy

2775

12436

1.46

55.00

1.8

1.7

0.87

0.80

mg/l

0.68

2117

9367

Cluster headache, strict, including avohilmo

757

4420

2.10

54.41

2.0

1.8

0.84

0.98

mg/l

0.77

569

3343

Hyperparathyroidism

2309

16759

1.49

54.34

2.0

1.7

1.45

1.38

mg/l

0.37

1817

13112

Other diseases of pancreas

1086

6908

1.82

54.28

2.0

1.7

1.64

1.37

mg/l

0.89

879

5387

Cirrhosis of liver, NAS

747

4336

2.10

54.26

2.4

1.8

2.44

1.38

mg/l

6.77

661

3425

Morphin

323

1365

3.05

54.15

2.1

1.6

1.17

1.62

mg/l

2.29

274

1066

Psoriatic arthropathies

1254

8201

1.72

54.01

1.8

1.7

1.02

1.21

mg/l

2.11

1004

6281

Hydronephrosis

1434

9657

1.66

54.01

1.9

1.7

2.15

1.25

mg/l

7.39

1202

7419

Colonic or urogenital fistula

3433

26697

1.38

53.98

1.9

1.8

1.13

1.20

mg/l

0.45

2578

20712

Abnormal results of function studies

1203

7853

1.76

53.73

2.2

1.8

1.14

1.21

mg/l

0.34

914

6020

Other hearing loss

3461

26007

1.37

53.71

1.8

1.7

1.36

1.48

mg/l

1.07

2656

20614

Fracture at wrist and hand level

4490

35884

1.32

53.64

1.8

1.10

1.19

mg/l

1.07

3413

27403

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

943

5821

1.90

53.62

2.1

1.9

1.01

1.09

mg/l

0.36

716

4354

Pollen allergy

2490

18266

1.46

53.09

2.1

2.0

0.85

0.99

mg/l

1.33

1795

13489

Persons with potential health hazards related to communicable diseases

5024

40486

1.30

53.07

2.3

1.9

1.08

1.04

mg/l

0.30

3686

30434

Spondylopathies (FG)

1739

12190

1.57

53.06

1.9

1.8

0.97

1.08

mg/l

1.13

1330

9213

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

643

3580

2.18

53.02

2.2

1.6

1.51

1.36

mg/l

0.57

546

2800

Primary coxarthrosis, bilateral

3497

27314

1.37

52.95

1.8

1.7

1.42

1.44

mg/l

0.09

2867

21561

Acute suppurative otitis media

3465

25130

1.37

52.49

2.1

1.9

0.96

1.02

mg/l

0.42

2499

18421

Disorders of calcium metabolism

856

5171

1.94

52.46

2.0

1.7

1.59

1.31

mg/l

1.52

681

3987

Cluster headache, wide,, including avohilmo

786

4682

2.04

52.45

1.9

1.8

0.87

0.98

mg/l

0.52

593

3545

Anosmia

265

961

3.18

52.36

1.8

1.3

1.32

0.76

mg/l

1.65

203

709

Other postsurgical states

872

5303

1.93

52.30

2.7

1.7

1.22

1.36

mg/l

0.42

696

4114

Diseases of middle ear and mastoid

7835

54165

1.23

52.27

2.0

1.8

1.07

1.13

mg/l

0.72

5820

41052

Suppurative and unspecified otitis media

4791

34298

1.31

52.21

2.1

1.8

1.00

1.09

mg/l

0.93

3493

25503

Abnormal findings on diagnostic imaging of other body structures

1889

13541

1.55

52.11

1.9

1.7

1.30

1.27

mg/l

0.17

1532

10535

Immunodeficiencies

681

3906

2.15

52.02

2.9

1.9

1.26

1.16

mg/l

0.30

563

2990

Bronchitis, not specified as acute or chronic

1070

6806

1.78

51.97

2.0

1.8

1.12

1.30

mg/l

1.14

843

5239

Congenital malformations of heart and great arteries

1586

10660

1.61

51.86

3.1

2.1

1.25

1.17

mg/l

0.43

1193

8093

Methotrexate

1746

12309

1.57

51.80

1.9

1.7

1.50

1.20

mg/l

2.60

1397

9476

Muscle strain

474

2395

2.44

51.64

2.1

1.7

0.92

1.12

mg/l

1.01

376

1806

Other disorders of nervous system

894

5504

1.91

51.62

2.0

1.7

1.08

1.29

mg/l

1.73

681

4326

Benign neoplasm: Ascending colon

1756

12456

1.57

51.59

2.0

1.7

1.26

1.41

mg/l

1.04

1385

9813

Fracture of skull and facial bones

2719

20567

1.42

51.58

2.0

1.8

1.20

mg/l

0.00

2100

15738

Spondyloarthritis

2263

16657

1.48

51.52

2.0

1.8

1.15

1.17

mg/l

0.13

1773

12778

Right bundle-branch block

494

2525

2.37

51.50

2.0

1.6

1.24

1.45

mg/l

1.00

381

1997

Open wound of wrist and hand

5875

46965

1.27

51.50

1.8

1.9

1.12

1.21

mg/l

1.01

4375

36014

Molar incisor enamel hypoplasia, with caries

135

353

5.87

51.49

10.7

3.5

2.95

2.10

mg/l

0.32

119

242

Otitis externa, unspecified

1537

10644

1.62

51.37

2.0

1.8

0.97

1.14

mg/l

1.55

1171

8154

Invasive ventilation

944

5886

1.87

51.30

2.8

1.8

2.32

1.36

mg/l

6.18

780

4565

Thyrotoxicosis

3353

26207

1.38

51.27

2.5

1.7

1.08

1.17

mg/l

1.30

2575

20328

Other degenerative diseases of the nervous system

3216

17963

1.38

51.25

1.7

1.6

1.48

1.53

mg/l

0.32

2482

14119

Nonsuppurative otitis media, including avohilmo

4193

28937

1.33

51.04

2.0

1.8

1.05

1.12

mg/l

0.52

3149

21556

Disorders of continuity of bone

1374

9335

1.67

50.90

2.0

1.8

1.03

1.11

mg/l

0.59

1116

7105

Blepharochalasis

3625

28612

1.36

50.76

1.7

1.18

1.38

mg/l

2.22

2852

22630

Osteonecrosis

853

5226

1.94

50.60

2.3

1.8

1.24

1.35

mg/l

0.73

726

4093

Other noninflammatory disorders of uterus, except cervix

2620

13098

1.45

50.47

1.8

1.7

1.20

1.31

mg/l

1.02

2055

10347

Diabetes mellitus in pregnancy

4509

23041

1.32

50.45

1.9

1.7

0.93

0.82

mg/l

1.79

3462

17201

Sicca syndrome [Sjögren]

1149

7574

1.76

50.20

2.0

1.7

1.09

1.17

mg/l

0.45

917

5875

Other condition

1889

13625

1.53

49.94

2.1

1.8

1.21

1.18

mg/l

0.10

1490

10448

Early lumbar disc prolapse, operated

1287

8605

1.67

49.93

1.8

1.7

0.66

0.93

mg/l

5.99

957

6443

Additional codes for the location of defect, injury or illness

817

4973

1.96

49.89

1.9

1.09

1.18

mg/l

0.45

645

3840

Oesophageal varices

538

2883

2.29

49.86

3.0

1.7

3.10

1.22

mg/l

8.31

472

2252

Crohn disease

1697

12020

1.57

49.72

2.0

1.8

1.09

1.08

mg/l

0.05

1275

9090

Hypoplasia of dental enamel

143

404

5.49

49.57

11.1

5.2

3.03

2.04

mg/l

0.45

129

289

Dialysis

546

2962

2.29

49.44

2.9

1.9

2.26

1.32

mg/l

2.11

500

2257

Arthropathies in other diseases classified elsewhere

500

2626

2.36

49.42

1.9

1.8

1.18

1.36

mg/l

0.74

396

1994

Atopic dermatitis, strict definition with reimbursement

4059

31196

1.33

49.38

1.9

0.97

1.03

mg/l

0.41

3014

23484

Scoliosis

1069

6883

1.75

49.23

2.0

1.8

1.25

1.28

mg/l

0.12

832

5183

Pre-eclampsia or poor fetal growth

4122

33069

1.33

48.88

2.1

1.7

1.26

0.90

mg/l

7.58

3221

25099

Chronic periodontitis, complicated

7319

60576

1.23

48.84

2.0

1.7

1.31

1.24

mg/l

0.91

5702

47608

Ulcerative colitis, NAS

1789

12822

1.54

48.82

2.2

1.8

1.22

1.12

mg/l

0.64

1405

9721

Reactive arthropathies, FINNGEN

914

5713

1.84

48.63

1.9

1.8

1.12

1.13

mg/l

0.03

727

4323

Immunodeficiency with predominantly antibody defects

420

2123

2.65

48.52

3.3

1.9

1.35

1.13

mg/l

0.48

347

1638

Infections with a predominantly sexual mode of transmission

4105

32956

1.32

48.45

1.9

1.8

0.87

1.01

mg/l

3.58

3045

24736

Injury of muscle and tendon at hip and thigh level

1361

9318

1.65

48.44

2.0

1.8

0.99

1.12

mg/l

1.17

1109

7178

Multiple myeloma and malignant plasma cell neoplasms

632

3611

2.13

48.23

2.4

1.7

1.54

mg/l

0.00

536

2855

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1774

12728

1.54

48.21

2.4

1.8

2.22

1.31

mg/l

12.59

1536

10041

Diseases of tongue

812

4936

1.91

48.21

1.9

1.6

1.01

1.46

mg/l

4.81

612

3939

2608

18454

1.42

48.19

1.7

1.45

1.61

mg/l

1.35

2074

14718

Chronic pancreatitis

1487

10329

1.60

48.16

1.9

1.8

1.65

1.33

mg/l

2.90

1205

8063

Radial styloid tenosynovitis [de Quervain]

752

4480

1.95

47.98

1.8

1.7

0.73

1.12

mg/l

6.45

593

3419

Myeloproliferative diseases

1046

6799

1.77

47.88

2.1

1.7

1.18

1.42

mg/l

1.85

835

5335

Acute laryngitis and tracheitis

1495

10188

1.58

47.54

2.3

1.8

0.90

1.05

mg/l

1.01

1101

7401

Artificial joint re-operation

900

5686

1.86

47.26

1.9

1.8

1.48

1.42

mg/l

0.29

750

4492

Olecranon bursitis

727

4293

1.95

47.24

2.0

1.8

1.34

1.49

mg/l

0.39

594

3337

Atypical facial pain

730

4378

2.00

47.20

2.2

1.8

0.99

1.15

mg/l

0.71

536

3356

Phobic anxiety disorders

1731

12329

1.53

47.20

2.1

1.8

1.04

1.01

mg/l

0.15

1274

9123

Unspecified mental disorder

5198

42930

1.27

47.09

1.9

1.8

1.09

1.12

mg/l

0.27

3973

32682

Other diseases of blood and blood-forming organs

908

5750

1.84

46.81

2.2

1.8

1.22

1.25

mg/l

0.13

724

4463

Dissociative [conversion] disorders

582

3278

2.17

46.73

2.0

1.7

0.79

1.04

mg/l

1.72

411

2458

Viral warts, including avohilmo

2854

22078

1.39

46.58

2.1

1.9

1.04

1.15

mg/l

0.80

2152

16744

Sequelae of other external causes

779

4749

1.93

46.58

2.3

1.7

1.30

1.19

mg/l

0.64

646

3659

Benign neoplasm: Stomach

1234

8370

1.68

46.55

2.4

1.8

1.08

1.35

mg/l

3.15

981

6546

Disorders of ocular muscles, binocular movement, accommodation and refraction

6473

54145

1.24

46.43

2.0

1.8

1.06

1.13

mg/l

0.90

4922

41404

Pneumocystosis

315

1459

3.10

46.42

2.5

1.7

1.90

1.46

mg/l

0.61

279

1146

Pneumocystosis, including avohilmo

315

1459

3.10

46.42

2.5

1.7

1.90

1.46

mg/l

0.61

279

1146

Injury of muscle and tendon at lower leg level

1859

13519

1.51

46.28

2.0

1.8

1.06

1.25

mg/l

2.62

1492

10460

Ptosis of eyelid

1410

9805

1.61

46.21

1.8

1.7

1.26

1.42

mg/l

0.79

1099

7711

Unspecified urinary incontinence

1165

7816

1.70

45.99

1.9

1.8

1.28

mg/l

0.03

819

6051

Female infertility, associated with anovulation

1065

6977

1.71

45.60

1.9

1.7

0.89

0.98

mg/l

0.70

847

5179

Algoneurodystrophy

515

2842

2.31

45.55

2.1

1.7

0.96

0.95

mg/l

0.01

396

2165

Other menopausal disorders

3337

14552

1.37

45.52

1.7

0.85

1.21

mg/l

12.18

2574

11458

Fracture of femur

3259

23059

1.35

45.47

1.9

1.7

1.75

1.49

mg/l

3.22

2694

18047

Sarcoidosis

1667

11988

1.55

45.41

2.2

1.8

1.31

1.21

mg/l

0.32

1306

9289

Endometriosis of rectovaginal septum and vagina

976

6302

1.77

45.40

1.8

1.7

0.92

1.23

mg/l

3.51

751

4904

Secondary and unspecified malignant neoplasm of lymph nodes

1037

6786

1.73

45.27

2.0

1.8

1.91

1.22

mg/l

3.05

849

5219

Disorders resulting from impaired renal tubular function

519

2867

2.27

45.16

2.3

1.8

2.08

1.30

mg/l

1.90

456

2234

Benign neoplasm: Transverse colon

1343

9309

1.63

45.04

1.9

1.8

1.26

1.43

mg/l

1.11

1092

7349

Hemiplegia

666

3921

2.01

44.97

2.7

1.7

0.91

1.26

mg/l

3.96

527

3021

Other specified and unspecified personality disorders

1204

8173

1.67

44.91

2.0

1.8

1.03

0.99

mg/l

0.22

896

6142

Hypertrophy of breast in women and men

2589

19925

1.41

44.89

1.8

0.83

1.00

mg/l

3.63

2030

15340

Benign neoplasm: Rectum, anus and anal canal

2424

18460

1.42

44.84

1.9

1.7

1.24

1.39

mg/l

1.58

1941

14554

Any death

7935

47627

1.22

44.83

2.4

1.7

2.57

1.13

mg/l

75.51

6748

37167

Cholangitis (primary sclerosing, PSC)

795

4902

1.88

44.74

2.6

1.8

2.00

1.37

mg/l

2.31

661

3775

Osteomyelitis

815

5067

1.86

44.66

2.1

1.8

1.33

1.40

mg/l

0.32

675

3951

Nasal polyp

2265

17053

1.43

44.56

1.7

1.8

1.08

1.33

mg/l

3.54

1787

13346

L01XX Other antineoplastic agents

736

4480

1.94

44.51

2.5

1.7

1.34

1.52

mg/l

0.75

588

3557

Salpingitis and oophoritis

2225

16804

1.45

44.49

1.9

1.7

0.97

1.06

mg/l

0.85

1702

13148

Colectomy operation

2019

14996

1.47

44.35

2.2

1.8

1.76

1.38

mg/l

4.26

1685

11717

Mental and behavioural disorders due to opioids

547

3068

2.17

44.26

2.3

1.9

1.17

0.96

mg/l

1.11

417

2234

Other/unspecified soft tissue disorders related to use, overuse and pressure

419

2149

2.42

44.23

1.8

1.7

0.86

1.13

mg/l

1.62

313

1620

Disturbance of activity and attention

1701

11945

1.51

44.14

2.2

2.0

0.75

0.98

mg/l

3.40

1148

8494

Other female pelvic inflammatory diseases

2033

15176

1.47

43.94

1.9

1.7

1.02

1.10

mg/l

0.42

1549

11761

Amenorrhoea

894

5677

1.78

43.87

2.2

1.7

0.83

1.04

mg/l

2.29

697

4238

Ovarian hyperstimulation (induction)

326

1572

2.96

43.80

2.4

1.7

1.10

0.74

mg/l

3.74

276

1160

Superficial injury of forearm

1359

9470

1.60

43.66

2.0

1.8

1.05

1.10

mg/l

0.18

1054

7110

IBD patients in KELA-register

2903

22687

1.37

43.65

1.9

1.8

1.14

1.11

mg/l

0.16

2223

17151

Other aneurysm

666

3946

1.96

43.40

2.9

1.7

1.98

1.46

mg/l

3.00

562

3081

Drug-induced adrenocortical insufficiency

316

1507

2.97

43.40

3.3

1.9

1.27

1.20

mg/l

0.14

260

1188

Hypertensive Renal Disease

443

2304

2.26

43.14

1.8

1.6

1.96

1.55

mg/l

1.02

382

1795

Other and unspecified myopathies

1086

7262

1.69

43.05

2.0

1.8

1.73

1.43

mg/l

1.36

861

5674

Delirium, not induced by alcohol and other psychoactive substances

1494

10558

1.55

43.00

1.8

1.7

1.86

1.55

mg/l

1.30

1223

8308

Other and unspecified mood [affective] disorders

980

6406

1.73

42.98

2.2

1.8

1.04

0.96

mg/l

0.25

716

4756

Vascular diseases of the intestine

503

2762

2.18

42.74

2.3

1.6

2.48

1.45

mg/l

3.86

434

2151

Charcot foot

266

1163

3.07

42.72

1.9

1.5

1.12

1.27

mg/l

0.52

224

888

Panniculitis affecting regions of neck and back

492

2689

2.21

42.72

2.1

1.7

0.99

1.15

mg/l

0.70

395

2073

Other peripheral vertigo

1179

8063

1.66

42.55

2.0

1.7

0.98

1.31

mg/l

4.75

906

6281

Lung diseases due to external agents

1592

11406

1.52

42.51

2.1

1.7

1.61

1.51

mg/l

0.44

1306

8955

Unknown and unspecified causes of morbidity

809

5037

1.80

42.27

1.7

1.5

0.93

1.29

mg/l

3.25

614

3851

Dysplasia of cervi uteri

2962

16270

1.36

42.07

1.7

1.02

1.14

mg/l

1.06

2229

12491

Oesophagitis

692

4197

1.92

41.79

2.1

1.8

0.98

1.36

mg/l

4.91

564

3287

Hyperkinetic disorders

1771

12625

1.48

41.78

2.2

2.1

0.76

1.00

mg/l

3.72

1194

8959

Other infectious diseases

953

6241

1.74

41.78

2.3

1.7

1.47

1.34

mg/l

0.47

776

4846

Medial epicondylitis

500

2763

2.17

41.74

1.7

0.89

1.17

mg/l

1.49

378

2114

Myeloproliferative diseases (CML excluded)

934

6107

1.76

41.70

2.1

1.7

1.15

1.40

mg/l

1.97

741

4798

Mental and behavioural disorders due to tobacco

1145

7819

1.66

41.70

1.9

1.8

1.05

1.17

mg/l

0.96

907

6040

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

1008

6713

1.72

41.65

2.3

1.8

1.47

1.26

mg/l

1.00

803

5211

Nontoxic multinodular goitre

2416

18599

1.41

41.63

1.7

1.08

1.29

mg/l

4.32

1901

14621

Smoking dependency

1145

7831

1.66

41.39

1.9

1.8

1.05

1.16

mg/l

0.93

907

6060

Benign neoplasm: Rectum

2156

16357

1.43

41.24

1.9

1.8

1.27

1.38

mg/l

0.91

1726

12900

Diseases of peritoneum

1239

8584

1.61

41.16

2.3

1.8

1.71

1.30

mg/l

3.45

999

6676

Oligomenorrhoea

498

2768

2.17

41.08

2.0

1.7

0.79

1.01

mg/l

1.91

367

2075

Other dialysis

425

2270

2.38

41.07

2.7

2.0

2.19

1.29

mg/l

1.77

387

1763

Other symptoms and signs involving the urinary system

1248

8641

1.60

41.05

1.9

1.8

1.28

1.34

mg/l

0.23

998

6709

Other disorders of white blood cells

711

4392

1.91

40.81

2.4

1.8

1.24

1.23

mg/l

0.02

568

3399

Dermatophytosis

1706

12515

1.50

40.73

1.9

1.8

1.20

1.30

mg/l

0.50

1340

9751

Other disorders of glucose regulation and pancreatic internal secretion

1052

7066

1.68

40.68

2.1

1.9

1.37

1.28

mg/l

0.27

828

5378

conjunctival haemorrhage

964

6381

1.73

40.65

2.4

1.8

1.26

1.42

mg/l

0.70

732

5025

Psoriasis

3568

28840

1.32

40.58

1.8

1.11

1.18

mg/l

0.69

2871

22347

Excessive earwax

8218

64652

1.20

40.54

1.8

1.12

1.31

mg/l

6.98

6348

50479

Herpesviral [herpes simplex] infections

1522

10980

1.53

40.53

2.1

1.8

1.08

1.16

mg/l

0.36

1175

8469

Cytomegalovirus infection, IBD co-morbidity

354

1798

2.61

40.29

3.8

2.0

2.36

1.20

mg/l

1.64

318

1399

Calcific tendinitis of shoulder

704

4318

1.87

40.15

1.8

1.6

0.79

1.20

mg/l

6.72

534

3341

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

5832

33160

1.24

40.02

1.7

1.44

1.18

mg/l

4.94

4538

25946

Alcohol abuse, main dg

1905

14233

1.45

39.99

1.9

1.25

1.17

mg/l

0.39

1514

10892

Benign neoplasm: Caecum

1311

9265

1.58

39.67

2.2

1.7

1.40

1.45

mg/l

0.20

1049

7289

Speech disturbances, not elsewhere classified

1112

7597

1.64

39.65

2.7

1.8

1.33

1.43

mg/l

0.31

888

5905

Other disorders of conjunctiva

1715

12644

1.49

39.63

2.2

1.7

1.27

1.37

mg/l

0.39

1328

9924

Open wound of ankle and foot

1298

9121

1.58

39.62

2.1

1.8

1.12

1.25

mg/l

1.03

1014

6888

Palmar fascial fibromatosis [Dupuytren]

1522

10911

1.50

39.47

1.7

1.37

1.72

mg/l

2.48

1212

8629

Other (seronegative) rheumatoid arthritis, wide

2326

17945

1.40

39.46

1.9

1.7

1.39

1.28

mg/l

1.04

1879

14022

Biological medication for rheuma

2273

17472

1.41

39.35

1.9

1.09

1.03

mg/l

0.62

1740

13199

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

2831

21642

1.35

39.35

1.7

2.39

1.23

mg/l

25.62

2412

16980

Inflammatory bowel disease, strict (require KELA)

2903

22991

1.35

39.32

1.9

1.8

1.14

1.10

mg/l

0.22

2223

17392

Alcohol dependence

3130

24971

1.33

39.32

1.9

1.8

1.41

1.26

mg/l

1.37

2499

19445

Other disorders of breast

1828

13687

1.47

39.04

1.8

1.7

0.97

1.02

mg/l

0.16

1370

10484

Benign neoplasm of other and unspecified endocrine glands

1660

12237

1.50

39.00

1.9

1.8

1.12

1.25

mg/l

1.19

1304

9514

Ankylosing spondylitis

1031

6932

1.65

38.99

1.9

1.7

1.03

1.28

mg/l

2.21

787

5316

Monoamine oxidase A inhibitors

1388

9892

1.54

38.94

1.9

1.7

1.02

1.26

mg/l

3.12

1067

7778

Other/unspecified cytomegaloviral diseases

311

1529

2.77

38.92

4.1

2.0

2.47

1.20

mg/l

1.60

285

1187

Hypertrophy of breast

2287

17679

1.41

38.77

1.8

1.7

0.77

0.94

mg/l

4.74

1785

13615

Sequelae of injuries of lower limb

1194

8324

1.61

38.71

2.0

1.8

1.01

1.13

mg/l

0.79

952

6394

Cytomegaloviral disease, including avohilmo

367

1914

2.51

38.66

3.7

1.9

2.30

1.19

mg/l

1.63

328

1490

Hereditary deficiency of other clotting factors

180

708

4.15

38.64

4.4

1.8

0.87

0.98

mg/l

0.24

131

555

Complications predominantly related to the puerperium

3411

27641

1.32

38.64

1.9

1.7

1.05

0.97

mg/l

0.77

2642

21099

Redundant prepuce, phimosis and paraphimosis

2241

16840

1.39

38.55

1.8

1.9

1.17

1.34

mg/l

1.54

1712

12721

Endometriosis of ovary

2050

14621

1.42

38.51

1.8

1.7

1.13

1.19

mg/l

0.25

1548

11382

Amputation of toe

841

5450

1.75

38.44

1.9

1.7

1.45

1.53

mg/l

0.31

706

4291

Presbycusis

1604

11542

1.48

38.30

1.6

1.7

1.48

1.68

mg/l

1.08

1216

9201

Other bursitis of hip

302

1453

2.66

38.28

2.6

1.6

1.18

1.29

mg/l

0.33

238

1111

Biomechanical lesions, not elsewhere classified

673

4174

1.90

38.16

2.0

1.7

1.31

1.28

mg/l

0.06

543

3240

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

966

6440

1.67

38.14

2.0

1.8

0.95

1.06

mg/l

0.63

733

4821

Cytomegaloviral disease

362

1889

2.51

38.11

3.8

1.9

2.32

1.19

mg/l

1.64

324

1472

Pneumothorax

826

5333

1.75

38.07

2.1

1.7

1.67

1.43

mg/l

0.93

671

4113

Convalescence

710

4452

1.86

38.06

2.1

1.6

0.98

1.07

mg/l

0.39

549

3404

Disorders of tooth development and eruption

2046

12555

1.42

38.03

2.0

1.7

1.00

1.27

mg/l

3.93

1527

9747

Periapical abscess

6011

51318

1.22

37.98

1.8

1.10

1.16

mg/l

0.79

4632

39761

Personal history of other diseases and conditions

1439

10319

1.52

37.97

2.7

1.8

1.05

1.01

mg/l

0.20

1097

7664

Other arterial embolism and thrombosis

360

1840

2.38

37.90

2.8

1.6

2.11

1.48

mg/l

2.35

303

1446

Multiple myeloma

366

1892

2.39

37.77

2.6

1.6

1.41

1.48

mg/l

0.14

317

1498

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

366

1892

2.39

37.77

2.6

1.6

1.41

1.48

mg/l

0.14

317

1498

Suppurative and necrotic conditions of lower respiratory tract

685

4256

1.86

37.72

2.4

1.7

1.69

1.40

mg/l

1.37

596

3329

Other benign neoplasms of skin

4657

38933

1.26

37.63

1.7

1.21

1.27

mg/l

0.63

3571

30402

Pregnancy with abortive outcome

8973

40877

1.19

37.58

1.7

1.02

1.12

mg/l

2.52

6879

31360

Other malignant neoplasms of skin (=non-melanoma skin cancer)

5557

31833

1.24

37.49

1.7

1.44

1.19

mg/l

4.80

4326

24914

malignant neoplasm of female genital organs, including Hilmo

2174

15942

1.41

37.45

1.7

1.87

1.12

mg/l

12.62

1806

12338

Assault by bodily force

1015

6888

1.65

37.43

2.0

1.9

0.85

0.93

mg/l

0.81

746

5030

Weight loss

1257

8898

1.57

37.34

2.1

1.8

1.29

1.36

mg/l

0.31

931

6870

Von Willebrand disease

235

1061

3.28

37.28

3.4

1.8

0.59

0.93

mg/l

3.17

183

810

SLE (Finngen)

497

2867

2.12

37.25

2.5

1.8

1.46

1.05

mg/l

2.51

410

2214

Nontoxic goitre/thyroid nodule

3636

29768

1.30

37.18

1.8

1.7

1.06

1.26

mg/l

5.19

2864

23307

Venous complications and haemorrhoids in pregnancy

317

1603

2.70

37.18

2.3

1.8

0.80

0.68

mg/l

0.79

245

1201

Basal cell carcinoma, including Hilmo

5613

32134

1.23

37.13

1.7

1.50

1.19

mg/l

4.83

4366

25149

Fracture of shoulder and upper arm

4472

37193

1.26

37.10

1.9

1.8

1.34

1.32

mg/l

0.21

3566

28731

Malignant neoplasm of skin, including Hilmo

6544

37542

1.21

36.91

1.7

1.45

1.14

mg/l

6.05

5101

29337

Congenital malformations of cardiac chambers and connections

110

325

5.57

36.90

5.9

4.4

1.83

1.19

mg/l

1.02

237

Paralytic ileus

466

2611

2.11

36.89

2.1

1.7

1.56

1.47

mg/l

0.21

391

2054

Progressive vascular leukoencephalopathy

523

3058

2.05

36.81

1.6

1.46

1.72

mg/l

1.16

401

2419

Benign neoplasm: Adrenal gland

979

6656

1.68

36.78

1.8

1.18

1.35

mg/l

1.16

781

5222

Recurrent dislocation of patella

692

4330

1.83

36.71

1.8

0.78

0.93

mg/l

1.43

504

3181

Congenital malformations of cardiac septa

818

5158

1.75

36.64

3.2

2.3

1.17

mg/l

0.01

628

3885

Anogenital herpesviral [herpes simplex] infection, including avohilmo

1517

11131

1.50

36.47

1.9

1.8

0.79

0.97

mg/l

2.02

1090

8251

Corneal ulcer

2320

18053

1.38

36.46

1.9

1.8

0.99

1.15

mg/l

2.85

1792

13825

Rash and other nonspecific skin eruption

1201

8470

1.58

36.43

1.9

1.8

1.11

1.23

mg/l

0.79

940

6538

Thyroiditis, ILD-related definition

1490

10910

1.51

36.37

1.9

1.8

1.02

1.05

mg/l

0.16

1130

8324

In situ neoplasms

5091

43047

1.24

36.32

1.8

1.7

1.44

1.29

mg/l

1.27

3984

33654

Tubulo-interstitial nephritis, not specified as acute or chronic

835

5462

1.72

36.23

2.1

1.7

1.29

1.22

mg/l

0.29

667

4181

Hyperhidrosis

429

2357

2.16

36.21

2.3

1.5

0.79

1.08

mg/l

2.46

320

1786

Trigeminal neuralgia

769

4969

1.78

36.19

2.0

1.8

0.78

1.20

mg/l

5.81

571

3847

Bicipital tendinitis

579

3471

1.93

36.18

2.0

1.7

0.89

1.31

mg/l

4.92

436

2681

Other abnormal products of conception

4391

23946

1.27

36.10

1.8

0.83

0.88

mg/l

0.64

3319

18231

Secondary uncertain malignant neoplasm

1540

11299

1.48

35.99

1.9

1.7

2.00

1.25

mg/l

5.81

1267

8761

Small fibre neuropathy

422

2351

2.25

35.97

2.4

1.8

1.44

1.31

mg/l

0.18

348

1837

Hepatic failure, not elsewhere classified

497

2890

2.08

35.91

3.1

1.8

2.80

1.27

mg/l

9.07

434

2256

Maternal care for other known or suspected fetal problems

3177

16014

1.32

35.84

1.9

1.7

0.90

0.79

mg/l

1.80

2427

11872

Other noninflammatory disorders of vagina

978

6637

1.65

35.78

1.8

1.7

0.88

1.21

mg/l

5.97

755

5141

Malignant neoplasm of skin

6150

35571

1.22

35.75

1.7

1.45

1.16

mg/l

5.20

4796

27800

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

940

6344

1.67

35.70

2.0

1.7

1.71

1.44

mg/l

0.81

780

4938

Other eating disorders

681

4276

1.83

35.60

2.5

1.9

0.75

0.98

mg/l

1.98

468

3120

Other diseases of biliary tract

1052

7256

1.62

35.59

2.5

1.8

2.25

1.41

mg/l

3.80

868

5611

Gestational diabetes (for exclusion)

5032

29196

1.25

35.58

1.9

1.8

0.94

0.83

mg/l

1.76

3865

21934

Ulcer of oesophagus

787

5107

1.74

35.57

1.9

1.7

1.31

1.48

mg/l

0.84

644

4036

Myelodysplastic syndrome, including Hilmo

375

1989

2.27

35.48

2.2

1.6

1.82

1.38

mg/l

1.70

327

1581

Haemolytic anaemias

473

2726

2.11

35.43

4.5

1.8

2.37

1.37

mg/l

1.80

394

2119

Rare circulating lymphoid malignancy, including Hilmo

368

1944

2.30

35.41

5.8

1.9

2.04

1.34

mg/l

1.34

316

1497

Polycythaemia vera

427

2379

2.17

35.20

2.1

1.7

1.15

1.38

mg/l

1.06

335

1873

Primary hyperparathyroidism

1363

9912

1.53

35.19

1.9

1.7

1.36

1.29

mg/l

0.23

1046

7759

Sacrococcygeal disorders, not elsewhere classified

433

2427

2.16

35.15

2.0

1.7

0.91

1.13

mg/l

1.04

330

1851

Non-follicular lymphoma

1097

7660

1.60

35.04

2.2

1.8

1.98

1.46

mg/l

2.15

905

6053

Abnormal weight loss

1150

8114

1.58

34.92

2.1

1.8

1.24

1.37

mg/l

0.75

860

6281

Diabetic nephropathy, excluding more controls

1821

11227

1.44

34.90

1.9

1.53

1.25

mg/l

2.51

1528

8806

Benign lipomatous neoplasm

3575

29378

1.29

34.88

1.8

1.06

1.24

mg/l

3.30

2792

22970

Abscess of anal and rectal regions

1029

7080

1.61

34.84

2.0

1.7

1.32

1.16

mg/l

0.75

794

5374

Retinal detachments and breaks

4235

35333

1.26

34.84

1.9

1.7

1.24

1.37

mg/l

1.85

3335

27909

Any event in hilmo or specialist outpatient

8.91

34.72

1.5

1.1

0.63

0.31

mg/l

2.69

Any prescribed medicine buy

11.14

34.44

2.0

1.4

1.17

1.19

mg/l

0.01

Portal vein thrombosis

246

1152

2.86

34.20

4.3

1.8

2.57

1.11

mg/l

6.60

210

900

Orchitis and epididymitis

988

6741

1.60

34.13

2.5

1.9

1.54

1.49

mg/l

0.12

774

5236

Diseases of spleen

280

1388

2.70

34.07

3.2

1.7

1.70

1.34

mg/l

1.17

232

1079

Cerebral cysts

747

4860

1.76

34.06

2.2

1.8

1.36

1.12

mg/l

0.84

558

3704

Disorders of oesophagus in diseases classified elsewhere

303

1533

2.53

34.05

2.2

1.7

1.22

1.35

mg/l

0.43

232

1207

Other congenital malformations, including avohilmo

1602

11964

1.46

34.01

2.1

2.0

1.23

1.08

mg/l

0.78

1252

9030

Meralgia paraesthetica

476

2784

2.08

33.99

2.1

1.7

1.18

1.14

mg/l

0.08

378

2137

Iridocyclitis

2767

22184

1.33

33.97

1.9

1.8

1.17

1.20

mg/l

0.15

2183

17172

Other disorders of penis

1062

7360

1.58

33.88

2.0

2.1

1.20

1.45

mg/l

1.36

808

5689

Basal cell carcinoma

5349

30956

1.23

33.85

1.7

1.50

1.20

mg/l

4.32

4143

24226

Dermatitis due to substances taken internally

707

4551

1.78

33.76

2.0

1.8

1.16

1.25

mg/l

0.37

561

3488

Protozoal diseases, including avohilmo

427

2433

2.17

33.72

2.4

1.7

1.67

1.28

mg/l

0.74

366

1892

Ethmoidectomy

1596

11949

1.46

33.70

1.8

0.92

1.15

mg/l

2.19

1180

9259

Hypertension, Pulmonary Arterial

147

547

4.02

33.68

8.2

1.7

1.56

1.57

mg/l

0.01

116

423

Protozoal diseases

413

2333

2.21

33.67

2.4

1.7

1.70

1.30

mg/l

0.74

357

1825

Other specified/unspecified bacterial intestinal infections

823

5487

1.71

33.58

2.1

1.8

1.10

1.25

mg/l

0.77

648

4251

Crohn's disease NAS

823

5487

1.70

33.52

1.9

1.14

1.04

mg/l

0.48

620

4107

Hypoglycaemia, other or unspecified

840

5619

1.69

33.36

2.2

1.9

1.44

1.21

mg/l

0.72

665

4288

Atopic dermatitis, strict definition

3821

30994

1.27

33.33

1.9

1.01

mg/l

0.01

2831

23262

Glomerulonephritis

1154

8207

1.56

33.31

2.2

1.9

1.77

1.29

mg/l

3.78

969

6330

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

571

3484

1.88

33.27

2.0

1.7

0.84

1.14

mg/l

2.39

461

2617

Kela-code for severe mental illness

4488

37807

1.24

33.10

1.9

1.8

1.14

1.13

mg/l

0.13

3423

28770

Psychotic depression

703

4499

1.74

33.01

1.8

1.7

1.00

1.22

mg/l

1.61

527

3490

Anaemia in chronic diseases classified elsewhere

334

1768

2.37

32.88

3.2

1.8

2.55

1.44

mg/l

1.66

293

1385

Focal epilepsy

2511

19962

1.34

32.80

2.1

1.9

1.19

1.25

mg/l

0.38

1970

15416

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

511

3087

1.99

32.60

2.1

1.8

1.08

1.02

mg/l

0.18

393

2342

Essential (haemorrhagic) thrombocythaemia

480

2837

2.02

32.56

2.0

1.7

1.04

1.25

mg/l

0.81

382

2205

Tobacco use

721

4725

1.77

32.44

1.9

1.7

1.19

1.12

mg/l

0.23

570

3608

Speech and linguistic disorders

1024

6816

1.58

32.38

3.2

2.3

1.51

1.13

mg/l

1.23

761

4852

Hypermobility syndrome

751

4977

1.75

32.33

1.9

1.8

0.70

0.83

mg/l

1.54

568

3726

Barrett oesophagus

614

3866

1.84

32.32

1.8

1.32

1.39

mg/l

0.18

489

3056

Maternal care for known or suspected abnormality of pelvic organs

3324

18368

1.30

32.22

2.0

1.8

0.99

0.83

mg/l

2.44

2574

13863

Disorders of psychological development

1388

9415

1.47

32.20

3.0

2.1

1.27

1.06

mg/l

0.94

1026

6639

Leisure time condition

2215

17411

1.36

32.15

1.9

1.8

1.27

1.26

mg/l

0.06

1711

13335

Other puerperal infections

1075

7630

1.58

32.13

2.1

1.7

0.97

0.84

mg/l

1.14

827

5646

Asthma mixed form (mode), excluding more controls

555

3362

1.84

31.97

2.0

1.5

0.93

1.24

mg/l

2.53

433

2521

Tumor necrosis factor alpha inhibitors

2006

15599

1.38

31.94

1.9

1.08

1.01

mg/l

0.62

1536

11768

Hypopituitarism

875

5951

1.65

31.92

2.1

0.97

1.15

mg/l

1.04

674

4500

Other and unspecified disorders of white blood cells

521

3174

1.95

31.83

2.3

1.8

1.14

1.27

mg/l

0.75

413

2463

Inflammatory diseases of the central nervous system

1022

7197

1.58

31.43

1.9

1.8

1.21

1.16

mg/l

0.22

799

5510

Obsessive-compulsive disorder

864

5859

1.63

31.40

2.0

1.8

0.84

1.01

mg/l

1.32

592

4250

Duodenal ulcer

1156

8255

1.52

31.30

2.0

1.7

1.54

mg/l

0.01

937

6554

Acute alcohol intoxication, ICD10

2394

19042

1.34

31.28

1.9

1.25

1.18

mg/l

0.44

1878

14628

FESS (DNB20)

1531

11524

1.45

31.22

1.8

0.88

1.15

mg/l

2.78

1130

8906

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

3089

25312

1.29

31.20

1.8

1.7

1.50

1.23

mg/l

4.07

2529

19787

Seborrhoeic keratosis

3003

24520

1.30

31.16

1.8

1.7

1.12

1.33

mg/l

3.89

2406

19283

Seropositive rheumatoid arthritis, wide

3165

25997

1.29

31.16

1.8

1.7

1.51

1.24

mg/l

3.97

2587

20328

Diffuse large B-cell lymphoma

579

3623

1.85

31.14

2.2

1.8

1.91

1.32

mg/l

1.92

472

2836

Diffuse large B-cell lymphoma, helper endpoint

579

3623

1.85

31.14

2.2

1.8

1.91

1.32

mg/l

1.92

472

2836

Diffuse large B-cell lymphoma, including Hilmo

579

3623

1.85

31.14

2.2

1.8

1.91

1.32

mg/l

1.92

472

2836

Other specified/unspecified spondylopathies

315

1651

2.32

31.11

1.9

1.6

1.22

1.52

mg/l

0.86

255

1309

Nail disorders

1058

7509

1.57

31.11

2.2

1.9

1.12

1.14

mg/l

0.08

817

5707

Other fall from one level to another

2705

21818

1.31

31.03

2.0

1.9

1.15

1.23

mg/l

0.52

2057

16644

Carbimazole or st.post thyroidectomy, condition for graves disease

2646

21366

1.32

31.03

2.6

1.7

1.00

1.10

mg/l

1.19

2056

16521

Special screening examination for other diseases and disorders

1322

9641

1.47

30.95

2.1

1.6

1.08

1.28

mg/l

2.39

1008

7454

Endometriosis ASRM stages 1,2

2275

18087

1.35

30.92

1.8

1.7

0.78

0.94

mg/l

3.10

1700

13839

Other and unspecified diseases of blood and blood-forming organs

365

2035

2.23

30.90

2.5

1.7

1.41

1.20

mg/l

0.67

307

1585

Exposure to other and unspecified inanimate mechanical forces

965

6743

1.60

30.89

2.2

1.9

1.09

1.14

mg/l

0.23

713

5085

Injury of eye and orbit

1706

13007

1.41

30.88

1.9

1.8

1.12

1.14

mg/l

0.12

1275

9868

Type 1 diabetes, wide definition, subgroup 1

2446

19485

1.33

30.84

1.9

1.8

1.07

1.12

mg/l

0.45

1901

14558

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

1344

9852

1.48

30.83

2.4

2.1

1.25

1.07

mg/l

0.63

1034

7323

Lymphoid leukaemia

644

4141

1.78

30.80

4.1

1.8

1.47

1.50

mg/l

0.08

539

3248

Allergic contact dermatitis

1712

13113

1.41

30.74

1.9

1.8

0.90

1.09

mg/l

2.78

1305

10134

Other peripheral vascular diseases

989

6944

1.58

30.70

1.9

1.7

1.14

1.16

mg/l

0.06

767

5339

Open wound of forearm

1174

8481

1.52

30.65

2.1

1.7

1.17

1.25

mg/l

0.39

901

6420

Other/unspecified seropositive rheumatoid arthritis

3129

25721

1.29

30.59

1.8

1.7

1.52

1.24

mg/l

4.15

2557

20110

Conotruncal defects

189

825

3.07

30.59

4.1

4.0

1.52

1.46

mg/l

0.07

145

603

Acute alcohol intoxication

2960

24133

1.29

30.48

1.9

1.8

1.26

mg/l

0.00

2324

18637

Viral hepatitis, including avohilmo

946

6608

1.60

30.40

2.2

1.8

1.44

0.99

mg/l

1.57

736

4928

Nonpyogenic thrombosis of intracranial venous system

176

766

3.45

30.38

3.9

1.8

2.27

1.30

mg/l

0.99

137

581

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

854

5832

1.63

30.37

2.1

1.9

1.16

0.97

mg/l

1.23

643

4223

Crohn's disease of small intestine

880

6069

1.63

30.36

2.1

1.8

1.01

1.03

mg/l

0.07

640

4549

Acute posthaemorrhagic anaemia

433

2522

2.01

30.30

2.6

1.7

1.50

1.42

mg/l

0.17

341

1961

Right ventricular outflow tract obstruction

128

466

4.01

30.20

4.6

4.3

1.64

1.78

mg/l

0.10

342

Follicular cysts of skin and subcutaneous tissue

2225

17648

1.35

30.12

1.9

1.8

1.02

1.21

mg/l

2.53

1707

13666

Type 1 diabetes

2932

23865

1.29

30.11

1.9

1.8

1.18

1.17

mg/l

0.10

2276

17914

Systemic lupus erythematosus

497

3051

1.96

30.03

2.5

1.7

1.46

1.07

mg/l

2.34

410

2336

Other congenital malformations

1055

7521

1.55

30.02

2.3

2.2

1.32

1.09

mg/l

0.95

824

5657

Mixed hyperlipidaemia

486

2933

1.93

29.96

1.8

1.6

1.09

1.42

mg/l

2.22

370

2271

malignant neoplasm of female genital organs

1870

14226

1.39

29.95

1.7

1.91

1.15

mg/l

10.50

1545

11003

Other crystal arthropathies

252

1240

2.53

29.86

1.8

1.6

1.27

1.68

mg/l

1.87

197

979

Recurrent dislocation and subluxation of joint

823

5589

1.63

29.83

2.0

1.8

0.92

1.02

mg/l

0.51

618

4161

Idiopathic thrombocytopenic purpura

402

2325

2.09

29.78

2.5

1.8

1.76

1.28

mg/l

0.91

332

1802

Eating disorders

1362

10122

1.47

29.72

2.3

1.8

0.89

1.01

mg/l

0.65

965

7468

Other viral hepatitis, including avohilmo

834

5720

1.64

29.62

2.3

1.8

1.40

0.95

mg/l

1.42

646

4233

Acquired haemolytic anaemia

331

1814

2.27

29.52

3.8

1.7

2.85

1.39

mg/l

2.04

285

1438

Strabismus

3207

26425

1.28

29.44

2.0

1.9

1.18

1.16

mg/l

0.08

2459

20212

Other specified/unspecified systemic involvement of connective tissue

734

4934

1.71

29.37

2.1

1.8

1.11

1.12

mg/l

0.02

589

3818

Mixed and other personality disorders

1022

7299

1.56

29.29

2.0

1.8

0.94

mg/l

0.02

735

5497

Non-Hodgkin lymphoma, all

505

3086

1.87

29.24

2.3

1.6

1.96

1.47

mg/l

1.86

437

2424

Gluteal tendinitis

549

3442

1.84

29.22

1.7

0.79

1.21

mg/l

5.26

418

2686

Maternal care for known or suspected fetal abnormality and damage

2071

13830

1.36

29.09

1.8

0.95

0.80

mg/l

1.42

1588

10354

Emotional disorders starting during childhood or adolecense, excluding more controls

496

2898

1.85

29.00

3.1

2.1

1.41

1.15

mg/l

0.33

317

2044

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

374

2149

2.16

28.99

1.8

1.9

2.22

1.24

mg/l

6.38

341

1658

Toxic effects of substances chiefly nonmedicinal as to source

1374

10280

1.45

28.94

2.0

1.9

1.15

mg/l

0.01

1027

7784

Other follicular disorders

970

6876

1.57

28.93

2.1

1.8

0.87

1.00

mg/l

1.08

752

5174

1275

9475

1.48

28.83

1.9

1.7

0.82

0.80

mg/l

0.09

962

7067

Crystal arthropathies, rheuma endpoint

252

1261

2.48

28.61

1.8

1.6

1.27

1.52

mg/l

0.99

197

997

Complications following infusion, transfusion and therapeutic injection

227

1110

2.72

28.53

3.6

1.7

1.50

1.27

mg/l

0.53

186

865

Other specified/unspecified inflammatory spondylopathies

586

3746

1.78

28.49

1.8

1.7

0.90

1.02

mg/l

0.57

453

2815

Left ventricular outflow tract obstruction, narrow definition

593

3817

1.78

28.40

3.5

2.2

1.50

1.20

mg/l

0.95

437

2893

Primary Sclerosing Cholangitis, IBD and UDCA required

305

1645

2.30

28.39

3.4

1.9

2.60

1.28

mg/l

2.01

257

1245

Retinal vascular occlusion

1332

9935

1.45

28.35

1.9

1.7

1.42

1.55

mg/l

0.56

1069

7855

Other specified/unspecified dorsopathies

431

2557

1.97

28.35

2.0

1.7

1.21

1.31

mg/l

0.16

345

1976

Dermatographic urticaria

887

6223

1.60

28.28

2.1

1.7

0.68

1.00

mg/l

7.82

649

4731

ILD medications: pirfenidone

161

687

3.34

28.21

2.5

1.6

1.54

1.46

mg/l

0.06

135

543

Inguinal hernia

7006

40826

1.17

28.17

1.9

1.8

1.36

1.28

mg/l

0.79

5476

31466

Other diseases of stomach and duodenum

753

5095

1.65

28.15

2.0

1.7

1.39

mg/l

0.02

598

3995

Contusion of other and unspecified parts of foot

689

4590

1.70

28.09

2.1

1.9

0.97

1.01

mg/l

0.10

501

3385

Other specified disorders of muscle

356

2001

2.10

28.08

2.6

1.7

1.11

1.31

mg/l

0.60

278

1531

Somnolence, stupor and coma

521

3250

1.83

28.02

2.2

1.8

1.42

1.28

mg/l

0.36

435

2502

Non-allergic asthma

987

7029

1.55

28.00

2.0

2.1

1.01

1.30

mg/l

2.88

781

5470

Discitis, unspecified

227

1106

2.59

27.84

2.9

1.6

1.47

1.53

mg/l

0.13

191

878

Acute and subacute iridocyclitis

2267

18189

1.33

27.81

1.9

1.8

1.12

1.20

mg/l

0.64

1788

14079

Persons encountering health services in circumstances related to reproduction

7103

41877

1.17

27.80

2.0

1.9

1.09

1.06

mg/l

0.31

5403

31845

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

1347

9952

1.44

27.78

1.7

1.84

1.47

mg/l

1.28

1065

7874

Iron deficiency

460

2817

1.94

27.66

2.4

1.9

0.93

0.95

mg/l

0.06

343

2076

Spontaneous abortion

5930

34597

1.19

27.49

1.8

1.7

0.91

1.05

mg/l

4.66

4572

26551

Other and unspecified immunodeficiencies with predominantly antibody defects

199

946

2.93

27.48

4.0

1.9

1.57

1.16

mg/l

0.46

165

744

Vitreous haemorrhage

1175

8657

1.49

27.47

1.8

1.20

1.38

mg/l

0.90

962

6748

Other viral hepatitis

780

5361

1.64

27.46

2.3

1.8

1.41

0.96

mg/l

1.35

609

3976

Memory loss

1030

7435

1.53

27.43

1.9

1.7

1.43

1.49

mg/l

0.19

793

5850

Postprocedural disorders of digestive system, not elsewhere classified

429

2582

1.98

27.43

2.5

1.8

1.63

1.21

mg/l

0.81

349

1991

Dislocation, sprain and strain of joints and ligaments of thorax

470

2895

1.91

27.42

2.2

1.8

1.06

1.23

mg/l

0.82

357

2206

Asthma mixed form (mode)

555

3500

1.75

27.41

2.0

1.6

0.93

1.27

mg/l

2.55

433

2646

Other epidermal thickening

563

3613

1.79

27.37

2.2

1.8

1.07

1.31

mg/l

1.53

458

2784

Wet age-related macular degeneration

1953

14842

1.35

27.25

1.8

1.7

1.60

1.64

mg/l

0.13

1560

11818

Leukaemia of unspecified cell type

155

663

3.36

27.20

5.5

1.7

3.49

1.53

mg/l

1.62

139

528

Peritonsillar abscess

2495

20232

1.30

27.18

1.9

1.8

0.98

1.16

mg/l

1.80

1908

15421

Complications of cardiac and vascular prosthetic devices, implants and grafts

268

1400

2.36

27.09

4.8

1.7

1.99

1.57

mg/l

0.92

237

1107

Retinal vascular disorders

1343

10096

1.44

27.05

1.9

1.7

1.41

1.56

mg/l

0.65

1077

7977

Diabetic retinopathy, excluding more controls

3160

14637

1.28

26.96

1.9

1.36

1.21

mg/l

1.38

2527

11472

Postprocedural musculoskeletal disorders, not elsewhere classified

857

6027

1.60

26.94

1.9

1.8

1.43

1.35

mg/l

0.27

745

4727

Abnormal findings on antenatal screening of mother

1088

7948

1.50

26.92

1.9

1.7

1.01

0.79

mg/l

2.65

836

5833

Eating disorder

1147

8440

1.49

26.80

2.3

1.9

0.83

0.97

mg/l

0.59

800

6180

Pyothorax

514

3244

1.83

26.77

2.0

1.7

1.70

1.42

mg/l

1.24

446

2555

Vasculitis limited to skin, not elsewhere classified

354

2041

2.11

26.73

2.0

1.8

1.30

mg/l

0.00

301

1574

Atrophic disorders of skin

1963

15588

1.35

26.70

1.9

1.7

1.06

1.13

mg/l

0.66

1516

12010

Giant cell arteritis

506

3196

1.84

26.62

2.1

1.7

1.36

1.52

mg/l

0.46

413

2532

Nonsuppurative otitis media

2776

19737

1.28

26.56

2.2

1.9

1.15

1.17

mg/l

0.06

2067

14453

Crushed, pushed or stepped on by crowd or human stampede

916

6502

1.55

26.56

2.1

2.0

1.29

1.00

mg/l

0.72

659

4726

Infective dermatitis

1331

10036

1.44

26.56

2.1

1.8

1.16

1.30

mg/l

1.04

1058

7792

Bursitis of shoulder

322

1793

2.15

26.53

1.9

1.6

0.92

1.17

mg/l

1.40

258

1374

Personal history of malignant neoplasm

1046

7622

1.51

26.46

2.0

1.7

1.17

1.12

mg/l

0.24

842

5869

Viral hepatitis

886

6278

1.57

26.45

2.2

1.8

1.46

0.98

mg/l

1.59

694

4699

Residual foreign body in soft tissue

587

3808

1.72

26.36

1.7

0.96

1.23

mg/l

2.24

454

2866

Other secondary gonarthrosis

622

4114

1.72

26.35

2.0

1.8

1.34

1.35

mg/l

0.05

517

3198

Drug-induced cataract

330

1883

2.19

26.30

2.9

1.8

1.59

1.24

mg/l

1.16

269

1459

Alzheimer disease, excluding more controls

1786

8935

1.36

26.23

1.6

1.75

1.83

mg/l

0.34

1399

7148

Ulcerative colitis (strict definition, require KELA)

1989

15828

1.34

26.16

1.9

1.15

1.08

mg/l

0.39

1563

12012

Female infertility, tubal origin

605

3975

1.72

26.15

1.8

1.6

1.14

1.00

mg/l

0.20

453

3060

Septal defects

735

4927

1.64

26.12

2.9

2.4

1.16

1.20

mg/l

0.13

565

3717

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

2133

17113

1.33

26.12

1.9

1.8

1.17

1.10

mg/l

0.45

1676

12987

Contraceptive management

5097

30793

1.20

26.12

1.9

1.8

0.91

0.98

mg/l

0.86

3881

23473

Other/unspecified reactive arthropathies

804

5622

1.61

26.07

1.9

1.8

1.17

1.10

mg/l

0.34

641

4285

!Aliquae complicationes praecoces traumatis

556

3605

1.77

25.95

2.3

1.8

1.43

1.24

mg/l

0.46

436

2755

Early complications of trauma

556

3605

1.77

25.95

2.3

1.8

1.43

1.24

mg/l

0.46

436

2755

Combinations of oral blood glucose lowering drugs

3162

26410

1.26

25.94

1.8

1.7

1.28

1.34

mg/l

0.32

2553

20783

Focal epilepsy, strict definition

2266

18303

1.31

25.88

2.1

1.9

1.22

1.27

mg/l

0.28

1782

14158

SLE, ICD10

462

2896

1.91

25.87

2.5

1.7

1.49

1.07

mg/l

2.39

382

2229

SLE, strict definition

462

2896

1.91

25.87

2.5

1.7

1.49

1.07

mg/l

2.39

382

2229

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

1927

15306

1.34

25.77

2.0

1.9

1.15

1.09

mg/l

0.42

1517

11605

Viral infections of the central nervous system, including avohilmo

943

6792

1.54

25.64

2.0

1.9

0.92

1.14

mg/l

1.85

686

5162

Tongue abnormality

740

5116

1.64

25.64

1.9

1.8

1.00

1.30

mg/l

2.67

556

4005

L04AC Interleukin inhibitors

828

5838

1.59

25.63

2.0

1.8

1.02

1.00

mg/l

0.07

639

4391

Effects of foreign body entering through natural orifice

2819

23314

1.27

25.58

1.8

1.9

1.13

1.22

mg/l

0.75

2122

17834

Drug-induced osteoporosis with pathological fracture

247

1305

2.49

25.54

2.7

1.7

1.88

1.31

mg/l

1.03

207

1036

Dissection of aorta

368

2148

1.99

25.52

2.8

1.6

3.31

1.53

mg/l

3.87

319

1681

Squamous cell neoplasms and carcinomas of the skin

1073

7840

1.48

25.48

1.7

1.83

1.50

mg/l

0.94

853

6219

Burns and corrosions

1619

12606

1.38

25.43

2.0

1.9

1.12

1.15

mg/l

0.11

1243

9581

Diabetic maculopathy, excluding more controls

1221

9134

1.44

25.43

1.9

1.7

1.26

mg/l

0.00

985

6953

Erosion of teeth , including avohilmo

3389

28553

1.25

25.39

2.1

1.8

0.96

1.07

mg/l

1.52

2509

21624

Arthropathic psoriasis

1344

10238

1.43

25.37

1.8

1.06

1.18

mg/l

0.87

1080

7910

Malignant neoplasm of urinary organs, including Hilmo

1218

9103

1.44

25.36

1.7

1.74

1.29

mg/l

4.02

1010

7108

Vitamin deficiency, wide

587

3866

1.72

25.27

2.2

1.7

1.23

mg/l

0.00

461

2954

Vitamin deficiency

587

3866

1.72

25.27

2.2

1.7

1.23

mg/l

0.00

461

2954

Visual field defects

970

7027

1.52

25.23

2.1

1.7

1.26

1.37

mg/l

0.44

752

5489

Focal epilepsy, mode (most common among epilepsy diagnosis)

2155

17367

1.32

25.17

2.0

1.9

1.22

1.27

mg/l

0.24

1698

13411

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

2059

16532

1.33

25.16

1.8

1.9

1.18

1.26

mg/l

0.48

1647

12804

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

2087

16766

1.32

25.15

1.7

2.34

1.24

mg/l

18.09

1781

13108

Anterior Iridocyclitis

2380

19420

1.30

25.08

1.9

1.8

1.20

mg/l

0.03

1870

15034

Disorders of refraction and accommodation

3552

29948

1.24

25.07

2.1

1.9

0.98

1.10

mg/l

1.54

2661

22800

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

370

2187

2.00

25.00

2.0

1.7

0.85

1.02

mg/l

0.68

290

1685

Mental disorders, not otherwise specified

1028

7540

1.50

25.00

2.0

1.9

0.84

0.97

mg/l

1.62

804

5631

Total colectomy operation

521

3366

1.79

24.99

2.6

1.8

1.77

1.18

mg/l

1.77

442

2545

Total colectomy

521

3366

1.79

24.99

2.6

1.8

1.77

1.18

mg/l

1.77

442

2545

Systemic lupus erythematosus, unspecified

407

2500

1.97

24.84

2.6

1.7

1.39

1.07

mg/l

1.68

337

1920

444

7037

0.58

24.77

1.7

1.8

2.63

1.41

mg/l

3.69

375

5591

Viral warts

1200

9016

1.45

24.75

2.3

1.9

1.03

1.12

mg/l

0.62

909

6847

Vulvovaginal ulceration/inflammation in other diseases

905

6522

1.54

24.74

2.0

1.8

0.67

0.92

mg/l

4.61

662

4942

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

1830

14530

1.35

24.70

1.8

1.9

1.21

1.26

mg/l

0.27

1466

11256

Abnormal serum enzyme levels

3291

26715

1.24

24.55

1.9

1.8

1.56

1.45

mg/l

0.65

2655

21101

Congenital malformations and deformations of the musculoskeletal system

1034

7549

1.49

24.55

2.5

2.2

1.27

1.06

mg/l

0.61

783

5586

Atrial septal defect

461

2882

1.85

24.54

3.2

2.4

1.15

1.26

mg/l

0.35

344

2194

Peroneal tendinitis

255

1364

2.34

24.53

2.0

1.7

0.96

1.01

mg/l

0.17

204

1033

Myocardial infarction, with ST-elevation

1802

14243

1.34

24.47

2.1

1.8

1.60

1.55

mg/l

0.24

1494

11282

Drug-induced neutropenia

846

6046

1.56

24.44

2.2

1.8

1.99

1.23

mg/l

4.33

678

4728

Other superficial mycoses, including avohilmo

1335

10197

1.41

24.42

1.9

1.8

0.81

1.07

mg/l

3.77

973

7595

Pediculosis, acariasis and other infestations, including avohilmo

2111

17040

1.31

24.41

2.0

1.9

0.99

1.09

mg/l

0.89

1587

12779

Hypocalcemia

326

1895

2.13

24.37

1.9

1.7

1.41

1.22

mg/l

0.57

262

1481

Acute peritonitis

726

5028

1.61

24.33

2.4

1.8

2.01

1.32

mg/l

5.15

616

3910

Anogenital herpesviral [herpes simplex] infection

846

6051

1.56

24.25

1.9

1.8

0.74

0.88

mg/l

1.59

608

4502

Seborrhoeic dermatitis

1152

8619

1.45

24.25

2.0

1.8

1.09

1.31

mg/l

1.43

890

6667

292

1627

2.16

24.22

2.1

1.7

1.55

1.56

mg/l

0.00

247

1285

Nonspecific lymphadenitis

705

4865

1.62

24.12

1.9

1.8

1.01

0.91

mg/l

0.53

539

3689

Eosinophilic disease (BM)

192

923

2.57

24.05

1.9

1.6

1.49

1.30

mg/l

0.34

155

714

Other Crohn's disease

853

6107

1.55

24.02

1.9

1.8

1.22

0.98

mg/l

1.49

622

4553

Hydrocele

1137

8443

1.43

23.97

1.9

1.44

1.62

mg/l

0.73

878

6672

Chronic viral hepatitis

643

4375

1.66

23.90

2.2

1.9

1.42

0.94

mg/l

1.14

500

3230

Lichen simplex chronicus and prurigo

758

5321

1.59

23.87

1.9

1.8

1.30

1.28

mg/l

0.05

617

4144

Single ventricle heart

15.07

23.80

6.0

6.4

2.05

1.90

mg/l

0.05

Other specified and unspecified disorders of eye and adnexa

480

3081

1.81

23.76

2.5

1.7

1.72

1.15

mg/l

0.74

369

2379

Otitis media, unspecified

1286

8986

1.41

23.73

2.5

2.0

1.14

1.07

mg/l

0.24

942

6547

Enteropathic arthropathies

304

1728

2.11

23.72

1.8

0.96

1.16

mg/l

0.91

244

1291

Sacroiliitis, not elsewhere classified

577

3828

1.69

23.71

1.9

1.7

0.95

mg/l

0.02

423

2849

Congenital malformations of aortic and mitral valves

499

3224

1.77

23.65

3.5

2.0

1.43

1.19

mg/l

0.61

362

2457

Acute generalized exanthematous pustulosis

561

3730

1.72

23.63

2.1

1.8

1.32

1.19

mg/l

0.49

454

2873

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

1067

7908

1.46

23.62

1.7

1.60

1.28

mg/l

2.40

878

6180

Habitual aborter

289

1618

2.14

23.55

2.0

1.6

0.67

0.83

mg/l

0.95

233

1186

Cyst of kidney

821

5867

1.55

23.46

1.9

1.7

1.39

1.45

mg/l

0.18

660

4643

Amyloidosis, other/unspecified

241

1279

2.32

23.45

2.1

1.7

1.75

1.59

mg/l

0.15

193

996

Intestinal malabsorption

580

3887

1.70

23.43

2.1

1.8

1.28

1.14

mg/l

0.49

445

2969

Malignant neoplasm of urinary organs

1036

7652

1.46

23.39

1.7

1.69

1.29

mg/l

2.96

854

5978

Maternal care related to the fetus and amniotic cavity and possible delivery problems

5602

28786

1.18

23.34

1.7

0.87

0.90

mg/l

0.42

4282

21917

Hepatomegaly and splenomegaly, not elsewhere classified

144

631

3.07

23.33

3.5

1.6

2.13

1.21

mg/l

1.10

123

487

Other disorders starting during childhood or adolecense, excluding more controls

495

3006

1.72

23.25

3.4

2.1

1.45

1.14

mg/l

0.47

347

2112

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

7808

54378

1.15

23.21

1.7

1.8

0.97

1.10

mg/l

3.71

5977

42036

Thyrotoxicosis with diffuse goitre

1735

13814

1.34

23.12

2.1

1.7

0.97

1.07

mg/l

1.14

1326

10675

Adalimumab

1221

9305

1.42

23.00

1.9

1.10

0.99

mg/l

0.92

947

6996

Other disorders involving the immune mechanism, not elsewhere classified

396

2448

1.90

22.90

4.1

2.0

1.56

1.19

mg/l

1.48

339

1887

Other inflammatory liver diseases

771

5473

1.57

22.88

2.1

1.8

1.59

1.16

mg/l

2.90

632

4242

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

733

5143

1.57

22.80

1.9

1.8

1.93

1.25

mg/l

3.20

602

3989

Prepatellar bursitis

491

3165

1.74

22.79

2.1

1.7

0.97

1.39

mg/l

4.42

388

2437

Lesion of lateral popliteal nerve

579

3892

1.68

22.75

2.2

1.7

1.21

1.24

mg/l

0.09

460

2989

Cerebral aneurysm, nonruptured

1015

7547

1.47

22.72

1.9

1.7

1.15

1.27

mg/l

0.69

817

5898

Other infective otitis externa

733

5165

1.58

22.71

1.8

1.07

1.17

mg/l

0.37

559

3980

Polyarthritis, unspecified

422

2640

1.83

22.59

2.0

1.9

1.32

1.34

mg/l

0.06

357

2012

Schizophrenia or delusion

3758

32221

1.21

22.58

1.9

1.8

1.24

1.10

mg/l

1.50

2854

24400

Visual impairment including blindness (binocular or monocular)

788

5607

1.54

22.55

1.9

1.7

1.25

1.44

mg/l

1.18

585

4364

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

2555

21211

1.27

22.52

1.9

1.8

0.87

0.95

mg/l

0.90

1882

15686

Heart failure and hypertrophic cardiomyopathy

243

1322

2.30

22.38

8.4

1.7

1.77

1.50

mg/l

0.48

196

1052

Complex cardiac defects

103

399

3.94

22.38

6.6

3.4

1.79

0.97

mg/l

1.78

306

Special screening examination for neoplasms

709

4934

1.56

22.35

1.8

1.6

1.68

1.34

mg/l

0.81

547

3885

Pleural plaque

921

6721

1.48

22.28

1.6

1.51

1.78

mg/l

1.28

744

5362

Generalized skin eruption due to drugs and medicaments

490

3208

1.76

22.22

2.1

1.9

1.26

1.21

mg/l

0.15

401

2465

Failed induction of labour

802

5773

1.55

22.22

1.9

1.8

1.23

0.73

mg/l

6.44

648

4208

Thyroiditis

884

6470

1.51

22.22

1.9

1.8

0.88

1.12

mg/l

2.51

676

4981

Agoraphobia

425

2683

1.82

22.19

2.1

1.7

0.93

mg/l

0.01

298

1983

Spinal instabilities

341

2038

1.96

22.13

1.8

1.7

0.93

1.09

mg/l

0.80

265

1561

Early lumbar disc prolapse operation

1319

10210

1.39

22.11

1.8

0.67

0.85

mg/l

3.38

982

7656

Benign neoplasm: Descending colon

802

5770

1.54

22.11

2.0

1.8

1.28

1.43

mg/l

0.59

656

4561

Presence of other devices

2725

22379

1.25

22.07

1.7

1.6

1.27

1.46

mg/l

2.86

2139

17631

Ectopic pregnancy

2068

16882

1.30

22.05

1.7

0.96

0.98

mg/l

0.12

1573

13024

Other and unspecified abdominal hernia

488

3190

1.75

22.04

2.0

1.7

1.10

1.32

mg/l

1.42

393

2507

Amyloidosis

275

1548

2.11

21.96

2.2

1.6

1.82

1.55

mg/l

0.30

218

1211

Abdominal aortic aneurysm (AAA)

919

6625

1.46

21.94

1.9

1.6

3.65

1.68

mg/l

21.68

789

5257

Type 1 diabetes, wide definition

2499

20695

1.26

21.89

1.9

1.8

1.07

1.14

mg/l

0.64

1943

15477

Antenatal screening

2796

13036

1.26

21.87

1.7

0.81

0.79

mg/l

0.20

2138

9797

Other and unspecified injuries of shoulder and upper arm

424

2695

1.83

21.86

2.0

1.8

1.09

1.20

mg/l

0.31

335

2057

Other/unspecified disorders of vestibular function

509

3372

1.73

21.83

2.0

1.7

1.09

1.29

mg/l

1.21

387

2638

Causalgia

235

1279

2.32

21.82

2.2

1.7

0.86

1.10

mg/l

0.94

183

995

Melanocytic naevi

3860

33296

1.21

21.77

2.1

1.8

1.12

1.13

mg/l

0.06

2977

25577

Lesion of radial nerve

452

2912

1.78

21.70

2.0

1.7

1.40

1.19

mg/l

0.46

344

2227

Mental and behavioural disorders due to use of other stimulants, including caffeine

366

2241

1.90

21.67

2.0

1.08

0.89

mg/l

1.00

272

1586

Simple and mucopurulent chronic bronchitis

432

2726

1.77

21.67

2.1

1.8

1.32

1.49

mg/l

0.40

333

2133

Scleritis and episcleritis

768

5513

1.55

21.67

2.1

1.8

0.89

1.02

mg/l

0.75

620

4222

Bitten or struck by other mammals

1434

11253

1.37

21.65

2.0

1.9

0.96

1.00

mg/l

0.23

1068

8488

Bacterial, viral and other infectious agents, including avohilmo

1077

8131

1.44

21.64

2.4

1.9

1.07

1.05

mg/l

0.08

828

6200

Schizophrenia, schizotypal and delusional disorders

3762

32373

1.21

21.59

1.9

1.8

1.23

1.10

mg/l

1.27

2855

24519

Malignant neoplasm of kidney, except renal pelvis

947

6991

1.47

21.58

1.7

1.63

1.30

mg/l

2.16

778

5480

Other congenital malformations of the digestive system, including avohilmo

583

3930

1.64

21.56

4.1

2.3

1.51

1.27

mg/l

0.61

443

2973

Benign neoplasm of mouth and pharynx

1230

9465

1.40

21.55

1.8

1.22

1.27

mg/l

0.26

965

7353

Psoriatic arthropathies, ICD10

1225

9432

1.41

21.54

1.8

1.02

1.15

mg/l

1.20

977

7310

Urethritis and urethral syndrome

290

1674

2.07

21.51

2.1

1.7

0.80

1.19

mg/l

3.77

230

1267

Event of undetermined intent

771

5531

1.54

21.41

2.2

1.9

1.06

1.08

mg/l

0.07

576

4144

Other congenital malformations of heart

109

440

3.53

21.37

6.7

3.2

1.54

1.08

mg/l

0.74

349

Pure hyperglyceridaemia

284

1632

2.07

21.26

2.1

1.7

1.12

1.39

mg/l

1.22

228

1255

Psoriasis vulgaris

2146

17635

1.29

21.16

1.8

1.13

1.23

mg/l

0.84

1708

13664

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

457

2980

1.77

21.15

2.0

1.8

0.76

1.01

mg/l

2.81

336

2266

Pneumonia due to Streptococcus pneumoniae

469

3048

1.73

21.14

2.5

1.7

1.95

1.24

mg/l

1.82

386

2287

Ovarian dysfunction

1008

7576

1.46

21.13

2.0

1.8

0.81

0.92

mg/l

1.03

747

5594

Nephrotic syndrome

378

2358

1.87

21.09

2.4

2.1

1.77

1.36

mg/l

1.48

333

1836

Use of disulfiram, acamprosate or naltrexone

1017

7648

1.45

21.08

1.8

1.25

1.09

mg/l

0.51

791

5837

Congenital varicose veins

351

4.26

21.04

3.3

2.0

1.08

0.82

mg/l

0.68

264

Other mental disorders due to brain damage and dysfunction and to physical disease

1332

10379

1.38

21.01

1.8

1.7

1.27

1.47

mg/l

1.66

1056

8162

Other psoriatic arthropathies

1192

9179

1.41

20.96

1.8

1.02

1.15

mg/l

1.01

951

7113

Mucosal proctocolitis

1486

11738

1.35

20.95

2.1

1.8

1.26

1.07

mg/l

1.34

1174

8878

Polycystic ovarian syndrome, broad definition

1456

11504

1.36

20.92

1.9

1.7

0.84

0.87

mg/l

0.26

1123

8495

Other strabismus

2583

21532

1.25

20.90

2.1

1.9

1.12

1.14

mg/l

0.12

1958

16397

Other/unspecified rheumatoid arthritis

1372

10756

1.37

20.75

1.9

1.7

1.50

1.33

mg/l

1.26

1111

8434

Other blood glucose lowering drugs, excl. Insulins

1712

13761

1.32

20.67

1.7

1.36

1.40

mg/l

0.13

1369

10762

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

1039

7885

1.44

20.62

1.9

1.7

0.96

0.97

mg/l

0.05

843

6045

Other symptoms and signs involving general sensations and perceptions

494

3277

1.70

20.62

1.9

1.8

1.18

1.36

mg/l

0.57

387

2505

Diabetic nephropathy

1837

14758

1.32

20.60

1.9

1.55

1.38

mg/l

1.22

1540

11740

Sleep disorders, other/unspecified

462

3027

1.74

20.59

2.0

1.9

0.79

1.05

mg/l

2.29

334

2260

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

967

7266

1.46

20.59

2.2

1.7

0.78

0.75

mg/l

0.21

765

5499

Other and unspecified vasculitis limited to skin

307

1832

2.01

20.57

1.9

1.8

1.35

1.30

mg/l

0.12

262

1411

Hidradenitis suppurativa

499

3344

1.71

20.43

1.9

1.8

0.81

0.94

mg/l

0.67

391

2531

Other predominantly sexually transmitted diseases, not elsewhere classified

2097

17263

1.28

20.42

1.9

1.8

0.85

0.93

mg/l

0.84

1566

12910

Benign neoplasm: Small intestine

465

3069

1.74

20.42

2.2

1.7

1.20

1.40

mg/l

1.02

382

2418

Fracture of forearm

7101

57328

1.14

20.40

1.8

1.29

1.19

mg/l

1.55

5532

44071

Other other unspecified disorders of the circulatory system

437

2843

1.77

20.37

2.2

1.8

1.26

1.25

mg/l

0.01

339

2232

Bell's palsy

1338

10470

1.37

20.37

2.0

1.8

1.28

1.26

mg/l

0.03

1038

8072

Deep endometriosis

1165

9005

1.41

20.31

1.8

0.95

1.03

mg/l

0.53

885

6853

Other and unspecified aplastic anaemias

165

814

2.65

20.29

2.8

1.7

1.46

1.36

mg/l

0.21

133

632

Corns and callosities

774

5616

1.52

20.23

1.9

1.8

1.29

1.31

mg/l

0.06

594

4354

Other and unspecified nonorganic psychotic disorders

2253

18670

1.27

20.16

1.9

1.8

1.15

1.03

mg/l

1.39

1678

13870

Hordeolum and other deep inflammation of eyelid

731

5258

1.54

20.15

2.1

1.8

0.92

1.15

mg/l

2.46

553

3972

Acute lymphadenitis

690

4909

1.55

20.13

1.9

0.92

1.01

mg/l

0.62

532

3708

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

364

2277

1.87

20.13

4.3

2.0

1.57

1.16

mg/l

1.56

311

1747

Pneumonitis due to solids and liquids

875

6445

1.46

20.06

2.1

1.7

1.84

1.48

mg/l

1.46

741

5054

Congenital malformations of the respiratory system, including avohilmo

255

1456

2.14

20.05

2.9

2.4

1.24

1.28

mg/l

0.07

190

1143

Monoarthritis, not elsewhere classified

477

3152

1.69

20.05

2.1

1.8

1.05

1.24

mg/l

0.94

372

2387

Complications of other internal prosthetic devices, implants and grafts

489

3260

1.69

20.04

2.3

1.7

1.39

1.32

mg/l

0.20

401

2506

Other and/or unspecified nontoxic goitre

953

7161

1.45

20.02

1.9

1.7

1.14

1.20

mg/l

0.22

760

5608

Myositis

293

1722

1.98

19.98

2.0

1.7

1.35

1.40

mg/l

0.10

230

1326

Viral infections of the central nervous system

847

6250

1.49

19.98

2.0

1.9

0.93

1.12

mg/l

1.34

618

4746

Specific development disorders of scholastic skills

486

3150

1.67

19.94

3.7

2.3

1.48

1.03

mg/l

0.61

337

2210

Other and unspecified trigeminal disorders

218

1190

2.28

19.92

2.2

1.6

0.84

1.19

mg/l

1.67

164

928

Sequelae of injuries of upper limb

1136

8743

1.40

19.91

1.8

0.99

1.12

mg/l

0.77

892

6712

Autoimmune hepatitis, wide definition

549

3756

1.64

19.84

2.3

1.8

1.58

1.11

mg/l

2.69

448

2887

Myelodysplastic syndrome

166

819

2.53

19.78

2.2

1.6

2.17

1.48

mg/l

1.37

148

648

Other congenital malformations of the digestive system

497

3304

1.67

19.76

4.5

2.3

1.61

1.27

mg/l

0.79

376

2490

Examination and encounter for administrative purposes

833

6095

1.47

19.73

1.7

1.11

1.53

mg/l

4.88

660

4816

Temporal arteritis

424

2760

1.77

19.72

2.0

1.6

1.39

1.51

mg/l

0.28

348

2177

Ingrowing nail

646

4568

1.57

19.69

2.1

1.8

1.14

1.13

mg/l

0.01

500

3446

Congenital malformations of pulmonary and tricuspid valves

109

456

3.28

19.66

5.3

3.6

1.42

1.08

mg/l

0.64

338

Acute nasopharyngitis (common cold)

1312

10185

1.36

19.63

1.8

0.96

1.11

mg/l

1.30

1016

7838

Other and unspecified injuries of ankle and foot

527

3585

1.65

19.56

1.8

1.9

0.68

1.05

mg/l

8.95

387

2656

Congenital malformations of great arteries

243

1338

2.12

19.55

4.5

3.3

1.78

1.50

mg/l

0.42

178

1014

Congenital malformation of biliary tract

184

6.38

19.46

14.8

4.5

1.78

2.36

mg/l

0.23

149

Testicular dysfunction

469

3118

1.70

19.45

2.0

1.9

0.93

1.19

mg/l

1.36

358

2341

Preterm labour and delivery

3045

26058

1.23

19.41

1.8

1.7

0.95

0.94

mg/l

0.03

2368

20050

Outcome of delivery

2003

10060

1.29

19.30

1.7

0.90

0.76

mg/l

1.06

1512

7485

Chronic lymphocytic leukaemia

329

2016

1.88

19.25

1.8

1.6

1.85

1.46

mg/l

0.70

277

1586

Chronic lymphocytic leukaemia, helper endpoint

329

2016

1.88

19.25

1.8

1.6

1.85

1.46

mg/l

0.70

277

1586

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

329

2016

1.88

19.25

1.8

1.6

1.85

1.46

mg/l

0.70

277

1586

Diabetic neuropathy

1271

9954

1.38

19.18

1.9

1.11

1.38

mg/l

4.75

1024

7963

Nonhereditary hypogammaglobulinemia

167

853

2.61

19.15

3.1

1.7

1.35

1.19

mg/l

0.14

144

675

Congenital malformations of trachea and bronchus

146

709

2.79

19.08

3.4

2.2

1.27

1.33

mg/l

0.07

114

572

Nummular dermatitis

942

7107

1.44

18.98

2.1

1.8

1.13

1.38

mg/l

1.52

720

5533

Varicose veins of other sites

677

4835

1.53

18.91

2.0

1.9

1.22

1.16

mg/l

0.19

503

3653

Other deformities of toe(s)

406

2631

1.75

18.85

1.7

1.8

1.16

1.29

mg/l

0.35

305

2008

Mixed disorders of conduct and emotions, excluding more controls

244

1369

2.02

18.85

2.1

0.93

0.97

mg/l

0.11

170

938

Bulimia nervosa (incl. atypical)

440

2912

1.72

18.84

2.1

1.8

0.99

0.87

mg/l

0.17

313

2152

Ménière disease

1043

8001

1.41

18.82

1.9

1.8

1.14

1.31

mg/l

0.79

804

6254

Cauda equina syndrome

197

1069

2.37

18.79

2.2

1.6

0.90

1.23

mg/l

0.90

156

837

Other surgical follow-up care

424

2784

1.73

18.75

2.3

1.8

1.37

1.09

mg/l

0.63

340

2093

Disorders of synovium and tendon in diseases classified elsewhere

258

1495

2.03

18.72

1.9

1.7

1.05

1.31

mg/l

1.05

200

1146

Other and unspecified injuries of wrist and hand

487

3296

1.67

18.71

1.9

0.75

1.10

mg/l

5.69

350

2494

Malignant neoplasm of other and unspecified female genital organs

221

1244

2.23

18.66

1.7

1.6

2.37

1.23

mg/l

4.07

201

974

Traumatic subarachnoid haemorrhage

395

2535

1.73

18.60

1.7

1.6

1.85

1.53

mg/l

0.63

306

1965

Biological medicines for asthma

304

1869

1.95

18.49

1.9

1.8

0.68

1.05

mg/l

2.86

240

1421

Postmenopausal osteoporosis with pathological fracture

757

5572

1.50

18.47

2.0

1.7

1.43

1.42

mg/l

0.03

616

4348

Leiomyoma of uterus

8191

41745

1.13

18.46

1.7

1.01

1.07

mg/l

1.04

6285

32494

Symptoms and signs involving emotional state

377

2421

1.78

18.42

3.1

1.9

0.94

1.13

mg/l

0.58

291

1849

Disorders of speech understanding and production

465

3047

1.66

18.39

3.1

2.5

1.55

1.35

mg/l

0.47

371

2222

Heterophoria

949

7208

1.43

18.38

2.2

2.0

0.96

1.12

mg/l

0.99

705

5469

Lack of expected normal physiological development

190

852

2.18

18.36

4.1

2.3

2.22

1.52

mg/l

0.54

146

562

Disorders of optic nerve and visual pathways

1104

8567

1.39

18.33

2.1

1.9

1.31

1.15

mg/l

0.38

851

6565

Torsion of ovary, ovarian pedicle and fallopian tube

291

1755

1.93

18.33

1.9

1.7

0.88

0.99

mg/l

0.42

229

1323

Single delivery by caesarean section

2296

10922

1.27

18.33

2.0

1.8

1.09

0.87

mg/l

2.95

1819

8056

Other congenital malformations of peripheral vascular system

199

1086

2.30

18.32

3.5

2.0

1.06

1.00

mg/l

0.12

159

835

Erythema nodosum

377

2440

1.80

18.32

2.1

1.7

1.14

1.08

mg/l

0.15

295

1883

Lactose intolerance

378

2432

1.77

18.30

1.9

1.8

1.61

1.14

mg/l

0.73

282

1830

Foreign body in alimentary tract

614

4356

1.56

18.27

1.9

1.30

1.36

mg/l

0.17

466

3328

Alcohol-induced chronic pancreatitis

697

5057

1.52

18.27

1.8

1.57

1.29

mg/l

1.14

555

3956

Specific development disorders of speech and language

626

4264

1.54

18.27

3.1

2.4

1.47

1.26

mg/l

0.63

488

3060

Other and unspecified mononeuropathies, also in other diseases

349

2209

1.82

18.24

1.7

0.85

1.31

mg/l

5.81

258

1715

Cervical polyps

1084

8377

1.39

18.23

1.7

1.05

1.21

mg/l

1.17

848

6574

Autoimmune hyperthyroidism

763

5626

1.49

18.17

1.9

1.7

0.96

1.04

mg/l

0.43

565

4350

Contusion of ankle

500

3419

1.64

18.13

2.1

1.9

1.09

1.05

mg/l

0.09

370

2543

Other and unspecified rosacea

1088

8447

1.39

18.12

1.8

0.91

1.13

mg/l

3.02

819

6564

Malignant neoplasm of colon, including Hilmo

1959

16100

1.27

18.12

1.8

1.7

1.89

1.30

mg/l

7.81

1617

12612

Acidosis

253

1474

2.03

18.12

2.4

1.8

1.96

1.46

mg/l

1.01

221

1152

Lichen ruber planus, wide definition including periferal and oral lichen planus

2623

22298

1.23

18.11

1.7

1.8

1.06

1.24

mg/l

3.17

2027

17486

Other erythematous conditions

435

2905

1.71

18.09

2.4

1.8

1.30

1.18

mg/l

0.28

339

2250

Intracerebral haemorrhage

1314

10382

1.34

18.06

2.4

1.7

1.66

1.61

mg/l

0.21

1079

8160

Polycystic ovarian syndrome

752

5546

1.49

18.01

2.0

1.8

0.77

0.90

mg/l

1.24

553

4062

Infection of intervertebral disc (pyogenic)

169

869

2.39

18.00

1.9

1.6

1.94

1.50

mg/l

0.60

150

698

Scabies, including avohilmo

1765

14454

1.29

17.97

2.0

1.9

0.96

1.04

mg/l

0.52

1308

10748

Other and unspecified vascular occlusions

994

7607

1.40

17.93

1.8

1.7

1.49

1.51

mg/l

0.05

793

6010

Emotional disorders and disorders of social functioning with onset specific to childhood

546

3694

1.58

17.92

3.1

2.4

1.23

1.08

mg/l

0.21

352

2581

Postzoster neuralgia

214

1199

2.19

17.92

2.1

1.6

1.12

1.45

mg/l

1.49

178

950

Carcinoma in situ of skin of other and unspecified parts of face

924

7010

1.43

17.90

1.8

1.7

1.84

1.62

mg/l

0.49

728

5577

Poisoning by narcotics and psychodysleptics [hallucinogens]

216

1210

2.16

17.89

2.0

1.8

1.38

0.99

mg/l

0.73

161

877

Other abnormalities of plasma proteins

217

1227

2.19

17.89

3.4

1.7

1.61

1.26

mg/l

0.84

184

956

Infective bursitis

307

1880

1.86

17.85

1.9

1.8

1.10

1.47

mg/l

2.16

248

1466

Congenital malformations of the respiratory system

228

1305

2.13

17.84

3.0

2.5

1.29

mg/l

0.00

173

1029

Other otitis externa (chronic)

786

5839

1.47

17.83

2.0

1.8

1.05

1.20

mg/l

0.58

567

4498

Other keratitis

1337

10651

1.34

17.76

2.1

1.8

1.04

1.15

mg/l

0.74

1014

8115

D07AA Corticosteroids, weak (group I)

1789

14665

1.28

17.75

1.9

2.0

1.16

1.10

mg/l

0.23

1364

11066

Other specified congenital malformation syndromes affecting multiple systems

207

1145

2.18

17.74

3.3

2.08

1.10

mg/l

1.67

160

863

Giant cell arteritis with polymyalgia rheumatica

424

2830

1.71

17.70

2.0

1.6

1.39

1.48

mg/l

0.19

348

2235

Lesion of plantar nerve

689

5025

1.51

17.69

1.8

0.90

1.24

mg/l

4.28

523

3922

Hypertrophic cardiomyopathy

469

3190

1.66

17.68

5.2

1.8

1.46

1.40

mg/l

0.14

355

2483

Other diseases of peritoneum

523

3641

1.62

17.63

2.2

1.7

1.22

1.17

mg/l

0.13

390

2829

Other and specified injuries of hip and thigh

289

1764

1.92

17.61

2.2

1.7

1.53

1.30

mg/l

0.32

232

1360

Dislocation, sprain and strain of joint and ligaments of hip

437

2931

1.68

17.55

1.9

1.7

1.38

1.27

mg/l

0.42

370

2267

Follow-up examination after treatment for malignant neoplasms

994

7591

1.39

17.53

1.7

1.6

1.62

1.52

mg/l

0.28

812

6002

Non-small cell lung cancer, adenocarcinoma

651

4682

1.51

17.53

1.8

1.7

2.13

1.39

mg/l

2.51

558

3687

Testicular hypofunction

417

2770

1.70

17.48

2.0

1.9

0.92

1.13

mg/l

0.91

319

2061

Malignant neoplasm of testis, including Hilmo

203

1111

2.14

17.46

1.8

1.9

1.17

1.01

mg/l

0.49

153

804

Gingival hyperplasia

430

2883

1.69

17.46

4.0

2.0

1.43

1.30

mg/l

0.42

341

2214

Impotence

584

4128

1.55

17.41

2.3

1.9

1.67

1.50

mg/l

0.43

459

3262

Sequelae of injuries of neck and trunk

362

2341

1.78

17.40

2.0

1.8

1.25

1.14

mg/l

0.35

277

1806

Post-traumatic wound infection, not elsewhere classified

344

2200

1.81

17.40

2.0

1.8

1.05

1.24

mg/l

1.08

269

1692

Maltreatment syndromes

623

4469

1.53

17.38

1.9

1.11

0.92

mg/l

0.29

459

3278

Exclusion endpoint for clefts

244

1423

2.02

17.36

3.1

1.98

1.12

mg/l

1.70

187

1063

Other diseases of gallbladder

508

3513

1.61

17.36

2.2

1.7

1.14

1.33

mg/l

0.91

406

2715

Attention to artificial openings

439

2941

1.66

17.31

2.8

1.8

2.08

1.36

mg/l

2.16

370

2288

Endometriosis diagnosis and infertility diagnosis occurring together

1319

10557

1.34

17.30

1.9

1.7

0.84

0.86

mg/l

0.15

1012

8000

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

1549

12598

1.31

17.30

1.8

1.01

1.20

mg/l

1.75

1213

9820

Rosacea

1544

12552

1.31

17.30

1.9

1.8

0.89

1.12

mg/l

4.34

1154

9722

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

254

1518

2.03

17.29

2.8

2.0

1.13

0.82

mg/l

0.43

192

1130

therapeutic use

367

2386

1.77

17.28

2.8

1.6

1.78

1.34

mg/l

0.91

291

1859

Gangrene, not elsewhere classified

396

3.10

17.24

2.3

1.6

1.46

1.58

mg/l

0.16

319

Acute bronchiolitis

572

3607

1.54

17.22

3.1

2.8

1.26

1.28

mg/l

0.02

408

2530

Inflammatory disorders of breast

821

6187

1.46

17.20

1.8

1.18

1.01

mg/l

0.81

624

4669

severe traumatic brain injury, does not include concussion

2404

20321

1.23

17.19

1.9

1.8

1.67

1.45

mg/l

1.60

1891

15931

Acute lymphocytic leukaemia, helper endpoint

102

442

3.15

17.17

13.2

2.5

1.85

0.91

mg/l

1.91

320

Acute lymphocytic leukaemia

102

442

3.15

17.17

13.2

2.5

1.85

0.91

mg/l

1.91

320

Acute lymphocytic leukaemia, including Hilmo

102

442

3.15

17.17

13.2

2.5

1.85

0.91

mg/l

1.91

320

Clear cell adenocarcinoma of kidney

512

3558

1.60

17.15

1.7

1.89

1.32

mg/l

2.40

429

2783

Malignant neoplasm of testis

187

1006

2.20

17.11

1.8

1.9

1.19

0.99

mg/l

0.62

139

724

Viral agents as the cause of diseases classified to other chapters, including avohilmo

330

2107

1.84

17.11

2.2

1.9

1.17

1.13

mg/l

0.10

274

1632

Other and unspecified erythematous conditions

395

2618

1.73

17.10

2.5

1.8

1.36

1.19

mg/l

0.41

309

2022

Whooping cough, including avohilmo

235

1372

2.06

17.08

2.1

1.7

0.97

mg/l

0.00

179

1006

Ankylosing spondylitis, ICD10

1000

7736

1.40

17.06

1.9

1.8

1.02

1.10

mg/l

0.41

758

5903

Unspecified chronic bronchitis

359

2296

1.73

17.03

2.5

1.6

1.00

1.46

mg/l

3.06

272

1800

Endometriosis of intestine

221

1264

2.09

17.02

2.2

1.6

0.96

0.77

mg/l

0.70

170

925

Other spirochaetal diseases, including avohilmo

4076

35935

1.18

16.99

1.7

1.8

1.02

1.18

mg/l

1.86

3032

27954

Malignant neoplasm of colon

1620

13210

1.29

16.98

1.8

1.7

1.88

1.31

mg/l

6.87

1342

10335

Respiratory conditions due to other external agents

255

1526

1.99

16.97

2.5

1.6

1.50

1.35

mg/l

0.34

209

1205

Other encephalitis

350

2266

1.79

16.95

2.0

1.8

1.00

1.20

mg/l

0.78

272

1727

Other abnormal findings of blood chemistry

567

4033

1.57

16.91

2.0

1.7

1.37

1.22

mg/l

0.42

437

3113

Other disorders of the genitourinary system

1424

11511

1.32

16.90

1.8

1.7

1.20

1.31

mg/l

0.65

1139

9004

Other maltreatment syndromes

373

2441

1.74

16.90

1.9

1.8

1.11

0.98

mg/l

0.44

283

1827

Kela reimbursement Agammaglobulinemia (D80-84)

136

677

2.72

16.86

3.2

1.8

1.08

1.13

mg/l

0.09

118

513

Encephalitis

367

2404

1.76

16.81

2.0

1.8

1.04

1.19

mg/l

0.54

281

1829

Aneurysms, operations, SAH

1799

14872

1.27

16.76

1.9

1.7

1.39

1.31

mg/l

0.40

1456

11654

Dronedarone medication

307

1920

1.83

16.68

1.9

1.6

0.95

1.54

mg/l

3.81

200

1553

Bacterial, viral and other infectious agents

970

7492

1.40

16.67

2.5

1.9

1.08

1.06

mg/l

0.10

750

5720

Raynaud syndrome

1067

8363

1.38

16.62

1.8

0.96

1.07

mg/l

0.57

797

6401

Episcleritis

648

4736

1.52

16.60

2.1

1.8

0.91

1.00

mg/l

0.37

523

3607

219

1248

2.03

16.56

2.4

2.1

1.14

1.06

mg/l

0.11

161

834

Colorectal cancer, including Hilmo

2874

23026

1.21

16.53

1.8

1.7

1.95

1.28

mg/l

12.18

2378

17999

Secondary thrombocytopenia

173

936

2.34

16.52

4.5

1.7

4.15

1.29

mg/l

2.68

154

739

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

203

1143

2.13

16.49

2.9

2.4

2.08

1.13

mg/l

0.65

148

869

Malignant neoplasm of mesothelium and soft tissue

432

2920

1.65

16.48

2.0

1.7

1.94

1.35

mg/l

1.37

363

2295

Infarction of spleen

108

499

3.14

16.47

2.6

1.8

2.15

1.61

mg/l

0.87

404

Abnormal findings on examination of urine, without diagnosis

497

3464

1.60

16.47

2.0

1.8

1.64

1.29

mg/l

1.19

407

2649

Malignant neoplasm of ovary, including Hilmo

730

5442

1.48

16.44

1.8

1.7

2.01

1.09

mg/l

8.38

630

4200

Other specified/unspecified necrotizing vasculopathies

185

1023

2.25

16.41

2.0

1.7

1.58

1.28

mg/l

0.56

155

814

Cystic fibrosis with intestinal manifestations

100

10.06

16.39

5.6

1.7

1.25

0.90

mg/l

0.23

Coeliac disease

1371

11061

1.32

16.34

1.8

1.14

1.16

mg/l

0.05

1072

8464

Campylobacter enteritis

342

2220

1.78

16.33

2.0

1.8

0.95

1.16

mg/l

1.22

280

1712

Non-small cell lung cancer

1043

8008

1.36

16.29

1.7

1.88

1.40

mg/l

2.45

891

6291

Spirochaetal infections, other/unspecified

1006

7844

1.39

16.26

1.7

1.8

1.12

1.25

mg/l

0.61

738

6122

Abnormal findings on diagnostic imaging of central nervous system

595

4295

1.53

16.26

2.1

1.8

1.21

1.08

mg/l

0.36

456

3261

Non-small cell lung cancer, including Hilmo

1534

11697

1.29

16.25

1.7

1.78

1.33

mg/l

3.66

1306

9217

Autonomic disorders

309

1962

1.83

16.23

2.0

1.7

1.58

1.19

mg/l

0.28

234

1528

Postviral fatigue syndrome

137

691

2.62

16.21

2.3

2.0

0.36

0.78

mg/l

3.98

515

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

707

5208

1.46

16.18

2.1

1.6

1.55

1.57

mg/l

0.03

555

4074

Focal brain injury

629

4534

1.48

16.18

1.7

1.6

1.57

1.47

mg/l

0.27

482

3509

Systemic sclerosis (FG)

284

1765

1.87

16.16

2.1

1.7

1.34

1.14

mg/l

0.31

233

1356

Supervision of normal pregnancy

2607

12664

1.23

16.14

1.7

0.74

0.79

mg/l

0.61

1975

9507

Lichen planus

1462

11907

1.31

16.12

1.7

1.8

1.19

1.31

mg/l

0.88

1148

9292

Other spirochaetal diseases

4015

35490

1.17

16.10

1.7

1.8

1.03

1.18

mg/l

1.80

2987

27603

Spirochaetal infections, other/unspecified, including avohilmo

4010

35454

1.17

16.03

1.7

1.8

1.03

1.18

mg/l

1.82

2982

27590

Gout due to impairment of renal function

150

781

2.46

16.02

2.7

1.7

1.47

1.62

mg/l

0.27

128

619

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

2473

17293

1.22

16.01

1.7

1.94

1.33

mg/l

5.95

2083

13575

Other disorders of optic [2nd] nerve and visual pathways

719

5359

1.47

16.00

2.1

1.9

1.59

1.28

mg/l

0.56

567

4099

Alzheimer’s disease (Atypical or mixed), excluding more controls

849

4761

1.40

15.98

1.5

1.6

1.76

2.00

mg/l

0.63

657

3818

Abnormal findings in secretions and smears from cervix uteri vagina vulva

6540

43644

1.13

15.96

1.7

0.89

0.98

mg/l

2.26

4982

33487

Cholangitis (primary sclerosing, PSC), with reimbursement 202

240

1439

1.99

15.91

3.7

2.0

1.76

1.24

mg/l

1.03

197

1116

Antepartum haemorrhage, not elsewhere classified

1055

8301

1.37

15.88

1.8

1.7

0.91

0.77

mg/l

1.09

795

6294

Subacute thyroiditis

449

3107

1.63

15.75

1.7

0.75

1.05

mg/l

3.00

345

2399

Hodgkin lymphoma, hilmo

344

2255

1.76

15.74

1.9

1.8

1.91

1.18

mg/l

1.07

281

1715

Exposure to other and unspecified animate mechanical forces

404

2739

1.68

15.70

2.0

1.9

1.27

0.99

mg/l

0.47

308

2055

Other articular cartilage disorders

271

1671

1.87

15.69

1.8

1.7

0.97

1.33

mg/l

2.38

223

1295

Volvulus

310

1971

1.78

15.63

2.0

1.7

1.67

1.42

mg/l

0.45

262

1550

Lichen planus, including avohilmo

2185

18536

1.24

15.59

1.7

1.8

1.10

1.26

mg/l

2.03

1706

14488

Dislocation, sprain and strain of joints and ligaments of head

490

3442

1.58

15.54

2.0

0.87

0.99

mg/l

0.55

370

2601

Glaucoma

6620

51061

1.13

15.52

1.7

1.37

mg/l

0.04

5173

40358

Burns and corrosions of external body surface, specified by site

1209

9670

1.33

15.47

2.0

1.9

1.24

1.16

mg/l

0.22

925

7334

Viral meningitis, including avohilmo

460

3209

1.61

15.44

2.2

1.8

0.82

1.03

mg/l

0.86

323

2428

Carcinoma in situ of skin of scalp and neck

311

1997

1.79

15.41

1.8

1.7

1.45

1.68

mg/l

0.87

252

1605

Etanercept

780

5925

1.44

15.41

1.9

1.8

1.18

1.00

mg/l

1.16

607

4488

Unspecified lump in breast

1846

15465

1.26

15.38

1.9

1.7

1.05

1.09

mg/l

0.24

1443

12001

Other ulcerative colitis

667

4946

1.48

15.36

1.9

1.8

1.10

1.05

mg/l

0.24

530

3713

Behavioural disorders, excluding more controls

234

1383

1.92

15.31

2.4

1.9

0.86

0.94

mg/l

0.25

172

999

Other inflammation of vagina/vulva

496

3520

1.59

15.31

1.9

1.8

0.85

0.91

mg/l

0.21

367

2648

Lyme disease

3972

35207

1.17

15.27

1.7

1.8

1.03

1.18

mg/l

1.75

2953

27408

Lyme disease, including avohilmo

3972

35207

1.17

15.27

1.7

1.8

1.03

1.18

mg/l

1.75

2953

27408

Malignant neoplasm of digestive organs, including Hilmo

4796

31469

1.15

15.24

1.9

1.7

2.26

1.20

mg/l

30.65

3990

24610

Spermatocele

725

5413

1.43

15.24

1.8

1.24

1.55

mg/l

1.31

550

4284

Cystic fibrosis with pulmonary manifestations

10.50

15.19

6.1

1.5

0.63

0.80

mg/l

0.53

ILD medications: nintedanib

350

3.40

15.18

2.6

1.5

1.52

1.33

mg/l

0.22

281

Other disorders of male genital organs

406

2745

1.63

15.18

1.8

2.0

1.25

1.37

mg/l

0.19

298

2059

Entropion and trichiasis of eyelid

868

6668

1.39

15.17

1.9

1.7

1.40

1.61

mg/l

0.85

695

5275

Schizoaffective disorder

872

6736

1.40

15.09

2.0

1.9

1.12

0.98

mg/l

0.87

649

5063

Vasomotor rhinitis (mode)

820

6290

1.41

15.04

1.7

1.8

0.98

1.19

mg/l

1.34

620

4863

Cardiomyopathy, Hypertrophic obstructive

204

1176

2.02

15.03

6.5

1.6

1.52

1.46

mg/l

0.07

156

936

Hereditary factor VIII deficiency

168

5.11

14.99

9.1

2.5

0.76

0.79

mg/l

0.09

136

Need for immunization against other single viral diseases

244

1498

1.94

14.96

2.4

1.8

1.46

1.22

mg/l

0.48

193

1173

Organic, including symptomatic, mental disorders

5793

36792

1.14

14.89

1.7

1.56

1.48

mg/l

0.76

4614

29047

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

177

1001

2.23

14.89

2.7

1.7

0.87

1.16

mg/l

1.15

144

785

Patent foramen ovale

273

1721

1.86

14.87

3.0

2.5

1.04

1.38

mg/l

0.90

205

1337

Cardiomyopathy in other diseases

356

3.21

14.85

2.1

1.9

0.94

1.68

mg/l

2.85

293

Postpartum care and examination

1649

8531

1.28

14.83

2.0

1.7

0.98

0.74

mg/l

2.38

1255

6218

Bullous disorders

619

4559

1.48

14.82

2.1

1.7

1.51

1.35

mg/l

0.35

488

3560

Benign neoplasm: Skin of eyelid, including canthus

1712

14277

1.26

14.82

1.7

1.8

1.26

1.31

mg/l

0.29

1308

11199

Malignant neoplasm of bladder, including Hilmo

1104

8626

1.33

14.80

1.8

1.7

1.87

1.43

mg/l

2.53

908

6842

Vitamin D deficiency

246

1513

1.91

14.76

2.3

1.7

1.27

1.09

mg/l

0.43

194

1142

Bicuspidal aortic valve syndrome

422

2917

1.62

14.74

2.9

1.9

1.39

1.12

mg/l

0.59

304

2234

Viral meningitis

436

3039

1.61

14.73

2.1

1.8

0.83

1.05

mg/l

0.84

306

2296

Ehlers-Danlos syndrome, including avohilmo

187

1078

2.16

14.72

2.8

1.8

0.70

0.86

mg/l

0.62

142

799

Colorectal cancer

2540

20952

1.21

14.65

1.7

1.94

1.29

mg/l

10.97

2100

16380

Macular pucker

1665

13860

1.27

14.65

1.7

1.50

mg/l

0.01

1314

11021

Hepatocellular carcinoma, including Hilmo

298

1902

1.76

14.64

2.6

1.7

2.76

1.41

mg/l

3.81

257

1498

Status epilepticus

381

2567

1.64

14.63

2.7

1.8

1.55

1.42

mg/l

0.28

315

1991

Dystonia

630

4675

1.48

14.61

2.0

1.9

1.09

1.16

mg/l

0.28

479

3622

Selective deficiency of immunoglobulin G [IgG] subclasses

110

536

2.83

14.58

3.2

1.9

1.30

1.23

mg/l

0.07

419

Tibial collateral bursitis [Pellegrini-Stieda]

149

795

2.31

14.55

1.8

1.6

1.43

1.25

mg/l

0.11

118

626

Chalazion

1286

10435

1.31

14.55

1.8

1.05

1.19

mg/l

0.86

979

8014

Postpartum haemorrhage

3195

23090

1.19

14.55

1.8

1.22

0.82

mg/l

8.65

2485

17321

Vestibular neuronitis

964

7578

1.37

14.54

2.0

1.8

0.89

1.28

mg/l

5.26

728

5910

Amputation of thigh

306

1967

1.73

14.49

3.1

1.6

2.10

1.64

mg/l

1.53

273

1565

Shock, not elsewhere classified

121

596

2.50

14.48

7.4

1.6

3.01

1.47

mg/l

1.79

106

467

Other and unspecified epidermal thickening

317

2075

1.75

14.47

2.2

1.8

1.08

1.26

mg/l

0.63

251

1598

Nontraumatic intracranial haemmorrhage

2095

17763

1.23

14.46

2.2

1.7

1.66

1.48

mg/l

1.49

1718

13954

Intentional self-harm by unspecified means

182

1038

2.13

14.44

2.4

1.9

0.67

0.95

mg/l

1.98

133

749

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

830

6281

1.39

14.43

2.2

2.3

1.23

1.01

mg/l

0.41

625

4637

Erythema intertrigo

310

2026

1.76

14.42

2.4

1.7

1.04

1.23

mg/l

0.89

241

1583

Lactose intolerance, other/unspecified

325

2137

1.72

14.39

1.9

1.8

1.37

1.13

mg/l

0.52

242

1604

Thrombotic microangiopathy

458

2.98

14.34

4.4

1.6

1.92

1.12

mg/l

2.23

373

Other congenital malformations of skin, including avohilmo

932

7313

1.37

14.31

1.9

1.09

1.13

mg/l

0.10

737

5518

Urethral stricture

563

4088

1.49

14.30

1.7

1.53

1.61

mg/l

0.12

414

3221

Hypoparathyroidism

427

2989

1.61

14.22

2.8

1.8

1.51

1.32

mg/l

0.43

338

2319

Degenerative macular diseases

1258

10205

1.30

14.20

1.8

1.7

1.51

1.50

mg/l

0.03

990

8059

Congenital malformations of the urinary system, including avohilmo

667

5002

1.45

14.19

2.2

2.1

2.04

1.22

mg/l

1.66

544

3767

Melanocytic naevi of trunk

1403

11542

1.29

14.04

2.2

1.8

1.13

1.18

mg/l

0.21

1058

8872

Hypertrophic disorders of skin

674

5077

1.44

14.04

2.0

1.8

0.95

1.03

mg/l

0.31

511

3819

Hypercalcemia

491

3526

1.55

14.01

2.1

1.7

1.72

1.38

mg/l

1.27

399

2744

Other and unspecified paralytic syndromes

188

1095

2.08

14.00

2.8

1.8

1.01

1.22

mg/l

0.53

160

843

Injuries involving multiple body regions

450

3179

1.58

14.00

2.0

1.7

1.07

1.14

mg/l

0.28

360

2419

Benign intracranial hypertension

152

833

2.29

13.99

2.2

1.8

0.74

0.88

mg/l

0.49

106

604

Secondary parkinsonism, excluding more controls

251

1549

1.81

13.95

1.9

1.6

1.40

1.68

mg/l

0.59

206

1208

Congenital malformations of the musculoskeletal system, not elsewhere classified

208

1251

2.01

13.93

3.0

2.1

1.31

0.83

mg/l

0.57

154

945

Other immunodeficiencies

155

857

2.27

13.92

2.8

2.0

0.89

1.21

mg/l

1.15

135

664

Contusion of toe(s) without damage to nail

335

2240

1.70

13.90

2.1

1.9

0.85

1.06

mg/l

1.07

258

1675

Secondary polycythaemia

284

1835

1.78

13.83

2.0

1.7

1.03

1.24

mg/l

0.77

219

1437

Endometriosis ASRM stages 3,4

2724

23748

1.20

13.83

1.8

1.7

1.08

1.03

mg/l

0.22

2051

18298

Disorder of external ear, unspecified

400

2778

1.62

13.81

1.7

0.93

1.20

mg/l

2.29

318

2135

Astigmatism

708

5368

1.42

13.80

2.3

2.1

1.10

1.21

mg/l

0.28

536

4049

Atopic conjunctivitis

528

3839

1.51

13.79

2.3

1.8

0.93

1.04

mg/l

0.47

411

2878

Polyarteritis nodosa and related conditions

178

1023

2.10

13.78

1.9

1.8

1.17

1.35

mg/l

0.44

146

809

Ulcerative colitis (strict definition, all Crohn cases excluded)

1605

13384

1.26

13.77

1.9

1.8

1.10

mg/l

0.00

1274

10154

Other disorders of amniotic fluid and membranes

1643

13265

1.26

13.73

1.8

0.78

0.82

mg/l

0.38

1253

9918

Malignant melanoma, including Hilmo

1828

15421

1.24

13.65

1.8

1.7

1.45

1.22

mg/l

0.99

1440

12040

Injury of other and unspecified intrathoracic organs

681

5150

1.43

13.60

1.8

1.7

1.87

1.34

mg/l

1.77

534

3971

Fall involving bed

368

2512

1.64

13.58

2.2

1.8

1.48

1.53

mg/l

0.11

303

1977

Chronic hepatitis, not elsewhere classified

405

2830

1.61

13.57

2.1

1.8

1.94

1.07

mg/l

3.78

325

2171

Idiopathic urticaria

288

1883

1.77

13.52

2.3

1.7

0.78

0.97

mg/l

1.18

235

1430

Infectious mononucleosis

957

7569

1.34

13.48

2.1

1.9

0.87

0.91

mg/l

0.18

665

5458

Infectious mononucleosis, including avohilmo

957

7569

1.34

13.48

2.1

1.9

0.87

0.91

mg/l

0.18

665

5458

Other and unspecified disorders of skin and subcutaneous tissue

685

5199

1.43

13.48

1.8

1.01

1.28

mg/l

2.53

493

4029

Ankle and foot

128

674

2.45

13.44

1.6

1.7

0.95

1.16

mg/l

0.54

529

Acne, including avohilmo

2650

18595

1.19

13.43

2.0

1.9

0.87

0.99

mg/l

1.50

1875

13435

Carcinoma in situ of skin

894

7033

1.36

13.42

2.0

1.7

1.48

1.49

mg/l

0.02

692

5538

Abscess of lung

190

1119

2.01

13.36

2.4

1.8

1.68

1.36

mg/l

0.46

163

884

Impetigo

520

3787

1.50

13.33

2.6

2.1

0.85

1.11

mg/l

2.39

400

2816

Other and unspecified mononeuropathies of upper limb

352

2398

1.65

13.33

1.8

1.7

1.35

1.12

mg/l

0.27

272

1828

Benign neoplasm: Duodenum

298

1971

1.74

13.26

2.0

1.7

1.30

1.40

mg/l

0.28

240

1560

Other diseases of spinal cord

345

2344

1.66

13.23

2.4

1.7

1.22

1.25

mg/l

0.10

278

1814

Panniculitis, unspecified

136

726

2.30

13.23

2.0

1.5

0.74

1.33

mg/l

3.98

114

560

Other bursitis, not elsewhere classified

121

618

2.39

13.21

1.8

1.5

1.08

1.37

mg/l

0.38

485

Haemangioma and lymphangioma, any site

1022

8192

1.33

13.17

2.1

1.9

1.21

1.18

mg/l

0.10

790

6293

Right hemicolectomy

596

4444

1.46

13.16

2.5

1.7

2.13

1.46

mg/l

2.60

507

3500

L01XE Protein kinase inhibitors

558

4136

1.48

13.15

2.3

1.8

2.27

1.37

mg/l

3.01

486

3241

Medical treatment for female infertility

2628

22715

1.19

13.14

1.8

1.7

1.00

0.80

mg/l

2.19

2057

17098

Amputation of foot

282

1835

1.75

13.14

2.0

1.7

1.68

1.58

mg/l

0.17

251

1473

6-mercaptopurine

401

2796

1.58

13.12

4.0

1.8

1.26

0.98

mg/l

0.82

312

2073

Benign neoplasm: Skin of other and unspecified parts of face

1138

9225

1.31

13.09

1.7

1.8

1.15

1.32

mg/l

1.29

868

7197

Manic episode

358

2454

1.63

13.06

2.1

1.7

1.19

1.06

mg/l

0.50

281

1851

Pleural plaque with presence of asbestos

667

5050

1.42

13.04

1.6

1.7

1.47

1.77

mg/l

1.15

525

4065

Ulcer of vagina/vulva

356

2451

1.65

13.03

2.0

1.8

0.93

1.03

mg/l

0.34

272

1867

Congenital malformations of genital organs

1081

8671

1.32

13.00

1.9

2.1

0.90

0.97

mg/l

0.42

842

6477

Fluid overload

224

4.05

12.98

2.5

1.6

1.17

1.34

mg/l

0.34

177

Postpartum hemorraghe, all women as controls

3195

27550

1.17

12.98

1.8

1.22

0.85

mg/l

7.72

2485

20745

Emotional disorders starting during childhood or adolescence

500

3584

1.49

12.91

3.1

2.4

1.42

1.13

mg/l

0.40

321

2498

Retinal haemorrhage

290

1909

1.72

12.90

2.0

1.7

1.38

1.39

mg/l

0.01

239

1502

Alcohol-induced acute pancreatitis

393

2751

1.59

12.87

1.8

1.56

1.30

mg/l

0.65

312

2149

Malignant neoplasm of breast, HER2-negative, including Hilmo

5259

30534

1.13

12.85

1.6

1.7

1.22

0.93

mg/l

8.79

4143

23568

Mixed connective tissue disease

228

1433

1.88

12.83

2.0

1.7

1.02

1.15

mg/l

0.46

202

1129

Other and unspecified psoriasis

742

5737

1.40

12.83

1.9

1.8

1.47

1.25

mg/l

0.91

581

4451

Malignant neoplasm of breast, including Hilmo

5258

30531

1.13

12.80

1.6

1.7

1.22

0.93

mg/l

8.80

4142

23565

Dependence on enabling machines and devices, not elsewhere classified

134

713

2.25

12.78

6.7

2.1

4.34

1.81

mg/l

1.47

119

572

Vitamin B12 deficiency anaemia

1050

8437

1.31

12.76

1.8

1.7

1.63

1.43

mg/l

0.66

845

6619

Somnolence

168

973

2.09

12.75

2.4

1.9

1.34

1.14

mg/l

0.20

132

744

278

1818

1.73

12.70

1.9

1.6

1.02

1.00

mg/l

0.04

208

1374

Other orthopaedic follow-up care

625

4719

1.43

12.69

1.9

1.7

1.02

1.14

mg/l

0.60

489

3599

Haemangioma, any site

954

7624

1.34

12.67

2.0

1.8

1.23

1.17

mg/l

0.19

738

5859

Other and unspecified mononeuropathies of lower limb

323

2191

1.67

12.62

1.9

1.6

1.09

1.22

mg/l

0.30

248

1688

Other and unspecified haemorrhagic conditions

204

1251

1.94

12.60

3.0

1.7

1.23

1.24

mg/l

0.01

171

974

Foreign body in respiratory tract

561

4180

1.46

12.59

2.0

1.9

0.90

1.20

mg/l

2.59

412

3172

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

980

7862

1.33

12.58

1.8

1.13

1.30

mg/l

1.08

765

6115

Drug-induced osteoporosis

178

1059

2.06

12.58

3.8

1.7

1.52

1.23

mg/l

0.53

149

840

Abnormal findings in nipple discharge synovial fluid wound secretions

199

1219

1.97

12.52

2.3

1.8

1.27

1.20

mg/l

0.10

161

951

Unspecified jaundice

474

3418

1.49

12.48

2.4

1.7

1.94

1.41

mg/l

1.29

381

2671

Microscopic polyangiitis

460

2.85

12.48

2.3

1.9

3.16

1.60

mg/l

1.37

370

Hirsutism in women

267

1753

1.77

12.47

1.9

1.8

0.95

0.80

mg/l

0.22

197

1310

Contact with heat and hot substances

593

4459

1.44

12.45

2.0

1.23

1.16

mg/l

0.24

453

3380

Cystic fibrosis, other manifestations/unspecified

116

6.87

12.44

5.7

1.9

1.38

1.13

mg/l

0.13

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

770

6007

1.38

12.43

1.9

0.99

1.01

mg/l

0.09

544

4464

Anorexia (incl.atypical)

666

5081

1.41

12.42

2.2

1.8

0.88

1.06

mg/l

1.52

463

3775

Hypotension due to drugs

175

1030

2.02

12.39

1.9

1.7

1.50

1.62

mg/l

0.18

144

840

Inguinal or femoral hernia, bilateral

1035

8333

1.31

12.39

1.8

1.18

1.41

mg/l

1.67

813

6630

Cystic kidney disease, including avohilmo

389

2743

1.58

12.36

2.2

1.9

2.42

1.22

mg/l

1.46

326

2103

Haemophagocytic lymphohistiocytosis

102

8.00

12.36

10.1

1.8

4.72

1.80

mg/l

1.29

Complications of genitourinary prosthetic devices, implants and grafts

303

2036

1.69

12.35

1.9

1.6

1.45

1.20

mg/l

0.51

243

1554

Other juvenile arthritis

418

2964

1.54

12.33

2.2

2.1

1.11

1.14

mg/l

0.09

323

2144

Cystic fibrosis

174

4.72

12.31

4.9

1.8

1.18

1.14

mg/l

0.03

127

Lichen sclerosus et atrophicus

1304

10806

1.28

12.28

1.8

1.7

1.07

1.18

mg/l

0.93

1011

8381

Short Achilles tendon (acquired)

296

1969

1.67

12.27

1.8

1.7

0.94

1.12

mg/l

0.54

252

1496

Benign neoplasm: Liver

303

2050

1.70

12.26

2.2

1.7

0.90

1.08

mg/l

0.75

241

1560

Crohn disease (strict definition, require KELA)

723

5606

1.39

12.25

1.9

1.00

1.01

mg/l

0.04

507

4173

Acne

1201

9781

1.28

12.25

2.3

1.9

0.84

1.00

mg/l

1.68

851

6960

Social phobias

939

7487

1.32

12.16

2.0

1.8

0.97

0.99

mg/l

0.13

678

5459

Pilonidal cyst

941

7525

1.33

12.13

2.0

1.8

1.01

0.99

mg/l

0.09

705

5558

Malignant neoplasm of breast

5144

30123

1.13

12.13

1.6

1.7

1.23

0.93

mg/l

9.07

4050

23252

Malignant neoplasm of breast, HER2-negative

5137

30087

1.13

12.12

1.6

1.7

1.23

0.93

mg/l

9.07

4047

23228

Hypertrophic scar

611

4642

1.43

12.09

2.0

1.8

0.96

1.01

mg/l

0.18

466

3479

Crohn disease (strict definition, require KELA, min 2 HDR)

714

5538

1.39

12.08

1.8

1.9

1.01

mg/l

0.01

499

4125

Allergic purpura

349

2422

1.62

12.08

2.1

1.8

1.21

1.13

mg/l

0.20

271

1834

Other noninflammatory disorders of cervix uteri

514

3801

1.47

12.06

1.9

1.7

1.07

1.35

mg/l

2.27

397

3017

Bruxism

247

1608

1.80

12.03

2.4

1.8

0.71

0.94

mg/l

1.35

175

1227

Unspecified threat to breathing

141

795

2.22

12.02

2.5

2.1

0.78

1.21

mg/l

2.14

111

605

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

569

4166

1.43

11.99

3.2

2.4

1.53

1.10

mg/l

0.70

407

2977

Inflammatory disease of cervix uteri

696

5401

1.40

11.97

1.7

0.80

1.13

mg/l

6.01

526

4224

Other specified/unspecified hearing loss

936

7493

1.32

11.96

1.9

1.8

1.44

1.42

mg/l

0.06

743

5870

Explicit fungal Sepsis, including avohilmo

473

2.60

11.91

6.7

1.6

2.48

1.57

mg/l

1.36

363

Pedestrian injured in transport accident

774

6074

1.36

11.88

1.9

1.8

1.18

1.12

mg/l

0.22

589

4649

Pedestrian injured in collision with pedal cycle

357

2497

1.60

11.87

1.9

1.8

1.05

1.17

mg/l

0.40

276

1940

Livedoid vasculitis

305

3.39

11.86

2.0

1.6

1.05

1.38

mg/l

0.79

244

Malignant melanoma

1615

13656

1.24

11.85

1.8

1.7

1.46

1.22

mg/l

0.89

1271

10639

Malignant neoplasm of breast, ER-positive, including Hilmo

3908

26083

1.15

11.85

1.6

1.7

1.24

0.97

mg/l

7.07

3081

20237

Benign neoplasm of middle ear and respiratory system

808

6374

1.35

11.82

1.9

1.8

1.24

1.35

mg/l

0.45

657

4973

Explicit fungal Sepsis

468

2.60

11.80

6.7

1.6

2.48

1.53

mg/l

1.46

358

Wegener granulomatosis

189

1157

1.94

11.80

2.6

1.7

1.97

1.37

mg/l

1.26

163

916

Chronic conjunctivitis

352

2461

1.60

11.79

1.9

1.8

0.95

1.26

mg/l

1.35

293

1905

Benign neoplasm: Rectosigmoid junction

432

3126

1.53

11.79

1.8

1.7

1.42

1.38

mg/l

0.08

353

2476

Benign neoplasm of meninges

1118

9165

1.29

11.78

2.0

1.7

1.48

1.29

mg/l

0.49

886

7158

Thiazolidinediones

1138

9332

1.29

11.74

1.8

1.7

1.55

1.39

mg/l

0.51

923

7319

Malignant neoplasm of heart, mediastinum and pleura

150

853

2.06

11.73

2.1

1.7

1.85

1.46

mg/l

0.79

120

672

Ulcerative rectosigmoiditis

907

7266

1.33

11.72

1.9

1.8

1.14

1.06

mg/l

0.44

708

5509

Disorders of plasma-protein metabolism, not elsewhere classified

499

2.57

11.71

2.7

1.6

1.35

1.37

mg/l

0.02

379

Benign neoplasm of ovary

1906

16397

1.22

11.71

1.7

1.05

1.15

mg/l

1.07

1522

12808

Malignant neoplasm of breast, HER-positive

3895

26043

1.15

11.69

1.6

1.7

1.24

0.97

mg/l

7.08

3070

20212

Pedal cyclist injured in other and unspecified transport accidents

1252

10370

1.27

11.69

1.7

1.8

1.13

1.16

mg/l

0.17

968

7881

Alzheimer’s disease (Late onset), excluding more controls

1375

7378

1.25

11.67

1.6

1.66

1.92

mg/l

1.71

1095

5916

Primary biliary cholangitis, wide definition

271

1804

1.71

11.64

2.9

1.7

1.93

1.14

mg/l

3.40

231

1412

Pneumonia derived septicemia

369

2597

1.57

11.63

2.8

1.8

2.63

1.39

mg/l

2.50

307

1986

Non-small cell lung cancer, adenocarcinoma, helper endpoint

651

5004

1.40

11.63

1.8

1.7

2.13

1.56

mg/l

1.65

558

3975

Family history of malignant neoplasm

1304

10855

1.27

11.62

1.7

1.6

0.99

0.98

mg/l

0.01

1024

8266

Ectropion of eyelid

392

2774

1.53

11.62

2.0

1.6

1.87

1.77

mg/l

0.13

316

2201

Crohn's disease of large intestine

570

4313

1.43

11.60

1.8

1.07

1.03

mg/l

0.13

416

3246

Hypogonadotropic hypogonadism

339

2353

1.60

11.59

2.0

1.9

0.63

1.11

mg/l

7.33

256

1738

Diffuse brain injury

350

2422

1.56

11.55

1.7

1.6

1.88

1.33

mg/l

0.84

252

1811

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

187

1130

1.87

11.54

2.1

1.7

1.73

1.39

mg/l

0.87

154

884

Hypertrichosis

296

2019

1.68

11.52

1.9

1.8

0.93

0.81

mg/l

0.18

218

1514

Femoral hernia

456

3333

1.49

11.50

1.8

1.7

1.23

1.30

mg/l

0.21

360

2611

Alcoholic liver disease

1014

8234

1.30

11.45

1.9

1.8

2.26

1.29

mg/l

7.72

868

6498

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

125

690

2.28

11.41

2.2

1.7

3.38

1.43

mg/l

0.78

104

548

Personal history of risk-factors, not elsewhere classified

173

1038

1.95

11.38

2.9

1.8

1.71

1.00

mg/l

0.50

136

778

Congenital malformations of gallbladder, bile ducts and liver

132

741

2.22

11.38

7.9

2.5

1.68

1.46

mg/l

0.26

110

595

Infections of genitourinary tract in pregnancy

1068

8744

1.30

11.37

1.8

0.83

1.02

mg/l

2.40

841

6634

Childhood allergy (age < 16)

1521

10536

1.23

11.34

2.3

2.2

1.39

1.04

mg/l

0.99

1024

7259

Seropositive rheumatoid arthritis, strict definition

1655

14110

1.23

11.32

1.8

1.7

1.62

1.22

mg/l

3.37

1357

10993

Aspergillosis, including avohilmo

124

686

2.28

11.27

3.2

1.7

2.28

1.52

mg/l

0.48

111

547

Other salmonella infections, including avohilmo

472

3484

1.47

11.24

2.0

1.7

0.94

1.18

mg/l

1.86

370

2653

Inguinal hernia, bilateral

1008

8184

1.30

11.23

1.8

1.19

1.41

mg/l

1.48

793

6510

Ulcerative enterocolitis

354

2498

1.58

11.22

2.1

1.8

1.40

1.02

mg/l

0.89

283

1899

Congenital aortic valve stenosis

285

3.08

11.21

6.3

3.1

1.55

1.16

mg/l

0.44

217

Effects of other external causes

334

2328

1.59

11.18

2.1

2.0

0.86

1.08

mg/l

0.91

236

1734

Paralytic strabismus

740

5825

1.36

11.15

1.8

1.34

1.36

mg/l

0.08

581

4560

Scar conditions and fibrosis of skin

484

3603

1.47

11.15

2.3

1.7

1.01

1.06

mg/l

0.11

379

2737

Crohn disease (strict definition, all UC cases excluded)

573

4366

1.42

11.13

1.8

1.9

0.98

1.02

mg/l

0.16

400

3270

Conduct disorder

238

1543

1.73

11.13

2.4

2.1

0.86

1.01

mg/l

0.48

174

1110

Congenital malformations of the urinary system

609

4675

1.40

11.12

2.3

2.1

2.12

1.15

mg/l

1.89

494

3508

Xerosis cutis

208

1320

1.83

11.11

2.4

1.7

1.16

1.43

mg/l

0.85

170

1038

Necrotizing fasciitis

366

2.82

11.08

2.4

1.5

1.69

1.62

mg/l

0.07

280

Respiratory disorders in diseases classified elsewhere

178

1095

1.95

11.07

2.8

1.7

1.79

1.32

mg/l

0.99

147

876

Operations for atrial fibrillation

177

1086

1.95

11.07

2.4

1.7

1.80

1.43

mg/l

0.65

141

867

Renal tubulo-interstitial disorders in diseases classified elsewhere

126

702

2.22

11.04

2.9

1.6

1.38

1.20

mg/l

0.38

102

544

Benign neoplasm: Liver/bile ducts

328

2300

1.61

11.04

2.2

1.7

0.93

1.08

mg/l

0.55

261

1758

Papilloedema, unspecified

279

1894

1.68

11.00

2.1

1.8

1.89

1.14

mg/l

0.57

219

1438

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

406

2952

1.53

10.96

1.8

1.9

0.86

1.15

mg/l

1.48

308

2237

Non-seminoma of testis, including Hilmo

364

2.71

10.93

1.6

1.9

1.43

0.81

mg/l

1.62

257

Malignant neoplasm of respiratory system and intrathoracic organs

2138

15376

1.19

10.91

1.7

1.86

1.35

mg/l

5.48

1798

12103

Malignant neoplasm of other connective and soft tissue, including Hilmo

423

3082

1.50

10.88

2.0

1.7

1.89

1.20

mg/l

1.57

343

2388

Open wound of abdomen, lower back and pelvis

355

2517

1.56

10.88

2.3

1.9

1.42

1.11

mg/l

0.77

270

1897

Motor disorders, excluding more controls

129

659

2.05

10.88

7.3

3.6

1.19

1.58

mg/l

0.50

467

Meningitis

547

4159

1.43

10.86

1.7

1.8

1.15

1.12

mg/l

0.09

419

3175

Fracture of neck

627

4847

1.39

10.83

1.8

1.7

1.49

1.44

mg/l

0.13

488

3781

Other mycoses, not elsewhere classified/unspecified, including avohilmo

228

1491

1.77

10.83

2.8

1.7

1.36

1.20

mg/l

0.33

188

1155

Struck by thrown, projected or falling objec

570

4350

1.41

10.82

2.0

1.9

1.19

1.11

mg/l

0.16

421

3292

Mental and behavioural disorders due to cannabinoids

317

2192

1.59

10.81

2.3

2.0

1.22

0.94

mg/l

0.76

205

1521

Other autoimmune haemolytic anaemias

157

940

2.02

10.79

3.0

1.7

3.12

1.48

mg/l

1.34

134

734

Intercostal neuropathy

113

617

2.33

10.77

1.8

1.7

0.98

1.49

mg/l

2.00

484

Aspergillosis

120

667

2.26

10.76

3.2

1.7

2.33

1.53

mg/l

0.49

107

536

Viral agents as the cause of diseases classified to other chapters

267

1808

1.69

10.76

2.3

1.9

1.23

1.15

mg/l

0.20

227

1411

Other and unspecified types of non-Hodgkin lymphoma, hilmo

422

3085

1.50

10.75

2.0

1.8

1.85

1.46

mg/l

0.99

350

2420

Complications of the puerperium, not elsewhere classified

519

3936

1.45

10.74

2.5

1.7

1.19

0.77

mg/l

2.81

409

2963

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

194

1222

1.85

10.69

2.0

1.6

2.05

1.20

mg/l

2.76

171

964

Other and unspecified disorders of autonomic nervous system

323

3.04

10.68

2.6

1.8

0.52

1.28

mg/l

2.77

247

Cushing syndrome

153

914

2.04

10.68

2.2

1.7

0.88

1.24

mg/l

1.78

123

708

Chronic myeloproliferative disease

170

1043

1.95

10.67

2.5

1.7

1.39

1.50

mg/l

0.17

136

828

Osteonecrosis due to drugs

184

1152

1.90

10.66

2.8

1.7

1.24

1.36

mg/l

0.38

156

919

Isolated proteinuria

312

2173

1.61

10.65

2.0

1.8

1.55

1.29

mg/l

0.63

258

1659

Toxic effect of other and unspecified substances

159

951

1.96

10.65

2.2

1.9

0.89

1.04

mg/l

0.50

123

722

Drug-induced polyneuropathy

122

686

2.25

10.64

5.8

1.9

2.28

1.36

mg/l

0.45

100

558

Acquired absence of limb

122

676

2.17

10.63

2.3

1.7

1.28

1.44

mg/l

0.37

102

545

Other meningitis

201

1281

1.83

10.63

1.9

1.8

1.31

1.21

mg/l

0.15

156

979

Assault by unspecified means

247

1642

1.70

10.62

2.0

1.9

1.16

1.03

mg/l

0.29

180

1224

Other disorders starting during childhood or adolescence

500

3698

1.43

10.59

3.4

2.6

1.67

1.13

mg/l

0.78

351

2617

Other disorders of pigmentation

496

3730

1.45

10.59

1.8

1.20

1.34

mg/l

0.35

381

2891

Other congenital malformations of skin

450

3340

1.48

10.58

2.1

1.9

1.16

1.17

mg/l

0.00

354

2522

Arthropathy in ulcerative colitis

170

1045

1.94

10.58

1.8

1.7

1.04

1.14

mg/l

0.26

138

808

Lower leg

101

536

2.45

10.57

1.8

2.1

1.32

1.33

mg/l

0.01

420

Oesophageal obstruction

359

2557

1.54

10.56

1.9

1.7

1.93

1.45

mg/l

0.82

299

2038

Other specified disorders of external ear

392

2845

1.52

10.53

1.7

1.03

1.44

mg/l

2.18

306

2249

Flatulence and related conditions

128

720

2.11

10.53

3.2

1.6

0.69

1.24

mg/l

3.88

103

561

Personal history of allergy to drugs, medicaments and biological substances

157

945

1.99

10.51

2.0

1.7

1.16

1.03

mg/l

0.09

125

735

Diabetic retinopathy

3938

22091

1.14

10.49

1.9

1.39

1.33

mg/l

0.42

3173

17585

Malignant neoplasm of corpus uteri, including Hilmo

981

8035

1.30

10.49

1.6

1.7

1.92

1.22

mg/l

4.09

794

6252

Malignant neoplasm of digestive organs

4239

29365

1.13

10.47

1.8

1.7

2.31

1.23

mg/l

27.98

3530

22962

Implicit parasitic Sepsis

364

2.81

10.46

2.7

1.7

1.43

1.21

mg/l

0.24

287

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

651

5104

1.38

10.44

1.8

0.95

1.25

mg/l

2.67

493

3998

Ehlers-Danlos syndrome

146

869

2.06

10.43

3.0

1.8

0.78

0.88

mg/l

0.24

108

653

Cystic kidney disease

351

2509

1.55

10.41

2.3

1.9

2.53

1.21

mg/l

1.45

292

1928

Shoulder region

186

1172

1.87

10.40

2.0

1.8

1.31

mg/l

0.00

143

921

Other and unspecified iridocyclitis

531

4046

1.42

10.40

1.9

1.8

0.94

1.22

mg/l

2.33

431

3092

Tracheo-bronchomalasia

273

2.93

10.39

2.0

1.6

0.52

0.85

mg/l

0.66

209

Hypertrophy of (infrapatellar) fat pad

122

682

2.15

10.36

2.2

1.7

0.59

1.19

mg/l

4.81

523

Car occupant injured in noncollision transport accident

404

2955

1.50

10.35

1.9

1.8

1.15

1.12

mg/l

0.10

328

2238

Prurigo nodularis

285

1970

1.63

10.27

2.0

1.7

1.59

1.32

mg/l

0.36

234

1549

Parkinson's disease, including avohilmo

1565

13369

1.22

10.22

1.7

1.43

1.54

mg/l

0.66

1274

10593

Kyphosis

151

898

1.96

10.22

2.0

1.7

1.12

1.36

mg/l

0.81

126

703

Chronic tubulo-interstitial nephritis

396

2886

1.50

10.22

1.8

1.6

1.29

1.12

mg/l

0.69

311

2196

Loose body in joint

247

1647

1.67

10.22

1.8

0.89

1.35

mg/l

2.79

181

1264

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

856

6934

1.32

10.21

2.0

1.8

1.01

1.21

mg/l

1.55

669

5386

Benign neoplasm: Cerebral meninges

1013

8350

1.29

10.21

2.1

1.7

1.49

1.27

mg/l

0.50

804

6508

Burns and corrosions confined to eye and internal organs

310

2176

1.59

10.21

1.9

1.8

0.76

1.08

mg/l

2.51

240

1662

Amputation of ankle bones

231

1522

1.70

10.20

2.1

1.7

1.56

1.50

mg/l

0.13

201

1213

Malignant neoplasm of ovary

527

4028

1.42

10.19

1.8

1.89

1.12

mg/l

5.29

447

3096

Disorders of magnesium metabolism

104

560

2.32

10.16

1.7

1.70

mg/l

0.00

442

Other and unspecified glaucoma

710

5620

1.34

10.14

1.7

1.8

1.75

1.54

mg/l

0.55

561

4437

Other misadventures during surgical and medical care

280

1936

1.64

10.11

2.2

1.7

1.45

1.23

mg/l

0.49

231

1510

Use of levodopa decarboxylase inhibitor

1372

11611

1.23

10.06

1.7

1.40

1.55

mg/l

0.92

1108

9202

Ulcerative proctitis

686

5424

1.35

10.05

1.9

1.8

1.01

1.02

mg/l

0.05

547

4078

Abrasion of teeth

4347

39654

1.13

10.03

1.7

1.8

0.97

1.13

mg/l

4.63

3259

30915

Achalasia of cardia

200

1287

1.78

9.98

1.9

1.7

0.96

1.33

mg/l

2.37

168

1011

Sudden idiopathic hearing loss

1048

8675

1.27

9.96

1.9

1.7

1.07

1.36

mg/l

3.08

790

6811

Congenital iodine-deficiency syndrome/hypothyroidism

323

2298

1.56

9.86

1.8

1.7

0.94

1.23

mg/l

2.53

253

1766

Whooping cough

459

2.45

9.84

2.5

1.8

1.12

1.18

mg/l

0.06

340

Systemic sclerosis

284

1984

1.62

9.79

2.1

1.7

1.34

1.09

mg/l

0.41

233

1548

Infection due to other mycobacteria, including avohilmo

184

1163

1.80

9.78

2.9

1.6

1.59

1.33

mg/l

0.24

151

897

IgA nephropathy (IgA glomerulonephritis)

265

1822

1.64

9.78

2.8

1.7

1.66

1.19

mg/l

1.50

226

1394

Implicit parasitic Sepsis, including avohilmo

434

2.51

9.76

2.7

1.7

1.35

1.17

mg/l

0.20

340

Behavioural disorders

234

1559

1.67

9.75

2.4

2.2

0.86

1.02

mg/l

0.50

172

1115

Defect, injury or illness of neck

457

2.48

9.72

1.6

1.8

0.79

1.10

mg/l

0.70

356

Impacted cerumen

1195

10034

1.25

9.71

1.9

1.8

1.23

1.42

mg/l

1.44

877

7853

Vertigo of central origin

188

1204

1.80

9.70

1.8

1.6

0.95

1.36

mg/l

1.47

136

943

Anankastic personality disorder

457

3451

1.45

9.65

1.8

0.92

0.98

mg/l

0.20

339

2592

Arthropod-borne viral fevers and viral haemorrhagic fevers

985

8137

1.28

9.65

1.7

1.8

1.13

1.24

mg/l

0.69

782

6316

Benign neoplasm: Pancreas

309

2196

1.58

9.65

2.0

1.7

1.31

1.38

mg/l

0.13

245

1731

Contracture of joint

144

859

1.94

9.63

1.8

1.6

1.43

1.33

mg/l

0.10

109

665

Erythema multiforme

265

1829

1.63

9.63

1.9

1.7

1.00

1.13

mg/l

0.60

209

1412

Graves disease, strict definition

1168

9816

1.25

9.62

2.0

1.8

0.80

1.03

mg/l

4.11

900

7542

Other retinal artery occlusion

240

1616

1.66

9.59

1.6

1.7

1.17

1.46

mg/l

1.37

187

1288

Other and unspecified follicular disorders

461

3486

1.44

9.57

2.4

1.8

0.87

1.11

mg/l

2.40

358

2625

Drug-induced systemic lupus erythematosus

528

2.39

9.55

2.9

1.8

1.30

1.08

mg/l

0.36

415

Spinal osteochondrosis

129

750

2.02

9.53

1.7

1.6

0.94

1.11

mg/l

0.45

103

561

Sequelae of injuries of head

564

4381

1.38

9.52

1.9

1.8

1.40

1.16

mg/l

0.53

427

3335

Alcohol withdrawal state with delirium

681

5413

1.34

9.50

1.8

1.35

1.31

mg/l

0.13

558

4250

Other specified disorders of kidney and ureter

356

2594

1.52

9.49

2.5

1.8

1.77

1.25

mg/l

1.83

287

2021

Other obstructive and reflux uropathy

450

3384

1.43

9.47

1.8

1.7

1.40

1.13

mg/l

1.07

365

2543

Neovascular glaucoma

417

3102

1.45

9.47

1.9

1.7

1.39

1.36

mg/l

0.08

347

2411

Superficial injury of neck

243

1652

1.66

9.46

2.2

1.9

1.04

1.08

mg/l

0.07

178

1234

Problems related to social environment

320

2283

1.54

9.42

1.9

1.7

1.07

1.21

mg/l

0.50

260

1756

Herpesviral keratitis and keratoconjunctivitis

462

3502

1.43

9.41

1.8

1.7

1.12

1.24

mg/l

0.37

358

2696

Hyperaldosteronism

313

2238

1.56

9.41

1.8

1.7

0.85

1.24

mg/l

3.07

233

1746

Malignant melanoma of skin, including Hilmo

1475

12630

1.21

9.40

1.6

1.7

1.45

1.21

mg/l

0.82

1169

9796

Family history of certain disabilities and chronic diseases leading to disablement

573

4468

1.38

9.40

2.0

1.7

0.78

0.97

mg/l

1.74

424

3336

Eosinophilia

193

1259

1.78

9.34

2.6

1.9

1.48

1.33

mg/l

0.27

156

974

Drug-induced headache, not elsewhere classified

468

2.49

9.33

2.1

1.7

0.82

0.89

mg/l

0.10

369

Hypermetropia

757

6092

1.31

9.33

2.1

0.99

1.24

mg/l

1.79

573

4619

Other and unspecified vaccines and biological substances

516

2.36

9.30

4.0

1.8

0.98

1.14

mg/l

0.17

401

Parkinson's disease, strict definition

1391

11867

1.22

9.30

1.7

1.45

1.55

mg/l

0.44

1137

9393

Other bursitis of elbow

107

595

2.16

9.30

3.0

1.6

1.32

1.44

mg/l

0.26

463

Foreign body entering into or through eye or natural orifice

822

6685

1.30

9.29

2.0

1.9

1.14

1.18

mg/l

0.11

605

5064

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

461

3480

1.42

9.29

2.5

1.6

2.78

1.37

mg/l

5.49

395

2751

Mixed disorders of conduct and emotions

244

1653

1.62

9.28

2.1

2.5

0.93

0.90

mg/l

0.09

170

1112

Aortic hypoplasia

6.65

9.27

18.6

7.0

2.28

2.32

mg/l

0.01

Infection due to other mycobacteria

170

1069

1.81

9.26

3.0

1.6

1.64

1.34

mg/l

0.26

139

836

Other sexually transmitted chlamydial diseases

714

5720

1.32

9.23

1.9

0.85

0.88

mg/l

0.18

507

4068

Other salmonella infections

383

2828

1.47

9.23

2.0

1.7

1.04

1.24

mg/l

1.08

299

2169

Conductive hearing loss, unspecified

868

7108

1.29

9.22

2.2

1.9

1.31

1.24

mg/l

0.26

687

5479

Personal history of medical treatment

136

815

1.98

9.22

2.7

1.8

1.36

1.27

mg/l

0.15

104

636

Chronic myeloid leukaemia, including Hilmo

112

635

2.13

9.21

2.0

1.7

1.47

1.05

mg/l

0.95

485

Other and unspecified injuries of abdomen, lower back and pelvis

187

1211

1.77

9.18

2.1

1.7

1.24

1.14

mg/l

0.14

147

917

Caught, crushed, jammed or pinched in or between objects

568

4437

1.37

9.18

1.9

0.95

1.09

mg/l

0.65

426

3333

Personal history of certain other diseases

230

1557

1.66

9.14

2.4

1.7

1.10

0.93

mg/l

0.53

177

1147

Malignant neoplasm of bronchus and lung, including Hilmo

2102

15386

1.17

9.11

1.7

1.99

1.35

mg/l

5.08

1775

12108

Perforation of tympanic membrane

1038

8660

1.26

9.10

1.8

1.08

1.28

mg/l

1.77

796

6642

Pulmonary oedema

184

1180

1.74

9.07

3.2

1.7

1.67

1.55

mg/l

0.24

158

954

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

336

2429

1.51

9.06

2.8

2.6

1.60

1.17

mg/l

0.92

265

1822

Mature T/NK-cell lymphomas, hilmo

157

981

1.87

9.06

2.4

1.7

1.70

1.43

mg/l

0.65

138

777

Hereditary hypogammaglobulinemia

281

3.07

9.06

2.6

1.7

0.87

1.56

mg/l

0.89

219

Pedal cyclist injured in transport accident

2527

22517

1.16

9.05

1.8

1.9

1.12

1.15

mg/l

0.26

1933

17211

Thyrotoxicosis with toxic multinodular goitre

640

5093

1.35

9.03

1.9

1.7

1.29

1.32

mg/l

0.11

511

3988

Twin gestation

1032

8628

1.26

9.03

1.8

1.7

1.04

0.78

mg/l

2.87

819

6592

Other sexually transmitted chlamydial diseases, including avohilmo

1116

9361

1.24

9.03

2.0

1.9

0.81

0.96

mg/l

1.57

785

6594

Moderate visual impairment, binocular

313

2241

1.52

8.99

1.8

1.7

1.29

1.49

mg/l

0.82

220

1760

Venous complications and haemorrhoids in the puerperium

149

930

1.94

8.99

2.1

1.8

2.15

1.01

mg/l

0.92

117

727

Hyperosmolality and hypernatraemia

152

937

1.85

8.98

1.9

1.7

1.58

1.49

mg/l

0.14

120

727

Corticotropin deficiency

118

692

2.11

8.97

2.0

1.8

0.76

1.29

mg/l

2.12

557

Hyposplenism

123

4.99

8.97

9.2

1.8

1.60

1.10

mg/l

0.86

101

Glaucoma secondary to other eye disorders

419

3149

1.44

8.93

1.9

1.8

1.39

1.33

mg/l

0.20

348

2454

malignant neoplasm of male genital organs, including Hilmo

2843

15242

1.15

8.90

1.6

1.8

1.68

1.29

mg/l

4.03

2242

12040

Injury of nerves at lower leg level

127

755

2.00

8.89

1.9

1.7

1.33

1.27

mg/l

0.06

108

598

Central retinal artery occlusion

223

1503

1.65

8.87

1.9

1.7

1.42

1.63

mg/l

0.56

187

1208

Other forms of systemic lupus erythematosus

116

680

2.11

8.85

2.1

1.7

1.48

1.08

mg/l

0.74

537

Toxic effect of contact with venomous animals

465

3566

1.42

8.85

2.0

1.9

1.13

1.11

mg/l

0.04

335

2733

Viral haemorrhagic fevers, not elsewhere classified/unspecified

812

6644

1.30

8.84

1.7

1.8

1.14

1.19

mg/l

0.21

643

5137

Malignant neoplasm of corpus uteri

879

7252

1.28

8.83

1.5

1.7

1.93

1.22

mg/l

3.67

714

5646

Carcinoma in situ of skin of upper limb, including shoulder

272

1918

1.58

8.82

1.8

1.7

2.09

1.53

mg/l

0.48

223

1532

Benign mammary dysplasia

1529

13234

1.21

8.81

1.7

1.04

1.18

mg/l

1.24

1214

10315

Isolated patent ductus arteriosus

116

662

2.04

8.79

3.9

4.1

1.33

1.76

mg/l

0.37

513

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

107

610

2.14

8.78

2.3

1.7

1.61

1.43

mg/l

0.21

499

Injury of nerves at forearm level

163

1037

1.83

8.78

2.7

1.7

0.70

1.28

mg/l

5.03

123

780

Disorders of adrenal gland, other and/or unspecified

405

2.52

8.77

2.4

1.7

0.73

1.16

mg/l

1.40

322

Polyhydramnios

549

4307

1.37

8.76

1.8

1.7

0.85

0.77

mg/l

0.54

436

3241

Other chondrocalcinosis

154

969

1.87

8.75

1.9

1.7

1.20

1.62

mg/l

1.78

124

782

Polycystic kidney disease

291

2083

1.56

8.73

2.3

1.9

2.16

1.18

mg/l

1.50

248

1614

Disorders of porphyrin and bilirubin metabolism

133

801

1.94

8.73

2.4

1.9

1.40

1.23

mg/l

0.13

607

Alzheimer’s disease (Early onset)

230

3353

0.65

8.73

1.6

1.7

1.87

1.48

mg/l

0.34

159

2639

Parkinson's disease

1490

12849

1.20

8.71

1.7

1.45

1.53

mg/l

0.42

1216

10181

Pyoderma gangrenosum

108

621

2.14

8.71

2.4

1.7

1.29

1.14

mg/l

0.27

482

Dislocation, sprain and strain of joints and ligaments of elbow

704

5678

1.32

8.70

2.0

1.9

0.76

1.06

mg/l

4.23

547

4246

Acquired absence of organs, not elsewhere classified

140

856

1.90

8.68

1.9

1.7

1.66

1.37

mg/l

0.47

116

670

Use of donepezil

1631

17892

0.84

8.66

1.5

1.7

1.78

1.63

mg/l

0.56

1244

14253

Colitis, primary sclerosing

168

1079

1.80

8.66

2.3

2.0

1.69

1.06

mg/l

1.56

139

818

Atrial septal defect, secundum type

293

2088

1.54

8.65

3.2

2.6

1.27

1.37

mg/l

0.22

215

1600

Molar incisor enamel hypoplasia

358

2510

1.46

8.65

6.3

2.8

2.18

1.10

mg/l

1.60

281

1808

532

4107

1.35

8.65

2.3

1.7

1.25

1.46

mg/l

0.81

438

3200

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

531

2.22

8.64

2.2

1.7

2.12

1.26

mg/l

0.43

418

Primary adrenocortical insufficiency

143

889

1.92

8.64

2.4

1.8

0.79

1.11

mg/l

1.77

108

701

Premenstrual syndrome

180

1169

1.74

8.63

1.7

1.6

0.57

0.81

mg/l

2.31

127

849

Deficiency of other B group vitamins

229

1564

1.63

8.63

2.0

1.7

1.26

1.32

mg/l

0.10

178

1227

Other and unspecified injuries of thorax

215

1456

1.67

8.61

1.9

1.7

1.18

1.22

mg/l

0.06

165

1123

Golimumab

410

3103

1.44

8.61

1.8

1.17

0.96

mg/l

1.08

315

2328

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

155

972

1.82

8.60

1.7

1.5

0.98

1.34

mg/l

1.00

127

762

Systemic sclerosis, icd10

279

1993

1.57

8.60

2.1

1.7

1.35

1.10

mg/l

0.40

231

1557

Intussusception

238

1643

1.61

8.54

1.7

1.01

1.14

mg/l

0.37

183

1271

Other neurotic disorders

492

3811

1.39

8.53

1.8

1.6

1.37

1.26

mg/l

0.25

365

2958

Chronic nephritic syndrome

395

2971

1.44

8.53

2.3

1.8

1.91

1.23

mg/l

3.65

342

2313

Gastrojejunal ulcer

141

866

1.87

8.52

1.8

1.7

1.07

1.46

mg/l

1.10

115

678

Retinal breaks without detachment

1717

15006

1.19

8.51

1.8

1.05

1.30

mg/l

3.47

1315

11805

Other acute viral hepatitis

160

1024

1.83

8.50

2.0

1.8

1.29

1.18

mg/l

0.17

132

780

Defects in the complement system

538

2.23

8.48

3.3

2.2

0.99

1.23

mg/l

0.44

416

Pregnancy, childbirth and the puerperium

3346

15791

1.14

8.48

1.7

1.8

1.14

1.24

mg/l

1.08

2559

11873

Hypersomnia

167

1077

1.79

8.47

1.9

1.8

0.90

1.18

mg/l

0.88

122

818

Previous suicide attempt

136

834

1.91

8.47

2.2

1.9

0.94

1.00

mg/l

0.12

102

626

Superficial injuries involving multiple body regions

301

2175

1.53

8.44

1.9

1.8

1.08

1.17

mg/l

0.27

239

1649

Exposure to other and unspecified man-made environmental factors

230

1589

1.64

8.43

2.6

1.8

0.83

1.11

mg/l

1.45

178

1199

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

673

5428

1.32

8.41

1.8

1.03

1.24

mg/l

1.35

530

4208

Thyroiditis, unspecified

184

1216

1.74

8.41

2.2

1.7

0.83

1.10

mg/l

1.33

139

932

Benign lipomatous neoplasm of other sites/unspecified

862

7125

1.27

8.41

1.6

1.8

1.20

1.37

mg/l

0.69

684

5585

Multiple gestation

1059

8937

1.25

8.39

1.9

1.7

1.04

0.78

mg/l

3.06

841

6821

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

161

1032

1.80

8.38

2.0

1.8

0.94

1.13

mg/l

0.55

124

791

Marginal zone B-cell lymphoma, including Hilmo

174

1132

1.75

8.38

2.0

1.6

1.58

1.33

mg/l

0.62

140

878

Type 1 diabetes, wide definition, subgroup 2

923

0.38

8.37

1.7

2.1

1.40

1.49

mg/l

0.09

723

Seminoma of testis, including Hilmo

104

589

2.06

8.37

1.8

1.06

0.95

mg/l

0.19

431

Benign neoplasm of eye and adnexa

1117

9468

1.24

8.34

2.0

1.8

1.07

1.31

mg/l

2.55

847

7386

Disorders in reading

172

1110

1.73

8.34

4.4

2.7

1.05

1.03

mg/l

0.03

120

772

Other lesions of median nerve

284

2033

1.54

8.34

1.6

1.16

1.32

mg/l

0.50

222

1592

Generalized epilepsy

460

3547

1.40

8.34

1.8

2.0

1.25

1.06

mg/l

0.29

344

2677

Open wound of hip and thigh

356

2642

1.46

8.34

2.0

1.9

1.05

1.08

mg/l

0.07

283

1972

Acne vulgaris

897

7419

1.26

8.32

2.4

1.9

0.79

0.97

mg/l

2.08

636

5247

All dysplastic lesions of the vulva

493

3853

1.39

8.31

1.9

1.8

0.95

0.97

mg/l

0.09

390

2959

Juvenile arthritis (FINNGEN)

465

3578

1.39

8.31

2.2

2.0

1.09

1.00

mg/l

0.37

366

2582

Guillain-Barre syndrome

185

1226

1.73

8.30

2.0

1.7

1.64

1.23

mg/l

0.55

147

962

Pneumococcal septicemia

350

2596

1.47

8.30

2.8

1.9

2.67

1.34

mg/l

2.63

291

1999

Other congenital malformations of circulatory system

294

2130

1.54

8.28

2.6

1.8

1.33

1.16

mg/l

0.34

239

1643

Assault by blunt object

170

1103

1.76

8.28

1.9

1.8

0.89

1.06

mg/l

0.56

129

821

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

386

2902

1.44

8.27

2.6

2.3

1.43

1.07

mg/l

0.31

288

2134

L02BG Aromatase inhibitors

3391

30500

1.13

8.25

1.6

1.7

1.32

1.20

mg/l

1.64

2699

23939

Ankylosing hyperostosis [Forestier]

143

889

1.84

8.24

1.7

1.29

1.48

mg/l

0.20

109

712

Dermatopolymyositis (FG)

151

952

1.81

8.24

2.2

1.7

1.30

1.26

mg/l

0.06

118

732

Transient global amnesia

925

7728

1.26

8.18

1.7

1.23

1.41

mg/l

0.61

702

6119

Hypoplasia of dental enamel , including avohilmo

339

2394

1.46

8.17

6.2

2.9

2.23

1.11

mg/l

1.55

265

1723

Ventricular septal defect, a heart condition

223

1525

1.61

8.16

4.4

3.3

1.47

1.40

mg/l

0.09

171

1143

Unspecified event, undetermined intent

282

2030

1.53

8.12

2.4

1.9

1.00

1.12

mg/l

0.46

210

1531

Contact with and exposure to communicable diseases

3596

32674

1.12

8.10

2.1

1.9

0.90

1.01

mg/l

1.30

2522

24417

Oral lichen planus, including avohilmo , including avohilmo

762

6264

1.29

8.07

1.7

1.8

0.84

1.16

mg/l

4.33

562

4884

Other disorders of central nervous system

154

988

1.81

8.07

2.1

1.8

1.23

1.32

mg/l

0.11

120

768

Orthopaedic devices associated with adverse incidents

206

1409

1.67

8.04

1.8

1.6

1.61

1.40

mg/l

0.28

152

1129

Burns and corrosions of multiple and unspecified body regions

248

1747

1.57

8.04

2.1

1.9

1.18

1.21

mg/l

0.05

189

1339

Other contact dermatitis

869

7220

1.26

8.03

1.9

1.8

0.98

1.16

mg/l

1.38

640

5569

Anomalies of dental arch relationship, including avohilmo

2205

17738

1.16

8.03

2.2

1.9

1.02

1.08

mg/l

0.26

1617

13327

Delayed milestone in childhood

143

790

1.79

8.03

6.4

5.8

3.02

1.69

mg/l

0.97

115

559

Disorders of eyelid in diseases classified elsewhere

350

2612

1.46

8.02

2.3

1.7

0.95

1.22

mg/l

1.48

261

2006

Other bursitis of knee

151

957

1.78

7.99

2.9

1.7

1.59

1.33

mg/l

0.38

115

737

Follicular lymphoma, hilmo

421

3230

1.41

7.98

2.0

1.7

1.38

1.45

mg/l

0.15

348

2543

Patellar tendinitis

185

1226

1.68

7.98

2.0

1.8

1.02

mg/l

0.00

138

910

Puerperal sepsis

1372

11877

1.21

7.98

1.7

1.8

0.93

1.03

mg/l

1.04

1059

9233

malignant neoplasm of male genital organs

2760

14909

1.14

7.97

1.6

1.8

1.72

1.30

mg/l

4.26

2170

11798

Other endocrine disorders

502

3757

1.36

7.97

3.0

2.6

1.96

1.23

mg/l

0.88

373

2795

Late syphilis, including avohilmo

188

1262

1.70

7.95

1.9

1.7

1.12

1.30

mg/l

0.56

153

998

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

394

3000

1.43

7.91

2.6

1.7

1.28

1.22

mg/l

0.12

313

2322

Other and unspecified nail disorders

273

1971

1.54

7.88

2.4

1.8

0.99

1.16

mg/l

0.74

205

1510

Malignant neoplasm of other connective and soft tissue

249

1758

1.56

7.86

2.1

1.7

2.08

1.24

mg/l

1.13

212

1361

Congenital deformities of feet, including avohilmo

430

3313

1.40

7.86

2.4

1.9

1.49

1.03

mg/l

0.64

344

2474

Eustachian salpingitis and obstruction

886

7395

1.26

7.86

1.7

1.8

0.91

0.89

mg/l

0.09

652

5475

Disturbances of smell and taste

441

3410

1.39

7.86

1.9

1.7

1.06

1.23

mg/l

0.53

349

2657

Contact with other hot fluids

337

2509

1.46

7.84

2.0

2.1

1.01

1.14

mg/l

0.48

251

1882

Ulcerative ileocolitis

430

3318

1.40

7.81

2.0

1.8

1.51

1.01

mg/l

1.58

336

2520

Other bursal cyst

164

1067

1.73

7.80

1.5

1.7

0.88

1.26

mg/l

1.80

120

836

Background retinopathy and retinal vascular changes

227

1583

1.59

7.78

1.9

1.7

1.13

1.32

mg/l

0.84

189

1243

Foreign body or object entering through skin

644

5211

1.31

7.77

1.9

1.8

1.30

1.10

mg/l

0.46

492

3929

Carcinoma in situ of skin of trunk

323

2390

1.47

7.77

1.7

1.6

1.48

1.62

mg/l

0.44

250

1904

Malnutrition

226

1575

1.59

7.74

3.3

2.2

1.70

1.41

mg/l

0.83

182

1230

Symptoms and signs involving appearance and behaviour

109

648

2.01

7.74

2.1

1.7

0.95

1.20

mg/l

0.58

493

Malignant melanoma of skin

1200

10280

1.21

7.73

1.7

1.48

1.21

mg/l

0.74

950

7996

Eclampsia

186

3.36

7.73

2.3

1.8

1.99

1.03

mg/l

1.08

150

Lesion of sciatic nerve

392

2975

1.41

7.73

1.7

1.55

1.57

mg/l

0.03

325

2352

Arteriovenous malformation of peripheral vessels

416

2.36

7.70

4.1

1.8

1.22

0.98

mg/l

0.29

325

ILD and respiratory illness in diseases classified elsewhere

410

2.39

7.70

2.8

1.7

1.54

1.55

mg/l

0.01

339

Medicines for HER+ breast cancer

4259

36598

1.11

7.69

1.7

1.28

1.14

mg/l

2.17

3370

28617

Serous carcinoma of ovary, including Hilmo

351

2644

1.45

7.68

1.8

2.40

1.18

mg/l

4.59

301

2044

Arthropathy in Crohn disease

132

829

1.88

7.67

1.8

1.7

0.94

1.04

mg/l

0.20

105

638

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

313

2.66

7.64

1.9

1.6

1.23

1.26

mg/l

0.03

253

Complications of labour and delivery

7616

39749

1.08

7.64

1.7

1.06

1.02

mg/l

0.38

5916

30303

Calcaneal spur

141

893

1.80

7.58

1.7

1.5

0.99

1.17

mg/l

0.38

106

691

Other specific arthropathies, wide

226

1581

1.58

7.57

1.7

1.6

1.19

1.16

mg/l

0.06

177

1217

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

203

2.98

7.56

2.2

2.6

0.94

0.93

mg/l

0.00

144

Other osteochondropathies

726

5972

1.28

7.55

1.8

0.99

1.06

mg/l

0.26

549

4563

UC patients in KELA-register (code 208), prior to 1994

437

3397

1.39

7.55

1.9

1.7

1.26

1.16

mg/l

0.31

364

2637

Use of ropinirole

352

2659

1.44

7.54

1.9

1.7

1.33

1.44

mg/l

0.25

286

2101

Other disorders of prostate

309

2268

1.46

7.54

1.7

1.35

1.69

mg/l

1.02

250

1805

Fasciculation

148

958

1.80

7.53

2.3

1.7

0.91

1.23

mg/l

1.06

111

743

Tetralogy of Fallot, a congenital heart defect.

236

2.78

7.50

3.0

2.9

1.69

1.20

mg/l

0.54

182

Other acquired deformities of musculoskeletal system and connective tissue

471

3698

1.37

7.49

1.9

1.7

0.93

1.15

mg/l

2.30

375

2843

Mantle cell lymphoma, including Hilmo

145

927

1.78

7.49

2.1

1.6

2.51

1.40

mg/l

0.82

129

721

Hepatocellular carcinoma

205

1402

1.60

7.49

2.7

1.7

3.15

1.44

mg/l

3.55

175

1110

Laparoscopic right hemicolectomy

572

4598

1.33

7.49

1.6

1.8

1.41

1.47

mg/l

0.23

456

3643

Prophylactic surgery

108

650

2.01

7.49

1.7

1.37

0.94

mg/l

0.34

505

Retinal detachment with retinal break

1295

11198

1.20

7.44

2.0

1.8

1.23

1.38

mg/l

1.24

1043

8788

Other renal tubulo-interstitial diseases

269

1952

1.52

7.44

2.0

1.7

1.28

1.03

mg/l

0.91

213

1490

Malignant neoplasm of liver and intrahepatic bile ducts

283

2054

1.48

7.44

2.8

1.7

2.90

1.41

mg/l

4.12

236

1628

Anomalies of pupillary function

249

1788

1.55

7.44

2.0

1.8

1.55

1.06

mg/l

0.43

180

1374

Malignant immunoproliferative diseases

123

766

1.91

7.43

3.0

1.8

2.23

1.52

mg/l

0.45

109

611

Other/unspecified crystal arthropathies

471

2.21

7.42

1.8

1.7

1.41

1.34

mg/l

0.11

377

Dependent personality disorder

231

1641

1.58

7.41

1.8

1.7

1.10

1.18

mg/l

0.22

178

1266

Polypectomy (DHB20)

660

5388

1.30

7.39

1.7

1.17

1.29

mg/l

0.34

516

4188

Corneal scars and opacities

304

2253

1.48

7.38

2.1

1.7

1.22

1.25

mg/l

0.08

233

1748

Injury of muscle and tendon at wrist and hand level

1404

12220

1.19

7.37

1.9

0.96

1.22

mg/l

2.41

1094

9485

Glaucoma suspect

4027

37108

1.11

7.36

1.8

1.7

1.28

1.36

mg/l

0.75

3120

29293

Other specified and unspecified retinal disorders

367

2794

1.42

7.36

2.6

1.7

1.13

1.30

mg/l

0.74

293

2174

Congenital stenosis of pulmonary valve

445

2.18

7.35

3.0

3.3

1.09

1.17

mg/l

0.09

346

Colon adenocarcinoma

1186

10184

1.21

7.35

1.7

1.81

1.31

mg/l

4.90

974

8014

Femoral hernia, unilateral

283

2072

1.49

7.35

1.9

1.7

1.19

1.29

mg/l

0.31

221

1626

Inguinal of femoral hernia, unilateral

283

2072

1.49

7.35

1.9

1.7

1.19

1.29

mg/l

0.31

221

1626

Inguinal hernia, unilateral

283

2072

1.49

7.35

1.9

1.7

1.19

1.29

mg/l

0.31

221

1626

Routine general health check-up of defined subpopulation

228

1600

1.55

7.32

2.7

1.6

1.30

0.98

mg/l

0.58

175

1225

Oral lichen planus and hypothyroidism or thyroxine medication

225

1598

1.59

7.32

1.8

1.7

0.78

1.12

mg/l

2.87

169

1257

Pulmonary eosinophilia, not elsewhere classified

139

892

1.81

7.31

2.0

1.6

1.38

1.29

mg/l

0.13

113

717

Follow-up care involving plastic surgery

419

3254

1.39

7.31

1.7

1.6

0.90

1.02

mg/l

0.73

306

2495

Malignant neoplasm of endocrine gland, including Hilmo

852

7137

1.25

7.30

2.0

1.8

1.11

1.04

mg/l

0.19

649

5449

Monoplegia

176

1189

1.68

7.28

3.6

1.8

1.35

1.25

mg/l

0.16

139

948

Contact with other sharp object(s)

726

5993

1.28

7.25

1.8

1.9

1.00

1.03

mg/l

0.07

541

4432

Hypertension, portal

237

2.88

7.23

4.1

1.6

2.89

1.35

mg/l

1.42

190

Acquired clawhand, clubhand, clawfoot and clubfoot

371

2.33

7.21

1.9

1.6

0.65

1.15

mg/l

1.71

286

IBD (strict) with PSC

118

729

1.89

7.20

2.4

2.1

1.61

0.97

mg/l

1.09

549

HSIL lesion of the vulva

214

1512

1.61

7.20

1.9

1.7

0.92

1.04

mg/l

0.45

173

1172

Pemphigoid

274

2002

1.50

7.19

1.7

1.45

1.50

mg/l

0.15

220

1588

Benign neoplasm of urinary organs

480

3796

1.35

7.18

1.8

1.7

1.69

1.34

mg/l

0.90

378

2969

Benign neoplasm: Parotid gland

789

6577

1.26

7.18

1.8

1.70

1.30

mg/l

1.73

615

5119

Spondylopathies in diseases classified elsewhere

128

802

1.81

7.17

2.4

1.6

1.22

1.50

mg/l

0.68

103

647

377

2.40

7.17

2.9

1.7

1.59

mg/l

0.01

312

Other injuries of lower limb, level unspecified

124

780

1.87

7.17

2.2

1.9

1.05

1.43

mg/l

1.01

102

616

Pyoderma

206

1435

1.60

7.16

2.1

1.9

0.85

1.13

mg/l

1.85

153

1125

Toxic effect of ethanol

410

3177

1.38

7.16

1.8

1.9

1.49

1.06

mg/l

1.11

310

2376

Postpartum hemorraghe, parous women as controls

3195

24429

1.12

7.15

1.8

1.22

0.84

mg/l

8.21

2485

18651

Erectile dysfunction, exclusion

207

2.83

7.14

16.8

1.6

1.75

2.17

mg/l

0.32

170

Encephalopathy

116

715

1.90

7.14

2.1

1.8

2.25

1.52

mg/l

0.81

569

Haemolytic-uraemic syndrome

174

3.34

7.14

4.5

2.1

5.79

0.88

mg/l

1.09

139

Carcinoma in situ of skin of ear and external auricular canal

153

1000

1.71

7.12

1.8

1.7

1.85

1.72

mg/l

0.12

118

813

Fibrosis of liver

559

2.06

7.12

2.9

1.8

1.58

1.42

mg/l

0.22

455

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

594

4798

1.30

7.11

2.5

1.7

2.70

1.38

mg/l

6.40

504

3773

Mesothelioma, including Hilmo

127

795

1.81

7.10

1.8

1.6

1.67

1.58

mg/l

0.14

105

634

Benign neoplasm of breast

1298

11295

1.20

7.10

1.8

1.7

0.97

1.13

mg/l

1.85

986

8737

Seminoma of testis

507

2.05

7.10

1.9

1.7

1.10

0.93

mg/l

0.28

373

Other disorders of optic disc

168

1133

1.70

7.09

2.2

1.8

2.11

1.24

mg/l

0.37

135

882

Maternal care for known or suspected malpresentation of fetus

2216

14161

1.15

7.09

1.8

0.88

0.78

mg/l

1.19

1679

10557

Sixth [abducent] nerve palsy

343

2603

1.43

7.08

1.8

1.44

1.40

mg/l

0.07

278

2035

Other prurigo

136

875

1.80

7.08

1.9

1.6

1.70

1.29

mg/l

0.27

113

692

Other facial nerve disorders

308

2302

1.46

7.06

1.8

1.7

0.79

1.15

mg/l

4.06

236

1759

Pediculosis, acariasis and other infestations

630

5145

1.30

7.05

2.1

1.8

1.07

1.14

mg/l

0.29

492

3899

Other mycoses, not elsewhere classified/unspecified

294

2.61

7.04

5.1

1.9

2.15

1.70

mg/l

0.33

231

Otorrhagia

562

2.05

7.01

2.9

2.0

0.99

1.60

mg/l

1.67

440

Malignant neoplasm of thymus, including Hilmo

292

2.54

7.00

2.2

1.7

1.13

1.05

mg/l

0.13

229

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

241

1741

1.54

7.00

2.0

1.7

0.79

0.68

mg/l

0.29

186

1314

Colorectal adenocarcinoma

2000

17612

1.15

6.99

1.7

1.95

1.31

mg/l

8.04

1646

13851

Drug-induced obesity

116

724

1.90

6.97

1.7

1.15

1.00

mg/l

0.34

543

Insulin, fast-acting (human)

1474

12919

1.18

6.95

1.8

0.99

1.10

mg/l

1.38

1150

9660

Lichen simplex chronicus

360

2759

1.41

6.95

1.8

1.7

1.24

1.19

mg/l

0.13

293

2142

Unspecified maternal hypertension

154

1027

1.74

6.94

1.9

1.7

1.07

0.75

mg/l

1.33

125

771

Fistulae involving female genital tract

178

1214

1.64

6.93

1.7

2.29

1.08

mg/l

1.02

138

949

Burn and corrosion of head and neck

226

1611

1.55

6.92

1.7

1.9

1.28

1.21

mg/l

0.10

170

1219

Mental retardation, excluding more controls

354

2597

1.40

6.90

2.3

2.2

1.38

1.22

mg/l

0.44

295

1980

Contracture of muscle

285

2.50

6.89

1.8

1.5

1.04

1.48

mg/l

0.58

224

Disorders of phosphorus metabolism and phosphatases

350

2.36

6.88

2.5

2.0

1.41

1.09

mg/l

0.39

271

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

351

2.37

6.88

2.3

1.7

2.50

1.32

mg/l

0.40

275

Other hereditary haemolytic anaemias

452

2.17

6.86

5.1

1.8

1.09

1.18

mg/l

0.16

346

Injury of intra-abdominal organs

267

1960

1.49

6.85

2.2

1.8

2.26

1.14

mg/l

2.07

207

1503

Other and unspecified acquired haemolytic anaemias

115

718

1.88

6.83

4.5

1.8

2.11

1.46

mg/l

0.38

571

Scleritis

160

1077

1.70

6.83

2.0

1.7

0.83

1.05

mg/l

0.96

124

838

Injury of nerves at ankle and foot level

542

2.04

6.82

2.0

1.7

0.88

1.20

mg/l

0.72

428

Tic and related disorders

126

789

1.77

6.82

3.5

2.6

1.07

1.02

mg/l

0.07

563

Abscess of Bartholin gland

322

2444

1.44

6.81

1.8

1.7

1.00

0.89

mg/l

0.38

241

1845

Inflammation of lacrimal passages (acute and unspecified)

199

1394

1.59

6.79

2.2

1.7

1.40

1.25

mg/l

0.20

164

1102

Other specified/unspecified disorders of bone/cartilage

290

2162

1.46

6.79

1.8

1.7

1.19

1.13

mg/l

0.10

223

1684

Injury of nerves and spinal cord at thorax level

374

2.30

6.77

1.8

1.9

1.54

1.58

mg/l

0.04

298

Carcinoma in situ of other and unspecified digestive organs

440

3474

1.36

6.76

2.2

1.7

1.77

1.41

mg/l

0.69

379

2750

Malignant neoplasm of breast, ER-negative, including Hilmo

2340

19768

1.14

6.73

1.7

1.27

1.06

mg/l

2.29

1856

15332

Carrier of infectious disease

282

2102

1.47

6.72

2.0

1.7

1.65

1.12

mg/l

0.63

210

1619

Benign neoplasm: Tongue

292

2187

1.46

6.70

1.9

1.7

1.28

1.24

mg/l

0.09

233

1694

Chronic iridocyclitis

502

4025

1.33

6.70

1.8

1.58

1.18

mg/l

0.74

386

3076

Presbyopia

871

7383

1.24

6.70

1.8

0.95

1.03

mg/l

0.24

671

5751

Oral lichen planus

300

2262

1.46

6.69

1.8

1.7

0.82

1.22

mg/l

3.94

233

1749

Malignant neoplasm of head and neck, including Hilmo

916

7763

1.23

6.69

1.7

1.8

1.41

1.26

mg/l

0.65

728

6038

Anuria and oliguria

483

2.08

6.69

2.3

2.0

1.16

1.52

mg/l

0.88

389

Other disorders of electrolyte and fluid balance, not elsewhere classified

101

609

1.92

6.66

2.1

1.6

1.40

1.38

mg/l

0.03

477

Scabies

490

3921

1.33

6.64

2.1

1.8

1.03

1.07

mg/l

0.12

379

2941

Other disorders of cornea

1022

8773

1.22

6.61

1.8

1.34

1.26

mg/l

0.26

793

6773

Inflammatory disorders of male genital organs, not elsewhere classified

133

856

1.73

6.59

1.8

1.64

1.44

mg/l

0.15

107

664

Left side

334

2.50

6.58

2.3

1.8

1.35

1.51

mg/l

0.19

265

Hypersplenism

315

2.44

6.55

3.0

1.6

1.62

1.00

mg/l

0.89

248

Other specified and unspecified disorders of eyelid

165

1127

1.66

6.54

1.7

1.6

1.21

1.35

mg/l

0.26

140

886

Alkalosis

153

3.19

6.53

3.3

1.7

1.08

1.48

mg/l

0.36

117

Nonalcoholic steatohepatitis

115

728

1.86

6.53

2.2

1.7

1.73

1.15

mg/l

0.60

584

Carcinoma in situ of other and unspecified sites

377

2929

1.38

6.52

1.8

1.7

1.50

1.64

mg/l

0.32

304

2336

Other disorders of Eustachian tube

330

2525

1.42

6.51

1.9

1.7

1.25

1.13

mg/l

0.15

253

1939

Burn and corrosion confined to eye and adnexa

254

1870

1.49

6.51

2.0

1.8

0.63

1.08

mg/l

6.53

193

1419

Delivery, wide proxy

3822

18700

1.11

6.49

1.7

1.22

1.20

mg/l

0.10

2944

14094

Specific developmental disorder of motor function

130

808

1.71

6.43

7.3

4.4

1.19

1.56

mg/l

0.51

555

Other protozoal intestinal diseases, including avohilmo

248

1821

1.49

6.43

1.8

1.24

1.08

mg/l

0.28

181

1382

Drug-induced Cushing's syndrome

4.61

6.42

2.2

1.7

0.59

1.30

mg/l

0.60

Marfan's syndrome

374

2.25

6.38

2.6

1.7

2.15

1.14

mg/l

1.13

294

Nontoxic single thyroid nodule

760

6393

1.25

6.37

2.2

1.7

0.93

1.15

mg/l

1.89

601

4972

Injury of nerves and spinal cord at neck level

235

1715

1.51

6.37

1.9

1.8

1.40

1.29

mg/l

0.08

182

1339

Other or unspecified immunodeficiency

276

2.52

6.36

2.4

2.2

0.67

1.35

mg/l

1.25

221

Chromosomal abnormalities, not elsewhere classified

219

1572

1.53

6.36

2.1

3.1

1.00

1.27

mg/l

0.72

176

1182

Burns classified according to extent of body surface involved

113

713

1.83

6.35

2.3

1.8

1.44

1.49

mg/l

0.05

552

Colitis due to radiation

110

688

1.83

6.34

2.3

1.7

1.64

1.56

mg/l

0.06

549

Toxic effect of corrosive substances

366

2.23

6.34

1.7

1.8

0.59

1.21

mg/l

2.08

264

Benign neoplasm: Other and unspecified parts of small intestine

179

1252

1.62

6.33

2.5

1.6

1.06

1.34

mg/l

1.11

155

987

Alcoholic gastritis

147

982

1.67

6.29

2.0

1.7

1.45

1.33

mg/l

0.16

123

778

Disorders of myoneural junction and muscle in diseases classified elsewhere

101

627

1.93

6.29

2.1

1.6

1.10

1.12

mg/l

0.04

504

Impaction of intestines

468

2.03

6.28

2.4

1.7

0.77

1.44

mg/l

2.69

379

Benign leiomyoma with endometriosis

1659

14792

1.16

6.27

1.7

1.13

1.17

mg/l

0.11

1245

11547

Mixed conductive and sensorineural hearing loss

1203

10485

1.19

6.27

1.7

1.33

1.40

mg/l

0.27

952

8263

Traumatic ischaemia of muscle

157

1071

1.66

6.27

3.0

1.7

1.49

1.24

mg/l

0.25

118

829

Viral conjunctivitis, including avohilmo

430

3420

1.35

6.27

1.9

1.8

1.00

1.03

mg/l

0.07

331

2605

Measles, including avohilmo

137

910

1.73

6.27

1.7

1.8

0.61

0.82

mg/l

0.97

111

703

Other conditions related to polyarteritis nodosa

164

3.12

6.25

1.7

1.6

1.12

1.08

mg/l

0.06

134

Suppurative otitis media, unspecified

262

1944

1.46

6.23

1.7

1.8

0.88

1.22

mg/l

2.53

198

1444

Nontoxic diffuse goitre

329

2532

1.41

6.23

2.0

1.6

1.21

1.12

mg/l

0.20

253

1970

Disorder of the sleep-wake schedule

191

1346

1.56

6.23

2.1

0.89

1.26

mg/l

1.52

141

1015

Psoriasis (vulgaris), strict definition

361

2811

1.38

6.22

1.6

1.8

1.26

1.09

mg/l

0.35

280

2137

Carcinoma in situ, bladder

347

2686

1.39

6.21

1.8

1.7

1.41

1.66

mg/l

0.70

275

2142

Gastrointestinal stromal tumor and sarcoma

129

844

1.74

6.21

1.6

2.02

1.35

mg/l

0.76

103

668

Bullous pemphigoid

216

1559

1.52

6.20

1.6

1.7

1.34

1.58

mg/l

0.92

171

1247

Measles

135

896

1.73

6.20

1.7

1.8

0.62

0.82

mg/l

0.95

109

693

Late syphilis

149

1007

1.68

6.19

1.9

1.7

1.25

1.35

mg/l

0.21

120

808

Sub-endpoint used in defining T1D endpoints

3088

27882

1.11

6.17

1.9

1.22

1.26

mg/l

0.27

2407

21215

Magnesium deficiency

246

2.64

6.15

2.4

1.7

1.27

1.24

mg/l

0.04

196

Sexual dysfunction

192

1357

1.55

6.14

2.1

1.8

0.82

1.18

mg/l

0.88

144

1031

Malignant neoplasm of thyroid gland, including Hilmo

754

6354

1.24

6.14

2.0

1.8

1.06

1.03

mg/l

0.07

579

4846

Benign neoplasm: Parathyroid gland

131

868

1.75

6.14

1.7

1.08

1.36

mg/l

0.72

103

686

Other congenital malformations of nervous system

116

743

1.79

6.14

2.6

2.2

0.85

1.03

mg/l

0.38

540

Juvenile osteochondrosis

338

2611

1.39

6.14

2.0

0.89

1.05

mg/l

0.79

252

1931

Localized skin eruption due to drugs and medicaments

143

965

1.70

6.13

1.8

1.16

1.27

mg/l

0.13

105

767

Failure of sterile precautions during surgical operation

218

2.73

6.13

2.6

1.8

1.03

1.40

mg/l

0.47

180

Benign neoplasm: salivary glands, exclude unknown (D119)

864

7368

1.23

6.13

1.7

1.8

1.65

1.33

mg/l

1.36

674

5744

Myasthenia gravis

187

1325

1.58

6.12

1.8

1.7

1.42

1.27

mg/l

0.30

149

1032

Adult respiratory distress syndrome

140

936

1.69

6.09

3.2

1.7

2.01

1.55

mg/l

0.80

125

741

Congenital deformities of feet

275

2069

1.44

6.08

2.7

2.0

1.38

1.01

mg/l

0.37

216

1542

Motor disorders

130

838

1.68

6.08

7.3

4.9

1.19

1.72

mg/l

0.80

585

Intentional self-harm by sharp object

267

1996

1.45

6.07

2.6

1.9

0.84

0.98

mg/l

0.72

185

1457

Unspecified nephritic syndrome

229

1678

1.50

6.06

2.1

1.7

2.01

1.26

mg/l

1.68

186

1311

Papillary adenocarcinoma of thyroid gland

529

4319

1.30

6.06

2.2

1.8

1.17

1.03

mg/l

0.27

410

3300

Drug-induced dystonia

226

2.68

6.06

1.6

1.7

1.00

1.30

mg/l

0.34

175

Calculus of lower urinary tract

483

3896

1.31

6.04

1.7

1.28

1.58

mg/l

1.36

391

3084

Use of biperiden

528

4312

1.30

6.03

1.7

1.04

1.12

mg/l

0.40

434

3317

Congenital malformations of ovaries, fallopian tubes and broad ligaments

635

5294

1.27

6.02

1.8

0.85

0.84

mg/l

0.06

505

3996

Ankylosing spondylitis, strict definition

455

3659

1.32

6.02

1.9

1.8

1.02

0.96

mg/l

0.15

337

2734

Marginal zone B-cell lymphoma

111

709

1.81

5.99

1.8

1.6

1.37

1.27

mg/l

0.18

560

Malignant neoplasm of other and ill-defined sites, including Hilmo

154

1046

1.62

5.99

1.7

1.6

2.31

1.25

mg/l

1.48

133

821

Malignant neoplasm of breast, HER-negative

2131

18518

1.14

5.99

1.7

1.27

1.08

mg/l

1.84

1689

14355

Poisoning by medicine, drug-induced

152

1043

1.66

5.96

2.0

1.8

0.82

1.06

mg/l

1.07

112

816

Other disorders of bone density and structure

281

2130

1.43

5.96

2.7

1.8

0.82

1.13

mg/l

2.51

212

1633

Acute drug-induced interstitial lung disorder

548

1.94

5.95

3.4

1.7

1.37

1.46

mg/l

0.11

436

Embolic stroke

414

3276

1.33

5.95

2.0

1.6

1.65

1.70

mg/l

0.12

331

2572

Benign neoplasm: Kidney

364

2858

1.37

5.95

1.8

1.7

1.78

1.33

mg/l

0.93

290

2230

Malignant neoplasm of thymus

248

2.55

5.94

2.3

1.7

1.22

0.85

mg/l

0.84

196

Other abnormal auditory perceptions

142

962

1.69

5.94

1.8

0.81

1.16

mg/l

1.20

106

745

Sequelae of intentional self-harm, assault and events of undetermined intent

510

1.98

5.92

2.3

2.0

0.91

0.95

mg/l

0.07

391

Acute epiglottitis

163

1128

1.60

5.91

2.1

1.7

1.93

1.22

mg/l

0.41

125

891

Colitis, primary sclerosing, strict definition

123

807

1.74

5.91

2.3

2.0

1.60

1.04

mg/l

0.99

102

609

Mantle cell lymphoma

607

1.86

5.90

2.2

1.7

1.80

1.41

mg/l

0.39

473

Other appendicitis

876

7503

1.22

5.89

1.7

1.8

1.21

1.14

mg/l

0.23

676

5787

Restrictive cardiomyopathy

250

2.57

5.89

5.3

1.8

1.06

1.26

mg/l

0.37

204

Arnold-Chiari syndrome

105

664

1.82

5.88

2.8

2.0

0.85

1.06

mg/l

0.40

478

Other intracranial haemorrhages

294

2236

1.41

5.88

2.9

1.6

2.18

1.73

mg/l

0.77

240

1776

Malignant neoplasm of oral cavity, including Hilmo

417

3320

1.33

5.87

1.6

1.8

1.56

1.28

mg/l

0.67

331

2565

Hypothyroidism due to medicaments and other exogenous substances

142

965

1.68

5.87

1.8

1.7

1.73

1.23

mg/l

0.76

100

777

Erectile dysfunction

681

5702

1.25

5.86

10.4

1.7

1.73

1.64

mg/l

0.19

553

4550

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

101

635

1.85

5.86

1.8

1.7

1.32

1.26

mg/l

0.10

507

Other superficial mycoses

257

1929

1.45

5.86

2.1

1.8

0.81

1.10

mg/l

2.12

192

1448

Paraplegia, diplegia of upper limbs

231

1706

1.48

5.85

2.5

1.9

1.43

1.34

mg/l

0.23

188

1323

Separation of retinal layers (serosa)

427

3419

1.33

5.85

2.2

1.7

1.37

1.16

mg/l

0.35

330

2631

Stenosis and insufficiency of lacrimal passages

947

8162

1.21

5.84

1.6

1.8

1.12

1.32

mg/l

1.46

717

6341

Autoimmune thyroiditis

217

1590

1.51

5.84

1.9

1.7

0.85

1.06

mg/l

0.91

162

1211

Other disorders of iris and ciliary body

280

2124

1.42

5.82

1.6

1.7

0.98

1.34

mg/l

2.57

215

1632

Osteopathy in diseases classified elsewhere

560

1.93

5.82

2.9

2.0

1.95

1.27

mg/l

0.50

462

Localized adiposity

419

2.14

5.81

2.3

1.7

0.98

1.12

mg/l

0.21

332

Habit and impulse disorders

181

1283

1.56

5.80

2.1

1.8

0.80

1.03

mg/l

0.67

130

931

Benign neoplasm: Other and unspecified parts of mouth

343

2684

1.38

5.80

1.8

1.7

1.10

1.21

mg/l

0.32

265

2099

Malignant neoplasm of bone and articular cartilage

107

682

1.80

5.78

3.8

1.8

1.40

1.09

mg/l

0.64

517

Aortic stenosis

102

3.89

5.78

4.0

4.2

1.54

1.89

mg/l

0.16

Other and unspecified acne

164

1145

1.59

5.75

2.9

2.0

1.15

0.98

mg/l

0.25

122

843

Malignant neoplasm of bone and articular cartilage, including Hilmo

185

1316

1.54

5.75

2.9

1.7

1.93

1.17

mg/l

0.72

153

1012

Malignant neoplasm of bronchus and lung

1792

13424

1.14

5.74

1.7

1.90

1.36

mg/l

4.76

1516

10583

Narcolepsy and cataplexy

450

1.99

5.73

1.9

1.6

1.19

1.43

mg/l

0.35

336

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

413

3310

1.34

5.73

1.7

1.8

0.88

0.81

mg/l

0.39

330

2533

Abscess of tendon sheath

413

2.04

5.72

2.0

1.6

1.00

1.39

mg/l

0.91

321

Abnormality of white blood cells, not elsewhere classified

110

713

1.80

5.72

2.3

1.7

1.29

1.35

mg/l

0.09

554

Congenital malformations of the nervous system

236

1753

1.47

5.71

2.4

2.5

0.81

1.18

mg/l

1.57

178

1309

Brain meningioma, including Hilmo

507

4147

1.29

5.69

1.8

1.67

1.17

mg/l

0.73

409

3191

LSIL lesion of the cervix uteri, vagina or vulva

1637

14672

1.15

5.69

1.7

0.93

0.90

mg/l

0.20

1223

11197

Benign neoplasm of other and unspecified sites

335

2618

1.38

5.69

1.9

1.8

1.25

1.23

mg/l

0.04

261

2035

Disorder of pancreatic internal secretion, other and/or unspecified

581

1.91

5.68

1.7

1.8

1.07

1.54

mg/l

0.79

464

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

947

8199

1.21

5.67

1.9

1.8

1.06

0.89

mg/l

1.26

716

6241

Motorcycle rider injured in other and unspecified transport accidents

565

4665

1.27

5.66

1.9

2.0

1.07

1.02

mg/l

0.16

427

3368

Malignant neoplasm of endocrine gland

732

6202

1.24

5.65

2.1

1.8

1.12

1.04

mg/l

0.21

567

4721

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

7.07

5.64

14.2

1.7

0.88

0.84

mg/l

0.05

Poor fetal growth

1441

12829

1.16

5.62

2.1

1.7

1.10

0.83

mg/l

2.97

1100

9570

Benign neoplasm of bone and articular cartilage

867

7453

1.21

5.61

1.8

1.03

1.12

mg/l

0.28

681

5697

Histrionic personality disorder

370

2.18

5.60

2.2

1.7

0.73

1.12

mg/l

1.61

296

Haemorrhagic disorder due to circulating anticoagulants

139

942

1.64

5.60

4.5

1.7

2.60

1.59

mg/l

1.35

110

757

Maze procedure for atrial fibrillation

342

2.26

5.60

2.2

1.7

1.43

1.75

mg/l

0.41

273

Abnormal reflex

392

2.13

5.59

2.1

1.7

0.69

1.39

mg/l

2.22

322

Other abnormal findings in urine

170

1202

1.57

5.59

2.1

1.8

1.87

1.41

mg/l

0.59

138

953

Disorders of iron metabolism

170

1200

1.57

5.59

1.8

1.7

1.23

1.17

mg/l

0.11

137

936

Other and unspecified intracranial injuries

300

2310

1.39

5.57

1.9

1.8

1.00

1.27

mg/l

1.47

238

1785

Vascular dementia (subcortical)

321

2489

1.37

5.56

1.7

1.6

1.43

1.68

mg/l

0.90

278

1973

Pre-eclampsia superimposed on chronic hypertension

454

2.04

5.56

2.3

1.7

1.02

0.76

mg/l

0.38

342

Aortic stenosis, including avohilmo

147

3.10

5.55

4.0

3.7

1.43

1.78

mg/l

0.23

119

Noonan syndrome

4.52

5.55

3.1

6.6

0.58

1.67

mg/l

0.53

Other factor of the environment

147

1018

1.63

5.52

2.0

1.7

0.96

1.20

mg/l

1.04

127

790

Atypical mycobacterium lung infection

127

851

1.69

5.51

2.5

1.6

1.26

1.42

mg/l

0.21

102

675

Other and unspecified diseases of spleen

313

2.27

5.48

1.5

1.8

1.45

0.92

mg/l

0.63

252

Use of antiglaucoma preparations and miotics

744

6319

1.23

5.48

1.6

1.8

1.53

1.56

mg/l

0.06

591

4962

Malignant neoplasm of head and neck

739

6265

1.23

5.47

1.7

1.8

1.48

1.28

mg/l

0.79

580

4906

Cutaneous lupus erythematosus

254

1926

1.44

5.46

1.9

1.7

0.99

1.15

mg/l

0.76

213

1489

Benign neoplasm: Skin of ear and external auricular canal

378

3008

1.34

5.45

1.8

1.7

1.59

1.38

mg/l

0.41

290

2349

Folate deficiency anaemia

116

765

1.72

5.45

2.2

1.6

1.20

1.45

mg/l

0.69

613

Spasmodic torticollis

344

2719

1.36

5.44

1.9

1.7

1.14

1.08

mg/l

0.13

261

2116

Syphilis, including avohilmo

262

1993

1.42

5.43

1.9

1.8

1.23

1.22

mg/l

0.01

204

1542

Syphilis

262

1993

1.42

5.43

1.9

1.8

1.23

1.22

mg/l

0.01

204

1542

Contusion of toe(s) with damage to nail

128

861

1.67

5.43

2.3

1.9

0.85

1.15

mg/l

1.05

644

Disseminated intravascular coagulation [defibrination syndrome]

222

2.57

5.42

3.9

1.7

5.90

1.05

mg/l

1.83

175

Other and unspecified injuries of neck

105

680

1.78

5.40

2.1

1.8

0.74

1.26

mg/l

1.80

509

Other and unspecified bullous disorders

125

842

1.69

5.40

2.2

1.8

1.75

1.30

mg/l

0.36

101

670

Androgenic alopecia

120

806

1.73

5.39

1.8

1.6

0.83

0.98

mg/l

0.30

627

Major anomalies of jaw size

282

2172

1.40

5.39

2.0

1.12

mg/l

0.01

214

1651

Varicella [chickenpox], including avohilmo

524

4321

1.27

5.37

2.6

2.2

1.27

1.10

mg/l

0.30

414

3279

Endometroid carcinoma of ovary, including Hilmo

101

651

1.80

5.36

2.0

1.6

1.59

1.10

mg/l

1.40

517

Benign neoplasm of major salivary glands

949

8241

1.20

5.36

1.7

1.8

1.65

1.35

mg/l

1.41

743

6440

Endometriosis of fallopian tube

571

1.85

5.35

1.7

1.6

0.63

0.96

mg/l

1.81

431

Male infertility

405

3242

1.31

5.33

2.4

1.9

1.35

0.96

mg/l

0.60

295

2281

Pustular psoriasis

486

3996

1.29

5.32

1.8

1.07

1.14

mg/l

0.30

391

3074

Injury of nerves at hip and thigh level

288

2.32

5.31

2.6

1.8

0.55

1.48

mg/l

2.82

232

Collapsed vertebra, not elsewhere classified

506

1.88

5.30

3.3

1.7

1.65

1.44

mg/l

0.22

408

Intrahepatic Cholestasis of Pregnancy (ICP)

796

6842

1.22

5.30

1.9

1.7

0.97

0.80

mg/l

1.47

601

5168

Dislocation of lens

142

973

1.59

5.28

1.8

1.7

1.50

1.46

mg/l

0.04

115

784

Social disorders starting during childhood or adolecense, excluding more controls

434

1.92

5.28

2.2

2.6

0.72

1.01

mg/l

0.98

309

Ulcerative colitis (strict) with PSC

588

1.83

5.28

2.2

2.1

1.69

1.04

mg/l

0.88

443

Other benign neoplasms of connective and other soft tissue

992

8652

1.19

5.28

1.7

1.8

1.13

1.19

mg/l

0.18

778

6680

Striae atrophicae

134

920

1.65

5.28

2.0

1.7

1.10

1.04

mg/l

0.09

703

Erosion and ectropion of cervix uteri

275

2114

1.40

5.25

2.0

1.7

0.98

1.27

mg/l

1.93

204

1658

Injury of muscle and tendon at ankle and foot level

268

2057

1.41

5.25

1.6

1.7

0.90

1.09

mg/l

0.41

203

1571

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

392

3153

1.32

5.23

1.9

1.7

1.23

1.28

mg/l

0.14

325

2459

Carcinoma in situ of skin of lower limb, including hip

221

1653

1.46

5.22

1.9

1.6

2.30

1.51

mg/l

0.53

169

1310

Iliotibial band syndrome

124

835

1.66

5.21

1.9

1.6

0.83

1.13

mg/l

1.16

103

647

Surgical ablation of atrial fibrillation

425

2.05

5.21

2.7

1.7

1.88

1.50

mg/l

0.37

342

Certolizumab pegol

213

1587

1.47

5.21

2.0

1.7

1.17

1.03

mg/l

0.48

170

1176

Prolapse and hernia of ovary and fallopian tube

330

2565

1.35

5.20

1.6

1.7

1.58

1.67

mg/l

0.15

264

2003

Torticollis

163

1153

1.54

5.20

2.1

1.8

0.72

1.09

mg/l

1.98

117

875

Exposure to other and unspecified forces of nature

524

1.91

5.19

2.4

1.8

1.62

1.20

mg/l

0.42

415

Toxic liver disease

169

1213

1.55

5.19

2.3

1.7

1.54

1.16

mg/l

0.54

132

940

Malignant neoplasm, without specification of site, including Hilmo

419

3377

1.30

5.18

1.7

1.6

2.13

1.35

mg/l

3.67

344

2654

Disorders of orbit

450

3680

1.30

5.17

2.0

1.8

1.19

1.18

mg/l

0.02

351

2826

Mesothelioma

612

1.76

5.11

1.8

1.6

1.89

1.69

mg/l

0.27

495

Personal history of allergy to analgesic agent

486

1.93

5.11

1.7

1.64

1.06

mg/l

0.22

375

Lupus nephritis

292

2.27

5.08

2.1

1.9

2.16

0.96

mg/l

1.09

228

Other specified and unspecified disorders of lens

576

1.80

5.06

1.6

1.06

1.67

mg/l

1.91

467

Pleural plaque without asbestos

315

2473

1.35

5.05

1.7

1.6

1.70

1.80

mg/l

0.13

270

1989

Brain meningioma

489

4040

1.28

5.04

1.8

1.70

1.17

mg/l

0.75

395

3110

Allergic contact dermatitis due to drugs in contact with skin

237

1804

1.43

5.03

2.0

1.6

0.92

1.20

mg/l

1.57

175

1402

Burn and corrosion of other internal organs

221

2.47

5.02

1.6

1.37

1.40

mg/l

0.02

174

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

449

3665

1.28

5.02

2.6

1.6

2.97

1.37

mg/l

6.03

379

2899

Systemic disorders of connective tissue in diseases classified elsewhere

286

2.28

5.02

6.0

2.0

1.00

1.34

mg/l

0.57

223

Malignant neoplasm of vulva, including Hilmo

146

1028

1.59

5.01

1.8

1.6

1.02

1.18

mg/l

0.55

113

809

Primary biliary cholangitis (PBC)

229

1733

1.44

5.01

2.1

1.8

1.90

1.14

mg/l

2.41

187

1363

Cholesteatoma of external ear

599

1.81

5.01

2.0

1.8

1.10

1.49

mg/l

1.22

482

Hereditary lymphedema, including avohilmo

163

2.96

5.00

2.1

1.9

1.36

1.13

mg/l

0.15

133

Selective deficiency of immunoglobulin A [IgA]y

338

2.15

5.00

2.0

1.37

1.02

mg/l

0.47

261

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

142

996

1.60

4.99

3.9

2.0

1.36

1.35

mg/l

0.03

114

784

Chronic myeloid leukaemia

344

2.11

4.99

2.0

1.7

1.22

1.10

mg/l

0.17

272

Migraine, unspecified, drug-induced

562

1.86

4.98

2.0

1.7

1.31

1.01

mg/l

0.31

442

Alzheimer’s disease (undefined)

539

0.38

4.98

1.3

1.6

1.07

1.62

mg/l

1.33

433

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

159

1137

1.55

4.98

1.7

0.97

1.14

mg/l

0.59

115

864

Disorders of optic nerve, not elsewhere classified

212

1588

1.46

4.98

1.9

1.7

1.66

1.34

mg/l

0.51

168

1235

Epiphora

233

1769

1.43

4.98

1.8

1.7

0.86

1.34

mg/l

4.07

182

1397

Intracranial and intraspinal abscess and granuloma

128

881

1.64

4.96

2.1

1.7

2.00

1.41

mg/l

0.88

111

692

Malignant neoplasm of small intestine, including Hilmo

281

2182

1.38

4.96

2.0

1.7

1.60

1.34

mg/l

0.50

225

1711

Burn and corrosion of trunk

302

2372

1.36

4.95

2.0

1.9

1.12

1.20

mg/l

0.17

226

1821

L02BA Anti-estrogens

1791

16256

1.13

4.94

1.7

1.33

1.09

mg/l

2.02

1410

12687

Valgus deformity, not elsewhere classified

517

1.84

4.94

2.9

1.7

1.43

1.16

mg/l

0.37

392

Amblyopia ex anopsia

390

3149

1.31

4.93

2.0

2.2

1.40

1.24

mg/l

0.18

279

2369

Diphtheria, including avohilmo

116

3.25

4.93

2.1

1.8

1.07

1.02

mg/l

0.05

101

Sequelae of infectious and parasitic diseases, including avohilmo

741

6354

1.21

4.93

2.0

1.7

1.05

1.12

mg/l

0.26

581

4886

Other protozoal intestinal diseases

159

1139

1.54

4.92

1.9

1.57

1.14

mg/l

0.58

119

879

Blood alcohol or alcohol intoxication level

245

1873

1.41

4.92

2.0

1.9

1.12

mg/l

0.00

203

1410

Diabetes insipidus

108

721

1.72

4.92

1.9

1.7

1.17

1.20

mg/l

0.04

562

Endometroid carcinoma of ovary

445

1.95

4.92

2.0

1.6

1.32

1.09

mg/l

0.47

352

Congenital malformations of spine and bony thorax, including avohilmo

473

1.89

4.91

4.1

2.7

1.56

0.98

mg/l

0.53

368

Lipomatosis, not elsewhere classified

225

2.50

4.91

2.1

1.7

1.00

1.29

mg/l

0.36

175

Malignant neoplasm of retroperitoneum and peritoneum

569

1.82

4.90

2.2

1.6

1.76

1.19

mg/l

2.13

456

Retained placenta and membranes, without haemorrhage

1280

11418

1.16

4.90

1.7

1.25

0.94

mg/l

2.71

988

8727

Embedded teeth, including avohilmo

961

8402

1.18

4.90

2.0

1.9

1.19

0.99

mg/l

1.00

711

6084

Placenta praevia

506

4214

1.27

4.89

1.9

1.7

1.34

0.73

mg/l

3.07

383

3189

Vascular syndromes of brain in cerebrovascular disorders

401

3252

1.30

4.88

2.1

1.7

1.39

1.52

mg/l

0.32

319

2550

Congenital ovarian cysts

500

4167

1.27

4.88

1.7

0.90

0.83

mg/l

0.22

394

3147

Kyphoscoliotic heart disease

3.78

4.88

2.3

1.8

1.21

1.89

mg/l

0.46

Malignant neoplasm of bladder

556

4635

1.24

4.87

1.7

1.6

2.17

1.49

mg/l

2.80

475

3670

Other and unspecified disorders of adult personality and behaviour

454

1.94

4.87

2.4

1.6

0.80

0.88

mg/l

0.15

342

Benign neoplasm: Anus and anal canal

279

2176

1.38

4.86

1.8

1.6

1.05

1.34

mg/l

1.86

223

1698

Diphtheria

105

3.46

4.86

2.2

1.8

1.17

1.02

mg/l

0.17

Crossbite

663

5180

1.22

4.86

3.7

2.2

1.38

1.11

mg/l

0.53

476

3814

Congenital malformations of spine and bony thorax

398

1.98

4.85

4.2

2.8

1.65

0.98

mg/l

0.56

303

Endocrine disorders, other/unspecified

205

1536

1.46

4.84

1.8

1.7

0.93

1.11

mg/l

0.76

143

1191

Pneumonia due to Haemophilus influenzae

273

2.23

4.83

1.9

1.7

0.84

1.24

mg/l

0.90

214

Other and unspecified primary disorders of muscles

531

1.84

4.83

2.1

2.20

1.35

mg/l

0.35

428

Cardiomyopathies, Secondary/extrinsic

466

1.88

4.83

7.5

1.8

1.87

1.40

mg/l

0.45

372

Injury of muscle and tendon at forearm level

194

1439

1.47

4.83

1.8

1.26

1.12

mg/l

0.35

152

1096

Fall on and from ladder

711

6093

1.22

4.82

2.0

1.8

1.43

1.39

mg/l

0.10

583

4797

Embolic stroke with flimmer

217

1622

1.42

4.82

2.0

1.7

1.36

1.72

mg/l

1.36

171

1315

Disorders of male genital organs in diseases classified elsewhere

412

1.92

4.80

2.0

1.9

0.98

1.59

mg/l

1.01

319

Lifestyle-related condition

134

939

1.61

4.79

2.1

1.7

0.99

1.20

mg/l

0.73

116

724

Myocardial infarction, unclassifiable

2048

16675

1.12

4.78

2.3

1.7

1.53

1.63

mg/l

0.63

1676

13200

Other disorders of peripheral nervous system

495

1.88

4.78

1.8

1.7

0.93

1.26

mg/l

0.90

398

Carcinoma in situ of colon

289

2273

1.37

4.78

1.8

1.7

1.69

1.34

mg/l

0.45

247

1805

Other primary thrombocytopenia

314

2.18

4.77

2.2

2.0

1.43

1.10

mg/l

0.48

243

Open wound of shoulder and upper arm

211

1587

1.44

4.76

1.9

1.8

1.44

1.15

mg/l

0.63

170

1202

Malignant neoplasm of prostate, including Hilmo

2665

14473

1.11

4.76

1.6

1.8

1.72

1.31

mg/l

3.93

2109

11520

Assault by other specified means

115

781

1.65

4.74

2.2

1.9

2.36

1.00

mg/l

0.47

590

Transient synovitis

512

1.80

4.74

3.2

1.8

0.96

1.34

mg/l

0.76

380

Other congenital malformations of intestine

620

1.75

4.74

3.2

2.2

0.90

1.13

mg/l

0.61

479

Contact with other specified venomous animals

520

1.84

4.72

1.8

1.31

mg/l

0.00

401

Gonococcal infection

332

2655

1.33

4.71

1.8

1.9

1.14

1.08

mg/l

0.17

240

1997

Fourth [trochlear] nerve palsy

228

1742

1.42

4.71

1.8

1.7

1.20

1.31

mg/l

0.24

171

1359

Hyperfunction of pituitary gland

522

4375

1.26

4.70

1.8

1.26

0.99

mg/l

0.53

411

3303

Foreign body on external eye

1457

13103

1.14

4.69

1.8

1.9

1.16

1.15

mg/l

0.03

1105

9991

Alzheimer’s disease, strict definition

2177

19173

0.90

4.69

1.6

1.7

1.85

1.63

mg/l

1.50

1713

15345

Contact with blunt object, undetermined intent

489

1.87

4.69

2.1

1.7

0.84

0.98

mg/l

0.30

375

609

1.77

4.67

2.3

1.6

1.15

1.06

mg/l

0.08

483

Other bacterial agents as the cause of diseases classified to other chapters

116

794

1.65

4.67

4.4

2.0

1.33

1.37

mg/l

0.07

631

Other nonthrombocytopenic purpura

110

746

1.68

4.67

1.9

1.63

1.32

mg/l

0.34

597

Acute and transient psychotic disorders

1195

10639

1.16

4.66

1.9

1.8

1.23

1.05

mg/l

1.56

933

8110

Parapsoriasis

202

1518

1.45

4.65

2.2

1.8

1.27

1.21

mg/l

0.07

164

1173

CR(E)ST syndrome

173

1276

1.51

4.64

2.0

1.6

1.39

1.11

mg/l

0.28

147

1016

Polyarteritis nodosa

473

1.86

4.62

2.0

1.8

0.94

1.56

mg/l

2.12

389

Other vitreous opacities

414

3398

1.29

4.62

1.8

1.7

1.20

1.22

mg/l

0.03

333

2638

Benign neoplasm: Other/unspecified site

164

1196

1.51

4.62

1.8

1.7

1.42

1.22

mg/l

0.32

124

951

Other injuries of spine and trunk, level unspecified

104

698

1.69

4.60

2.2

1.8

0.99

1.31

mg/l

0.93

551

Varicella [chickenpox]

452

3740

1.27

4.60

2.6

2.0

1.33

1.08

mg/l

0.43

363

2848

Benign neoplasm: Pituitary gland, craniopharyngeal duct

533

4486

1.25

4.60

1.8

1.02

1.15

mg/l

0.43

410

3419

Gonococcal infection, including avohilmo

359

2904

1.31

4.59

1.8

1.9

1.11

1.07

mg/l

0.12

257

2165

Other specified/unspecified deforming dorsopathies

181

1337

1.47

4.59

1.7

1.03

1.09

mg/l

0.11

134

1019

Transepidermal elimination disorders

109

3.41

4.59

2.3

1.5

1.70

1.85

mg/l

0.05

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

558

4716

1.24

4.58

1.9

1.7

0.89

0.97

mg/l

0.26

424

3597

Desensitization to allergens

565

4777

1.24

4.55

2.0

0.64

0.90

mg/l

4.67

409

3499

Rickettsioses, including avohilmo

139

2.80

4.54

2.1

1.8

1.21

1.04

mg/l

0.17

119

Burn and corrosion of hip and lower limb, except ankle and foot

240

1853

1.39

4.53

2.2

1.9

1.72

1.21

mg/l

0.31

173

1408

Demyelinating diseases of the central nervous system

911

8001

1.18

4.51

1.8

0.86

0.96

mg/l

0.87

669

6070

151

1041

1.50

4.51

3.0

5.1

1.58

1.67

mg/l

0.10

716

Evidence of alcohol involvement determined by level of intoxication

115

789

1.63

4.51

2.0

0.92

1.14

mg/l

0.65

596

172

1192

1.46

4.50

3.2

4.8

2.23

1.60

mg/l

0.49

115

813

Pustulosis palmaris et plantaris

438

3631

1.28

4.49

1.7

1.8

1.06

1.15

mg/l

0.37

351

2792

Tarsal tunnel syndrome

116

802

1.64

4.49

1.7

1.6

1.50

1.12

mg/l

0.31

633

Failed attempted abortion

144

1036

1.55

4.49

1.9

1.7

0.98

0.78

mg/l

0.28

109

786

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

947

8349

1.18

4.49

1.9

1.8

1.06

0.91

mg/l

1.04

716

6368

Benign neoplasm: Larynx

294

2330

1.34

4.48

1.8

1.7

1.07

1.40

mg/l

1.75

235

1835

Use of anticholinesterases

3121

25837

0.92

4.48

1.5

1.7

1.72

1.61

mg/l

0.63

2406

20610

N06DA Anticholinesterases

3121

25837

0.92

4.48

1.5

1.7

1.72

1.61

mg/l

0.63

2406

20610

Recurrent and persistent haematuria

100

671

1.70

4.46

1.9

1.7

0.84

1.40

mg/l

2.55

523

Rickettsioses

108

3.12

4.46

1.9

1.8

1.04

1.08

mg/l

0.03

Malignant neoplasm of thyroid gland

673

5785

1.21

4.46

2.0

1.8

1.12

1.04

mg/l

0.19

523

4404

Deformity of finger(s)

431

1.88

4.46

1.8

1.5

1.53

1.14

mg/l

0.45

335

Generalized epilepsy, mode (most common among epilepsy diagnosis)

311

2485

1.33

4.45

1.7

2.0

1.42

1.11

mg/l

0.32

230

1891

273

2154

1.36

4.44

2.0

1.7

0.94

0.99

mg/l

0.08

195

1667

Klinefelter syndrome, karyotype 47 XXY

134

2.83

4.44

1.6

2.8

0.78

0.82

mg/l

0.06

Reduction defects of lower limb, including avohilmo

245

2.26

4.44

1.9

2.1

1.37

1.08

mg/l

0.32

190

Senility

552

1.68

4.41

1.5

3.40

1.80

mg/l

0.42

432

Sequelae of other and unspecified infectious and parasitic diseases

553

4688

1.24

4.40

2.0

1.7

0.88

0.97

mg/l

0.30

421

3578

Sequelae of infectious and parasitic diseases

720

6221

1.20

4.39

2.0

1.7

1.06

1.12

mg/l

0.24

566

4779

Tetraplegia

536

1.78

4.39

2.0

2.2

1.63

1.44

mg/l

0.17

433

Other infective (teno)synovitis

297

2.09

4.37

1.6

0.68

1.34

mg/l

1.96

231

Mental and behavioural disorders due to hallucinogens

364

1.96

4.36

1.7

1.94

0.84

mg/l

0.65

267

Benign neoplasm: Hypopharynx

321

2.06

4.36

1.6

1.9

1.17

1.53

mg/l

0.61

256

Tooth eruption problems

1522

13290

1.13

4.35

2.4

2.0

1.16

1.04

mg/l

0.61

1117

9541

Certain conditions originating in the perinatal period

763

5860

1.19

4.34

2.8

2.4

1.59

1.06

mg/l

1.06

547

4146

Liposarcoma, including Hilmo

103

697

1.66

4.34

1.8

1.7

1.29

1.17

mg/l

0.28

549

Polymyositis

619

1.72

4.34

2.3

1.7

1.44

1.40

mg/l

0.04

500

Wide developmental disorders, excluding more controls

264

2007

1.34

4.33

2.0

2.3

0.72

1.18

mg/l

2.50

182

1389

Synovial hypertrophy, not elsewhere classified

646

1.67

4.33

1.6

1.7

0.74

1.15

mg/l

1.82

488

Other bullous disorders

272

2150

1.36

4.33

2.1

1.8

1.30

1.24

mg/l

0.07

210

1676

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

211

1615

1.42

4.32

2.0

1.7

0.95

1.36

mg/l

2.17

165

1256

Spinal enthesopathy

206

1543

1.39

4.32

1.5

1.66

1.68

mg/l

0.04

165

1230

Hypersensitivity angiitis

360

1.99

4.32

3.2

1.8

2.07

1.53

mg/l

0.46

291

Macular hole

549

4658

1.23

4.32

2.1

1.8

1.04

1.49

mg/l

5.31

424

3687

Other complications of labour and delivery, not elsewhere classified

1360

10853

1.14

4.31

1.7

1.8

1.15

0.75

mg/l

5.02

1032

7850

Epileptic seizures related to drugs

197

2.39

4.31

2.2

1.9

1.03

0.88

mg/l

0.16

152

Malignant neoplasm of small intestine

210

1602

1.41

4.30

2.0

1.7

1.58

1.31

mg/l

0.82

171

1261

Adenocarcinoma and Papillary adenocarcinoma of kidney

115

797

1.61

4.30

1.6

1.17

1.41

mg/l

0.63

616

Use of selegiline

401

3302

1.28

4.29

1.8

1.7

1.28

1.52

mg/l

1.23

324

2614

Benign neoplasm of other and unspecified intrathoracic organs

118

826

1.60

4.27

2.5

1.7

1.17

1.30

mg/l

0.21

663

Viral encephalitis, not elsewhere classified/unspecified

206

1574

1.42

4.27

2.0

1.7

0.95

1.34

mg/l

1.91

162

1222

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

120

838

1.58

4.27

2.8

1.8

2.05

1.20

mg/l

0.50

102

656

Unequal limb length (acquired)

582

1.70

4.27

2.3

2.0

0.63

1.12

mg/l

2.38

399

Urticaria due to cold and heat

653

1.69

4.27

2.3

1.6

0.89

0.82

mg/l

0.16

495

Pneumoconiosis due to asbestos and other mineral fibres

162

1182

1.46

4.25

1.6

1.7

1.28

1.91

mg/l

2.31

122

956

Other and unspecified corneal deformities and disorders

336

2729

1.31

4.24

1.8

1.7

1.28

1.15

mg/l

0.17

257

2105

All dysplastic lesions of the cervix uteri, vagina or vulva

3537

32389

1.08

4.22

1.7

1.8

0.96

0.92

mg/l

0.37

2670

24649

Dermatopolymyositis

153

1121

1.50

4.22

2.2

1.8

1.30

1.24

mg/l

0.09

119

892

Other congenital malformations, not elsewhere classified

596

1.70

4.20

3.0

2.5

1.58

1.10

mg/l

0.33

449

Injury of blood vessels at lower leg level

324

2.02

4.20

2.0

1.7

1.35

1.55

mg/l

0.25

259

Motor- or nonmotor-vehicle accident in traffic area

533

1.75

4.20

1.6

2.0

0.87

1.16

mg/l

0.64

405

Other injuries of upper limb, level unspecified

134

961

1.54

4.19

2.0

1.8

1.22

1.30

mg/l

0.11

105

733

Mixed specific developmental disorders

173

1180

1.44

4.18

4.7

3.8

1.11

1.40

mg/l

0.56

137

812

Unspecified visual impairment (binocular)

159

1172

1.48

4.18

1.9

1.05

1.25

mg/l

0.54

122

916

Hypoplasia of dental enamel, prenatal , including avohilmo

277

2.07

4.18

13.6

4.9

3.61

2.36

mg/l

0.23

204

Peptic ulcer

668

1.64

4.17

2.3

1.6

2.17

1.39

mg/l

0.53

529

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

796

6978

1.19

4.16

1.9

1.7

0.97

0.83

mg/l

1.06

601

5281

conjunctival degenerations and deposits

211

1624

1.40

4.14

1.8

1.6

0.72

1.35

mg/l

8.27

169

1282

Malignant neoplasm of prostate

2593

14198

1.10

4.14

1.6

1.8

1.75

1.32

mg/l

4.11

2045

11303

Use of rasagiline

243

1909

1.37

4.13

1.9

1.6

1.76

1.43

mg/l

0.54

200

1514

Unspecified multiple injuries

245

2.21

4.11

1.8

0.96

1.42

mg/l

0.70

188

Varus deformity, not elsewhere classified

112

778

1.59

4.11

1.5

1.8

1.22

1.36

mg/l

0.17

596

Periodontal disease, other/unspecified

279

2226

1.34

4.11

1.8

1.7

1.28

1.19

mg/l

0.13

218

1727

Diastasis of muscle

100

680

1.64

4.11

1.7

1.6

0.93

1.17

mg/l

0.73

521

Acute hepatitis B

319

2.02

4.11

1.9

1.7

1.96

1.22

mg/l

0.42

253

Pigmented purpuric dermatosis

123

877

1.58

4.10

1.8

1.6

1.41

1.42

mg/l

0.01

684

Carcinoma in situ of skin, other sites/unspecified

155

1143

1.49

4.10

1.9

1.7

1.38

1.54

mg/l

0.36

127

913

Other lack of coordination

175

1315

1.45

4.10

2.0

1.8

1.30

1.27

mg/l

0.03

133

1027

Persistent delusional disorders

747

6514

1.19

4.09

1.8

1.20

1.19

mg/l

0.04

578

4991

Systemic sclerosis,strict definition

109

762

1.63

4.08

2.0

1.7

1.20

1.05

mg/l

0.31

601

Thalassaemia

267

2.12

4.08

6.0

2.4

1.16

mg/l

0.00

201

Benign neoplasm: Oesophagus

128

918

1.55

4.07

1.9

1.7

0.96

1.38

mg/l

2.09

737

Mild or no visual impairment, binocular

358

1.94

4.06

2.4

1.9

1.16

1.55

mg/l

0.43

280

Convergence insufficiency and excess

152

1121

1.49

4.06

2.4

1.8

0.68

1.09

mg/l

2.43

122

850

Melanocytic naevi of upper limb, including shoulder

252

1993

1.36

4.06

2.0

1.7

2.11

1.20

mg/l

0.61

193

1538

Other infestations, including avohilmo

186

1414

1.43

4.06

1.6

1.8

1.18

1.26

mg/l

0.16

153

1118

Other congenital malformations of upper alimentary tract

532

1.75

4.05

2.0

1.7

1.62

mg/l

0.00

410

Left hemicolectomy

213

1646

1.39

4.04

2.2

1.7

1.91

1.39

mg/l

1.98

184

1316

Calcification and ossification of muscle

167

2.49

4.04

2.2

1.7

1.29

1.79

mg/l

0.45

133

Benign neoplasm: Other parts of oropharynx

103

712

1.63

4.02

1.9

1.7

1.95

1.27

mg/l

0.57

575

Hyphaema and other vascular disorders of iris and ciliary body

201

1541

1.40

4.02

1.7

1.03

1.37

mg/l

1.81

156

1196

Contact with lifting and transmission devices, not elsewhere classified

177

1336

1.44

4.01

1.7

1.8

1.36

1.21

mg/l

0.19

133

1020

Optic neuritis

445

3740

1.26

4.01

1.9

1.8

0.78

0.98

mg/l

2.11

333

2822

Iridocyclitis in diseases classified elsewhere

195

1493

1.41

4.01

1.7

1.8

1.15

1.26

mg/l

0.23

148

1155

Other specified and unspecified disorders of conjunctiva

112

786

1.59

4.00

3.6

1.6

2.09

1.41

mg/l

0.27

618

Ebstein's anomaly

109

3.10

3.99

11.6

2.8

1.51

0.71

mg/l

1.02

Other and unspecified medical devices associated with adverse incidents

409

1.89

3.99

2.2

1.8

1.70

1.54

mg/l

0.09

331

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

374

1.89

3.99

3.8

1.7

0.88

0.98

mg/l

0.31

288

Aphakia

129

918

1.50

3.93

1.7

1.6

1.61

1.34

mg/l

0.26

100

732

Other/unspecified mastoiditis and related conditions

337

1.94

3.93

1.8

2.03

1.41

mg/l

0.23

268

Complications following abortion and ectopic and molar pregnancy

337

2764

1.30

3.93

1.7

1.8

1.19

1.13

mg/l

0.10

252

2164

Villonodular synovitis (pigmented)

573

1.69

3.93

1.5

1.6

1.36

1.19

mg/l

0.18

439

Maternal care for cervical incompetence

406

3394

1.27

3.92

1.8

1.23

1.02

mg/l

0.80

318

2594

Open bite

537

4582

1.22

3.92

2.6

2.1

0.95

0.99

mg/l

0.12

398

3378

Burns and corrosions of multiple body regions

638

1.64

3.92

2.0

1.8

1.13

1.63

mg/l

1.12

500

Hypothermia

175

1323

1.43

3.88

1.6

1.9

1.93

1.42

mg/l

0.65

141

1040

Dementia in Alzheimer disease

1446

13320

0.89

3.87

1.5

1.6

1.87

1.70

mg/l

0.59

1111

10618

Combined immunodeficiencies

109

765

1.58

3.87

2.6

1.8

1.39

1.49

mg/l

0.11

610

Torsion of testis

151

1107

1.44

3.87

2.3

2.4

1.14

1.11

mg/l

0.04

100

765

Gilbert syndrome

535

1.71

3.87

1.8

1.74

1.23

mg/l

0.25

410

Malignant neoplasm of anus and anal canal, including Hilmo

125

898

1.53

3.86

2.0

1.6

2.07

1.14

mg/l

0.64

104

690

Alzheimer’s disease (undefined), excluding more controls

467

0.43

3.85

1.3

1.6

1.07

2.06

mg/l

2.61

365

Premature rupture of membranes

2448

16176

1.10

3.84

1.7

1.8

0.84

0.83

mg/l

0.07

1791

12085

Other congenital malformations of intestine, including avohilmo

118

843

1.55

3.83

2.9

2.1

0.91

1.21

mg/l

1.05

649

Renal cell carcinoma of kidney

268

2137

1.32

3.82

1.7

1.6

1.24

1.39

mg/l

0.49

211

1677

Meningitis, viral

358

1.92

3.81

1.5

1.7

0.58

1.02

mg/l

1.20

273

Benign neoplasm: Connective and other soft tissue, unspecified

123

886

1.53

3.80

1.8

1.6

0.87

1.22

mg/l

1.60

105

704

Other rupture of muscle

456

1.76

3.80

1.9

1.6

1.16

1.36

mg/l

0.26

360

Melanoma in situ

422

3545

1.25

3.79

2.2

1.7

1.70

1.45

mg/l

0.22

322

2806

Cholinergic urticaria

365

1.89

3.79

1.7

1.6

0.72

1.04

mg/l

0.75

281

Malignant neoplasm of oral cavity

306

2485

1.30

3.78

1.6

1.72

1.34

mg/l

0.72

239

1938

Nutritional marasmus

109

2.78

3.77

2.8

2.5

2.94

0.78

mg/l

0.88

Macular cyst

294

2385

1.31

3.77

1.6

1.8

1.28

1.36

mg/l

0.23

235

1881

Alopecia areata

290

2353

1.31

3.76

1.9

2.0

1.07

1.04

mg/l

0.07

221

1791

Benign neoplasm: Conjunctiva

320

2621

1.29

3.76

1.7

1.02

1.21

mg/l

0.76

229

2029

Acute hepatitis B, including avohilmo

327

1.94

3.76

1.9

1.7

1.96

1.22

mg/l

0.43

259

Other degenerative diseases of the basal ganglia

178

1360

1.42

3.76

1.4

1.7

1.51

1.53

mg/l

0.01

140

1079

Other localized connective tissue disorders

204

1589

1.39

3.75

2.2

1.8

0.94

1.18

mg/l

1.28

162

1222

Exposure to smoke, fire and flames

241

1912

1.34

3.74

1.9

1.04

1.21

mg/l

0.59

192

1480

Tic disorders

119

848

1.52

3.73

3.5

2.8

0.98

1.15

mg/l

0.31

606

Other secondary gout

239

2.17

3.73

2.4

1.7

1.48

1.70

mg/l

0.24

187

Juvenile rheumatoid arthirtis

215

1681

1.36

3.71

1.9

1.8

1.05

1.01

mg/l

0.09

181

1235

Arteriovenous malformation of cerebral vessels

117

842

1.55

3.69

1.9

1.6

1.07

1.22

mg/l

0.32

100

672

Perioral dermatitis

263

2119

1.33

3.68

2.0

1.8

0.72

0.97

mg/l

2.08

197

1602

Viral conjunctivitis

228

1806

1.35

3.66

1.9

1.7

0.98

1.06

mg/l

0.24

174

1392

Family history of other conditions

163

1233

1.43

3.66

1.8

1.03

1.15

mg/l

0.20

126

927

Other demyelinating diseases of the central nervous system

391

3278

1.26

3.65

1.8

0.87

0.94

mg/l

0.23

267

2479

Infliximab

212

1660

1.36

3.65

1.6

1.9

0.79

0.97

mg/l

0.46

143

1195

Cysts of oral region, not elsewhere classified

571

4932

1.20

3.64

2.0

1.8

1.12

1.22

mg/l

0.40

450

3789

Malignant neoplasm of cervix uteri, including Hilmo

255

2048

1.33

3.64

2.0

1.7

1.79

1.02

mg/l

1.31

204

1550

Qualitative platelet defects

286

2.03

3.64

4.6

2.0

1.87

1.01

mg/l

0.56

226

Other and unspecified disorders of pigmentation

561

1.67

3.63

2.0

1.7

0.66

1.27

mg/l

3.00

442

Hereditary erythropoietic porphyria

4.37

3.62

3.0

1.7

0.88

1.26

mg/l

—

Injury of cranial nerves

456

1.75

3.61

1.9

1.7

0.88

1.28

mg/l

1.09

358

Benign neoplasm: Pineal gland

168

2.40

3.61

1.9

1.8

0.63

1.05

mg/l

0.48

126

Chronic hepatitis NAS

139

1034

1.48

3.61

1.9

1.7

2.16

1.20

mg/l

1.78

114

808

Convergent concomitant strabismus

575

4972

1.20

3.60

2.2

1.9

1.08

1.05

mg/l

0.08

451

3717

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

140

2.55

3.59

1.5

1.7

0.87

1.77

mg/l

0.81

113

Haemorrhagic and haematological disorders of fetus and newborn

127

875

1.47

3.58

7.0

5.6

1.23

1.82

mg/l

1.14

633

Phakomatoses, not elsewhere classified

118

853

1.52

3.58

1.9

2.2

1.02

1.06

mg/l

0.05

648

Other proliferative retinopathy

339

1.89

3.58

1.6

1.8

1.09

1.21

mg/l

0.16

267

Short stature, not elsewhere classified

177

1249

1.39

3.58

5.2

4.3

2.13

1.35

mg/l

0.52

135

878

Occupant of heavy transport vehicle injured in other and unspecified transport accidents

402

1.80

3.56

1.6

1.8

0.87

1.42

mg/l

1.56

310

Abscess of external ear

147

1103

1.46

3.56

1.9

1.8

0.98

1.20

mg/l

0.82

109

838

Spina bifida

162

2.43

3.56

1.5

2.4

0.67

0.85

mg/l

0.48

126

Contact with other and unspecified heat and hot substances

498

1.71

3.56

1.8

1.22

1.35

mg/l

0.11

384

Exposure to unspecified smoke, fire and flames

103

729

1.57

3.54

2.0

1.8

1.31

1.51

mg/l

0.27

552

Congenital malformations of uterus and cervix

236

1889

1.34

3.54

1.8

0.85

mg/l

0.02

186

1417

Injury of urinary and pelvic organs

199

1553

1.37

3.53

2.0

1.8

1.92

1.24

mg/l

1.15

153

1192

Chondromalacia

281

2292

1.31

3.51

1.7

1.8

0.90

1.13

mg/l

0.49

206

1786

Respiratory tuberculosis, confirmed, including avohilmo

164

1244

1.41

3.51

2.2

1.7

1.23

1.50

mg/l

0.79

129

992

Operations 1 for CAVS

206

2.21

3.51

8.5

3.0

1.94

1.58

mg/l

0.14

173

Calcific tendinitis

670

1.58

3.50

1.9

1.7

0.90

1.37

mg/l

1.49

521

Relapsing polychondritis

186

2.35

3.50

2.6

1.8

0.50

1.53

mg/l

1.84

154

Pemphigus

501

1.70

3.50

2.5

1.8

3.04

1.37

mg/l

0.71

406

Other secondary coxarthrosis

326

2696

1.28

3.49

1.7

1.58

1.21

mg/l

1.29

260

2095

Occupational exposure to risk-factors

312

2569

1.28

3.49

1.8

1.7

1.14

1.35

mg/l

0.63

247

2013

Chorioretinal inflammation

285

2327

1.30

3.49

2.3

1.7

1.10

1.18

mg/l

0.17

224

1790

Autism spe, excluding more controls

197

1523

1.35

3.48

2.1

0.75

1.05

mg/l

1.41

129

1061

Cerebral palsy

158

1198

1.42

3.46

3.1

2.3

2.93

1.12

mg/l

1.23

126

873

Other congenital malformations of respiratory system

144

2.59

3.46

2.2

3.0

1.17

1.27

mg/l

0.06

120

Other acquired deformities of ankle and foot

590

1.62

3.45

1.7

1.6

0.82

1.16

mg/l

1.14

447

Primary open-angle glaucoma

3216

29137

1.08

3.44

1.7

1.47

1.52

mg/l

0.29

2516

23146

Contact with sharp object, undetermined intent

245

1970

1.32

3.43

2.0

1.9

1.17

1.06

mg/l

0.20

182

1487

Malignant neoplasm of tongue, including Hilmo

234

1869

1.33

3.43

1.6

1.7

1.54

1.27

mg/l

0.63

187

1459

Common variable immunodeficiency

472

1.73

3.43

2.0

1.8

1.02

1.17

mg/l

0.25

368

Neuroendocrine tumor and carcinoma of lung

610

1.62

3.41

1.7

1.6

1.75

1.06

mg/l

1.16

487

Oher contracture of tendon (sheath)

221

2.09

3.40

1.6

1.5

0.69

1.46

mg/l

1.72

180

Other hyperalimentation

254

2.07

3.40

1.8

1.7

0.84

1.46

mg/l

1.06

207

Melanocytic naevi, other sites/unspecified

864

7714

1.16

3.39

2.0

1.8

1.05

1.11

mg/l

0.35

689

5912

Use of rotigotine

119

874

1.51

3.38

2.2

1.7

1.05

1.41

mg/l

1.20

104

701

Chylothorax

166

2.39

3.38

3.5

2.7

1.61

1.06

mg/l

0.70

132

Tic and related disorders

126

925

1.47

3.38

3.5

2.8

1.07

1.15

mg/l

0.12

651

Epidural haemorrhage

563

1.60

3.38

1.9

1.7

1.36

mg/l

0.00

438

Sequelae of other and unspecified effects of external causes

458

1.74

3.37

2.3

1.7

1.26

1.18

mg/l

0.08

365

Reduction defects of lower limb

164

2.31

3.37

1.8

2.3

1.31

1.27

mg/l

0.03

124

Congenital mitral valve regurgitation

109

2.72

3.37

6.8

3.4

1.31

1.79

mg/l

0.22

Allergic colitis

184

1422

1.36

3.36

2.1

3.4

1.05

1.40

mg/l

0.69

137

989

105

752

1.53

3.36

2.0

1.9

1.02

1.13

mg/l

0.18

564

Secondary parkinsonism

251

2028

1.31

3.35

1.9

1.7

1.40

1.44

mg/l

0.07

206

1589

Isolated proteinuria with specified morphological lesion

119

874

1.50

3.34

2.2

1.8

1.67

1.27

mg/l

0.35

100

690

Behçet disease

217

2.14

3.34

2.5

1.7

1.09

0.84

mg/l

0.18

168

Assault by sharp object

169

1302

1.39

3.34

1.9

1.75

1.03

mg/l

0.53

133

977

Other and unspecified injuries of forearm

612

1.60

3.33

2.0

0.83

1.17

mg/l

0.75

466

Secondary parkinsonism+Parkinsonism in other disease

255

2066

1.30

3.31

1.9

1.7

1.38

1.44

mg/l

0.10

210

1618

Dementia due to Parkinsons disease, excluding more controls

186

1444

1.35

3.31

1.7

1.5

1.56

1.87

mg/l

0.48

148

1144

Hypertrophy of tongue papillae

149

1136

1.43

3.29

1.8

1.7

1.12

1.31

mg/l

0.52

110

882

Meckel's diverticulum

443

1.72

3.28

1.8

0.86

1.30

mg/l

0.89

354

Rare circulating lymphoid malignancy

361

1.79

3.28

4.8

1.8

2.77

1.37

mg/l

1.03

288

Injury of blood vessels at hip and thigh level

249

2.05

3.28

2.3

1.6

1.09

1.25

mg/l

0.29

211

Neuroendocrine tumor and carcinoma of stomach

331

1.84

3.28

1.5

1.8

1.28

1.22

mg/l

0.04

266

Contact with sharp glass

383

3233

1.24

3.27

1.8

1.9

0.79

1.02

mg/l

2.02

273

2396

Other disorders of binocular movement

235

1895

1.32

3.27

2.3

2.0

0.80

1.11

mg/l

2.27

186

1461

Autoimmune polyglandular failure

113

2.86

3.27

3.0

1.7

0.67

1.56

mg/l

0.76

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

212

2.16

3.26

1.5

1.8

1.67

1.66

mg/l

0.00

178

Personality and behavioural disorders due to brain disease, damage and dysfunction

146

1107

1.42

3.25

1.9

1.8

1.19

1.38

mg/l

0.40

116

873

Motorcycle rider injured in noncollision transport accidents

279

2285

1.28

3.24

2.0

1.9

0.90

1.10

mg/l

0.89

227

1670

Chorioretinal scars

272

1.97

3.24

2.8

2.0

1.03

1.46

mg/l

0.65

217

Cardiovascular disorders originating in the perinatal period

170

2.15

3.24

4.5

6.7

1.13

2.44

mg/l

1.07

133

Other and unspecified disease of Bartholin gland

279

2296

1.29

3.24

1.7

1.8

1.08

1.11

mg/l

0.07

201

1800

Non-seminoma of testis

151

2.29

3.23

1.6

1.89

0.65

mg/l

1.38

105

Schizophrenia

1597

14718

1.11

3.23

1.8

1.11

1.08

mg/l

0.20

1217

11178

Burn and corrosion of wrist and hand

366

3082

1.24

3.23

1.9

0.89

1.12

mg/l

1.52

281

2311

Asymmetry of jaw

148

1128

1.42

3.22

1.9

0.90

0.95

mg/l

0.10

106

852

Mental retardation

355

2952

1.24

3.22

2.4

2.8

1.37

1.27

mg/l

0.27

296

2226

Acute appendicitis, with complications

1990

18505

1.10

3.21

1.9

1.8

1.46

1.22

mg/l

1.64

1558

14493

Benign neoplasm: Bronchus and lung

125

929

1.46

3.21

1.8

1.7

1.25

1.36

mg/l

0.17

100

749

Hereditary corneal dystrophies

330

2759

1.26

3.21

1.7

1.8

1.48

1.40

mg/l

0.13

251

2154

Horner syndrome

124

922

1.47

3.21

1.8

1.7

2.73

1.30

mg/l

0.45

737

Other congenital malformations of limb(s)

533

1.62

3.18

3.3

2.6

1.32

0.92

mg/l

0.55

383

Carcinoma in situ of vulva

103

749

1.54

3.18

1.8

1.7

0.87

1.04

mg/l

0.37

580

Primary open-angle glaucoma, strict

2629

24621

1.08

3.18

1.8

1.7

1.47

1.50

mg/l

0.16

2041

19552

Chronic suppurative otitis media

602

5268

1.18

3.17

2.5

1.8

1.16

1.34

mg/l

0.80

466

4009

Respiratory tuberculosis, confirmed

159

1220

1.39

3.17

2.3

1.7

1.25

1.48

mg/l

0.63

126

977

Benign neoplasm: Choroid

629

5535

1.18

3.16

2.0

1.8

1.01

1.32

mg/l

2.93

487

4340

Cyclic neutropenia

156

2.40

3.16

2.1

0.73

1.52

mg/l

0.93

120

Vascular dementia

830

7132

1.15

3.16

1.7

1.6

1.46

1.74

mg/l

2.05

698

5669

Intermittent heterotropia

560

4875

1.19

3.14

2.5

2.2

1.09

1.15

mg/l

0.22

418

3617

Pedal cyclist injured in noncollision transport accidents

1170

10654

1.13

3.14

1.8

1.9

1.17

1.12

mg/l

0.20

901

8109

Injury of blood vessels at abdomen, lower back and pelvis level

305

1.88

3.14

2.7

1.8

2.39

1.24

mg/l

0.48

239

Clubfoot

103

746

1.52

3.13

2.8

2.0

0.92

1.16

mg/l

0.57

571

Unspecified abortion

508

4412

1.20

3.13

2.0

1.7

0.92

0.90

mg/l

0.05

390

3443

Other and unspecified myoneural disorders

291

1.92

3.13

2.0

1.7

1.36

1.62

mg/l

0.23

231

Chronic suppurative otitis media, including avohilmo

730

6480

1.16

3.12

2.3

1.9

1.09

1.29

mg/l

1.20

565

4911

Respiratory tuberculosis, bacteriologically and histologically confirmed

164

1267

1.37

3.12

2.2

1.7

1.24

1.47

mg/l

0.67

130

1012

Other disorders of choroid

138

1045

1.42

3.11

2.4

1.7

1.19

1.38

mg/l

0.45

110

825

Pituitary-dependent Cushing's disease

246

2.03

3.11

1.5

1.8

0.73

1.15

mg/l

0.80

202

Complications peculiar to reattachment and amputation

489

1.65

3.10

2.6

1.7

1.48

1.38

mg/l

0.11

404

Increased muscle tone

548

1.62

3.10

1.8

2.0

1.41

1.51

mg/l

0.08

433

Other superficial injuries of ankle and foot

506

1.64

3.09

1.9

2.4

1.06

1.22

mg/l

0.22

390

Moderate visual impairment, monocular

354

1.80

3.09

1.8

1.7

1.09

1.28

mg/l

0.28

278

Malignant neoplasm of rectum, including Hilmo

1091

9902

1.13

3.07

1.7

2.07

1.27

mg/l

5.40

901

7742

Migraine without aura, drug-induced

123

923

1.46

3.07

2.5

1.7

0.92

mg/l

0.01

701

Bilateral cryptorchidism (undescended testicles)

2.61

3.06

2.6

6.1

1.36

2.05

mg/l

0.27

Melanocytic naevi of lower limb, including hip

453

3908

1.21

3.06

2.3

1.7

0.95

1.09

mg/l

0.68

341

3007

Alzheimer disease

2946

22339

0.93

3.06

1.6

1.7

1.78

1.61

mg/l

1.23

2311

17884

Polyglandular dysfunction

187

2.21

3.05

3.2

1.8

1.37

1.48

mg/l

0.06

147

Multifocal fibrosclerosis

469

1.68

3.04

1.8

1.6

1.37

1.49

mg/l

0.12

385

Malignant neoplasm of tonsil and base of tongue, including Hilmo

213

1711

1.32

3.03

1.7

1.66

1.25

mg/l

1.09

174

1334

Malignant neoplasm of eye and adnexa, including Hilmo

139

1056

1.41

3.03

2.0

1.8

1.35

1.24

mg/l

0.22

116

830

Vertical strabismus

333

2803

1.25

3.02

1.8

1.29

mg/l

0.00

258

2167

Endometriosis in cutaneous scar

262

1.93

3.01

2.2

1.7

0.68

0.87

mg/l

0.48

197

Bacterial meningitis

330

2780

1.25

2.98

1.7

1.8

1.12

1.20

mg/l

0.28

252

2146

Chronic mastoiditis

231

1877

1.30

2.98

1.7

1.20

1.46

mg/l

0.88

174

1473

LSIL lesion of the vulva

306

2568

1.26

2.98

2.0

1.7

0.95

0.87

mg/l

0.31

236

1975

Erythrasma

157

2.24

2.97

1.4

1.8

1.12

1.52

mg/l

0.37

131

Mental retardation, wide definition

373

3143

1.22

2.95

2.3

2.8

1.39

1.26

mg/l

0.35

308

2375

Exophthalmic conditions

110

815

1.48

2.95

1.7

1.42

1.30

mg/l

0.13

648

Drug-induced aplastic anaemia

109

2.61

2.95

1.9

1.8

2.33

1.60

mg/l

0.34

Neuroendocrine tumor and carcinoma of pancreas

488

1.64

2.94

1.8

1.7

1.48

1.07

mg/l

1.00

383

Other nonscarring hair loss

126

956

1.44

2.94

2.8

1.7

0.90

0.95

mg/l

0.10

728

Benign neoplasm: Heart

241

1.97

2.93

3.1

1.9

1.55

1.15

mg/l

0.26

205

Other drug-induced secondary parkinsonism

105

775

1.50

2.93

2.0

1.6

0.93

1.47

mg/l

2.39

621

Colon adenocarcinoma, helper endpoint

1186

10843

1.12

2.93

1.7

1.81

1.52

mg/l

1.90

974

8559

Benign neoplasm: Skin of lower limb, including hip

276

2293

1.27

2.93

1.9

1.7

1.23

1.14

mg/l

0.16

216

1763

Thyrotoxicosis with toxic single thyroid nodule

699

1.53

2.92

2.1

1.7

0.88

1.15

mg/l

1.08

552

Abnormality of red blood cells

407

1.71

2.92

1.9

2.0

1.81

1.38

mg/l

0.23

320

Alzheimer disease, including avohilmo

3407

24874

0.94

2.92

1.6

1.7

1.73

1.61

mg/l

0.89

2669

19852

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

2.98

2.92

3.6

2.2

1.02

1.39

mg/l

0.17

Congenital malformations of lung, including avohilmo

203

2.06

2.92

2.1

2.6

1.77

1.07

mg/l

0.24

162

Other conjunctival vascular disorders and cysts

221

1795

1.31

2.91

1.7

0.89

1.22

mg/l

2.88

178

1406

Other and unspecified thalassaemias

102

2.60

2.90

5.6

3.4

1.02

mg/l

0.00

Other congenital musculoskeletal deformities, including avohilmo

248

1.92

2.90

2.6

0.89

1.01

mg/l

0.15

183

Other and unspecified mental retardation

143

1088

1.39

2.90

2.6

3.9

1.47

1.70

mg/l

0.33

123

839

Granulomatous disorders of skin and subcutaneous tissue

270

2241

1.27

2.90

2.5

1.7

1.06

1.14

mg/l

0.24

210

1713

Acute mastoiditis

664

1.52

2.88

2.0

1.8

0.69

1.21

mg/l

2.16

518

Motor neuron disease (with DMD)

159

1235

1.35

2.88

1.8

1.6

1.25

1.51

mg/l

0.69

126

966

Effects of heat and light

547

1.57

2.85

2.2

1.7

1.48

1.44

mg/l

0.04

430

Certain zoonotic bacterial diseases, including avohilmo

290

2425

1.26

2.85

1.9

1.7

1.08

1.22

mg/l

0.52

239

1865

Female infertility, uterine origin

304

1.80

2.84

1.7

1.6

0.76

0.67

mg/l

0.28

221

LSIL lesion of the cervix uteri

1275

11731

1.11

2.84

1.7

1.8

0.92

0.87

mg/l

0.33

955

8887

Drug-induced thyroiditis

207

2.09

2.84

2.0

1.5

2.41

1.34

mg/l

0.56

162

Disorders of brain, other and unspecified

691

1.50

2.83

2.5

1.7

2.32

1.37

mg/l

0.70

546

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

395

1.71

2.82

1.7

1.01

1.27

mg/l

0.43

326

Other specified and unspecified disorders of iris and ciliary body

298

1.83

2.82

1.4

1.9

0.58

1.22

mg/l

1.81

238

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

369

1.72

2.82

2.7

1.7

1.64

1.25

mg/l

0.39

295

Perforation of oesophagus

353

1.74

2.81

2.0

1.7

2.20

1.49

mg/l

0.49

284

Aggressive periodontitis

223

1823

1.30

2.81

1.7

1.32

1.22

mg/l

0.12

169

1411

Disorder of thyroid, unspecified

134

1030

1.41

2.81

1.9

1.6

1.19

1.14

mg/l

0.07

815

Other acute skin changes due to ultraviolet radiation

315

2656

1.24

2.80

1.8

1.7

1.31

1.22

mg/l

0.21

250

2074

Other and unspecified atrophic disorders of skin

372

1.74

2.80

2.7

1.7

1.29

1.20

mg/l

0.13

309

Dissection of cerebral arteries, nonruptured

576

1.56

2.79

1.8

1.7

0.85

1.13

mg/l

0.64

454

Social disorders starting during childhood or adolescence

514

1.57

2.79

2.2

2.8

0.72

1.09

mg/l

0.93

353

Psoas tendinitis

402

1.68

2.78

1.5

1.7

0.70

1.09

mg/l

1.11

307

Degenerative diseases of the nervous system

3348

25367

0.94

2.78

1.6

1.7

1.73

1.58

mg/l

1.18

2638

20232

Palindromic rheumatism

100

736

1.48

2.77

1.9

1.5

0.97

1.39

mg/l

1.07

572

Contact with other hot metals

150

1171

1.37

2.77

2.2

1.9

1.59

1.35

mg/l

0.29

118

906

Malignant neoplasm of anus and anal canal

388

1.70

2.77

1.9

1.7

1.13

1.12

mg/l

0.01

305

Rheumatoid lung disease

341

1.77

2.76

2.5

1.7

2.35

1.64

mg/l

0.37

283

Other assisted single delivery

187

1505

1.33

2.76

1.8

1.9

0.98

0.66

mg/l

0.68

131

1132

Myositis ossificans

191

2.04

2.75

1.9

1.8

0.77

1.73

mg/l

1.87

161

Other specified transport accidents

435

1.64

2.75

1.6

2.2

1.28

1.08

mg/l

0.20

332

Enterohaemorrhagic Escherichia coli infection

133

2.32

2.74

2.2

1.9

0.97

0.93

mg/l

0.07

107

Undescended testicle

527

1.54

2.74

3.4

4.4

1.44

1.77

mg/l

0.38

383

Glaucoma-related operations

516

4529

1.18

2.74

1.6

1.8

1.34

1.54

mg/l

0.77

401

3573

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

188

1509

1.32

2.73

1.6

1.7

1.30

1.17

mg/l

0.34

151

1181

Other abnormal immunological findings in serum

205

1665

1.31

2.73

2.3

1.9

1.14

mg/l

0.01

162

1267

Unspecified severe protein-energy malnutrition

126

2.35

2.72

3.2

1.9

1.24

1.08

mg/l

0.21

Other zoonotic bacterial diseases, not elsewhere classified, including avohilmo

309

1.79

2.72

3.2

2.0

1.22

1.29

mg/l

0.07

252

Disorders of other and unspecified cranial nerves

372

1.70

2.71

2.1

1.7

0.98

1.42

mg/l

0.86

306

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

152

1179

1.35

2.71

3.8

2.8

1.74

1.36

mg/l

0.23

105

853

Tuberculosis

489

4265

1.18

2.71

2.1

1.7

1.36

1.59

mg/l

0.85

397

3350

Enduring personality changes

293

1.81

2.70

2.0

1.9

0.81

1.07

mg/l

0.44

225

Disorders of pituitary gland, other and/or unspecified

448

1.64

2.70

1.5

1.8

0.83

1.21

mg/l

1.27

351

Scarlet fever, including avohilmo

611

1.51

2.69

2.1

2.0

1.01

0.98

mg/l

0.04

458

Hip and thigh

194

2.06

2.69

2.8

2.6

0.99

1.06

mg/l

0.10

159

Malignant neoplasm, without specification of site

260

2154

1.25

2.68

1.8

1.6

2.09

1.39

mg/l

2.05

211

1709

Osteosarcoma, including Hilmo

246

1.88

2.68

6.9

1.8

2.06

1.22

mg/l

0.80

190

Combined immunodeficiency, unspecified

3.06

2.68

2.0

2.5

1.47

1.94

mg/l

—

Diabetic retinopathy, strict definition

1734

14364

1.09

2.68

1.9

2.0

1.22

1.31

mg/l

0.56

1377

11419

Crushing injury of lower leg

179

2.10

2.68

1.8

1.7

0.81

1.48

mg/l

1.00

150

Other disorders of amino-acid metabolism

325

1.75

2.68

5.5

1.6

10.13

1.10

mg/l

1.30

251

Myotonic dystrophy (Steinert)

232

1.93

2.68

1.5

1.9

1.12

1.28

mg/l

0.16

191

Contact with nonpowered hand tool

385

3314

1.21

2.67

1.9

1.8

1.08

1.26

mg/l

0.59

305

2514

Disorders of parathyroid gland, other and/or unspecified

550

1.57

2.67

2.0

1.6

2.03

1.29

mg/l

0.31

452

Dacryoadenitis

599

1.54

2.67

2.5

1.7

0.91

1.32

mg/l

1.11

484

Postpartum haemorrhage due to anatomy

1215

11191

1.11

2.67

1.8

1.10

0.94

mg/l

1.13

940

8448

Myopia

1379

12752

1.10

2.67

2.1

1.9

1.05

1.04

mg/l

0.03

1024

9570

Other specified/unspecified disorders of ear

248

1.90

2.67

1.9

1.7

0.79

1.13

mg/l

0.47

185

Toxic effect of organic solvents

262

1.84

2.67

1.6

1.9

0.70

1.31

mg/l

1.57

197

Secondary systemic amyloidosis

209

1.99

2.66

1.9

1.5

4.99

1.60

mg/l

0.61

160

Tick-borne viral encephalitis, including avohilmo

441

1.64

2.66

1.6

1.7

0.92

1.32

mg/l

0.90

350

Lagophthalmos

124

951

1.41

2.66

1.7

1.6

1.18

1.42

mg/l

0.75

766

Tuberculosis, IBD comorbidity

581

5136

1.16

2.66

2.1

1.8

1.58

1.55

mg/l

0.05

462

4047

Other and unspecified cicatricial alopecia

243

1.96

2.66

1.6

1.8

0.60

1.21

mg/l

1.53

199

Postpartum haemorrhage due to retained placenta

1445

13406

1.10

2.65

1.8

1.7

1.40

0.84

mg/l

6.37

1148

10219

Other and unspecified acute skin changes due to ultraviolet radiation

220

1803

1.28

2.65

1.8

1.7

1.42

1.39

mg/l

0.06

177

1425

Benign neoplasm: Skin of trunk

407

3524

1.20

2.65

2.1

1.7

0.94

1.21

mg/l

1.11

308

2716

Malignant neoplasm of renal pelvis, including Hilmo

722

1.46

2.64

1.7

2.25

1.46

mg/l

1.25

564

Exposure to ignition of highly flammable material

311

1.76

2.63

1.6

1.8

1.00

1.33

mg/l

0.63

242

Other adrenocortical overactivity

390

1.65

2.63

2.6

3.0

0.96

1.67

mg/l

0.99

277

Disorders of lacrimal system and orbit in diseases classified elsewhere

244

2028

1.27

2.62

1.9

1.7

1.01

1.08

mg/l

0.14

186

1565

Generalized epilepsy, strict definition

215

1761

1.29

2.62

1.8

2.1

1.66

1.21

mg/l

0.32

156

1331

Benign neoplasm: Nasopharynx

660

1.50

2.62

1.8

1.06

1.42

mg/l

1.19

520

Mitochondrial myopathy

321

1.77

2.62

2.1

1.9

2.78

1.05

mg/l

0.37

256

Atlantoaxial subluxation

457

1.60

2.62

1.9

1.6

1.49

1.37

mg/l

0.15

360

Congenital malformations of eye, ear, face and neck

610

5424

1.16

2.62

2.0

2.1

1.13

1.06

mg/l

0.20

453

4051

Respiratory and cardiovascular disorders specific to the perinatal period

150

1044

1.34

2.60

3.9

5.3

1.34

1.85

mg/l

0.90

103

735

Testicular dysfunction, other/unspecified

359

1.68

2.60

1.9

1.7

0.86

1.64

mg/l

1.52

270

Toxic effect of carbon monoxide

172

1379

1.33

2.59

2.0

1.7

0.93

1.28

mg/l

2.13

136

1061

Malignant neoplasm of bone and articular cartilage of limbs

304

1.76

2.59

3.7

1.8

2.03

1.22

mg/l

0.91

234

Other congenital malformations of urinary system

376

1.67

2.59

2.6

1.87

1.19

mg/l

0.45

285

Postdysenteric arthropathy

739

1.47

2.59

1.7

1.6

0.70

1.20

mg/l

3.47

570

Other chromosome abnormalities, not elsewhere classified

312

1.75

2.58

2.1

4.6

1.47

1.93

mg/l

0.23

240

Dissocial personality disorder

149

1174

1.35

2.57

2.0

1.9

1.41

1.06

mg/l

0.83

112

887

Malignant neoplasm of vulva

739

1.46

2.57

1.8

1.6

1.19

1.22

mg/l

0.06

584

Congenital malformations of lung

173

2.07

2.57

2.2

2.7

1.87

1.12

mg/l

0.23

141

Lesion of femoral nerve

587

1.53

2.56

1.8

1.6

1.35

1.03

mg/l

0.52

470

Graves ophthalmopathy, strict

224

1854

1.28

2.55

2.0

1.7

1.01

1.05

mg/l

0.07

170

1447

Typhoid and paratyphoid fevers, including avohilmo

495

1.58

2.55

2.0

1.7

0.98

1.21

mg/l

0.41

402

Labour and delivery complicated by fetal stress [distress]

2828

17422

1.07

2.54

1.8

1.7

0.85

0.75

mg/l

1.79

2126

12847

Unspecified parasitic disease, including avohilmo

604

1.51

2.54

2.1

1.7

1.28

1.34

mg/l

0.07

478

Organ-limited amyloidosis

320

1.71

2.54

2.0

1.6

1.90

1.57

mg/l

0.29

251

Severe visual impairment, monocular

104

784

1.44

2.54

1.8

1.7

1.07

1.40

mg/l

0.80

630

Telogen effluvium

160

2.15

2.54

5.7

1.8

1.39

1.13

mg/l

0.18

126

L02BX Other hormone antagonists and related agents

468

4103

1.18

2.53

1.5

1.7

2.33

1.77

mg/l

1.49

390

3297

Sequelae of burns, corrosions and frostbite

346

1.70

2.53

2.0

1.8

1.22

1.30

mg/l

0.06

265

Other congenital malformations of integument, including avohilmo

228

1.90

2.52

2.0

1.9

1.76

1.45

mg/l

0.24

186

Laparoscopic left hemicolectomy

166

1332

1.33

2.52

1.9

1.7

1.88

1.37

mg/l

0.81

137

1060

Benign neoplasm: Tonsil

123

951

1.40

2.52

1.7

0.91

1.26

mg/l

1.52

760

Exposure to uncontrolled fire, not in building or structure

160

2.13

2.52

1.9

2.1

1.47

mg/l

0.00

130

Unspecified parasitic disease

580

1.52

2.51

2.1

1.7

1.21

1.36

mg/l

0.20

459

Carcinoma in situ of other and unspecified genital organs

211

1742

1.29

2.51

1.8

1.7

0.91

1.00

mg/l

0.26

170

1340

Other nutritional anaemias

696

1.46

2.50

2.2

1.8

1.93

1.51

mg/l

0.44

548

Procedures for purposes other than remedying health state

247

2067

1.26

2.49

1.6

0.98

1.01

mg/l

0.07

185

1577

Congenital lactase deficiency

191

2.00

2.47

2.2

1.6

4.66

1.23

mg/l

0.45

146

Actinomycosis

243

1.82

2.47

1.8

1.7

1.62

1.24

mg/l

0.31

195

Drug-induced hypoglycaemia without coma

148

1171

1.34

2.47

1.8

1.7

1.28

1.35

mg/l

0.09

115

893

Bullous keratopathy

572

1.51

2.46

1.9

1.7

1.64

1.53

mg/l

0.08

468

Foreign body granuloma of skin and subcutaneous tissue

253

1.83

2.46

1.6

1.7

1.36

1.30

mg/l

0.04

201

Cyst of Bartholin Gland

396

3448

1.20

2.46

1.7

1.8

0.78

0.92

mg/l

1.10

318

2639

Congenital deformities of hip

166

1329

1.32

2.45

2.3

2.5

1.29

1.12

mg/l

0.21

125

977

Cysticercosis, including avohilmo

7.40

2.45

2.5

1.4

0.34

0.63

mg/l

—

Cysticercosis

7.40

2.45

2.5

1.4

0.34

0.63

mg/l

—

Maternal care for known or suspected disproportion

451

3964

1.18

2.45

1.7

0.70

0.67

mg/l

0.08

335

3043

Contact urticaria

238

1.85

2.43

1.9

1.7

0.53

0.79

mg/l

2.09

185

Right side

427

1.63

2.43

2.7

1.8

0.95

1.56

mg/l

1.97

358

Donors of organs and tissues

145

1148

1.34

2.43

2.0

1.6

1.02

1.05

mg/l

0.07

110

850

Thyrotoxicosis factitia

264

1.84

2.42

1.9

1.8

0.51

1.33

mg/l

2.44

218

Non-small cell lung cancer, squamous

350

3001

1.20

2.42

1.5

1.6

1.29

1.41

mg/l

0.43

297

2367

Malignant neoplasm of oesophagus

218

1800

1.27

2.42

1.7

2.59

1.34

mg/l

2.95

189

1415

Accessory breast

535

1.54

2.42

1.9

1.7

0.94

0.82

mg/l

0.19

409

Acquired pure red cell aplasia [erythroblastopenia]

302

1.73

2.41

3.0

1.7

0.80

1.62

mg/l

1.97

235

Galactorrhea

113

872

1.41

2.41

2.2

1.7

0.67

0.83

mg/l

0.63

660

Benign neoplasm: Connective and other soft tissue of trunk, unspecified

485

1.57

2.40

1.8

0.78

1.30

mg/l

1.98

369

Other disorders of thyroid

138

1091

1.36

2.40

1.9

1.7

1.23

1.17

mg/l

0.09

102

855

Thyrotropin deficiency

116

898

1.40

2.39

1.7

0.61

1.13

mg/l

2.75

695

Cholera, including avohilmo

132

2.19

2.39

1.7

1.5

1.38

1.44

mg/l

0.03

106

Pseudopolyposis of colon

200

1.93

2.38

1.5

1.8

0.77

0.83

mg/l

0.11

165

Motor neuron disease ALS

151

1198

1.32

2.38

1.8

1.6

1.21

1.52

mg/l

0.85

122

936

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

138

1089

1.35

2.37

1.7

1.8

0.77

1.29

mg/l

2.68

102

810

Ankyloglossia

132

1028

1.35

2.37

3.9

3.3

1.26

1.30

mg/l

0.04

721

Other specified and unspecified disorders of choroid

296

1.74

2.36

3.0

1.7

1.21

1.43

mg/l

0.24

239

Delivery

4497

22729

1.05

2.36

1.8

1.16

1.18

mg/l

0.15

3494

17225

Maxillary hypoplasia

248

1.82

2.36

2.0

2.3

0.72

1.16

mg/l

0.55

185

Other disorders of binocular vision

130

1021

1.36

2.35

2.2

1.9

1.03

0.97

mg/l

0.08

104

771

Alcohol induced polyneuropathy

724

1.44

2.34

2.0

1.6

1.75

1.40

mg/l

0.34

584

Other diseases caused by chlamydiae, including avohilmo

161

1299

1.32

2.34

2.0

1.8

1.31

0.82

mg/l

1.33

113

983

Ulcer of oesophagus, drug-induced

303

1.71

2.34

1.6

1.7

2.14

1.68

mg/l

0.24

242

Benign neoplasm: Endocrine pancreas

488

1.56

2.34

1.7

1.8

2.16

1.60

mg/l

0.40

388

Burn and corrosion, body region unspecified

436

1.58

2.33

1.9

0.89

1.26

mg/l

0.99

346

Inhalation and ingestion of other objects causing obstruction of respiratory tract

435

1.58

2.33

2.1

1.9

2.42

1.35

mg/l

0.31

356

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

555

1.51

2.33

1.4

1.7

1.18

1.24

mg/l

0.08

447

Hyperkinetic disorders (excl. ADHD)

160

1264

1.31

2.32

2.4

2.8

1.36

1.24

mg/l

0.09

110

892

Hyperprolactinaemia

358

3110

1.20

2.31

1.9

1.8

0.87

0.91

mg/l

0.12

282

2360

Pseudomembranous colitis

623

1.47

2.31

1.9

1.6

1.11

1.22

mg/l

0.11

493

Disorders of visual cortex

4.31

2.31

3.4

4.0

0.58

0.86

mg/l

—

114

882

1.38

2.31

2.0

1.7

1.14

1.36

mg/l

0.61

703

Apocrine sweat disorders, other sweat gland disorders

315

1.71

2.30

2.0

1.7

0.87

1.20

mg/l

0.70

260

Chromomycosis and phaeomycotic abscess, including avohilmo

315

1.71

2.30

1.9

1.04

1.13

mg/l

0.09

247

Thalassaemia trait

2.88

2.29

2.9

2.18

0.67

mg/l

—

Haematosalpinx/Haematoma of broad ligament

127

2.19

2.29

2.0

1.8

0.45

0.80

mg/l

1.55

101

Congenital malformations of nose, including avohilmo

164

2.01

2.28

1.9

2.3

0.66

1.12

mg/l

0.58

129

Other hypertrichosis

259

1.79

2.28

2.1

2.0

0.74

0.98

mg/l

0.30

204

Melanocytic naevi of other and unspecified parts of face

584

5236

1.15

2.28

2.1

1.8

1.08

1.07

mg/l

0.00

459

4028

Pectus excavatum

279

1.70

2.28

1.6

2.3

1.40

1.36

mg/l

0.03

194

Other obstructed labour

772

7026

1.13

2.27

1.7

1.8

0.95

0.91

mg/l

0.18

587

5376

Chronic respiratory disease originating in the perinatal period

118

2.17

2.27

3.8

7.2

2.13

1.96

mg/l

0.06

Myotonic disorders

608

1.47

2.27

1.5

1.9

1.21

1.09

mg/l

0.14

479

Colorectal neuroendocrine tumor and carcinoma

135

1071

1.35

2.27

1.8

1.6

0.88

0.96

mg/l

0.23

114

809

Effects of other deprivation

189

1.95

2.25

1.8

2.0

0.63

1.12

mg/l

1.19

139

Seronegative juvenile rheumatoid arthritis

172

1402

1.29

2.25

2.1

2.2

1.15

0.90

mg/l

0.65

133

1020

Congenital deformities of hip, including avohilmo

187

1534

1.28

2.25

2.2

2.4

1.28

1.11

mg/l

0.22

136

1129

MS-disease / Multiple Sclerosis

745

6772

1.13

2.25

1.8

0.81

0.93

mg/l

0.97

550

5128

Hereditary spherocytosis

180

1.94

2.25

2.0

2.3

1.30

0.84

mg/l

0.67

140

Nosocomial condition (hospital)

405

1.58

2.24

2.3

1.7

1.45

1.41

mg/l

0.05

328

Pectus excavatum, including avohilmo

337

1.63

2.24

1.6

2.7

1.24

1.27

mg/l

0.02

236

Congenital malformations of breast, including avohilmo

191

1579

1.28

2.23

1.9

1.8

0.86

0.82

mg/l

0.10

151

1184

Crohn's disease (strict) with PSC

121

2.22

2.23

3.3

1.9

0.63

0.69

mg/l

0.14

Tuberculosis, wide

595

5333

1.14

2.23

2.1

1.8

1.56

1.55

mg/l

0.01

473

4206

Distal bite

311

2651

1.20

2.21

2.6

0.92

1.16

mg/l

0.82

230

1923

LeFortI or BSSO operation

413

3635

1.18

2.21

1.6

1.8

0.67

0.90

mg/l

3.06

301

2731

Other deformity of hallux (acquired)

558

1.48

2.21

1.8

1.7

1.32

1.33

mg/l

0.00

433

Abnormal findings in cerebrospinal fluid

221

1.85

2.21

2.0

1.8

0.72

1.15

mg/l

0.57

179

Listeriosis, including avohilmo

349

1.63

2.21

1.9

1.7

1.87

1.43

mg/l

0.48

278

Pedestrian injured in other and unspecified transport accidents

126

997

1.36

2.21

1.8

1.20

1.19

mg/l

0.01

101

783

Tuberculosis, wide, including avohilmo

605

5431

1.14

2.21

2.0

1.8

1.54

mg/l

0.01

481

4283

Perichondritis of external ear

165

1345

1.30

2.20

1.8

1.7

1.35

1.41

mg/l

0.08

139

1059

Unspecified renal colic

468

1.54

2.19

2.1

1.6

0.99

1.22

mg/l

0.38

361

Blindness, monocular

715

1.42

2.19

2.3

1.7

1.73

1.46

mg/l

0.20

562

Idiopathic peripheral autonomic neuropathy

269

1.74

2.19

1.8

1.7

1.42

0.87

mg/l

0.82

219

Respiratory tuberculosis, confirmed and not-confirmed

419

3680

1.17

2.18

2.1

1.6

1.32

1.53

mg/l

0.73

330

2894

Hydatidiform mole

146

1178

1.33

2.18

1.5

1.6

0.77

0.84

mg/l

0.20

117

903

Frostbite

103

793

1.39

2.18

2.0

1.8

1.12

1.32

mg/l

0.35

604

Hereditary nephropathy, not elsewhere classified

207

1.89

2.18

4.5

1.6

0.96

1.21

mg/l

0.49

167

Respiratory tuberculosis

419

3681

1.17

2.17

2.1

1.7

1.32

1.53

mg/l

0.73

330

2895

Autoimmune hepatitis

744

1.42

2.17

2.3

1.8

2.24

1.21

mg/l

1.58

579

Amoebiasis, including avohilmo

621

1.45

2.17

1.9

2.0

0.83

1.47

mg/l

1.03

492

Syndactyly, including avohilmo

220

1.80

2.17

3.7

2.1

1.04

mg/l

0.01

163

Other or unspecified common variable immunodeficiency

263

1.77

2.17

2.1

1.8

0.85

0.89

mg/l

0.04

203

Superficial injury of ankle and foot, unspecified

392

1.59

2.17

1.9

2.0

0.78

1.02

mg/l

0.42

294

Granulosa cell carcinoma of ovary

319

1.67

2.16

1.7

1.08

mg/l

0.01

260

Other acantholytic disorders

199

1.89

2.16

4.4

1.7

0.81

1.35

mg/l

1.39

164

Disorders of puberty, all

138

1099

1.32

2.16

2.4

3.0

2.04

1.31

mg/l

0.34

740

Pemphigus vulgaris

161

2.03

2.15

3.1

1.9

4.55

1.48

mg/l

0.45

132

Benign neoplasm: Pelvic bones, sacrum and coccyx

336

1.65

2.15

1.7

1.8

2.75

1.09

mg/l

0.42

262

Other and unspecified neuropathies

302

1.68

2.15

1.9

2.0

1.33

1.63

mg/l

0.32

238

Panhypopituitarism

164

1340

1.30

2.14

1.9

1.46

1.38

mg/l

0.07

122

1041

Acne varioliformis

192

1.91

2.14

1.8

1.7

1.14

1.28

mg/l

0.12

160

Abnormal findings in peritoneal fluid saliva

262

1.73

2.13

1.4

1.8

2.57

1.10

mg/l

0.70

218

Mandibular retrognathia

614

5521

1.14

2.13

2.1

2.0

0.99

0.98

mg/l

0.02

458

4136

Failure in dosage during surgical and medical care

118

2.33

2.13

2.0

1.9

1.09

1.19

mg/l

0.07

Postinfectious hypothyroidism

420

1.57

2.12

1.7

1.6

1.29

1.24

mg/l

0.03

344

Mental and behavioural disorders due to cocaine

108

2.24

2.12

2.2

1.8

1.38

0.81

mg/l

0.64

Birth trauma

366

1.58

2.12

2.6

3.1

2.31

1.00

mg/l

0.43

268

Sleepwalking [somnambulism]

231

1.79

2.12

2.7

2.1

0.93

0.75

mg/l

0.22

166

Migraine with aura, drug-induced

109

853

1.38

2.12

1.9

1.7

0.87

0.99

mg/l

0.23

669

Infections of breast associated with childbirth

387

3405

1.18

2.12

1.9

1.7

1.09

0.84

mg/l

0.95

298

2551

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

122

968

1.35

2.11

1.5

1.7

0.65

0.84

mg/l

0.95

721

Unattended death

681

0.64

2.11

2.0

1.7

0.90

1.43

mg/l

1.85

538

Neonatal jaundice from other and unspecified causes

672

1.39

2.11

8.3

6.3

1.14

2.08

mg/l

1.65

489

Benign neoplasm: Skin of upper limb, including shoulder

195

1626

1.26

2.10

1.8

1.7

0.98

1.24

mg/l

1.28

153

1265

Coarctation of the aorta

718

1.40

2.10

6.6

3.1

2.28

1.26

mg/l

1.27

550

L02BB Anti-androgens

733

6666

1.12

2.10

1.6

1.7

2.35

1.74

mg/l

1.98

596

5350

Deep bite

1063

8627

1.10

2.10

2.3

2.1

0.97

1.11

mg/l

0.84

796

6392

Retinoschisis and retinal cysts

208

1743

1.25

2.10

1.7

1.06

1.36

mg/l

1.26

158

1389

Dementia in other diseases classified elsewhere

397

3492

1.17

2.09

1.8

1.7

1.40

1.55

mg/l

0.40

302

2764

Toxic erythema

116

2.17

2.09

1.7

1.6

0.60

0.92

mg/l

0.88

Acute myringitis

530

1.48

2.09

3.2

2.1

1.15

1.19

mg/l

0.05

416

Primary ovarian failure

202

1693

1.26

2.09

2.0

1.8

0.83

0.82

mg/l

0.03

150

1293

Certain zoonotic bacterial diseases

176

1454

1.28

2.09

1.7

1.11

1.28

mg/l

0.45

145

1131

Malignant neoplasm of tongue

173

1424

1.28

2.08

1.6

1.7

1.74

1.24

mg/l

1.04

136

1104

Monosomies and deletions from the autosomes, not elsewhere classified

168

1.91

2.08

3.8

5.5

1.51

2.15

mg/l

0.23

132

Other melanin hyperpigmentation

208

1746

1.25

2.07

1.8

1.7

1.24

1.36

mg/l

0.17

159

1361

Other and unspecified hypertrophic disorders of skin

541

1.48

2.07

1.8

1.09

1.19

mg/l

0.11

424

Actinomycosis, including avohilmo

296

1.66

2.07

1.7

1.53

1.14

mg/l

0.37

240

Meningococcal infection, including avohilmo

548

1.46

2.06

1.7

1.30

1.11

mg/l

0.24

418

Other and unspecified localized connective tissue disorders

242

1.77

2.06

2.5

1.8

1.29

1.17

mg/l

0.10

194

Foreign object accidentally left in body during surgical and medical care

258

1.74

2.05

1.7

2.27

1.18

mg/l

0.73

211

Adenocarcinoma and papillary adenocarcinoma of stomach

149

1836

0.79

2.05

1.6

3.80

1.34

mg/l

1.40

127

1453

Family history of mental and behavioural disorders

139

2.03

2.05

2.3

1.7

0.98

0.77

mg/l

0.36

106

Congenital malformations of breast

177

1467

1.28

2.05

1.9

1.7

0.88

0.81

mg/l

0.20

142

1101

Alzheimer’s disease (Late onset)

2045

17790

0.94

2.05

1.6

1.7

1.78

1.66

mg/l

0.75

1617

14230

Open wound of thorax

144

1166

1.31

2.05

1.9

1.8

1.16

1.18

mg/l

0.05

120

891

Subarachnoid haemorrhage

937

8636

1.11

2.04

1.9

1.7

1.65

1.37

mg/l

1.26

766

6766

Helminthiases, including avohilmo

410

3628

1.17

2.03

2.3

2.0

1.01

1.18

mg/l

0.66

307

2746

Injury of nerves at wrist and hand level

356

3121

1.18

2.03

1.8

1.9

0.97

1.10

mg/l

0.52

264

2389

Neuromyelitis optica

211

1.83

2.02

2.2

1.9

0.68

1.22

mg/l

0.95

168

Atypical virus infections of central nervous system, including avohilmo

726

1.40

2.01

1.6

1.7

1.31

1.22

mg/l

0.06

568

Adrenogenital disorders

315

1.63

2.01

1.9

0.79

1.40

mg/l

1.13

245

Lesion of medial popliteal nerve

317

1.65

2.00

1.9

1.6

0.61

1.30

mg/l

2.36

264

Cachexia

321

1.59

2.00

1.4

1.5

1.66

1.45

mg/l

0.28

260

Diseases caused by chlamydiae, including avohilmo

148

1208

1.30

1.99

2.0

1.8

1.36

0.80

mg/l

1.42

103

913

Other infiltrative disorders of skin and subcutaneous tissue

350

1.60

1.99

2.4

1.8

1.33

1.35

mg/l

0.01

277

Pityriasis rosea

640

1.42

1.98

2.1

1.8

1.67

1.17

mg/l

0.29

482

Intracranial and intraspinal phlebitis and thrombophlebitis

3.61

1.98

2.2

2.1

0.75

2.36

mg/l

—

Benign neoplasm: Appendix

107

843

1.36

1.98

1.9

1.7

1.24

1.35

mg/l

0.19

670

Hereditary motor and sensory neuropathy

640

1.42

1.97

1.6

1.8

1.02

1.30

mg/l

0.35

507

Guttate psoriasis

144

1174

1.30

1.97

1.7

1.11

1.08

mg/l

0.04

112

899

Toxic effect of other gases, fumes and vapours

416

1.53

1.97

2.4

1.8

1.11

1.32

mg/l

0.22

332

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

228

1.77

1.97

2.4

1.8

1.97

1.26

mg/l

0.60

197

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

112

2.19

1.96

2.8

2.3

1.77

1.70

mg/l

0.03

Benign neoplasm: Skin, unspecified

380

3357

1.17

1.96

1.7

0.97

1.20

mg/l

1.18

304

2602

Sunburn

150

1.99

1.96

1.8

1.6

1.09

0.84

mg/l

0.20

120

Unspecified contracted kidney

409

1.53

1.95

3.2

1.8

1.99

1.38

mg/l

0.79

324

Malignant neoplasm of base of tongue, including Hilmo

588

1.43

1.95

1.8

1.7

2.17

1.20

mg/l

1.14

465

Pathological resorption of teeth

354

3115

1.18

1.94

1.9

1.8

0.98

1.14

mg/l

0.74

280

2399

Acanthosis nigricans

236

1.73

1.94

1.9

1.8

0.75

1.27

mg/l

0.86

179

Undescended testis, unilateral

413

1.49

1.94

3.7

4.2

1.46

1.44

mg/l

0.01

295

Mucinosis of skin

2.58

1.94

1.7

2.6

0.21

0.81

mg/l

—

HSIL lesion of the cervix uteri, vagina or vulva

2288

21782

1.07

1.94

1.8

1.00

0.91

mg/l

0.64

1732

16609

Maternal care for (suspected) damage to fetus from alcohol

271

1.71

1.93

2.1

1.8

0.85

0.96

mg/l

0.11

204

Primary angle-closure glaucoma

379

3347

1.17

1.93

1.6

1.7

1.34

1.50

mg/l

0.44

302

2637

Protein-energy malnutrition of moderate and mild degree

686

1.40

1.93

4.0

2.1

1.72

1.43

mg/l

0.52

533

Bicornuate uterus

575

1.45

1.92

1.8

1.7

0.70

0.81

mg/l

0.29

433

Lymphangioma, anys site

582

1.43

1.92

3.4

2.3

2.02

1.30

mg/l

0.36

455

Relapsing fevers, including avohilmo

157

1.90

1.92

2.4

2.0

1.24

1.29

mg/l

0.03

130

Paranoid personality disorder

177

1477

1.26

1.92

1.9

1.7

0.99

1.15

mg/l

0.57

139

1138

Vascular dementia (mixed)

162

1334

1.27

1.92

1.6

1.7

1.54

1.68

mg/l

0.35

137

1078

Open wounds involving multiple body regions

286

1.65

1.91

2.1

2.0

0.97

1.26

mg/l

0.43

232

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

154

1267

1.28

1.91

1.9

2.20

1.12

mg/l

0.50

123

977

Malignant neoplasm of oesophagus, including Hilmo

287

2486

1.19

1.90

1.6

1.7

2.58

1.34

mg/l

2.36

245

1947

Unspecified hairloss

2.40

1.90

2.6

1.6

1.51

1.68

mg/l

0.07

Other mosquito-borne viral fevers

159

1.94

1.90

1.4

1.8

1.21

1.52

mg/l

0.24

131

Any dementia, excluding more controls

3551

23394

1.05

1.90

1.7

1.6

1.61

mg/l

0.00

2842

18604

Factitial dermatitis

387

1.55

1.89

2.2

1.7

0.82

1.29

mg/l

1.31

317

Unspecified transport accident

327

1.59

1.89

1.9

1.8

1.03

1.19

mg/l

0.20

257

Osteochondrosis of ankle, juvenile

445

1.49

1.89

1.5

2.1

0.94

mg/l

0.00

318

Other fusion of spine

129

2.07

1.88

1.6

1.5

0.70

1.42

mg/l

0.78

102

Atypical virus infections of central nervous system

716

1.39

1.88

1.6

1.7

1.31

1.23

mg/l

0.06

561

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

688

1.38

1.87

3.8

1.7

1.63

1.13

mg/l

0.94

515

Muscle wasting and atrophy, not elsewhere classified

403

1.51

1.87

1.9

1.6

1.17

1.68

mg/l

1.01

319

Central nervous system disorder causing precocious puberty

166

1.86

1.87

2.1

3.5

6.91

1.37

mg/l

0.51

111

Defect, injury or illness of face

121

2.07

1.86

1.9

2.0

0.46

0.92

mg/l

2.42

Vascular dementia (multiple infarctions)

788

0.70

1.86

2.1

1.6

1.83

1.72

mg/l

0.06

631

Malignant neoplasm of cervix uteri

170

1418

1.26

1.86

1.7

1.6

2.11

0.91

mg/l

1.46

135

1058

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

112

891

1.33

1.85

2.2

2.5

0.87

1.04

mg/l

0.42

652

Severe visual impairment, binocular

362

1.54

1.84

1.7

1.13

1.49

mg/l

0.58

291

Lumbosacral root disorders, not elsewhere classified

111

886

1.33

1.84

1.8

1.7

1.29

1.35

mg/l

0.05

719

Streptococcus and staphylococcus as the cause of diseases classified to other chapters, including avohilmo

577

1.42

1.84

4.1

1.8

1.84

1.37

mg/l

0.30

442

Cystic disease of liver

536

1.45

1.84

2.4

1.8

1.79

1.28

mg/l

0.82

435

Cerebral arteritis

192

1.80

1.83

1.7

1.8

0.82

1.23

mg/l

0.52

157

Burn and corrosion of ankle and foot

134

1094

1.30

1.82

1.8

1.22

1.42

mg/l

0.40

102

852

Acquired atrophy of ovary and fallopian tube

200

1.77

1.82

2.0

1.8

1.45

1.05

mg/l

0.52

152

Dyshidrosis [pompholyx]

160

1331

1.27

1.81

1.9

1.6

0.62

1.02

mg/l

3.36

102

1011

Melanoma in situ of lower limb, including hip

555

1.44

1.81

3.5

1.7

4.29

1.31

mg/l

0.50

457

Burn and corrosion of shoulder and upper limb, except wrist and hand

196

1659

1.23

1.81

1.9

1.34

1.26

mg/l

0.12

163

1263

Other diseases caused by chlamydiae

119

962

1.32

1.81

2.2

1.7

1.41

0.85

mg/l

1.25

757

Nightmares

184

1.80

1.9

1.6

0.74

1.04

mg/l

0.34

135

HSIL lesion of the vagina

146

1208

1.29

1.80

1.7

1.18

1.00

mg/l

0.41

120

937

Hypersensitivity pneumonitis due to organic dust

150

1242

1.28

1.80

2.1

1.7

1.08

1.35

mg/l

0.78

121

983

Benign neoplasm: Long bones of lower limb

310

2721

1.18

1.79

2.0

1.8

0.98

1.08

mg/l

0.40

242

2054

Overjet

198

1664

1.23

1.79

3.1

2.9

0.88

1.19

mg/l

0.80

147

1219

Graves ophthalmopathy

240

2072

1.21

1.79

2.0

1.7

1.01

1.06

mg/l

0.08

184

1614

Benign neoplasm of other and unspecified female genital organs

404

3610

1.16

1.78

1.7

1.8

0.90

1.11

mg/l

1.34

305

2795

Retrobulbar neuritis in diseases classified elsewhere

292

1.63

1.78

2.5

1.8

0.51

1.06

mg/l

1.47

219

IPHG Phlebitis and thrombophlebitis of intracranial venous sinuses

4.20

1.78

2.6

2.4

0.89

3.11

mg/l

—

Benign neoplasm: Central nervous system, other parts/unspecified

275

1.64

1.78

2.0

0.84

1.56

mg/l

1.38

228

Disorders of glossopharyngeal nerve

139

1.98

1.77

3.5

1.9

1.12

1.33

mg/l

0.20

121

All dysplastic lesions of the cervix uteri

3030

28635

1.05

1.77

1.7

1.8

0.96

0.90

mg/l

0.48

2278

21748

Other porphyria

124

2.05

1.76

2.1

1.6

0.54

1.07

mg/l

1.20

101

Acute alcohol intoxication ICD-9

275

2392

1.19

1.76

1.7

1.06

1.37

mg/l

2.01

220

1880

Acute nephritic syndrome

188

1591

1.24

1.76

2.2

1.8

1.66

1.31

mg/l

0.71

155

1236

Carcinoma in situ of breast

311

1.62

1.76

2.0

1.7

0.62

1.08

mg/l

1.30

258

Assault by hanging, strangulation and suffocation

202

1.76

1.75

1.9

0.45

1.07

mg/l

1.08

150

Aortic arch syndrome [Takayasu]

156

1.92

1.75

2.6

1.7

0.69

1.04

mg/l

0.72

123

Divergent concomitant strabismus

730

6719

1.11

1.75

1.9

1.18

1.10

mg/l

0.27

560

5100

Benign lipomatous neoplasm of of intra-abdominal organs

235

1.69

1.74

1.9

0.61

1.50

mg/l

2.09

194

Helminthiases

161

1345

1.26

1.74

2.9

1.9

1.29

1.22

mg/l

0.11

119

1047

Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere

3.47

1.74

3.0

2.4

2.21

1.64

mg/l

—

Nystagmus and other irregular eye movements

135

1109

1.29

1.74

2.0

2.3

1.33

1.27

mg/l

0.07

102

868

Benign neoplasm: Orbit, unspecified

480

1.46

1.74

2.7

1.8

1.21

1.34

mg/l

0.11

374

Atrioventricular septal defect

284

1.61

1.73

4.4

3.2

1.41

1.55

mg/l

0.11

225

Malignant neoplasm of gum, including Hilmo

670

1.37

1.73

1.7

1.6

1.88

1.19

mg/l

0.41

524

Drug-induced tremor

524

1.44

1.73

2.0

1.8

1.13

1.44

mg/l

0.58

425

Liposarcoma

513

1.43

1.73

1.9

1.7

1.30

1.22

mg/l

0.12

415

Acquired keratosis [keratoderma] palmaris et plantaris

335

1.56

1.73

2.0

1.6

0.90

1.47

mg/l

1.13

275

Scarlet fever

452

1.45

1.72

2.1

1.9

0.92

1.03

mg/l

0.13

336

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

235

1.66

1.71

1.5

1.7

1.68

1.14

mg/l

0.27

186

Meningococcal infection

540

1.41

1.70

1.7

1.33

1.12

mg/l

0.25

411

219

1.69

1.70

2.3

1.7

1.15

0.68

mg/l

0.61

168

Benign neoplasm: Skin of scalp and neck

240

2078

1.20

1.70

1.5

1.8

1.70

1.27

mg/l

0.77

188

1622

Other transepidermal elimination disorders

4.39

1.70

2.7

1.8

1.17

2.08

mg/l

—

Tick-borne viral encephalitis

353

1.53

1.70

1.7

0.80

1.32

mg/l

1.44

285

Colour vision deficiencies

258

1.60

1.70

1.5

1.9

2.46

1.54

mg/l

0.30

198

Glaucoma, exfoliation

958

8916

1.09

1.68

1.5

1.7

1.59

1.61

mg/l

0.05

774

7046

Other and unspecified granulomatous disorders of skin and subcutaneous tissue

278

1.61

1.68

1.7

1.6

1.03

1.17

mg/l

0.15

234

Universal erythroderma, KELA reimbursement

128

1050

1.29

1.68

1.7

1.31

1.20

mg/l

0.16

101

819

Labour and delivery complicated by umbilical cord complications

495

4489

1.13

1.68

1.7

1.8

0.80

0.86

mg/l

0.24

369

3406

Malignant neoplasm of tonsil and base of tongue

172

1450

1.24

1.68

1.7

1.77

1.19

mg/l

1.41

140

1133

Injury of nerves at shoulder and upper arm level

106

853

1.32

1.67

2.0

1.7

0.74

1.24

mg/l

3.20

663

Other congenital malformations of tongue, mouth and pharynx

111

888

1.30

1.67

4.7

3.1

2.24

1.36

mg/l

0.44

629

Evidence of alcohol involvement determined by blood alcohol level

140

1160

1.27

1.67

2.0

1.8

1.23

1.21

mg/l

0.03

118

884

Carcinoma in situ of oral cavity, oesophagus and stomach

405

1.48

1.66

1.6

1.7

1.31

1.51

mg/l

0.23

325

Human immunodeficiency virus [HIV] disease resulting in other conditions

151

1261

1.26

1.65

1.9

2.25

1.12

mg/l

0.51

120

971

Sequelae of malnutrition and other nutritional deficiencies

149

1.86

1.65

2.0

1.9

1.32

1.67

mg/l

0.37

126

Sequelae of poisoning by drugs, medicaments and biological substances

119

2.02

1.64

1.8

1.9

0.69

0.87

mg/l

0.30

Small plaque parapsoriasis

189

1.75

1.64

2.0

1.7

0.70

1.14

mg/l

1.41

156

Enteropathogenic Escherichia coli infection

264

1.62

1.63

1.6

1.9

1.05

1.21

mg/l

0.22

214

Superficial frostbite

519

1.41

1.63

2.0

1.8

0.61

1.26

mg/l

4.12

398

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

456

1.43

1.62

1.7

2.85

1.49

mg/l

1.03

361

Viral infections of central nervous system, not elsewhere classified/unspecified

107

866

1.31

1.62

1.7

1.06

1.11

mg/l

0.13

655

Disorders of amino-acid transport

111

2.01

1.62

4.2

1.5

8.52

0.78

mg/l

0.65

Vitreous prolapse

240

1.66

1.61

1.5

1.7

1.22

1.42

mg/l

0.11

194

Placental disorders

795

1.33

1.61

2.3

1.8

1.14

0.76

mg/l

0.79

589

Chromophobe cell carcinoma of kidney

382

1.49

1.61

1.7

1.21

1.14

mg/l

0.10

305

Anisometropia and aniseikonia

293

2584

1.17

1.61

2.2

1.9

1.19

1.24

mg/l

0.09

213

1986

Other specified/unspecified disorders of middle ear and mastoid

208

1.73

1.61

1.5

1.7

1.82

1.43

mg/l

0.17

169

Congenital musculoskeletal deformities of head, face, spine and chest

100

801

1.31

1.60

2.3

2.6

0.90

1.00

mg/l

0.18

591

Vitamin A deficiency

314

1.54

1.60

2.0

1.8

1.02

1.48

mg/l

0.76

255

Sleep terrors [night terrors]

150

1.83

1.60

1.9

2.5

0.60

1.49

mg/l

1.05

105

Anorexia

146

1222

1.26

1.59

2.4

1.8

1.49

1.18

mg/l

0.35

104

933

Hyperchylomicronaemia

127

1.92

1.59

3.9

1.4

3.32

1.06

mg/l

0.86

108

Other specified acquired deformities of limbs

340

1.51

1.59

1.9

2.1

1.61

1.23

mg/l

0.25

262

Malignant neoplasm of floor of mouth, including Hilmo

564

1.38

1.58

1.8

1.7

1.75

1.18

mg/l

0.75

446

Findings of drugs and other substances, not normally found in blood

298

1.56

1.58

1.8

1.45

1.36

mg/l

0.07

234

Other and unspecified nonscarring hair loss

709

1.35

1.58

2.0

1.7

0.83

1.00

mg/l

0.29

540

Human immunodeficiency virus [HIV] disease, including avohilmo

171

1452

1.23

1.58

1.9

2.13

1.11

mg/l

0.53

137

1113

Malignant neoplasm of vagina

168

1.80

1.57

1.6

1.8

1.52

1.41

mg/l

0.09

139

Malignant neoplasm of rectum

859

7987

1.09

1.57

1.6

1.7

2.16

1.28

mg/l

4.66

710

6263

Malignant neoplasm of adrenal gland

324

1.53

1.57

2.7

2.0

1.05

0.86

mg/l

0.37

255

Precocious central puberty

435

1.44

1.56

1.7

2.3

3.66

0.99

mg/l

0.53

312

Acrodermatitis continua

144

1.86

1.56

1.4

1.7

0.70

1.39

mg/l

0.77

114

Mastocytosis

429

1.46

1.56

1.9

2.0

1.08

1.74

mg/l

0.56

348

Juvenile Open Angle Glaucoma

437

1.45

1.55

2.0

1.7

0.72

0.94

mg/l

0.61

340

Sexual assault by bodily force

193

1.73

1.55

1.8

0.74

1.01

mg/l

0.25

142

Embedded and impacted teeth

2926

22830

1.05

1.54

2.0

1.9

1.02

1.01

mg/l

0.10

2138

16466

Other congenital malformations of female genitalia

701

1.34

1.54

1.8

1.9

0.75

0.85

mg/l

0.23

511

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS